source,citation,relation,ID,title,authors,journal,year,fulltext_online_link,fulltext_location
11215168.pdf,"Assaad, F., T. Bektimirov, and K. L. Esteves. 1984. Influenza—world experience, p. 5–38. In C. H. Stuart-Harris (ed.), The molecular virology and epidemiology of influenza. Academic Press, London.",references,NOT found in MAS
11215168.pdf,"Belshe, R. B., E. Burke, F. Newman, R. L. Cerruti, and I. S. Sim. 1989. Resistance of influenza A virus to amantidine and rimatidine: result of one decade of surveillance. J. Infect. Dis. 159:430–435.",references,NOT found in MAS
11215168.pdf,"Bergogne-Berezin, E. 1988. Pharmacokinetics of antibiotics in respiratory secretions, p. 608–631. In J. Pennington (ed.), Respiratory infections; diagnosis and management. Raven Press, New York, N.Y.",references,NOT found in MAS
11215168.pdf,"Burnet, F. M. 1948. Mucins and mucoids in relation to influenza virus action. Aust. J. Exp. Biol. Med. Sci. 26:381–387.",references,10.1038/icb.1948.38,MUCINS AND MUCOIDS IN RELATION TO INFLUENZA VIRUS ACTION,"[[u'FM', u'', u'Burnet']]",Immunology and Cell Biology,1948,"[u'http://dx.doi.org/10.1038/icb.1948.38', u'http://www.nature.com/doifinder/10.1038/icb.1948.38']",./output/11215168.pdf/10.1038~icb.1948.38
10.1038/icb.1948.38,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/11215168.pdf/citedby/7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
10.1038/icb.1948.38,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf'],./output/11215168.pdf/citedby/11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071
10.1038/icb.1948.38,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.1038/icb.1948.38,"Varghese, J., , Development of neuraminidase inhibitors as anti-influenza virus drugs, Drug Development Research, 1999",cited-by,10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6,Development of neuraminidase inhibitors as anti-influenza virus drugs,"[['Joseph', 'N.', 'Varghese']]",Drug Development Research,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291098-2299%28199903/04%2946%3A3/4%3C176%3A%3AAID-DDR4%3E3.0.CO%3B2-6'],
10.1038/icb.1948.38,"Kuhn, R., Brossmer, R., , Über das durch Viren der Influenza-Gruppe spaltbare Trisaccharid der Milch, European Journal of Inorganic Chemistry, 1959",cited-by,10.1002/cber.19590920729,Über das durch Viren der Influenza-Gruppe spaltbare Trisaccharid der Milch,"[['Richard', '', 'Kuhn'], ['Reinhard', '', 'Brossmer']]",European Journal of Inorganic Chemistry,1959,[u'http://doi.wiley.com/10.1002/cber.19590920729'],./output/11215168.pdf/citedby/10.1002~cber.19590920729
10.1038/icb.1948.38,"Colman, P., , Zanamivir: an influenza virus neuraminidase inhibitor, Expert Review of Anti-infective Therapy, 2005",cited-by,10.1586/14787210.3.2.191,Zanamivir: an influenza virus neuraminidase inhibitor,"[['PM', '', 'Colman']]",Expert Review of Anti-infective Therapy,2005,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.3.2.191'],
10.1038/icb.1948.38,"Sidwell, R., Smee, D., Bailey, K., et. al, Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice, International Immunopharmacology, 2001",cited-by,10.1016/S1567-5769(01)00058-3,Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice,"[['Robert', 'W', 'Sidwell'], ['Donald', 'F', 'Smee'], ['Kevin', 'W', 'Bailey'], ['Roger', 'A', 'Burger']]",International Immunopharmacology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1567576901000583', u'http://linkinghub.elsevier.com/retrieve/pii/S1567576901000583']",
10.1038/icb.1948.38,"Stickl, H., Böcker, H., , Wirkungen des Influenzavirus, European Journal of Pediatrics, 1958",cited-by,10.1007/BF00435892,Wirkungen des Influenzavirus,"[['H.', '', 'Stickl'], ['H.', '', 'B\xc3\xb6cker']]",European Journal of Pediatrics,1958,"[u'http://www.springerlink.com/content/u2871w6k80249312', u'http://www.springerlink.com/index/10.1007/BF00435892', u'http://www.springerlink.com/index/pdf/10.1007/BF00435892']",./output/11215168.pdf/citedby/10.1007~BF00435892
10.1038/icb.1948.38,"Springer, G., , Über fucosehaltige Mucine vorwiegend entodermalen Ursprungs mit Blutgruppen- und anderen biologischen Eigenschaften, Journal of Molecular Medicine-jmm, 1955",cited-by,10.1007/BF01467964,Über fucosehaltige Mucine vorwiegend entodermalen Ursprungs mit Blutgruppen- und anderen biologischen Eigenschaften,"[['Georg', 'F.', 'Springer']]",Journal of Molecular Medicine-jmm,1955,"[u'http://www.springerlink.com/content/un4267084g72617m', u'http://www.springerlink.com/index/10.1007/BF01467964', u'http://www.springerlink.com/index/pdf/10.1007/BF01467964']",./output/11215168.pdf/citedby/10.1007~BF01467964
10.1038/icb.1948.38,"Stickl, H., Aufmkolk, H., , Neuramins�urehaltige K�rpersubstanzen in ihrer Wirkung auf das Bakterienwachstum: Ein Beitrag �ber Natur und Vorkommen unspezifischer Resistenzfaktoren, European Journal of Pediatrics, 1961",cited-by,10.1007/BF00436270,Neuramins�urehaltige K�rpersubstanzen in ihrer Wirkung auf das Bakterienwachstum: Ein Beitrag �ber Natur und Vorkommen unspezifischer Resistenzfaktoren,"[['H.', '', 'Stickl'], ['H.', '', 'Aufmkolk']]",European Journal of Pediatrics,1961,"[u'http://www.springerlink.com/index/10.1007/BF00436270', u'http://www.springerlink.com/index/pdf/10.1007/BF00436270']",./output/11215168.pdf/citedby/10.1007~BF00436270
10.1038/icb.1948.38,"Stary, Z., , Mucosaccharides and glycoproteins, Reviews of Physiology Biochemistry and Pharmacology, 1959",cited-by,10.1007/BF02269582,Mucosaccharides and glycoproteins,"[['Z.', '', 'Stary']]",Reviews of Physiology Biochemistry and Pharmacology,1959,"[u'http://www.springerlink.com/content/f019g333167127x0', u'http://www.springerlink.com/index/10.1007/BF02269582']",./output/11215168.pdf/citedby/10.1007~BF02269582
10.1038/icb.1948.38,"LAURELL, A., , INHIBITOR CAPACITY OF SOME PURIFIED HUMAN SERUM PROTEINS ON HEMAGGLUTINATION BY INFLUENZA VIRUS, Acta Pathologica Microbiologica Scandinavica, 2009",cited-by,10.1111/j.1699-0463.1960.tb01132.x,INHIBITOR CAPACITY OF SOME PURIFIED HUMAN SERUM PROTEINS ON HEMAGGLUTINATION BY INFLUENZA VIRUS,"[['ANNA-BRITA', '', 'LAURELL']]",Acta Pathologica Microbiologica Scandinavica,2009,[u'http://doi.wiley.com/10.1111/j.1699-0463.1960.tb01132.x'],./output/11215168.pdf/citedby/10.1111~j.1699-0463.1960.tb01132.x
10.1038/icb.1948.38,"Lal, S., Chow, V., , Avian Influenza H5N1 Virus: An Emerging Global Pandemic, , 2007",cited-by,10.1159/000096691,Avian Influenza H5N1 Virus: An Emerging Global Pandemic,"[['Sunil', 'K.', 'Lal'], ['Vincent', 'T. K.', 'Chow']]",,2007,"[u'http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=96691&Ausgabe=0&ProduktNr=232155&filename=96691.pdf', u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000096691']",./output/11215168.pdf/citedby/10.1159~000096691
10.1038/icb.1948.38,"Stickl, H., , Über die Freisetzung von bakterienfördernden Substanzen aus receptorhaltigen Materialien des Körpers durch Influenza-A-Virus, Medical Microbiology and Immunology, 1962",cited-by,10.1007/BF02161329,Über die Freisetzung von bakterienfördernden Substanzen aus receptorhaltigen Materialien des Körpers durch Influenza-A-Virus,"[['H.', '', 'Stickl']]",Medical Microbiology and Immunology,1962,"[u'http://www.springerlink.com/index/m115pk017411q793.pdf', u'http://www.springerlink.com/content/m115pk017411q793', u'http://www.springerlink.com/index/10.1007/BF02161329', u'http://www.springerlink.com/index/pdf/10.1007/BF02161329']",./output/11215168.pdf/citedby/10.1007~BF02161329
10.1038/icb.1948.38,"Deibel, R., , Virushämagglutination, Journal of Molecular Medicine-jmm, 1957",cited-by,10.1007/BF01482155,Virushämagglutination,"[['Rudolf', '', 'Deibel']]",Journal of Molecular Medicine-jmm,1957,"[u'http://www.springerlink.com/content/g103u3v326332347', u'http://www.springerlink.com/index/10.1007/BF01482155', u'http://www.springerlink.com/index/pdf/10.1007/BF01482155']",./output/11215168.pdf/citedby/10.1007~BF01482155
10.1038/icb.1948.38,"Tongeren, H., , Biochemical properties and the production of toxins and enzymes by Staphylococci isolated from cases of secondary pneumonia following influenza, Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology, 1954",cited-by,10.1007/BF02543708,Biochemical properties and the production of toxins and enzymes by Staphylococci isolated from cases of secondary pneumonia following influenza,"[['H.', 'A. E. Van', 'Tongeren']]",Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology,1954,"[u'http://www.springerlink.com/content/y86877l271104w1q', u'http://www.springerlink.com/index/10.1007/BF02543708', u'http://www.springerlink.com/index/pdf/10.1007/BF02543708']",./output/11215168.pdf/citedby/10.1007~BF02543708
10.1038/icb.1948.38,"Gravenstein, S., Drinka, P., Osterweil, D., et. al, Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1097/00130535-200511000-00001,Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population,"[['Stefan', '', 'Gravenstein'], ['Paul', '', 'Drinka'], ['Dan', '', 'Osterweil'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult'], ['Arvydas', '', 'Ambrozaitis'], ['Ruth', '', 'Kandel'], ['Ellen', '', 'Binder'], ['Janet', '', 'Hammond'], ['Janet', '', 'McElhaney'], ['Nancy', '', 'Flack'], ['Janet', '', 'Daly'], ['Oliver', '', 'Keene']]",Journal of The American Medical Directors Association,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00130535-200511000-00001'],
10.1038/icb.1948.38,"Groth, S., , Nasal mucus and influenza viruses. I. The haemagglutinin inhibitor in nasal secretions, Journal of Hygiene, 1952",cited-by,10.1017/S0022172400019756,Nasal mucus and influenza viruses. I. The haemagglutinin inhibitor in nasal secretions,"[['S.', 'Fazekas De St', 'Groth']]",Journal of Hygiene,1952,[u'http://www.journals.cambridge.org/abstract_S0022172400019756'],./output/11215168.pdf/citedby/10.1017~S0022172400019756
10.1038/icb.1948.38,"Horsfall, F., , FACTORS CONCERNED WITH VIRAL PROLIFERATION IN VIVO, Annals of The New York Academy of Sciences, 1952",cited-by,10.1111/j.1749-6632.1952.tb39967.x,FACTORS CONCERNED WITH VIRAL PROLIFERATION IN VIVO,"[['Frank', 'L.', 'Horsfall']]",Annals of The New York Academy of Sciences,1952,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1749-6632.1952.tb39967.x'],
11215168.pdf,"Couch, A. B. 1993. Advances in influenza virus vaccine research. Ann. N. Y. Acad. Sci. 685:803–812.",references,10.1111/j.1749-6632.1993.tb35946.x,Advances in Influenza Virus Vaccine Research,"[[u'ROBERT', u'B.', u'COUCH']]",Annals of The New York Academy of Sciences,1993,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1749-6632.1993.tb35946.x'],./output/11215168.pdf/10.1111~j.1749-6632.1993.tb35946.x
10.1111/j.1749-6632.1993.tb35946.x,"Nichol, K., Wuorenma, J., Sternberg, T., , Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens, , 1998",cited-by,"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","[['Kristin', 'L.', 'Nichol'], ['J.', '', 'Wuorenma'], ['T.', 'von', 'Sternberg']]",,1998,"[u'http://archinte.highwire.org/cgi/reprint/158/16/1769.pdf', u'http://archinte.ama-assn.org/cgi/reprint/158/16/1769.pdf']","./output/11215168.pdf/citedby/13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens"
10.1111/j.1749-6632.1993.tb35946.x,"Belshe, R., Gruber, W., Mendelman, P., et. al, Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine, Journal of Pediatrics, 2000",cited-by,10.1016/S0022-3476(00)70097-7,"Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine","[['Robert', 'B.', 'Belshe'], ['William', 'C.', 'Gruber'], ['Paul', 'M.', 'Mendelman'], ['Iksung', '', 'Cho'], ['Keith', '', 'Reisinger'], ['Stan', 'L.', 'Block'], ['Janet', '', 'Wittes'], ['Dominick', '', 'Iacuzio'], ['Pedro', '', 'Piedra'], ['John', '', 'Treanor'], ['James', '', 'King'], ['Karen', '', 'Kotloff'], ['David', 'I.', 'Bernstein'], ['Frederick', 'G.', 'Hayden'], ['Ken', '', 'Zangwill'], ['Lihan', '', 'Yan'], ['Mark', '', 'Wolff']]",Journal of Pediatrics,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0022347600700977', u'http://linkinghub.elsevier.com/retrieve/pii/S0022347600700977']",./output/11215168.pdf/citedby/10.1016~S0022-3476(00)70097-7
10.1111/j.1749-6632.1993.tb35946.x,"Nichol, K., Baken, L., Nelson, A., , Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease, , 1999",cited-by,"5884544Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease","Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease","[['Kristin', 'L.', 'Nichol'], ['Leslie', '', 'Baken'], ['Andrew', '', 'Nelson']]",,1999,"[u'http://www.separ.es/guia_epoc/gecarp/gepubli/publdoc/041-040-nicholkl-relation-between-influenza-vaccination-and-outpatient-visits.pdf', u'http://www.taiss.com/gepoc/gecarp/gepubli/publdoc/041-040-nicholkl-relation-between-influenza-vaccination-and-outpatient-visits.pdf']","./output/11215168.pdf/citedby/5884544Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease"
10.1111/j.1749-6632.1993.tb35946.x,"Cox, R., Brokstad, K., Ogra, P., , Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines, Scandinavian Journal of Immunology, 2004",cited-by,10.1111/j.0300-9475.2004.01382.x,"Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines","[['R.', 'J.', 'Cox'], ['K.', 'A.', 'Brokstad'], ['P.', '', 'Ogra']]",Scandinavian Journal of Immunology,2004,"[u'http://biologie.univ-mrs.fr/upload/p270/3_La_grippe.pdf', u'http://cmbi.bjmu.cn/news/report/2005/flu/54.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.0300-9475.2004.01382.x']",./output/11215168.pdf/citedby/10.1111~j.0300-9475.2004.01382.x
10.1111/j.1749-6632.1993.tb35946.x,"Ott, G., Barchfeld, G., Nest, G., , Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59, Vaccine, 1995",cited-by,10.1016/0264-410X(95)00089-J,Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59,"[['Gary', '', 'Ott'], ['Gail', 'L.', 'Barchfeld'], ['Gary', 'Van', 'Nest']]",Vaccine,1995,"[u'http://www.sciencedirect.com/science/article/pii/0264410X9500089J', u'http://linkinghub.elsevier.com/retrieve/pii/0264410X9500089J']",
10.1111/j.1749-6632.1993.tb35946.x,"Lee, P., Matchar, D., Clements, D., et. al, Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults, , 2002",cited-by,5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,"[['Patrick', 'Y.', 'Lee'], ['David', 'B.', 'Matchar'], ['Dennis', 'A.', 'Clements'], ['Joel', '', 'Huber'], ['John', 'D.', 'Hamilton'], ['Eric', 'D.', 'Peterson']]",,2002,[u'http://www.pforster.ch/yvaccin/DocumVaccinInfluenzaBAG/Lee_2002.pdf'],./output/11215168.pdf/citedby/5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults
10.1111/j.1749-6632.1993.tb35946.x,"Babai, I., Barenholz, Y., Zakay-Rones, Z., et. al, A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin–neuraminidase and IL2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains, Vaccine, 2001",cited-by,10.1016/S0264-410X(01)00326-7,A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin–neuraminidase and IL2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains,"[['Ilan', '', 'Babai'], ['Yechezkel', '', 'Barenholz'], ['Zichria', '', 'Zakay-Rones'], ['Evgenia', '', 'Greenbaum'], ['Sarit', '', 'Samira'], ['Igal', '', 'Hayon'], ['Mark', '', 'Rochman'], ['Eli', '', 'Kedar']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X01003267', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X01003267']",
10.1111/j.1749-6632.1993.tb35946.x,"Kati, W., Montgomery, D., Carrick, R., et. al, In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.1014-1021.2002,"In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication","[['Warren', 'M.', 'Kati'], ['Debra', '', 'Montgomery'], ['Robert', '', 'Carrick'], ['Larisa', '', 'Gubareva'], ['Clarence', '', 'Maring'], ['Keith', '', 'McDaniel'], ['Kevin', '', 'Steffy'], ['Akhteruzzaman', '', 'Molla'], ['Frederick', '', 'Hayden'], ['Dale', '', 'Kempf'], ['William', '', 'Kohlbrenner']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/1014.pdf', u'http://journals.pasteur.ac.ir/AAC02/46(4)/1014.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.1014-1021.2002']",./output/11215168.pdf/citedby/10.1128~AAC.46.4.1014-1021.2002
10.1111/j.1749-6632.1993.tb35946.x,"O'Hagan, D., Ott, G., Nest, G., , Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles, Molecular Medicine Today, 1997",cited-by,10.1016/S1357-4310(96)10058-7,Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles,"[['Derek', 'T.', ""O'Hagan""], ['Gary', 'S.', 'Ott'], ['Gary', 'Van', 'Nest']]",Molecular Medicine Today,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1357431096100587', u'http://linkinghub.elsevier.com/retrieve/pii/S1357431096100587']",
10.1111/j.1749-6632.1993.tb35946.x,"Danenberg, H., BEN-YEHUDA, A., ZAKAY-RONES, Z., et. al, Dehydroepiandrosterone Treatment Is Not Beneficial to the Immune Response to Influenza in Elderly Subjects, Journal of Clinical Endocrinology & Metabolism, 1997",cited-by,10.1210/jc.82.9.2911,Dehydroepiandrosterone Treatment Is Not Beneficial to the Immune Response to Influenza in Elderly Subjects,"[['H.', 'D.', 'Danenberg'], ['A.', '', 'BEN-YEHUDA'], ['Z.', '', 'ZAKAY-RONES'], ['D.', 'J.', 'GROSS'], ['G.', '', 'FRIEDMAN']]",Journal of Clinical Endocrinology & Metabolism,1997,"[u'http://jcem.endojournals.org/cgi/reprint/82/9/2911.pdf', u'http://jcem.endojournals.org/cgi/doi/10.1210/jc.82.9.2911']",./output/11215168.pdf/citedby/10.1210~jc.82.9.2911
10.1111/j.1749-6632.1993.tb35946.x,"Casagrandi, R., Bolzoni, L., Levin, S., et. al, The SIRC model and influenza A, Mathematical Biosciences, 2006",cited-by,10.1016/j.mbs.2005.12.029,The SIRC model and influenza A,"[['Renato', '', 'Casagrandi'], ['Luca', '', 'Bolzoni'], ['Simon', 'A.', 'Levin'], ['Viggo', '', 'Andreasen']]",Mathematical Biosciences,2006,"[u'http://home.dei.polimi.it/casagran/pubs/a15.pdf', u'http://www.sciencedirect.com/science/article/pii/S0025556405002464', u'http://linkinghub.elsevier.com/retrieve/pii/S0025556405002464']",
10.1111/j.1749-6632.1993.tb35946.x,"Brett, I., Johansson, B., , Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system, Virology, 2005",cited-by,10.1016/j.virol.2005.06.006,"Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system","[['Ian', 'C.', 'Brett'], ['Bert', 'E.', 'Johansson']]",Virology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S004268220500334X', u'http://linkinghub.elsevier.com/retrieve/pii/S004268220500334X']",
10.1111/j.1749-6632.1993.tb35946.x,"Nichol, K., , Live attenuated influenza virus vaccines: new options for the prevention of influenza, Vaccine, 2001",cited-by,10.1016/S0264-410X(01)00143-8,Live attenuated influenza virus vaccines: new options for the prevention of influenza,"[['Kristin', 'L.', 'Nichol']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X01001438', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X01001438']",
10.1111/j.1749-6632.1993.tb35946.x,"NORIEGA, F., LOSONSKY, G., WANG, J., et. al, Further Characterization of DaroA DvirG Shigellaflexneri 2a Strain CVD 1203 as a MucosalShigellaVaccine and as a Live-Vector Vaccine for Delivering Antigens of EnterotoxigenicEscherichia coli, , 1996",cited-by,14063165Further Characterization of DaroA DvirG Shigellaflexneri 2a Strain CVD 1203 as a MucosalShigellaVaccine and as a Live-Vector Vaccine for Delivering Antigens of EnterotoxigenicEscherichia coli,Further Characterization of DaroA DvirG Shigellaflexneri 2a Strain CVD 1203 as a MucosalShigellaVaccine and as a Live-Vector Vaccine for Delivering Antigens of EnterotoxigenicEscherichia coli,"[['FERNANDO', 'R.', 'NORIEGA'], ['GENEVIEVE', '', 'LOSONSKY'], ['JIN', 'YUAN', 'WANG'], ['SAMUEL', 'B.', 'FORMAL'], ['ANDMYRON', 'M.', 'LEVINE']]",,1996,"[u'http://iai.asm.org/cgi/reprint/64/1/23.pdf', u'http://iai.highwire.org/cgi/reprint/64/1/23.pdf']",
10.1111/j.1749-6632.1993.tb35946.x,"Fleming, D., Elliot, A., , The impact of influenza on the health and health care utilisation of elderly people, Vaccine, 2005",cited-by,10.1016/j.vaccine.2005.04.018,The impact of influenza on the health and health care utilisation of elderly people,"[['Douglas', 'M.', 'Fleming'], ['Alex', 'J.', 'Elliot']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05004585', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/124.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05004585']",
10.1111/j.1749-6632.1993.tb35946.x,"Bryant, W., Ompad, D., Sisco, S., et. al, Determinants of influenza vaccination in hard-to-reach urban populations, Preventive Medicine, 2006",cited-by,10.1016/j.ypmed.2006.03.018,Determinants of influenza vaccination in hard-to-reach urban populations,"[['W.', 'K.', 'Bryant'], ['D.', 'C.', 'Ompad'], ['S.', '', 'Sisco'], ['S.', '', 'Blaney'], ['K.', '', 'Glidden'], ['E.', '', 'Phillips'], ['D.', '', 'Vlahov'], ['S.', '', 'Galea']]",Preventive Medicine,2006,"[u'http://projectviva.org/wp-content/uploads/2007/06/bryant_determinants%20of%20influenza%20vaccination.pdf', u'http://www.sciencedirect.com/science/article/pii/S0091743506001393', u'http://linkinghub.elsevier.com/retrieve/pii/S0091743506001393']",./output/11215168.pdf/citedby/10.1016~j.ypmed.2006.03.018
10.1111/j.1749-6632.1993.tb35946.x,"Bae, K., Choi, J., Jang, Y., et. al, Innovative vaccine production technologies: The evolution and value of vaccine production technologies, Archives of Pharmacal Research, 2009",cited-by,10.1007/s12272-009-1400-1,Innovative vaccine production technologies: The evolution and value of vaccine production technologies,"[['KyungDong', '', 'Bae'], ['JunYoul', '', 'Choi'], ['YangSuk', '', 'Jang'], ['SangJeom', '', 'Ahn'], ['ByungKi', '', 'Hur']]",Archives of Pharmacal Research,2009,"[u'http://www.springerlink.com/content/gq7gh55k5qm2121k', u'http://www.springerlink.com/index/gq7gh55k5qm2121k.pdf', u'http://www.springerlink.com/index/10.1007/s12272-009-1400-1', u'http://www.springerlink.com/index/pdf/10.1007/s12272-009-1400-1']",./output/11215168.pdf/citedby/10.1007~s12272-009-1400-1
10.1111/j.1749-6632.1993.tb35946.x,"Cianci, C., Krystal, M., , Development of antivirals against influenza, Expert Opinion on Investigational Drugs, 1998",cited-by,10.1517/13543784.7.2.149,Development of antivirals against influenza,"[['Christopher', '', 'Cianci'], ['Mark', '', 'Krystal']]",Expert Opinion on Investigational Drugs,1998,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.7.2.149'],./output/11215168.pdf/citedby/10.1517~13543784.7.2.149
10.1111/j.1749-6632.1993.tb35946.x,"Eyles, J., Williamson, E., Alpar, H., , Intranasal Administration of Influenza Vaccines: Current Status, Biodrugs, 2000",cited-by,10.2165/00063030-200013010-00005,Intranasal Administration of Influenza Vaccines: Current Status,"[['Jim', 'E.', 'Eyles'], ['E.', 'Diane', 'Williamson'], ['H.', 'Oya', 'Alpar']]",Biodrugs,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00063030-200013010-00005'],
10.1111/j.1749-6632.1993.tb35946.x,"Wyde, P., , Chemotherapy of respiratory viruses: prospects and challenges, Drug Resistance Updates, 1999",cited-by,10.1054/drup.1999.0091,Chemotherapy of respiratory viruses: prospects and challenges,"[['Philip', 'R.', 'Wyde']]",Drug Resistance Updates,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1368764699900912', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764699900912']",
10.1111/j.1749-6632.1993.tb35946.x,"Audsley, J., Tannock, G., , The role of cell culture vaccines in the control of the next influenza pandemic, Expert Opinion on Biological Therapy, 2004",cited-by,10.1517/14712598.4.5.709,The role of cell culture vaccines in the control of the next influenza pandemic,"[['J', 'M', 'Audsley'], ['G', 'A', 'Tannock']]",Expert Opinion on Biological Therapy,2004,[u'http://informahealthcare.com/doi/abs/10.1517/14712598.4.5.709'],./output/11215168.pdf/citedby/10.1517~14712598.4.5.709
10.1111/j.1749-6632.1993.tb35946.x,"Nichol, K., Tummers, K., Hoyer-Leitzel, A., et. al, Modeling Seasonal Influenza Outbreak in a Closed College Campus: Impact of Pre-Season Vaccination, In-Season Vaccination and Holidays/Breaks, PLOS One, 2010",cited-by,10.1371/journal.pone.0009548,"Modeling Seasonal Influenza Outbreak in a Closed College Campus: Impact of Pre-Season Vaccination, In-Season Vaccination and Holidays/Breaks","[['Kristin', 'L.', 'Nichol'], ['Kate', '', 'Tummers'], ['Alanna', '', 'Hoyer-Leitzel'], ['Jennifer', '', 'Marsh'], ['Matt', '', 'Moynihan'], ['Steven', '', 'McKelvey'], ['Andrew', '', 'Yates']]",PLOS One,2010,"[u'http://dx.doi.org/10.1371/journal.pone.0009548', u'http://adsabs.harvard.edu/abs/2010PLoSO...5.9548N']",./output/11215168.pdf/citedby/10.1371~journal.pone.0009548
10.1111/j.1749-6632.1993.tb35946.x,"Milman, U., Ben-Moshe, S., Hermoni, D., , The role of the patient care team in elderly people decision on influenza vaccination, Patient Education and Counseling, 2005",cited-by,10.1016/j.pec.2004.08.017,The role of the patient care team in elderly people decision on influenza vaccination,"[['Uzi', '', 'Milman'], ['Shlomi', '', 'Ben-Moshe'], ['Doron', '', 'Hermoni']]",Patient Education and Counseling,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0738399104002721', u'http://linkinghub.elsevier.com/retrieve/pii/S0738399104002721']",
10.1111/j.1749-6632.1993.tb35946.x,"Takagi, Y., Higashi, N., Kawai, S., et. al, Effects of traditional oriental medicine on influenza virus infection: Enhancing effect of traditional oriental medicines on antibody production to B strain after vaccination with influenza HA vaccine in aged mice, International Congress Series, 2004",cited-by,10.1016/j.ics.2004.01.092,Effects of traditional oriental medicine on influenza virus infection: Enhancing effect of traditional oriental medicines on antibody production to B strain after vaccination with influenza HA vaccine in aged mice,"[['Y', '', 'Takagi'], ['N', '', 'Higashi'], ['S', '', 'Kawai'], ['A', '', 'Maeda'], ['N', '', 'Ueba']]",International Congress Series,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0531513104000329', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513104000329']",
10.1111/j.1749-6632.1993.tb35946.x,"Coffin, S., , Future vaccines, Primary Care, 2001",cited-by,10.1016/S0095-4543(05)70045-2,Future vaccines,"[['Susan', 'E.', 'Coffin']]",Primary Care,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0095454305700452', u'http://linkinghub.elsevier.com/retrieve/pii/S0095454305700452']",./output/11215168.pdf/citedby/10.1016~S0095-4543(05)70045-2
10.1111/j.1749-6632.1993.tb35946.x,"Albon, E., , Influenza vaccination of health care workers (HCW) to reduce influenza-related outcomes in high risk patients: A systematic review of clinical and cost-effectiveness A West Midlands Health Technology Assessment Collaboration Report, , 0",cited-by,13113938Influenza vaccination of health care workers (HCW) to reduce influenza-related outcomes in high risk patients: A systematic review of clinical and cost-effectiveness A West Midlands Health Technology Assessment Collaboration Report,Influenza vaccination of health care workers (HCW) to reduce influenza-related outcomes in high risk patients: A systematic review of clinical and cost-effectiveness A West Midlands Health Technology Assessment Collaboration Report,"[['Esther', '', 'Albon']]",,0,[u'http://www.rep.bham.ac.uk/2004/eswi.pdf'],
10.1111/j.1749-6632.1993.tb35946.x,"Khleif, S., Frederickson, H., , The Role of Vaccines in Cancer Prevention, , 0",cited-by,10.1007/978-1-4615-1657-6_12,The Role of Vaccines in Cancer Prevention,"[['Samir', 'N.', 'Khleif'], ['Helen', '', 'Frederickson']]",,0,"[u'http://www.springerlink.com/index/jp8681vm4h455676.pdf', u'http://www.springerlink.com/content/jp8681vm4h455676']",./output/11215168.pdf/citedby/10.1007~978-1-4615-1657-6_12
11215168.pdf,"Eisenberg, E. J., A. Bidgood, and K. C. Cundy. 1997. Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104. Antimicrob. Agents Chemother. 41:1949–1952.",references,NOT found in MAS
11215168.pdf,"Hayden, F. G., and H. J. Hay. 1992. Emergence and transmission of influenza A viruses resistant to amantadine and rimantidine. Curr. Top. Microbiol. Immunol. 176:119–130.",references,NOT found in MAS
11215168.pdf,"Hayden, F. G., M. Lobo, J. J. Treanor, M. Miller, and R. G. Mills. 1997. Efficacy and tolerability of oral GS 4104 for early treatment of experimental influenza in humans, abstr. LB-26, p. 7. In 37th Interscience Conference on Antimicrobial Agents and Chemotherapy Program Addendum. American Society for Microbiology, Washington, D.C.",references,NOT found in MAS
11215168.pdf,"Hayden, F. G., A. D. M. E. Osterhaus, J. J. Treanor, D. M. Fleming, F. Y. Aoki, K. G. Nicholson, A. M. Bohnen, H. M. Hirst, O. Keene, and K. Wightman. 1997. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N. Engl. J. Med. 337: 874–880.",references,10.1056/NEJM199709253371302,Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections,"[[u'Frederick', u'G.', u'Hayden'], [u'Albert', u'D. M. E.', u'Osterhaus'], [u'John', u'J.', u'Treanor'], [u'Douglas', u'M.', u'Fleming'], [u'Fred', u'Y.', u'Aoki'], [u'Karl', u'G.', u'Nicholson'], [u'Arthur', u'M.', u'Bohnen'], [u'Hilary', u'M.', u'Hirst'], [u'Oliver', u'', u'Keene'], [u'Kevin', u'', u'Wightman']]",New England Journal of Medicine,1997,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199709253371302'],./output/11215168.pdf/10.1056~NEJM199709253371302
10.1056/NEJM199709253371302,"Bartlett, J., Dowell, S., Mandell, L., et. al, Practice Guidelines for the Management of Community‐Acquired Pneumonia in Adults, Clinical Infectious Diseases, 2000",cited-by,10.1086/313954,Practice Guidelines for the Management of Community‐Acquired Pneumonia in Adults,"[['John', 'G.', 'Bartlett'], ['Scott', 'F.', 'Dowell'], ['Lionel', 'A.', 'Mandell'], ['Daniel', 'M.', 'Musher'], ['Michael', 'J.', 'Fine']]",Clinical Infectious Diseases,2000,"[u'http://www.gata.edu.tr/dahilibilimler/ailehekimligi/dosyalar/111.pdf', u'http://www2.medicine.wisc.edu/home/files/domfiles/infectiousdisease/CommunityAcquiredAdultPneumonia.pdf', u'http://www.gata.edu.tr/dahilibilimler/nefroloji/dosyalar/111.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/313954', u'http://www.antiinfectieux.org/antiinfectieux/Assets/PTS/infections-respiratoires/pneumonie/CAP-IDSA-guideline.pdf']",./output/11215168.pdf/citedby/10.1086~313954
10.1056/NEJM199709253371302,"Nicholson, K., Wood, J., Zambon, M., , Influenza, Lancet, 2003",cited-by,10.1016/S0140-6736(03)14854-4,Influenza,"[['Karl', 'G', 'Nicholson'], ['John', 'M', 'Wood'], ['Maria', '', 'Zambon']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603148544', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603148544']",
10.1056/NEJM199709253371302,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, Lancet, 2000",cited-by,10.1016/S0140-6736(99)11433-8,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699114338', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699114338']",
10.1056/NEJM199709253371302,"Cox, N., Subbarao, K., , Influenza, Lancet, 1999",cited-by,10.1016/S0140-6736(99)01241-6,Influenza,"[['Nancy', 'J', 'Cox'], ['Kanta', '', 'Subbarao']]",Lancet,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699012416', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699012416']",
10.1056/NEJM199709253371302,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']",
10.1056/NEJM199709253371302,"Elden, L., Nijhuis, M., Schipper, P., et. al, Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR, Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.1.196-200.2001,Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR,"[['L.', 'J. R. van', 'Elden'], ['M.', '', 'Nijhuis'], ['P.', '', 'Schipper'], ['R.', '', 'Schuurman'], ['A.', 'M. van', 'Loon']]",Journal of Clinical Microbiology,2001,[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.1.196-200.2001'],./output/11215168.pdf/citedby/10.1128~JCM.39.1.196-200.2001
10.1056/NEJM199709253371302,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']",./output/11215168.pdf/citedby/5346198Neuraminidase Inhibitors for Influenza
10.1056/NEJM199709253371302,"Boivin, G., Hardy, I., Tellier, G., et. al, Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition, Clinical Infectious Diseases, 2000",cited-by,10.1086/317425,Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition,"[['Guy', '', 'Boivin'], ['Isabelle', '', 'Hardy'], ['Guy', '', 'Tellier'], ['Jean', '', 'Maziade']]",Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/317425'],./output/11215168.pdf/citedby/10.1086~317425
10.1056/NEJM199709253371302,"UYEKI, T., , Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza, Pediatric Infectious Disease Journal, 2003",cited-by,10.1097/01.inf.0000050458.35010.b6,Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza,"[['TIMOTHY', 'M.', 'UYEKI']]",Pediatric Infectious Disease Journal,2003,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200302000-00015'],
10.1056/NEJM199709253371302,"HEDRICK, J., BARZILAI, A., BEHRE, U., et. al, Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial, Pediatric Infectious Disease Journal, 2000",cited-by,10.1097/00006454-200005000-00005,Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial,"[['JAMES', 'A.', 'HEDRICK'], ['ASHER', '', 'BARZILAI'], ['ULRICH', '', 'BEHRE'], ['FREDERICK', 'W.', 'HENDERSON'], ['JANET', '', 'HAMMOND'], ['LUCY', '', 'REILLY'], ['OLIVER', '', 'KEENE']]",Pediatric Infectious Disease Journal,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200005000-00005'],
10.1056/NEJM199709253371302,"Ward, C., Dempseyb, M., Ring, C., et. al, Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement, Journal of Clinical Virology, 2004",cited-by,10.1016/S1386-6532(03)00122-7,Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement,"[['C.', 'L.', 'Ward'], ['M.', 'H.', 'Dempseyb'], ['C.', 'J. A', 'Ring'], ['R.', 'E', 'Kempson'], ['L', '', 'Zhang'], ['D', '', 'Gor'], ['B.', 'W', 'Snowden'], ['M', '', 'Tisdale']]",Journal of Clinical Virology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1386653203001227', u'http://www.hvidovre-hospital.dk/HHmikrobiologisk.nsf/pics/Influenza1.pdf/$FILE/Influenza1.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653203001227']",./output/11215168.pdf/citedby/10.1016~S1386-6532(03)00122-7
10.1056/NEJM199709253371302,"Rimmelzwaan, G., Baars, M., Claas, E., et. al, Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro, Journal of Virological Methods, 1998",cited-by,10.1016/S0166-0934(98)00071-8,"Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro","[['G.', 'F', 'Rimmelzwaan'], ['M', '', 'Baars'], ['E.', 'C. J', 'Claas'], ['A.', 'D. M. E', 'Osterhaus']]",Journal of Virological Methods,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0166093498000718', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093498000718']",
10.1056/NEJM199709253371302,"Cunney, R., Bialachowski, A., Thornley, D., et. al, An Outbreak of Influenza A in a Neonatal Intensive Care Unit, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501786,An Outbreak of Influenza A in a Neonatal Intensive Care Unit,"[['Robert', 'J.', 'Cunney'], ['Anne', '', 'Bialachowski'], ['Diane', '', 'Thornley'], ['Fiona', 'M.', 'Smaill'], ['Ross', 'A.', 'Pennie']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501786'],./output/11215168.pdf/citedby/10.1086~501786
10.1056/NEJM199709253371302,"Varghese, J., Smith, P., Sollis, S., et. al, Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, Structure, 1998",cited-by,10.1016/S0969-2126(98)00075-6,Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase,"[['Joseph', 'N', 'Varghese'], ['Paul', 'W', 'Smith'], ['Steven', 'L', 'Sollis'], ['Tony', 'J', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Jennifer', 'L', 'McKimm-Breschkin'], ['Peter', 'M', 'Colman']]",Structure,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0969212698000756', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212698000756']",
10.1056/NEJM199709253371302,"PELTOLA, V., MCCULLERS, J., , Respiratory viruses predisposing to bacterial infections: role of neuraminidase, Pediatric Infectious Disease Journal, 2004",cited-by,10.1097/01.inf.0000108197.81270.35,Respiratory viruses predisposing to bacterial infections: role of neuraminidase,"[['VILLE', 'T.', 'PELTOLA'], ['JONATHAN', 'A.', 'MCCULLERS']]",Pediatric Infectious Disease Journal,2004,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200401001-00013'],
10.1056/NEJM199709253371302,"Heikkinen, T., Marttila, J., Salmi, A., et. al, Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses, Journal of Clinical Microbiology, 2002",cited-by,10.1128/JCM.40.11.4337-4339.2002,Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses,"[['Terho', '', 'Heikkinen'], ['Jane', '', 'Marttila'], ['Aimo', 'A.', 'Salmi'], ['Olli', '', 'Ruuskanen']]",Journal of Clinical Microbiology,2002,"[u'http://jcm.asm.org/cgi/reprint/40/11/4337.pdf', u'http://jcm.asm.org/cgi/doi/10.1128/JCM.40.11.4337-4339.2002']",./output/11215168.pdf/citedby/10.1128~JCM.40.11.4337-4339.2002
10.1056/NEJM199709253371302,"Heikkinen, T., Chonmaitree, T., , Importance of Respiratory Viruses in Acute Otitis Media, Clinical Microbiology Reviews, 2003",cited-by,10.1128/CMR.16.2.230-241.2003,Importance of Respiratory Viruses in Acute Otitis Media,"[['Terho', '', 'Heikkinen'], ['Tasnee', '', 'Chonmaitree']]",Clinical Microbiology Reviews,2003,[u'http://cmr.asm.org/cgi/doi/10.1128/CMR.16.2.230-241.2003'],./output/11215168.pdf/citedby/10.1128~CMR.16.2.230-241.2003
10.1056/NEJM199709253371302,"Jefferson, T., Jones, M., Doshi, P., et. al, Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis, British Medical Journal, 2009",cited-by,10.1136/bmj.b5106,Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis,"[['Tom', '', 'Jefferson'], ['Mark', '', 'Jones'], ['Peter', '', 'Doshi'], ['Chris', 'Del', 'Mar']]",British Medical Journal,2009,"[u'http://www.bmj.com/cgi/reprint/339/dec07_2/b5106.pdf', u'http://dx.doi.org/10.1136/bmj.b5106', u'http://www.bmj.com/cgi/doi/10.1136/bmj.b5106']",./output/11215168.pdf/citedby/10.1136~bmj.b5106
10.1056/NEJM199709253371302,"Furuta, Y., Takahashi, K., Fukuda, Y., et. al, In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.977-981.2002,In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705,"[['Y.', '', 'Furuta'], ['K.', '', 'Takahashi'], ['Y.', '', 'Fukuda'], ['M.', '', 'Kuno'], ['T.', '', 'Kamiyama'], ['K.', '', 'Kozaki'], ['N.', '', 'Nomura'], ['H.', '', 'Egawa'], ['S.', '', 'Minami'], ['Y.', '', 'Watanabe'], ['H.', '', 'Narita'], ['K.', '', 'Shiraki']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://journals.pasteur.ac.ir/aac02/46(4)/977.pdf', u'http://aac.asm.org/cgi/reprint/46/4/977.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.977-981.2002']",./output/11215168.pdf/citedby/10.1128~AAC.46.4.977-981.2002
10.1056/NEJM199709253371302,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.1056/NEJM199709253371302,"BOIVIN, G., HARDY, I., KRESS, A., , Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR, Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.2.730-732.2001,Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,"[['GUY', '', 'BOIVIN'], ['ISABELLE', '', 'HARDY'], ['ANDREW', '', 'KRESS']]",Journal of Clinical Microbiology,2001,"[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.2.730-732.2001', u'http://jcm.asm.org/cgi/reprint/39/2/730.pdf']",./output/11215168.pdf/citedby/10.1128~JCM.39.2.730-732.2001
10.1056/NEJM199709253371302,"Stiver, G., , The treatment of influenza with antiviral drugs, , 0",cited-by,10332941The treatment of influenza with antiviral drugs,The treatment of influenza with antiviral drugs,"[['Grant', '', 'Stiver']]",,0,"[u'http://www.ualberta.ca/~mlalu/ref03.pdf', u'http://www.ualberta.ca/~mlalu/CMAJantiviral.pdf', u'http://www.cmaj.ca/cgi/reprint/168/1/49.pdf']",./output/11215168.pdf/citedby/10332941The treatment of influenza with antiviral drugs
10.1056/NEJM199709253371302,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']",
10.1056/NEJM199709253371302,"Khan, K., , Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults, Clinical Infectious Diseases, 2001",cited-by,10.1086/324491,Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults,"[['Kamran', '', 'Khan']]",Clinical Infectious Diseases,2001,"[u'http://www.pceo.org/pubs/CID%20Article.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/324491']",./output/11215168.pdf/citedby/10.1086~324491
10.1056/NEJM199709253371302,"Treanor, J., Falsey, A., , Respiratory viral infections in the elderly, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00062-5,Respiratory viral infections in the elderly,"[['John', '', 'Treanor'], ['Ann', '', 'Falsey']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000625', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000625']",
10.1056/NEJM199709253371302,"Hayden, F., , Antivirals for influenza: Historical perspectives and lessons learned, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.05.016,Antivirals for influenza: Historical perspectives and lessons learned,"[['Frederick', 'G.', 'Hayden']]",Antiviral Research,2006,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-10.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354206001653', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206001653']",./output/11215168.pdf/citedby/10.1016~j.antiviral.2006.05.016
10.1056/NEJM199709253371302,"Heikkinen, T., Marttila, J., Salmi, A., et. al, Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses, , 0",cited-by,10724682Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses,Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses,"[['Terho', '', 'Heikkinen'], ['Jane', '', 'Marttila'], ['Aimo', 'A.', 'Salmi'], ['Olli', '', 'Ruuskanen']]",,0,[u'http://jcm.asm.org/cgi/reprint/40/11/4337.pdf'],./output/11215168.pdf/citedby/10724682Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses
10.1056/NEJM199709253371302,"Smith, K., Roberts, M., , Cost-effectiveness of newer treatment strategies for influenza, American Journal of Medicine, 2002",cited-by,10.1016/S0002-9343(02)01222-6,Cost-effectiveness of newer treatment strategies for influenza,"[['Kenneth', 'J', 'Smith'], ['Mark', 'S', 'Roberts']]",American Journal of Medicine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0002934302012226', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934302012226']",./output/11215168.pdf/citedby/10.1016~S0002-9343(02)01222-6
10.1056/NEJM199709253371302,"Walsh, E., Cox, C., Falsey, A., , Clinical Features of Influenza A Virus Infection in Older Hospitalized Persons, Journal of The American Geriatrics Society, 2002",cited-by,10.1046/j.1532-5415.2002.50404.x,Clinical Features of Influenza A Virus Infection in Older Hospitalized Persons,"[['Edward', 'E.', 'Walsh'], ['Christopher', '', 'Cox'], ['Ann', 'R.', 'Falsey']]",Journal of The American Geriatrics Society,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2002.50404.x'],
10.1056/NEJM199709253371302,"Lee, C., Loeb, M., Phillips, A., et. al, Zanamivir Use During Transmission of Amantadine‐Resistant Influenza A in a Nursing Home, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501727,Zanamivir Use During Transmission of Amantadine‐Resistant Influenza A in a Nursing Home,"[['Christine', '', 'Lee'], ['Mark', '', 'Loeb'], ['Anne', '', 'Phillips'], ['Judy', '', 'Nesbitt'], ['Karen', '', 'Smith'], ['Margaret', '', 'Fearon'], ['Margaret', 'A.', 'McArthur'], ['Tony', '', 'Mazzulli'], ['Yan', '', 'Li'], ['Allison', '', 'McGeer']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501727'],./output/11215168.pdf/citedby/10.1086~501727
10.1056/NEJM199709253371302,"Barnett, J., Cadman, A., Burrell, F., et. al, In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir, Virology, 1999",cited-by,10.1006/viro.1999.0058,In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir,"[['J.', 'M.', 'Barnett'], ['A.', '', 'Cadman'], ['F.', 'M.', 'Burrell'], ['S.', 'H.', 'Madar'], ['A.', 'P.', 'Lewis'], ['M.', '', 'Tisdale'], ['R.', '', 'Bethell']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299900582', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299900582']",
10.1056/NEJM199709253371302,"BOIVIN, G., HARDY, I., KRESS, A., , Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR, , 0",cited-by,11106017Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,"[['GUY', '', 'BOIVIN'], ['ISABELLE', '', 'HARDY'], ['ANDREW', '', 'KRESS']]",,0,[u'http://jcm.asm.org/cgi/reprint/39/2/730.pdf'],./output/11215168.pdf/citedby/11106017Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR
10.1056/NEJM199709253371302,"Boeckh, M., , The challenge of respiratory virus infections in hematopoietic cell transplant recipients, British Journal of Haematology, 2008",cited-by,10.1111/j.1365-2141.2008.07295.x,The challenge of respiratory virus infections in hematopoietic cell transplant recipients,"[['Michael', '', 'Boeckh']]",British Journal of Haematology,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2141.2008.07295.x'],
10.1056/NEJM199709253371302,"Sato, M., Hosoya, M., Kato, K., et. al, VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS, Pediatric Infectious Disease Journal, 2005",cited-by,10.1097/01.inf.0000180976.81055.ce,VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS,"[['Masatoki', '', 'Sato'], ['Mitsuaki', '', 'Hosoya'], ['Kazuo', '', 'Kato'], ['Hitoshi', '', 'Suzuki']]",Pediatric Infectious Disease Journal,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200510000-00019'],
10.1056/NEJM199709253371302,"Stamboulian, D., Bonvehí, P., Nacinovich, F., et. al, INFLUENZA, Infectious Disease Clinics of North America, 2000",cited-by,10.1016/S0891-5520(05)70222-1,INFLUENZA,"[['Daniel', '', 'Stamboulian'], ['Pablo', 'E.', 'Bonveh\xc3\xad'], ['Francisco', 'M.', 'Nacinovich'], ['Nancy', '', 'Cox']]",Infectious Disease Clinics of North America,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0891552005702221', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552005702221']",./output/11215168.pdf/citedby/10.1016~S0891-5520(05)70222-1
10.1056/NEJM199709253371302,"Murphy, K., Eivindson, A., Pauksens, K., et. al, Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study, Clinical Drug Investigation, 2000",cited-by,10.2165/00044011-200020050-00005,"Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study","[['Kevin', 'R.', 'Murphy'], ['Arne', '', 'Eivindson'], ['Karlis', '', 'Pauksens'], ['William', 'J.', 'Stein'], ['Guy', '', 'Tellier'], ['Richard', '', 'Watts'], ['Stephen', 'J.', 'Sharp'], ['Elke', '', 'Loeschel']]",Clinical Drug Investigation,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200020050-00005'],
10.1056/NEJM199709253371302,"Kaiser, L., Henry, D., Flack, N., et. al, Short‐Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo‐Controlled Study, Clinical Infectious Diseases, 2000",cited-by,10.1086/313696,Short‐Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo‐Controlled Study,"[['Laurent', '', 'Kaiser'], ['Dan', '', 'Henry'], ['Nancy', 'P.', 'Flack'], ['Oliver', '', 'Keene'], ['Frederick', 'G.', 'Hayden']]",Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/313696'],./output/11215168.pdf/citedby/10.1086~313696
10.1056/NEJM199709253371302,"Arden, N., , Control of Influenza in the Long‐Term–Care Facility: A Review of Established Approaches and Newer Options, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501702,Control of Influenza in the Long‐Term–Care Facility: A Review of Established Approaches and Newer Options,"[['Nancy', 'H.', 'Arden']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501702'],./output/11215168.pdf/citedby/10.1086~501702
10.1056/NEJM199709253371302,"Johny, A., Clark, A., Price, N., et. al, The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation, Bone Marrow Transplantation, 2002",cited-by,10.1038/sj.bmt.1703343,The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation,"[['AA', '', 'Johny'], ['A', '', 'Clark'], ['N', '', 'Price'], ['D', '', 'Carrington'], ['A', '', 'Oakhill'], ['DI', '', 'Marks']]",Bone Marrow Transplantation,2002,"[u'http://www.nature.com/doifinder/10.1038/sj.bmt.1703343', u'http://dx.doi.org/10.1038/sj.bmt.1703343']",./output/11215168.pdf/citedby/10.1038~sj.bmt.1703343
10.1056/NEJM199709253371302,"Boivin, G., Goyette, N., , Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00219-4,Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors,"[['Guy', '', 'Boivin'], ['Nathalie', '', 'Goyette']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201002194', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201002194']",
10.1056/NEJM199709253371302,"Zalman, L., Brothers, M., Dragovich, P., et. al, Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor, Antimicrobial Agents and Chemotherapy, 2000",cited-by,10.1128/AAC.44.5.1236-1241.2000,"Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor","[['L.', 'S.', 'Zalman'], ['M.', 'A.', 'Brothers'], ['P.', 'S.', 'Dragovich'], ['R.', '', 'Zhou'], ['T.', 'J.', 'Prins'], ['S.', 'T.', 'Worland'], ['A.', 'K.', 'Patick']]",Antimicrobial Agents and Chemotherapy,2000,"[u'http://aac.asm.org/cgi/doi/10.1128/AAC.44.5.1236-1241.2000', u'http://aac.asm.org/cgi/reprint/44/5/1236.pdf']",./output/11215168.pdf/citedby/10.1128~AAC.44.5.1236-1241.2000
10.1056/NEJM199709253371302,"Church, D., Davies, H., Mitton, C., et. al, Clinical and Economic Evaluation of Rapid Influenza A Virus Testing in Nursing Homes in Calgary, Canada, Clinical Infectious Diseases, 2002",cited-by,10.1086/338960,"Clinical and Economic Evaluation of Rapid Influenza A Virus Testing in Nursing Homes in Calgary, Canada","[['Deirdre', 'L.', 'Church'], ['H.', 'Dele', 'Davies'], ['Craig', '', 'Mitton'], ['Heather', '', 'Semeniuk'], ['Melissa', '', 'Logue'], ['Colleen', '', 'Maxwell'], ['Cam', '', 'Donaldson']]",Clinical Infectious Diseases,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/338960'],./output/11215168.pdf/citedby/10.1086~338960
10.1056/NEJM199709253371302,"Billings, J., Hertz, M., Wendt, C., , Community respiratory virus infections following lung transplantation, Transplant Infectious Disease, 2001",cited-by,10.1034/j.1399-3062.2001.003003138.x,Community respiratory virus infections following lung transplantation,"[['J.', 'L.', 'Billings'], ['M.', 'I.', 'Hertz'], ['C.', 'H.', 'Wendt']]",Transplant Infectious Disease,2001,[u'http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-3062.2001.003003138.x'],./output/11215168.pdf/citedby/10.1034~j.1399-3062.2001.003003138.x
10.1056/NEJM199709253371302,"Villar, E., Barroso, I., , Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview, Glycoconjugate Journal, 2006",cited-by,10.1007/s10719-006-5433-0,Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview,"[['Enrique', '', 'Villar'], ['Isabel', 'Mu\xc3\xb1oz', 'Barroso']]",Glycoconjugate Journal,2006,"[u'http://www.springerlink.com/content/n549v716hp2mr30p', u'http://www.springerlink.com/index/n549v716hp2mr30p.pdf', u'http://www.springerlink.com/index/10.1007/s10719-006-5433-0', u'http://www.springerlink.com/index/pdf/10.1007/s10719-006-5433-0']",./output/11215168.pdf/citedby/10.1007~s10719-006-5433-0
10.1056/NEJM199709253371302,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']",
10.1056/NEJM199709253371302,"Gravenstein, S., Drinka, P., Osterweil, D., et. al, Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.006,Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population,"[['Stefan', '', 'Gravenstein'], ['Paul', '', 'Drinka'], ['Dan', '', 'Osterweil'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult'], ['Arvydas', '', 'Ambrozaitis'], ['Ruth', '', 'Kandel'], ['Ellen', '', 'Binder'], ['Janet', '', 'Hammond'], ['Janet', '', 'McElhaney'], ['Nancy', '', 'Flack'], ['Janet', '', 'Daly'], ['Oliver', '', 'Keene']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005323', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005323']",
10.1056/NEJM199709253371302,"Rothberg, M., He, S., Rose, D., , Management of influenza symptoms in healthy adults, Journal of General Internal Medicine, 2003",cited-by,10.1046/j.1525-1497.2003.20822.x,Management of influenza symptoms in healthy adults,"[['Michael', 'B.', 'Rothberg'], ['Shunian', '', 'He'], ['David', 'N.', 'Rose']]",Journal of General Internal Medicine,2003,"[u'http://www.springerlink.com/index/c2hlvw3483877856.pdf', u'http://www.springerlink.com/content/c2hlvw3483877856', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1497.2003.20822.x']",./output/11215168.pdf/citedby/10.1046~j.1525-1497.2003.20822.x
10.1056/NEJM199709253371302,"McKimm-Breschkin, J., , Neuraminidase inhibitors for the treatment and prevention of influenza, Expert Opinion on Pharmacotherapy, 2002",cited-by,10.1517/14656566.3.2.103,Neuraminidase inhibitors for the treatment and prevention of influenza,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Expert Opinion on Pharmacotherapy,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.3.2.103'],./output/11215168.pdf/citedby/10.1517~14656566.3.2.103
10.1056/NEJM199709253371302,"CASS, L., GUNAWARDENA, K., MACMAHON, M., et. al, Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir, Respiratory Medicine, 2000",cited-by,10.1053/rmed.1999.0718,Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir,"[['L.', 'M. R.', 'CASS'], ['K.', 'A.', 'GUNAWARDENA'], ['M.', 'M.', 'MACMAHON'], ['A.', '', 'BYE']]",Respiratory Medicine,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0954611199907187', u'http://linkinghub.elsevier.com/retrieve/pii/S0954611199907187']",./output/11215168.pdf/citedby/10.1053~rmed.1999.0718
10.1056/NEJM199709253371302,"Oxford, J., Bossuyt, S., Balasingam, S., et. al, Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors, Clinical Microbiology and Infection, 2003",cited-by,10.1046/j.1469-0691.2003.00564.x,Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors,"[['J.', 'S.', 'Oxford'], ['S.', '', 'Bossuyt'], ['S.', '', 'Balasingam'], ['A.', '', 'Mann'], ['P.', '', 'Novelli'], ['R.', '', 'Lambkin']]",Clinical Microbiology and Infection,2003,"[u'http://birdflubook.com/resources/Oxford1.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1469-0691.2003.00564.x']",./output/11215168.pdf/citedby/10.1046~j.1469-0691.2003.00564.x
10.1056/NEJM199709253371302,"Varghese, J., , Development of neuraminidase inhibitors as anti-influenza virus drugs, Drug Development Research, 1999",cited-by,10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6,Development of neuraminidase inhibitors as anti-influenza virus drugs,"[['Joseph', 'N.', 'Varghese']]",Drug Development Research,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291098-2299%28199903/04%2946%3A3/4%3C176%3A%3AAID-DDR4%3E3.0.CO%3B2-6'],
10.1056/NEJM199709253371302,"Gavin, P., Thomson, R., , Review of Rapid Diagnostic Tests for Influenza, , 2003",cited-by,5357707Review of Rapid Diagnostic Tests for Influenza,Review of Rapid Diagnostic Tests for Influenza,"[['Patrick', 'J', 'Gavin'], ['Richard', 'B', 'Thomson']]",,2003,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/diagnosis/diagnosis-4.pdf'],./output/11215168.pdf/citedby/5357707Review of Rapid Diagnostic Tests for Influenza
10.1056/NEJM199709253371302,"Beigel, J., , Influenza, Critical Care Medicine, 2008",cited-by,10.1097/CCM.0b013e318180b039,Influenza,"[['John', 'H.', 'Beigel']]",Critical Care Medicine,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-200809000-00025'],
10.1056/NEJM199709253371302,"Englund, J., , Antiviral therapy of influenza, Seminars in Pediatric Infectious Diseases, 2002",cited-by,10.1053/spid.2002.122999,Antiviral therapy of influenza,"[['Janet', 'A.', 'Englund']]",Seminars in Pediatric Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1045187002500571', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187002500571']",./output/11215168.pdf/citedby/10.1053~spid.2002.122999
10.1056/NEJM199709253371302,"SAGRERA, X., GINOVART, G., RASPALL, F., et. al, Outbreaks of influenza A virus infection in neonatal intensive care units, Pediatric Infectious Disease Journal, 2002",cited-by,10.1097/00006454-200203000-00007,Outbreaks of influenza A virus infection in neonatal intensive care units,"[['XAVIER', '', 'SAGRERA'], ['GEMMA', '', 'GINOVART'], ['FREDERIC', '', 'RASPALL'], ['NURIA', '', 'RABELLA'], ['PERE', '', 'SALA'], ['MONTSERRAT', '', 'SIERRA'], ['XAVIER', '', 'DEMESTRE'], ['CLARA', '', 'VILA']]",Pediatric Infectious Disease Journal,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200203000-00007'],
10.1056/NEJM199709253371302,"BRADLEY, J., , Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines, Pediatric Infectious Disease Journal, 2002",cited-by,10.1097/00006454-200206000-00035,Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines,"[['JOHN', 'S.', 'BRADLEY']]",Pediatric Infectious Disease Journal,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200206000-00035'],
10.1056/NEJM199709253371302,"Kawai, N., Ikematsu, H., Iwaki, N., et. al, A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2007.09.002,A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B,"[['Naoki', '', 'Kawai'], ['Hideyuki', '', 'Ikematsu'], ['Norio', '', 'Iwaki'], ['Tetsunari', '', 'Maeda'], ['Hideo', '', 'Kanazawa'], ['Takashi', '', 'Kawashima'], ['Osame', '', 'Tanaka'], ['Satoshi', '', 'Yamauchi'], ['Kenichi', '', 'Kawamura'], ['Toru', '', 'Nagai'], ['Satsuki', '', 'Horii'], ['Nobuo', '', 'Hirotsu'], ['Seizaburo', '', 'Kashiwagi']]",Journal of Infection,2008,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-25.pdf', u'http://www.sciencedirect.com/science/article/pii/S0163445307007578', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445307007578']",./output/11215168.pdf/citedby/10.1016~j.jinf.2007.09.002
10.1056/NEJM199709253371302,"Carr, M., Sayre, N., Duffy, M., et. al, Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses, Journal of Virological Methods, 2008",cited-by,10.1016/j.jviromet.2008.07.011,Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses,"[['Michael', 'J.', 'Carr'], ['Naomi', '', 'Sayre'], ['Margaret', '', 'Duffy'], ['Jeff', '', 'Connell'], ['William', 'W.', 'Hall']]",Journal of Virological Methods,2008,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-4.pdf', u'http://www.sciencedirect.com/science/article/pii/S016609340800253X', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-3.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S016609340800253X']",./output/11215168.pdf/citedby/10.1016~j.jviromet.2008.07.011
10.1056/NEJM199709253371302,"Neuzil, K., O’Connor, T., Gorse, G., et. al, Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine, Clinical Infectious Diseases, 2003",cited-by,10.1086/345668,Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine,"[['Kathleen', 'M.', 'Neuzil'], ['Theresa', 'Z.', 'O\xe2\x80\x99Connor'], ['Geoffrey', 'J.', 'Gorse'], ['Kristin', 'L.', 'Nichol']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/345668'],./output/11215168.pdf/citedby/10.1086~345668
10.1056/NEJM199709253371302,"Smith, K., Roberts, M., , Cost-effectiveness of Newer Treatment Strategies for Influenza, , 0",cited-by,5139943Cost-effectiveness of Newer Treatment Strategies for Influenza,Cost-effectiveness of Newer Treatment Strategies for Influenza,"[['Kenneth', 'J.', 'Smith'], ['Mark', 'S.', 'Roberts']]",,0,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-13.pdf'],./output/11215168.pdf/citedby/5139943Cost-effectiveness of Newer Treatment Strategies for Influenza
10.1056/NEJM199709253371302,"Jr, J., Michaelis, M., Doerr, H., , The threat of avian influenza A (H5N1). Part III: antiviral therapy, Medical Microbiology and Immunology, 2007",cited-by,10.1007/s00430-007-0048-z,The threat of avian influenza A (H5N1). Part III: antiviral therapy,"[['Jindrich', 'Cinatl', 'Jr'], ['Martin', '', 'Michaelis'], ['Hans', 'W.', 'Doerr']]",Medical Microbiology and Immunology,2007,"[u'http://www.springerlink.com/index/41xpm470518281m7.pdf', u'http://www.springerlink.com/content/41xpm470518281m7', u'http://www.springerlink.com/index/10.1007/s00430-007-0048-z', u'http://www.springerlink.com/index/pdf/10.1007/s00430-007-0048-z']",./output/11215168.pdf/citedby/10.1007~s00430-007-0048-z
10.1056/NEJM199709253371302,"Rawlinson, W., Waliuzzaman, Z., Fennell, M., et. al, New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults, Journal of Medical Virology, 2004",cited-by,10.1002/jmv.20155,New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults,"[['William', 'D.', 'Rawlinson'], ['Zubair', 'M.', 'Waliuzzaman'], ['Michael', '', 'Fennell'], ['James', 'R.', 'Appleman'], ['Craig', 'D.', 'Shimasaki'], ['Ian', 'W.', 'Carter']]",Journal of Medical Virology,2004,[u'http://doi.wiley.com/10.1002/jmv.20155'],./output/11215168.pdf/citedby/10.1002~jmv.20155
10.1056/NEJM199709253371302,"Dharnidharka, V., Harmon, W., , Management of pediatric postrenal transplantation infections, Seminars in Nephrology, 2001",cited-by,10.1053/snep.2001.24947,Management of pediatric postrenal transplantation infections,"[['Vikas', 'R.', 'Dharnidharka'], ['William', 'E.', 'Harmon']]",Seminars in Nephrology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0270929501700514', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=asnep0210521']",
10.1056/NEJM199709253371302,"Monto, A., Moult, A., Sharp, S., , Effect of zanamivir on duration and resolution of influenza symptoms, Clinical Therapeutics, 2000",cited-by,10.1016/S0149-2918(00)83026-X,Effect of zanamivir on duration and resolution of influenza symptoms,"[['Arnold', 'S.', 'Monto'], ['Andrew', 'B.', 'Moult'], ['Stephen', 'J.', 'Sharp']]",Clinical Therapeutics,2000,"[u'http://www.sciencedirect.com/science/article/pii/S014929180083026X', u'http://linkinghub.elsevier.com/retrieve/pii/S014929180083026X']",
10.1056/NEJM199709253371302,"Dreitlein, W., Maratos, J., Brocavich, J., , Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, 2001",cited-by,10.1016/S0149-2918(01)80042-4,Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza,"[['William', 'B.', 'Dreitlein'], ['Julia', '', 'Maratos'], ['Joseph', '', 'Brocavich']]",Clinical Therapeutics,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0149291801800424', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291801800424']",
10.1056/NEJM199709253371302,"Low, D., , Reducing antibiotic use in influenza: challenges and rewards, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2007.01910.x,Reducing antibiotic use in influenza: challenges and rewards,"[['D.', '', 'Low']]",Clinical Microbiology and Infection,2008,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01910.x'],./output/11215168.pdf/citedby/10.1111~j.1469-0691.2007.01910.x
10.1056/NEJM199709253371302,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004'],
10.1056/NEJM199709253371302,"Unoshima, M., Iwasaka, H., Eto, J., et. al, Antiviral Effects of Geranylgeranylacetone: Enhancement of MxA Expression and Phosphorylation of PKR during Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2003",cited-by,10.1128/AAC.47.9.2914-2921.2003,Antiviral Effects of Geranylgeranylacetone: Enhancement of MxA Expression and Phosphorylation of PKR during Influenza Virus Infection,"[['Masako', '', 'Unoshima'], ['Hideo', '', 'Iwasaka'], ['Junko', '', 'Eto'], ['Yoshiko', '', 'Takita-Sonoda'], ['Takayuki', '', 'Noguchi'], ['Akira', '', 'Nishizono']]",Antimicrobial Agents and Chemotherapy,2003,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.47.9.2914-2921.2003'],./output/11215168.pdf/citedby/10.1128~AAC.47.9.2914-2921.2003
10.1056/NEJM199709253371302,"Suess, T., Buchholz, U., Dupke, S., et. al, Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009, American Journal of Epidemiology, 2010",cited-by,10.1093/aje/kwq071,"Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009","[['T.', '', 'Suess'], ['U.', '', 'Buchholz'], ['S.', '', 'Dupke'], ['R.', '', 'Grunow'], ['Matthias', 'an der', 'Heiden'], ['A.', '', 'Heider'], ['B.', '', 'Biere'], ['B.', '', 'Schweiger'], ['W.', '', 'Haas'], ['G.', '', 'Krause']]",American Journal of Epidemiology,2010,[u'http://aje.oxfordjournals.org/cgi/doi/10.1093/aje/kwq071'],./output/11215168.pdf/citedby/10.1093~aje~kwq071
10.1056/NEJM199709253371302,"McCullers, J., , Antiviral therapy of influenza, Expert Opinion on Investigational Drugs, 2005",cited-by,10.1517/13543784.14.3.305,Antiviral therapy of influenza,"[['Jonathan', 'A', 'McCullers']]",Expert Opinion on Investigational Drugs,2005,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.14.3.305'],./output/11215168.pdf/citedby/10.1517~13543784.14.3.305
10.1056/NEJM199709253371302,"Rothbarth, P., Groen, J., Bohnen, A., et. al, Influenza virus serology—a comparative study, Journal of Virological Methods, 1999",cited-by,10.1016/S0166-0934(98)00174-8,Influenza virus serology—a comparative study,"[['Philip', 'H', 'Rothbarth'], ['Jan', '', 'Groen'], ['Arthur', 'M', 'Bohnen'], ['Ronald', 'de', 'Groot'], ['Albert', 'D. M. E', 'Osterhaus']]",Journal of Virological Methods,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166093498001748', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093498001748']",
10.1056/NEJM199709253371302,"Abed, Y., Boivin, G., , Treatment of respiratory virus infections, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.01.006,Treatment of respiratory virus infections,"[['Yacine', '', 'Abed'], ['Guy', '', 'Boivin']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016635420600026X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420600026X']",
10.1056/NEJM199709253371302,"Ambrozaitis, A., Gravenstein, S., Essen, G., et. al, Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.007,Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population,"[['Arvydas', '', 'Ambrozaitis'], ['Stefan', '', 'Gravenstein'], ['Gerrit', 'A. van', 'Essen'], ['Ethan', '', 'Rubinstein'], ['Ligita', '', 'Balciuniene'], ['Ausra', '', 'Stikleryte'], ['Catriona', '', 'Crawford'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005335', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005335']",
10.1056/NEJM199709253371302,"Olshaker, J., , Influenza, Emergency Medicine Clinics of North America, 2003",cited-by,10.1016/S0733-8627(03)00018-X,Influenza,"[['Jonathan', 'S', 'Olshaker']]",Emergency Medicine Clinics of North America,2003,"[u'http://www.sciencedirect.com/science/article/pii/S073386270300018X', u'http://linkinghub.elsevier.com/retrieve/pii/S073386270300018X']",./output/11215168.pdf/citedby/10.1016~S0733-8627(03)00018-X
10.1056/NEJM199709253371302,"Horváth, A., Andersen, I., Junker, K., et. al, Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00158-9,Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies,"[['A', '', 'Horv\xc3\xa1th'], ['I', '', 'Andersen'], ['K', '', 'Junker'], ['B', 'Lyck', 'Fogh-Schultz'], ['E', 'Holm', 'Nielsen'], ['S', '', 'Gizurarson'], ['O', '', 'Andersen'], ['J', '', 'K\xc3\xa1rm\xc3\xa1n'], ['E', '', 'Rajnav\xc3\xb6lgyi'], ['A', '', 'Erdei'], ['S.-E', '', 'Svehag']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001589', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001589']",
10.1056/NEJM199709253371302,"Awofeso, N., Fennell, M., Waliuzzaman, Z., et. al, Influenza outbreak in a correctional facility, Australian and New Zealand Journal of Public Health, 2001",cited-by,10.1111/j.1467-842X.2001.tb00655.x,Influenza outbreak in a correctional facility,"[['Niyi', '', 'Awofeso'], ['Michael', '', 'Fennell'], ['Zubair', '', 'Waliuzzaman'], ['Caroline', '', ""O'Connor""], ['Debbie', '', 'Pittam'], ['Leng', '', 'Boonwaat'], ['Sophie', '', 'Kantzow'], ['William', 'D.', 'Rawlinson']]",Australian and New Zealand Journal of Public Health,2001,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1467-842X.2001.tb00655.x'],
10.1056/NEJM199709253371302,"Colman, P., , Zanamivir: an influenza virus neuraminidase inhibitor, Expert Review of Anti-infective Therapy, 2005",cited-by,10.1586/14787210.3.2.191,Zanamivir: an influenza virus neuraminidase inhibitor,"[['PM', '', 'Colman']]",Expert Review of Anti-infective Therapy,2005,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.3.2.191'],
10.1056/NEJM199709253371302,"Snelgrove, R., Williams, A., Thorpe, C., et. al, Manipulation of immunity to and pathology of respiratory infections, Expert Review of Anticancer Therapy, 2004",cited-by,10.1586/14787210.2.3.413,Manipulation of immunity to and pathology of respiratory infections,"[['Robert', '', 'Snelgrove'], ['Andrew', '', 'Williams'], ['Callum', '', 'Thorpe'], ['Tracy', '', 'Hussell']]",Expert Review of Anticancer Therapy,2004,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.2.3.413'],
10.1056/NEJM199709253371302,"Simor, A., , Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?, Infection Control and Hospital Epidemiology, 2002",cited-by,10.1086/501971,Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?,"[['Andrew', '', 'Simor']]",Infection Control and Hospital Epidemiology,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501971'],./output/11215168.pdf/citedby/10.1086~501971
10.1056/NEJM199709253371302,"Plakokefalos, E., Markoulatos, P., Spyrou, N., et. al, Molecular and phylogenetic analysis of haemagglutinin and neuraminidase sequences from recent human influenza type A (H3N2) viral isolates in Southern Greece, Archives of Virology, 2001",cited-by,10.1007/s007050170041,Molecular and phylogenetic analysis of haemagglutinin and neuraminidase sequences from recent human influenza type A (H3N2) viral isolates in Southern Greece,"[['E.', 'T.', 'Plakokefalos'], ['P.', '', 'Markoulatos'], ['N.', '', 'Spyrou'], ['T.', 'A.', 'Bei'], ['N.', 'C.', 'Vamvakopoulos']]",Archives of Virology,2001,"[u'http://www.springerlink.com/content/g02fkr4ufxg76ccf', u'http://www.springerlink.com/index/g02fkr4ufxg76ccf.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s007050170041', u'http://www.springerlink.com/index/pdf/10.1007/s007050170041']",./output/11215168.pdf/citedby/10.1007~s007050170041
10.1056/NEJM199709253371302,"Neuzil, K., , Influenza: New insights into an old disease, Current Infectious Disease Reports, 2000",cited-by,10.1007/s11908-000-0039-3,Influenza: New insights into an old disease,"[['Kathleen', 'M.', 'Neuzil']]",Current Infectious Disease Reports,2000,"[u'http://www.springerlink.com/index/0765517834762225.pdf', u'http://www.springerlink.com/content/0765517834762225', u'http://www.springerlink.com/index/pdf/10.1007/s11908-000-0039-3', u'http://www.springerlink.com/index/10.1007/s11908-000-0039-3']",./output/11215168.pdf/citedby/10.1007~s11908-000-0039-3
10.1056/NEJM199709253371302,"Sahasrabudhe, A., Lawrence, L., Epa, V., et. al, Substrate, Inhibitor, or Antibody Stabilizes the Glu 119 Gly Mutant Influenza Virus Neuraminidase, Virology, 1998",cited-by,10.1006/viro.1998.9222,"Substrate, Inhibitor, or Antibody Stabilizes the Glu 119 Gly Mutant Influenza Virus Neuraminidase","[['Anjali', '', 'Sahasrabudhe'], ['Lynne', '', 'Lawrence'], ['V.', 'Chandana', 'Epa'], ['Joseph', 'N.', 'Varghese'], ['Peter', 'M.', 'Colman'], ['Jennifer', 'L.', 'McKimm-Breschkin']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0042682298992224', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682298992224']",
10.1056/NEJM199709253371302,"Klumpp, K., , Recent advances in the discovery and development of anti-influenza drugs, Expert Opinion on Therapeutic Patents, 2004",cited-by,10.1517/13543776.14.8.1153,Recent advances in the discovery and development of anti-influenza drugs,"[['Klaus', '', 'Klumpp']]",Expert Opinion on Therapeutic Patents,2004,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.14.8.1153'],./output/11215168.pdf/citedby/10.1517~13543776.14.8.1153
10.1056/NEJM199709253371302,"Colman, P., , Neuraminidase inhibitors as antivirals, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00132-9,Neuraminidase inhibitors as antivirals,"[['P.', 'M', 'Colman']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02001329', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02001329']",
10.1056/NEJM199709253371302,"Monto, A., Fendrick, A., , Developments in Influenza Prevention and Treatment: A Managed Care Perspective, Disease Management & Health Outcomes, 2000",cited-by,10.2165/00115677-200007050-00001,Developments in Influenza Prevention and Treatment: A Managed Care Perspective,"[['Arnold', 'S.', 'Monto'], ['A.', 'Mark', 'Fendrick']]",Disease Management & Health Outcomes,2000,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00115677-200007050-00001', u'http://diseasemanagement.adisonline.com/pt/re/dmo/pdfhandler.00115677-200007050-00001.pdf', u'http://diseasemanagement.adisonline.com/pt/re/dmo/fulltext.00115677-200007050-00001.htm']",
10.1056/NEJM199709253371302,"Drinka, P., Gravenstein, S., Schilling, M., et. al, Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols, , 0",cited-by,12341046Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols,Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols,"[['Paul', 'J.', 'Drinka'], ['Stefan', '', 'Gravenstein'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Barbara', 'A.', 'Miller'], ['Peter', '', 'Shult']]",,0,"[u'http://archinte.ama-assn.org/cgi/reprint/158/19/2155.pdf', u'http://archinte.highwire.org/cgi/reprint/158/19/2155.pdf']",./output/11215168.pdf/citedby/12341046Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols
10.1056/NEJM199709253371302,"Ishizuka, H., Yoshiba, S., Okabe, H., et. al, Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS8958, in Healthy Male Volunteers, Journal of Clinical Pharmacology, 2010",cited-by,10.1177/0091270009356297,"Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS8958, in Healthy Male Volunteers","[['Hitoshi', '', 'Ishizuka'], ['Satoshi', '', 'Yoshiba'], ['Hiromi', '', 'Okabe'], ['Kazutaka', '', 'Yoshihara']]",Journal of Clinical Pharmacology,2010,"[u'http://www.jclinpharm.org/cgi/doi/10.1177/0091270009356297', u'http://dx.doi.org/10.1177/0091270009356297']",./output/11215168.pdf/citedby/10.1177~0091270009356297
10.1056/NEJM199709253371302,"Ruf, B., Szucs, T., , Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy, Infection, 2009",cited-by,10.1007/s15010-009-8241-1,Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy,"[['B.', 'R.', 'Ruf'], ['T.', '', 'Szucs']]",Infection,2009,"[u'http://www.springerlink.com/content/880245655hpk7483', u'http://www.springerlink.com/index/880245655hpk7483.pdf', u'http://www.springerlink.com/index/10.1007/s15010-009-8241-1', u'http://www.springerlink.com/index/pdf/10.1007/s15010-009-8241-1']",./output/11215168.pdf/citedby/10.1007~s15010-009-8241-1
10.1056/NEJM199709253371302,"Imuta, F., Toyoda, M., Toyoda, T., , New application method of zanamivir with a straw, Pediatrics International, 2003",cited-by,10.1046/j.1442-200X.2003.01724.x,New application method of zanamivir with a straw,"[['Fusae', '', 'Imuta'], ['Michiko', '', 'Toyoda'], ['Tetsuya', '', 'Toyoda']]",Pediatrics International,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1442-200X.2003.01724.x'],./output/11215168.pdf/citedby/10.1046~j.1442-200X.2003.01724.x
10.1056/NEJM199709253371302,"Kaiser, L., Couch, R., Galasso, G., et. al, First International Symposium on Influenza and Other Respiratory Viruses: summary and overview, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00034-0,First International Symposium on Influenza and Other Respiratory Viruses: summary and overview,"[['Laurent', '', 'Kaiser'], ['Robert', 'B', 'Couch'], ['George', 'J', 'Galasso'], ['W.', 'Paul', 'Glezen'], ['Robert', 'G', 'Webster'], ['Peter', 'F', 'Wright'], ['Frederick', 'G', 'Hayden']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000340', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000340']",
10.1056/NEJM199709253371302,"Cianci, C., Krystal, M., , Development of antivirals against influenza, Expert Opinion on Investigational Drugs, 1998",cited-by,10.1517/13543784.7.2.149,Development of antivirals against influenza,"[['Christopher', '', 'Cianci'], ['Mark', '', 'Krystal']]",Expert Opinion on Investigational Drugs,1998,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.7.2.149'],./output/11215168.pdf/citedby/10.1517~13543784.7.2.149
10.1056/NEJM199709253371302,"Barbani, M., Gorgievski-Hrisoho, M., , Rapid detection of respiratory picornaviruses in nasopharyngeal aspirates by immunofluorescence assay, Journal of Clinical Virology, 2009",cited-by,10.1016/j.jcv.2009.05.008,Rapid detection of respiratory picornaviruses in nasopharyngeal aspirates by immunofluorescence assay,"[['Maria', 'Teresa', 'Barbani'], ['Meri', '', 'Gorgievski-Hrisoho']]",Journal of Clinical Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1386653209002030', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653209002030']",
10.1056/NEJM199709253371302,"Salzberger, B., Plentz, A., Ehrenstein, B., et. al, Influenza, Der Pneumologe, 2006",cited-by,10.1007/s10405-005-0074-8,Influenza,"[['B.', '', 'Salzberger'], ['A.', '', 'Plentz'], ['B.', '', 'Ehrenstein'], ['W.', '', 'Jilg']]",Der Pneumologe,2006,"[u'http://www.springerlink.com/content/7g3g89680n3t5q3n', u'http://www.springerlink.com/index/10.1007/s10405-005-0074-8', u'http://www.springerlink.com/index/pdf/10.1007/s10405-005-0074-8']",./output/11215168.pdf/citedby/10.1007~s10405-005-0074-8
10.1056/NEJM199709253371302,"Townsend, K., Eiland, L., , Combating Influenza with Antiviral Therapy in the Pediatric Population, Pharmacotherapy, 2006",cited-by,10.1592/phco.2006.26.1.95,Combating Influenza with Antiviral Therapy in the Pediatric Population,"[['Kara', 'A.', 'Townsend'], ['Lea', 'S.', 'Eiland']]",Pharmacotherapy,2006,[u'http://www.atypon-link.com/PPI/doi/abs/10.1592/phco.2006.26.1.95'],
10.1056/NEJM199709253371302,"Genugten, M., Heijnen, M., , The expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.02.007,The expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands,"[['Marianne', 'L. L van', 'Genugten'], ['Marie-Louise', 'A', 'Heijnen']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204001066', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001066']",
10.1056/NEJM199709253371302,"Schwarzinger, M., Lacombe, K., Carrat, F., , Economic evaluations of neuraminidase inhibitors to control influenza, , 2003",cited-by,10.1586/14737167.3.2.147,Economic evaluations of neuraminidase inhibitors to control influenza,"[['Michael', '', 'Schwarzinger'], ['Karine', '', 'Lacombe'], ['Fabrice', '', 'Carrat']]",,2003,[u'http://www.future-drugs.com/doi/abs/10.1586/14737167.3.2.147'],
10.1056/NEJM199709253371302,"Kuijper, E., Meer, J., Jong, M., et. al, Usefulness of Gram Stain for Diagnosis of Lower Respiratory Tract Infection or Urinary Tract Infection and as an Aid in Guiding Treatment, Carcinogenesis, 2003",cited-by,10.1007/s10096-003-0892-8,Usefulness of Gram Stain for Diagnosis of Lower Respiratory Tract Infection or Urinary Tract Infection and as an Aid in Guiding Treatment,"[['E.', 'J.', 'Kuijper'], ['J.', 'van der', 'Meer'], ['M.', 'D. de', 'Jong'], ['P.', '', 'Speelman'], ['J.', '', 'Dankert']]",Carcinogenesis,2003,"[u'http://www.springerlink.com/index/hwdml44mxdu3dynr.pdf', u'http://www.springerlink.com/content/hwdml44mxdu3dynr']",./output/11215168.pdf/citedby/10.1007~s10096-003-0892-8
10.1056/NEJM199709253371302,"Höffken, G., Gillissen, A., , Efficacy and safety of zanamivir in patients with influenza - impact of age, severity of infections and specific risk factors, Medical Microbiology and Immunology, 2002",cited-by,10.1007/s00430-002-0140-3,"Efficacy and safety of zanamivir in patients with influenza - impact of age, severity of infections and specific risk factors","[['Gert', '', 'H\xc3\xb6ffken'], ['Adrian', '', 'Gillissen']]",Medical Microbiology and Immunology,2002,"[u'http://www.springerlink.com/index/xw6cyvhlgd0majnf.pdf', u'http://www.springerlink.com/content/xw6cyvhlgd0majnf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00430-002-0140-3', u'http://www.springerlink.com/index/pdf/10.1007/s00430-002-0140-3']",./output/11215168.pdf/citedby/10.1007~s00430-002-0140-3
10.1056/NEJM199709253371302,"Hayden, F., , Influenza virus neuraminidase inhibitors: clinical aspects, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00358-2,Influenza virus neuraminidase inhibitors: clinical aspects,"[['Frederick', 'G.', 'Hayden']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003582', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003582']",
10.1056/NEJM199709253371302,"Kuehnert, M., Cardo, D., , Infections associated with health-care personnel: Vaccine-preventable diseases and bloodborne pathogens, Current Infectious Disease Reports, 2000",cited-by,10.1007/s11908-000-0047-3,Infections associated with health-care personnel: Vaccine-preventable diseases and bloodborne pathogens,"[['Matthew', 'J.', 'Kuehnert'], ['Denise', 'M.', 'Cardo']]",Current Infectious Disease Reports,2000,"[u'http://www.springerlink.com/index/w448u2457558425h.pdf', u'http://www.springerlink.com/content/w448u2457558425h', u'http://www.springerlink.com/index/10.1007/s11908-000-0047-3', u'http://www.springerlink.com/index/pdf/10.1007/s11908-000-0047-3']",./output/11215168.pdf/citedby/10.1007~s11908-000-0047-3
11215168.pdf,"Hayden, F. G., J. J. Treanor, A. F. Betts, M. Lobo, J. D. Esinhart, and E. K. Hussey. 1996. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 275:295–299.",references,NOT found in MAS
11215168.pdf,"Kim, C. U., N. Bischofberger, M. A. Williams, W. Lew, J. Merson, and C. Sweet. 1997. Efficacy of GS 4104 in ferrets infected with influenza A virus. Antivir. Res. 34:A74. (Abstract 114.)",references,10.1016/S0166-3542(97)83253-6,Efficacy of GS 4104 in ferrets infected with influenza A virus,"[[u'C.', u'U.', u'Kim'], [u'N.', u'', u'Bischofberger'], [u'M.', u'A.', u'Williams'], [u'W.', u'', u'Lew'], [u'J.', u'', u'Merson'], [u'C.', u'', u'Sweet']]",Antiviral Research,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0166354297832536', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354297832536']",
10.1016/S0166-3542(97)83253-6,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.1016/S0166-3542(97)83253-6,"Leneva, I., Roberts, N., Govorkova, E., et. al, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00123-6,The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses,"[['Irina', 'A.', 'Leneva'], ['Noel', '', 'Roberts'], ['Elena', 'A.', 'Govorkova'], ['Olga', 'G.', 'Goloubeva'], ['Robert', 'G.', 'Webster']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001236', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001236']",
10.1016/S0166-3542(97)83253-6,"Li, Z., Sun, J., Liang, G., et. al, On Three-Dimensional Holographic Vector of Atomic Interaction Field Analysis for Influenza Neuraminidase Inhibitors, Chemical Biology & Drug Design, 2009",cited-by,10.1111/j.1747-0285.2008.00767.x,On Three-Dimensional Holographic Vector of Atomic Interaction Field Analysis for Influenza Neuraminidase Inhibitors,"[['Zhiliang', 'S.', 'Li'], ['Jiaying', 'Y.', 'Sun'], ['Guizhao', 'Z.', 'Liang'], ['Fenglin', 'L.', 'Lu'], ['Wanping', 'P.', 'Zhu'], ['Mengjun', 'J.', 'Zhang'], ['Yonghong', '', 'Zhang'], ['Shanbin', 'B.', 'Yang'], ['Mao', '', 'Shu'], ['Guohua', 'H.', 'Chen'], ['Tingting', 'T.', 'Lu']]",Chemical Biology & Drug Design,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1747-0285.2008.00767.x'],
11215168.pdf,"Kim, C. U., W. Lew, M. A. Williams, H. Liu, L. Zhang, S. Swaminathan, N. Bischofberger, M. S. Chen, D. B. Mendel, C. Y. Tai, W. G. Laver, and R. C. Stevens. 1997. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119:681–690.",references,10.1021/ja963036t,"Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site:  Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity","[[u'Choung', u'U.', u'Kim'], [u'Willard', u'', u'Lew'], [u'Matthew', u'A.', u'Williams'], [u'Hongtao', u'', u'Liu'], [u'Lijun', u'', u'Zhang'], [u'S.', u'', u'Swaminathan'], [u'Norbert', u'', u'Bischofberger'], [u'Ming', u'S.', u'Chen'], [u'Dirk', u'B.', u'Mendel'], [u'Chun', u'Y.', u'Tai'], [u'W.', u'Graeme', u'Laver'], [u'Raymond', u'C.', u'Stevens']]",Journal of The American Chemical Society,1997,[u'http://pubs.acs.org/doi/abs/10.1021/ja963036t'],./output/11215168.pdf/10.1021~ja963036t
10.1021/ja963036t,"Kiso, M., Mitamura, K., Sakai-Tagawa, Y., et. al, Resistant influenza A viruses in children treated with oseltamivir: descriptive study, Lancet, 2004",cited-by,10.1016/S0140-6736(04)16934-1,Resistant influenza A viruses in children treated with oseltamivir: descriptive study,"[['Maki', '', 'Kiso'], ['Keiko', '', 'Mitamura'], ['Yuko', '', 'Sakai-Tagawa'], ['Kyoko', '', 'Shiraishi'], ['Chiharu', '', 'Kawakami'], ['Kazuhiro', '', 'Kimura'], ['Frederick', 'G', 'Hayden'], ['Norio', '', 'Sugaya'], ['Yoshihiro', '', 'Kawaoka']]",Lancet,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0140673604169341', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-19.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673604169341']",./output/11215168.pdf/citedby/10.1016~S0140-6736(04)16934-1
10.1021/ja963036t,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, Lancet, 2000",cited-by,10.1016/S0140-6736(99)11433-8,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699114338', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699114338']",
10.1021/ja963036t,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']",
10.1021/ja963036t,"Russell, R., Haire, L., Stevens, D., et. al, The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design, Nature, 2006",cited-by,10.1038/nature05114,The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design,"[['Rupert', 'J.', 'Russell'], ['Lesley', 'F.', 'Haire'], ['David', 'J.', 'Stevens'], ['Patrick', 'J.', 'Collins'], ['Yi', 'Pu', 'Lin'], ['G.', 'Michael', 'Blackburn'], ['Alan', 'J.', 'Hay'], ['Steven', 'J.', 'Gamblin'], ['John', 'J.', 'Skehel']]",Nature,2006,"[u'http://www.nature.com/doifinder/10.1038/nature05114', u'http://dx.doi.org/10.1038/nature05114']",./output/11215168.pdf/citedby/10.1038~nature05114
10.1021/ja963036t,"Bräse, S., Gil, C., Knepper, K., et. al, Organic Azides: An Exploding Diversity of a Unique Class of Compounds, Angewandte Chemie-international Edition, 2005",cited-by,10.1002/anie.200400657,Organic Azides: An Exploding Diversity of a Unique Class of Compounds,"[['Stefan', '', 'Br\xc3\xa4se'], ['Carmen', '', 'Gil'], ['Kerstin', '', 'Knepper'], ['Viktor', '', 'Zimmermann']]",Angewandte Chemie-international Edition,2005,[u'http://doi.wiley.com/10.1002/anie.200400657'],./output/11215168.pdf/citedby/10.1002~anie.200400657
10.1021/ja963036t,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']",./output/11215168.pdf/citedby/5346198Neuraminidase Inhibitors for Influenza
10.1021/ja963036t,"Wagner, R., Matrosovich, M., Klenk, H., , Functional balance between haemagglutinin and neuraminidase in influenza virus infections, Reviews in Medical Virology, 2002",cited-by,10.1002/rmv.352,Functional balance between haemagglutinin and neuraminidase in influenza virus infections,"[['Ralf', '', 'Wagner'], ['Mikhail', '', 'Matrosovich'], ['Hans-Dieter', '', 'Klenk']]",Reviews in Medical Virology,2002,[u'http://doi.wiley.com/10.1002/rmv.352'],./output/11215168.pdf/citedby/10.1002~rmv.352
10.1021/ja963036t,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, , 0",cited-by,12760434Influenza virus neuraminidase inhibitors,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",,0,[u'http://www.birdflumanual.com/resources/Medical_References/files/antineuraminidase%20therapy%20lancet.pdf'],
10.1021/ja963036t,"Ives, J., Carr, J., Mendel, D., et. al, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(02)00053-0,The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo,"[['J.', 'A. L.', 'Ives'], ['J.', 'A.', 'Carr'], ['D.', 'B.', 'Mendel'], ['C.', 'Y.', 'Tai'], ['R.', '', 'Lambkin'], ['L.', '', 'Kelly'], ['J.', 'S.', 'Oxford'], ['F.', 'G.', 'Hayden'], ['N.', 'A.', 'Roberts']]",Antiviral Research,2002,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-20.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354202000530', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-21.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354202000530']",./output/11215168.pdf/citedby/10.1016~S0166-3542(02)00053-0
10.1021/ja963036t,"Asano, N., , Glycosidase inhibitors: update and perspectives on practical use, Glycobiology, 2003",cited-by,10.1093/glycob/cwg090,Glycosidase inhibitors: update and perspectives on practical use,"[['Naoki', '', 'Asano']]",Glycobiology,2003,"[u'http://glycob.oxfordjournals.org/cgi/reprint/cwg090v1.pdf', u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/cwg090']",./output/11215168.pdf/citedby/10.1093~glycob~cwg090
10.1021/ja963036t,"McKimm-Breschkin, J., Trivedi, T., Hampson, A., et. al, Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir, Antimicrobial Agents and Chemotherapy, 2003",cited-by,10.1128/AAC.47.7.2264-2272.2003,Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir,"[['J.', '', 'McKimm-Breschkin'], ['T.', '', 'Trivedi'], ['A.', '', 'Hampson'], ['A.', '', 'Hay'], ['A.', '', 'Klimov'], ['M.', '', 'Tashiro'], ['F.', '', 'Hayden'], ['M.', '', 'Zambon']]",Antimicrobial Agents and Chemotherapy,2003,"[u'http://aac.highwire.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.47.7.2264-2272.2003']",./output/11215168.pdf/citedby/10.1128~AAC.47.7.2264-2272.2003
10.1021/ja963036t,"Clercq, E., , Antivirals and antiviral strategies, Nature Reviews Microbiology, 2004",cited-by,10.1038/nrmicro975,Antivirals and antiviral strategies,"[['Erik', 'De', 'Clercq']]",Nature Reviews Microbiology,2004,"[u'http://dx.doi.org/10.1038/nrmicro975', u'http://www.nature.com/doifinder/10.1038/nrmicro975']",./output/11215168.pdf/citedby/10.1038~nrmicro975
10.1021/ja963036t,"Clercq, E., , Strategies in the design of antiviral drugs, Nature Reviews Drug Discovery, 2002",cited-by,10.1038/nrd703,Strategies in the design of antiviral drugs,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2002,"[u'http://dx.doi.org/10.1038/nrd703', u'http://www.nature.com/doifinder/10.1038/nrd703']",./output/11215168.pdf/citedby/10.1038~nrd703
10.1021/ja963036t,"Collins, P., Haire, L., Lin, Y., et. al, Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants, Nature, 2008",cited-by,10.1038/nature06956,Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants,"[['Patrick', 'J.', 'Collins'], ['Lesley', 'F.', 'Haire'], ['Yi', 'Pu', 'Lin'], ['Junfeng', '', 'Liu'], ['Rupert', 'J.', 'Russell'], ['Philip', 'A.', 'Walker'], ['John', 'J.', 'Skehel'], ['Stephen', 'R.', 'Martin'], ['Alan', 'J.', 'Hay'], ['Steven', 'J.', 'Gamblin']]",Nature,2008,"[u'http://www.nature.com/doifinder/10.1038/nature06956', u'http://dx.doi.org/10.1038/nature06956']",./output/11215168.pdf/citedby/10.1038~nature06956
10.1021/ja963036t,"Karlsson, K., , Meaning and therapeutic potential of microbial recognition of host glycoconjugates, Molecular Microbiology, 1998",cited-by,10.1046/j.1365-2958.1998.00854.x,Meaning and therapeutic potential of microbial recognition of host glycoconjugates,"[['Karl-Anders', '', 'Karlsson']]",Molecular Microbiology,1998,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2958.1998.00854.x'],./output/11215168.pdf/citedby/10.1046~j.1365-2958.1998.00854.x
10.1021/ja963036t,"Oxford, J., , Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology, Reviews in Medical Virology, 2000",cited-by,10.1002/(SICI)1099-1654(200003/04)10:2<119::AID-RMV272>3.0.CO;2-O,"Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology","[['J.', 'S.', 'Oxford']]",Reviews in Medical Virology,2000,[u'http://doi.wiley.com/10.1002/%28SICI%291099-1654%28200003/04%2910%3A2%3C119%3A%3AAID-RMV272%3E3.0.CO%3B2-O'],
10.1021/ja963036t,"Vilchez, R., McCurry, K., Dauber, J., et. al, Influenza Virus Infection in Adult Solid Organ Transplant Recipients, American Journal of Transplantation, 2002",cited-by,10.1034/j.1600-6143.2002.20315.x,Influenza Virus Infection in Adult Solid Organ Transplant Recipients,"[['Regis', 'A.', 'Vilchez'], ['Kenneth', '', 'McCurry'], ['James', '', 'Dauber'], ['Aldo', '', 'Iacono'], ['Bartley', '', 'Griffith'], ['John', '', 'Fung'], ['Shimon', '', 'Kusne']]",American Journal of Transplantation,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1600-6143.2002.20315.x'],./output/11215168.pdf/citedby/10.1034~j.1600-6143.2002.20315.x
10.1021/ja963036t,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/11215168.pdf/citedby/7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
10.1021/ja963036t,"Tisdale, M., , Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors, Reviews in Medical Virology, 2000",cited-by,10.1002/(SICI)1099-1654(200001/02)10:1<45::AID-RMV265>3.0.CO;2-R,Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors,"[['Margaret', '', 'Tisdale']]",Reviews in Medical Virology,2000,[u'http://doi.wiley.com/10.1002/%28SICI%291099-1654%28200001/02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R'],
10.1021/ja963036t,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x'],
10.1021/ja963036t,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf'],./output/11215168.pdf/citedby/11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071
10.1021/ja963036t,"Varghese, J., Smith, P., Sollis, S., et. al, Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, Structure, 1998",cited-by,10.1016/S0969-2126(98)00075-6,Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase,"[['Joseph', 'N', 'Varghese'], ['Paul', 'W', 'Smith'], ['Steven', 'L', 'Sollis'], ['Tony', 'J', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Jennifer', 'L', 'McKimm-Breschkin'], ['Peter', 'M', 'Colman']]",Structure,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0969212698000756', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212698000756']",
10.1021/ja963036t,"Sidwell, R., Huffman, J., Barnard, D., et. al, Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor, Antiviral Research, 1998",cited-by,10.1016/S0166-3542(97)00065-X,"Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor","[['Robert', 'W.', 'Sidwell'], ['John', 'H.', 'Huffman'], ['Dale', 'L.', 'Barnard'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Ann', '', 'Morrison'], ['Timothy', '', 'Syndergaard'], ['Choung', 'U.', 'Kim']]",Antiviral Research,1998,"[u'http://www.sciencedirect.com/science/article/pii/S016635429700065X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635429700065X']",
10.1021/ja963036t,"Coleman, R., Smyth, K., Cao, Q., et. al, Structure-based maximal affinity model predicts small-molecule druggability, Nature Biotechnology, 2007",cited-by,10.1038/nbt1273,Structure-based maximal affinity model predicts small-molecule druggability,"[['Ryan', 'G', 'Coleman'], ['Kathleen', 'T', 'Smyth'], ['Qing', '', 'Cao'], ['Patricia', '', 'Soulard'], ['Daniel', 'R', 'Caffrey'], ['Anna', 'C', 'Salzberg'], ['Enoch', 'S', 'Huang'], ['Alan', 'C', 'Cheng']]",Nature Biotechnology,2007,"[u'http://sws.bu.edu/eshuang/papers/Cheng07.pdf', u'http://dx.doi.org/10.1038/nbt1273', u'http://www.nature.com/doifinder/10.1038/nbt1273']",./output/11215168.pdf/citedby/10.1038~nbt1273
10.1021/ja963036t,", Catalytic Asymmetric Hetero-Diels–Alder Reactions of Carbonyl Compounds and Imines, Angewandte Chemie-international Edition, 2000",cited-by,10.1002/1521-3773(20001016)39:20<3558::AID-ANIE3558>3.0.CO;2-I,Catalytic Asymmetric Hetero-Diels–Alder Reactions of Carbonyl Compounds and Imines,[],Angewandte Chemie-international Edition,2000,[u'http://doi.wiley.com/10.1002/1521-3773%2820001016%2939%3A20%3C3558%3A%3AAID-ANIE3558%3E3.0.CO%3B2-I'],
10.1021/ja963036t,"Clercq, E., , Antiviral agents active against influenza A viruses, Nature Reviews Drug Discovery, 2006",cited-by,10.1038/nrd2175,Antiviral agents active against influenza A viruses,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2006,"[u'http://dx.doi.org/10.1038/nrd2175', u'http://www.nature.com/doifinder/10.1038/nrd2175']",./output/11215168.pdf/citedby/10.1038~nrd2175
10.1021/ja963036t,"SMEE, D., HUFFMAN, J., MORRISON, A., et. al, Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.743-748.2001,Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities,"[['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['ANN', 'C.', 'MORRISON'], ['DALE', 'L.', 'BARNARD'], ['ROBERT', 'W.', 'SIDWELL']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://journals.pasteur.ac.ir/AAC01/45(3)/743.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.743-748.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.3.743-748.2001
10.1021/ja963036t,"Wang, M., Tai, C., Mendel, D., , Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.12.3809-3816.2002,Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir,"[['Michael', 'Z.', 'Wang'], ['Chun', 'Y.', 'Tai'], ['Dirk', 'B.', 'Mendel']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/12/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.12.3809-3816.2002']",./output/11215168.pdf/citedby/10.1128~AAC.46.12.3809-3816.2002
10.1021/ja963036t,"Itzstein, M., , The war against influenza: discovery and development of sialidase inhibitors, Nature Reviews Drug Discovery, 2007",cited-by,10.1038/nrd2400,The war against influenza: discovery and development of sialidase inhibitors,"[['Mark', 'von', 'Itzstein']]",Nature Reviews Drug Discovery,2007,"[u'http://dx.doi.org/10.1038/nrd2400', u'http://www.nature.com/doifinder/10.1038/nrd2400']",./output/11215168.pdf/citedby/10.1038~nrd2400
10.1021/ja963036t,"MCKIMM-BRESCHKIN, J., SAHASRABUDHE, A., BLICK, T., et. al, Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors, , 1998",cited-by,13896013Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,"[['JENNIFER', 'L.', 'MCKIMM-BRESCHKIN'], ['ANJALI', '', 'SAHASRABUDHE'], ['TONY', 'J.', 'BLICK'], ['MANDY', '', 'MCDONALD'], ['PETER', 'M.', 'COLMAN'], ['GRAHAM', 'J.', 'HART'], ['RICHARD', 'C.', 'BETHELL'], ['JOSEPH', 'N.', 'VARGHESE']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/3/2456.pdf'],./output/11215168.pdf/citedby/13896013Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors
10.1021/ja963036t,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.1021/ja963036t,", Katalytische asymmetrische Hetero-Diels-Alder-Reaktionen von Carbonylverbindungen und Iminen, Angewandte Chemie, 2000",cited-by,10.1002/1521-3757(20001016)112:20<3702::AID-ANGE3702>3.0.CO;2-R,Katalytische asymmetrische Hetero-Diels-Alder-Reaktionen von Carbonylverbindungen und Iminen,[],Angewandte Chemie,2000,[u'http://doi.wiley.com/10.1002/1521-3757%2820001016%29112%3A20%3C3702%3A%3AAID-ANGE3702%3E3.0.CO%3B2-R'],
10.1021/ja963036t,"Sears, P., Wong, C., , Enzyme action in glycoprotein synthesis, Experientia, 1998",cited-by,10.1007/s000180050146,Enzyme action in glycoprotein synthesis,"[['P.', '', 'Sears'], ['C.-H.', '', 'Wong']]",Experientia,1998,"[u'http://www.springerlink.com/content/dj9ypk3xnhdcw1t9', u'http://www.springerlink.com/index/dj9ypk3xnhdcw1t9.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s000180050146', u'http://www.springerlink.com/index/pdf/10.1007/s000180050146']",./output/11215168.pdf/citedby/10.1007~s000180050146
10.1021/ja963036t,"Govorkova, E., Fang, H., Tan, M., et. al, Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4855-4863.2004,Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells,"[['Elena', 'A.', 'Govorkova'], ['Hong-Bin', '', 'Fang'], ['Ming', '', 'Tan'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4855.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4855-4863.2004']",./output/11215168.pdf/citedby/10.1128~AAC.48.12.4855-4863.2004
10.1021/ja963036t,"Kuhn, P., Wilson, K., Patch, M., et. al, The genesis of high-throughput structure-based drug discovery using protein crystallography, Current Opinion in Chemical Biology, 2002",cited-by,10.1016/S1367-5931(02)00361-7,The genesis of high-throughput structure-based drug discovery using protein crystallography,"[['Peter', '', 'Kuhn'], ['Keith', '', 'Wilson'], ['Marianne', 'G', 'Patch'], ['Raymond', 'C', 'Stevens']]",Current Opinion in Chemical Biology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1367593102003617', u'http://linkinghub.elsevier.com/retrieve/pii/S1367593102003617', u'http://www.osti.gov/servlets/purl/815941']",
10.1021/ja963036t,"Hayden, F., , Antivirals for influenza: Historical perspectives and lessons learned, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.05.016,Antivirals for influenza: Historical perspectives and lessons learned,"[['Frederick', 'G.', 'Hayden']]",Antiviral Research,2006,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-10.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354206001653', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206001653']",./output/11215168.pdf/citedby/10.1016~j.antiviral.2006.05.016
10.1021/ja963036t,"Obayashi, E., Yoshida, H., Kawai, F., et. al, The structural basis for an essential subunit interaction in influenza virus RNA polymerase, Nature, 2008",cited-by,10.1038/nature07225,The structural basis for an essential subunit interaction in influenza virus RNA polymerase,"[['Eiji', '', 'Obayashi'], ['Hisashi', '', 'Yoshida'], ['Fumihiro', '', 'Kawai'], ['Naoya', '', 'Shibayama'], ['Atsushi', '', 'Kawaguchi'], ['Kyosuke', '', 'Nagata'], ['Jeremy', 'R. H.', 'Tame'], ['Sam-Yong', '', 'Park']]",Nature,2008,"[u'http://www.nature.com/doifinder/10.1038/nature07225', u'http://dx.doi.org/10.1038/nature07225', u'http://adsabs.harvard.edu/abs/2008Natur.454.1127O']",./output/11215168.pdf/citedby/10.1038~nature07225
10.1021/ja963036t,"Serruto, D., Rappuoli, R., , Post-genomic vaccine development, Febs Letters, 2006",cited-by,10.1016/j.febslet.2006.04.084,Post-genomic vaccine development,"[['Davide', '', 'Serruto'], ['Rino', '', 'Rappuoli']]",Febs Letters,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0014579306005412', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-15.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0014579306005412']",./output/11215168.pdf/citedby/10.1016~j.febslet.2006.04.084
10.1021/ja963036t,"Bräse, S., Gil, C., Knepper, K., et. al, Organische Azide - explodierende Vielfalt bei einer einzigartigen Substanzklasse, Angewandte Chemie, 2005",cited-by,10.1002/ange.200400657,Organische Azide - explodierende Vielfalt bei einer einzigartigen Substanzklasse,"[['Stefan', '', 'Br\xc3\xa4se'], ['Carmen', '', 'Gil'], ['Kerstin', '', 'Knepper'], ['Viktor', '', 'Zimmermann']]",Angewandte Chemie,2005,[u'http://doi.wiley.com/10.1002/ange.200400657'],./output/11215168.pdf/citedby/10.1002~ange.200400657
10.1021/ja963036t,"Ishikawa, H., Suzuki, T., Hayashi, Y., , High-Yielding Synthesis of the Anti-Influenza Neuramidase Inhibitor (−)-Oseltamivir by Three “One-Pot” Operations, Angewandte Chemie-international Edition, 2009",cited-by,10.1002/anie.200804883,High-Yielding Synthesis of the Anti-Influenza Neuramidase Inhibitor (−)-Oseltamivir by Three “One-Pot” Operations,"[['Hayato', '', 'Ishikawa'], ['Takaki', '', 'Suzuki'], ['Yujiro', '', 'Hayashi']]",Angewandte Chemie-international Edition,2009,[u'http://doi.wiley.com/10.1002/anie.200804883'],./output/11215168.pdf/citedby/10.1002~anie.200804883
10.1021/ja963036t,"Reece, P., , Neuraminidase inhibitor resistance in influenza viruses, Journal of Medical Virology, 2007",cited-by,10.1002/jmv.20951,Neuraminidase inhibitor resistance in influenza viruses,"[['Phillip', 'Andrew', 'Reece']]",Journal of Medical Virology,2007,[u'http://doi.wiley.com/10.1002/jmv.20951'],./output/11215168.pdf/citedby/10.1002~jmv.20951
10.1021/ja963036t,"Ikeda, M., , Towards bacterial strains overproducing l -tryptophan and other aromatics by metabolic engineering, Applied Microbiology and Biotechnology, 2006",cited-by,10.1007/s00253-005-0252-y,Towards bacterial strains overproducing l -tryptophan and other aromatics by metabolic engineering,"[['Masato', '', 'Ikeda']]",Applied Microbiology and Biotechnology,2006,"[u'http://www.springerlink.com/content/71185513831uk3u0', u'http://www.springerlink.com/index/71185513831uk3u0.pdf', u'http://www.springerlink.com/index/10.1007/s00253-005-0252-y', u'http://www.springerlink.com/index/pdf/10.1007/s00253-005-0252-y']",./output/11215168.pdf/citedby/10.1007~s00253-005-0252-y
10.1021/ja963036t,"Satoh, N., Akiba, T., Yokoshima, S., et. al, A Practical Synthesis of (−)-Oseltamivir, Angewandte Chemie-international Edition, 2007",cited-by,10.1002/anie.200701754,A Practical Synthesis of (−)-Oseltamivir,"[['Nobuhiro', '', 'Satoh'], ['Takahiro', '', 'Akiba'], ['Satoshi', '', 'Yokoshima'], ['Tohru', '', 'Fukuyama']]",Angewandte Chemie-international Edition,2007,"[u'http://doi.wiley.com/10.1002/anie.200701754', u'https://netfiles.uiuc.edu/jsmoore/www/09fa/notes/Fukuyama07.pdf']",./output/11215168.pdf/citedby/10.1002~anie.200701754
10.1021/ja963036t,"Moscona, A., , Medical Management of Influenza Infection, Annual Review of Medicine, 2008",cited-by,10.1146/annurev.med.59.061506.213121,Medical Management of Influenza Infection,"[['Anne', '', 'Moscona']]",Annual Review of Medicine,2008,"[u'http://www.cornellpediatrics.org/bm~doc/medical-management-of-inf.pdf', u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.med.59.061506.213121']",./output/11215168.pdf/citedby/10.1146~annurev.med.59.061506.213121
10.1021/ja963036t,"Leyssen, P., Clercq, E., Neyts, J., , Molecular strategies to inhibit the replication of RNA viruses, Antiviral Research, 2008",cited-by,10.1016/j.antiviral.2008.01.004,Molecular strategies to inhibit the replication of RNA viruses,"[['Pieter', '', 'Leyssen'], ['Erik', 'De', 'Clercq'], ['Johan', '', 'Neyts']]",Antiviral Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208000247', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208000247']",
10.1021/ja963036t,"Magnani, J., Ernst, B., , From carbohydrate leads to glycomimetic drugs, Nature Reviews Drug Discovery, 2009",cited-by,10.1038/nrd2852,From carbohydrate leads to glycomimetic drugs,"[['John', 'L.', 'Magnani'], ['Beat', '', 'Ernst']]",Nature Reviews Drug Discovery,2009,"[u'http://www.nature.com/doifinder/10.1038/nrd2852', u'http://dx.doi.org/10.1038/nrd2852']",./output/11215168.pdf/citedby/10.1038~nrd2852
10.1021/ja963036t,"Elinav, E., Strowig, T., Henao-Mejia, J., et. al, NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis, Cell, 2011",cited-by,10.1016/j.cell.2011.04.022,NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis,"[['Eran', '', 'Elinav'], ['Till', '', 'Strowig'], ['Jorge', '', 'Henao-Mejia'], ['John', '', 'Bertin']]",Cell,2011,[u'http://www.sciencedirect.com/science/article/pii/S0092867411004806'],
10.1021/ja963036t,"Russell, R., Kerry, P., Stevens, D., et. al, Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion, Proceedings of The National Academy of Sciences, 2008",cited-by,10.1073/pnas.0807142105,Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion,"[['Rupert', 'J.', 'Russell'], ['Philip', 'S.', 'Kerry'], ['David', 'J.', 'Stevens'], ['David', 'A.', 'Steinhauer'], ['Stephen', 'R.', 'Martin'], ['Steven', 'J.', 'Gamblin'], ['John', 'J.', 'Skehel']]",Proceedings of The National Academy of Sciences,2008,"[u'http://www.pnas.org/cgi/doi/10.1073/pnas.0807142105', u'http://alt.coxnewsweb.com/shared-blogs/austin/health/upload/2009/02/premier_flu_researcher_at_ut_s/PNAS-Chemical inhibitor against HA.pdf']",./output/11215168.pdf/citedby/10.1073~pnas.0807142105
10.1021/ja963036t,"Molla, A., Kati, W., Carrick, R., et. al, In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675, Journal of Virology, 2002",cited-by,10.1128/JVI.76.11.5380-5386.2002,"In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675","[['Akhteruzzaman', '', 'Molla'], ['Warren', '', 'Kati'], ['Robert', '', 'Carrick'], ['Kevin', '', 'Steffy'], ['Yan', '', 'Shi'], ['Debra', '', 'Montgomery'], ['Nanette', '', 'Gusick'], ['Vincent', 'S.', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['Teresa', 'I.', 'Ng'], ['Clarence', '', 'Maring'], ['Dale', 'J.', 'Kempf'], ['William', '', 'Kohlbrenner']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/11/5380.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.11.5380-5386.2002']",./output/11215168.pdf/citedby/10.1128~JVI.76.11.5380-5386.2002
10.1021/ja963036t,"Zurcher, T., Yates, P., Daly, J., et. al, Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro, , 2006",cited-by,6952646Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro,Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro,"[['Thomas', '', 'Zurcher'], ['Phillip', 'J.', 'Yates'], ['Janet', '', 'Daly'], ['Anjali', '', 'Sahasrabudhe'], ['Matthew', '', 'Walters'], ['Laura', '', 'Dash'], ['Margaret', '', 'Tisdale']]",,2006,"[u'http://jac.oxfordjournals.org/cgi/reprint/58/4/723.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkl321v1.pdf']",
10.1021/ja963036t,"Clercq, E., Field, H., , Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy, British Journal of Pharmacology, 2006",cited-by,10.1038/sj.bjp.0706446,Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy,"[['Erik', 'De', 'Clercq'], ['Hugh', 'J', 'Field']]",British Journal of Pharmacology,2006,[u'http://blackwell-synergy.com/doi/abs/10.1038/sj.bjp.0706446'],
10.1021/ja963036t,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf'],./output/11215168.pdf/citedby/6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts
10.1021/ja963036t,"Aoki, F., Doucette, K., , Oseltamivir: a clinical and pharmacological perspective, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.10.1671,Oseltamivir: a clinical and pharmacological perspective,"[['Fred', 'Y', 'Aoki'], ['Karen', 'E', 'Doucette']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.10.1671'],./output/11215168.pdf/citedby/10.1517~14656566.2.10.1671
10.1021/ja963036t,"Zhang, T., , A Concise Synthesis of (−)-Oseltamivir, Angewandte Chemie-international Edition, 2008",cited-by,10.1002/anie.200800282,A Concise Synthesis of (−)-Oseltamivir,"[['Ting', '', 'Zhang']]",Angewandte Chemie-international Edition,2008,[u'http://doi.wiley.com/10.1002/anie.200800282'],./output/11215168.pdf/citedby/10.1002~anie.200800282
10.1021/ja963036t,"Singer, A., Nunn, M., Gould, E., et. al, Potential Risks Associated with the Proposed Widespread Use of Tamiflu, Environmental Health Perspectives, 2006",cited-by,10.1289/ehp.9574,Potential Risks Associated with the Proposed Widespread Use of Tamiflu,"[['Andrew', 'C.', 'Singer'], ['Miles', 'A.', 'Nunn'], ['Ernest', 'A.', 'Gould'], ['Andrew', 'C.', 'Johnson']]",Environmental Health Perspectives,2006,[u'http://www.ehponline.org/ambra-doi-resolver/10.1289/ehp.9574'],./output/11215168.pdf/citedby/10.1289~ehp.9574
10.1021/ja963036t,"Li, C., Yu, Q., Ye, Z., et. al, A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir, Cell Research, 2007",cited-by,10.1038/cr.2007.27,A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir,"[['Chuan-Yun', '', 'Li'], ['Quan', '', 'Yu'], ['Zhi-Qiang', '', 'Ye'], ['Ying', '', 'Sun'], ['Quanyuan', '', 'He'], ['Xiao-Mo', '', 'Li'], ['Wuxue', '', 'Zhang'], ['Jingchu', '', 'Luo'], ['Xiaocheng', '', 'Gu'], ['Xiaofeng', '', 'Zheng'], ['Liping', '', 'Wei']]",Cell Research,2007,"[u'http://www.nature.com/doifinder/10.1038/cr.2007.27', u'http://dx.doi.org/10.1038/cr.2007.27']",./output/11215168.pdf/citedby/10.1038~cr.2007.27
10.1021/ja963036t,"Noah, D., Krug, R., , Influenza Virus Virulence and Its Molecular Determinants, Advances in Virus Research, 2005",cited-by,10.1016/S0065-3527(05)65004-X,Influenza Virus Virulence and Its Molecular Determinants,"[['Diana', 'L.', 'Noah'], ['Robert', 'M.', 'Krug']]",Advances in Virus Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S006535270565004X', u'http://linkinghub.elsevier.com/retrieve/pii/S006535270565004X']",
10.1021/ja963036t,"Crain, S., Shen, K., , Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice, Brain Research, 2004",cited-by,10.1016/j.brainres.2003.09.068,"Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice","[['Stanley', 'M.', 'Crain'], ['Ke-Fei', '', 'Shen']]",Brain Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0006899303038460', u'http://linkinghub.elsevier.com/retrieve/pii/S0006899303038460']",
10.1021/ja963036t,"Laver, W., Bischofberger, N., Webster, R., , The Origin and Control of Pandemic Influenza, , 2000",cited-by,10259737The Origin and Control of Pandemic Influenza,The Origin and Control of Pandemic Influenza,"[['W.', 'Graeme', 'Laver'], ['Norbert', '', 'Bischofberger'], ['Robert', 'G.', 'Webster']]",,2000,"[u'http://birdflubook.com/resources/LAVER173.pdf', u'http://muse.jhu.edu/about/publishers.html/journals/perspectives_in_biology_and_medicine/v043/43.2laver.html']",./output/11215168.pdf/citedby/10259737The Origin and Control of Pandemic Influenza
10.1021/ja963036t,"Bouvier, N., Lowen, A., Palese, P., , Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol, Journal of Virology, 2008",cited-by,10.1128/JVI.01226-08,Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol,"[['Nicole', 'M.', 'Bouvier'], ['Anice', 'C.', 'Lowen'], ['Peter', '', 'Palese']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/20/10052.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01226-08']",./output/11215168.pdf/citedby/10.1128~JVI.01226-08
10.1021/ja963036t,"Shibasaki, M., Kanai, M., , Synthetic Strategies for Oseltamivir Phosphate, European Journal of Organic Chemistry, 2008",cited-by,10.1002/ejoc.200800033,Synthetic Strategies for Oseltamivir Phosphate,"[['Masakatsu', '', 'Shibasaki'], ['Motomu', '', 'Kanai']]",European Journal of Organic Chemistry,2008,[u'http://doi.wiley.com/10.1002/ejoc.200800033'],./output/11215168.pdf/citedby/10.1002~ejoc.200800033
10.1021/ja963036t,"Hosfield, D., Palan, J., Hilgers, M., et. al, A fully integrated protein crystallization platform for small-molecule drug discovery, Journal of Structural Biology, 2003",cited-by,10.1016/S1047-8477(03)00051-0,A fully integrated protein crystallization platform for small-molecule drug discovery,"[['David', '', 'Hosfield'], ['John', '', 'Palan'], ['Mark', '', 'Hilgers'], ['Daniel', '', 'Scheibe'], ['Duncan', 'E.', 'McRee'], ['Raymond', 'C.', 'Stevens']]",Journal of Structural Biology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1047847703000510', u'http://linkinghub.elsevier.com/retrieve/pii/S1047847703000510']",
10.1021/ja963036t,"Laver, G., Garman, E., , Pandemic influenza: its origin and control, Microbes and Infection, 2002",cited-by,10.1016/S1286-4579(02)00013-8,Pandemic influenza: its origin and control,"[['Graeme', '', 'Laver'], ['Elspeth', '', 'Garman']]",Microbes and Infection,2002,"[u'http://birdflubook.com/resources/laver1309.pdf', u'http://www.sciencedirect.com/science/article/pii/S1286457902000138', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-37.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457902000138']",./output/11215168.pdf/citedby/10.1016~S1286-4579(02)00013-8
10.1021/ja963036t,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']",
10.1021/ja963036t,"Rinaudo, C., Telford, J., Rappuoli, R., et. al, Vaccinology in the genome era, Journal of Clinical Investigation, 2009",cited-by,10.1172/JCI38330,Vaccinology in the genome era,"[['C.', 'Daniela', 'Rinaudo'], ['John', 'L.', 'Telford'], ['Rino', '', 'Rappuoli'], ['Kate', 'L.', 'Seib']]",Journal of Clinical Investigation,2009,[u'http://www.jci.org/articles/view/38330'],./output/11215168.pdf/citedby/10.1172~JCI38330
10.1021/ja963036t,"Xu, X., Zhu, X., Dwek, R., et. al, Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase, Journal of Virology, 2008",cited-by,10.1128/JVI.00959-08,Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase,"[['Xiaojin', '', 'Xu'], ['Xueyong', '', 'Zhu'], ['Raymond', 'A.', 'Dwek'], ['James', '', 'Stevens'], ['Ian', 'A.', 'Wilson']]",Journal of Virology,2008,"[u'http://www.medicasur.com.mx/work/sites/Medica_en_linea/resources/LocalContent/8797/38/STRUCTURAL_CHARACTERIZATION_OF_THE_1918_INFLUENZA_VIRUS_H1N1_NEURAMINIDASE_10493_2008.pdf', u'http://jvi.asm.org/cgi/reprint/82/21/10493.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00959-08']",./output/11215168.pdf/citedby/10.1128~JVI.00959-08
10.1021/ja963036t,"McKimm-Breschkin, J., , Neuraminidase inhibitors for the treatment and prevention of influenza, Expert Opinion on Pharmacotherapy, 2002",cited-by,10.1517/14656566.3.2.103,Neuraminidase inhibitors for the treatment and prevention of influenza,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Expert Opinion on Pharmacotherapy,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.3.2.103'],./output/11215168.pdf/citedby/10.1517~14656566.3.2.103
10.1021/ja963036t,"Yun, N., Linde, N., Zacks, M., et. al, Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1), Virology, 2008",cited-by,10.1016/j.virol.2007.12.029,"Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)","[['Nadezhda', 'E.', 'Yun'], ['Nathaniel', 'S.', 'Linde'], ['Michele', 'A.', 'Zacks'], ['Ian', 'G.', 'Barr'], ['Aeron', 'C.', 'Hurt'], ['Jeanon', 'N.', 'Smith'], ['Natallia', '', 'Dziuba'], ['Michael', 'R.', 'Holbrook'], ['Lifang', '', 'Zhang'], ['John', 'M.', 'Kilpatrick'], ['C.', 'Shane', 'Arnold'], ['Slobodan', '', 'Paessler']]",Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0042682207008562', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682207008562']",
10.1021/ja963036t,"Du, Q., Wang, S., Chou, K., , Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus, Biochemical and Biophysical Research Communications, 2007",cited-by,10.1016/j.bbrc.2007.08.025,Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus,"[['Qi-Shi', '', 'Du'], ['Shu-Qing', '', 'Wang'], ['Kuo-Chen', '', 'Chou']]",Biochemical and Biophysical Research Communications,2007,"[u'http://people.virginia.edu/~fc8b/kchou/new/paper/BBRC_H5N1_150_loop_2007.pdf', u'http://www.sciencedirect.com/science/article/pii/S0006291X07017317', u'http://linkinghub.elsevier.com/retrieve/pii/S0006291X07017317']",
10.1021/ja963036t,"Varghese, J., , Development of neuraminidase inhibitors as anti-influenza virus drugs, Drug Development Research, 1999",cited-by,10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6,Development of neuraminidase inhibitors as anti-influenza virus drugs,"[['Joseph', 'N.', 'Varghese']]",Drug Development Research,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291098-2299%28199903/04%2946%3A3/4%3C176%3A%3AAID-DDR4%3E3.0.CO%3B2-6'],
10.1021/ja963036t,", A Concise and Flexible Synthesis of the Potent Anti‐Influenza Agents Tamiflu and Tamiphosphor, Angewandte Chemie-international Edition, 2008",cited-by,10.1002/anie.200801959,A Concise and Flexible Synthesis of the Potent Anti‐Influenza Agents Tamiflu and Tamiphosphor,[],Angewandte Chemie-international Edition,2008,[u'http://doi.wiley.com/10.1002/anie.200801959'],./output/11215168.pdf/citedby/10.1002~anie.200801959
10.1021/ja963036t,"Morrissey, B., Downard, K., , A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry, Proteomics, 2006",cited-by,10.1002/pmic.200500642,A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry,"[['Bethny', '', 'Morrissey'], ['Kevin', 'M.', 'Downard']]",Proteomics,2006,[u'http://doi.wiley.com/10.1002/pmic.200500642'],./output/11215168.pdf/citedby/10.1002~pmic.200500642
10.1021/ja963036t,"Kubinyi, H., , Structure-based design of enzyme inhibitors and receptor ligands, , 0",cited-by,11607428Structure-based design of enzyme inhibitors and receptor ligands,Structure-based design of enzyme inhibitors and receptor ligands,"[['Hugo', '', 'Kubinyi']]",,0,[u'http://www.kubinyi.de/coddd-1.pdf'],./output/11215168.pdf/citedby/11607428Structure-based design of enzyme inhibitors and receptor ligands
10.1021/ja963036t,"Sweet, C., Jakeman, K., Bush, K., et. al, Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.996-1004.2002,Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection,"[['Clive', '', 'Sweet'], ['Kenneth', 'J.', 'Jakeman'], ['Karen', '', 'Bush'], ['Pamela', 'C.', 'Wagaman'], ['Linda', 'A.', 'Mckown'], ['Anthony', 'J.', 'Streeter'], ['Daksha', '', 'Desai-Krieger'], ['Pooran', '', 'Chand'], ['Yarlagadda', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/996.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.996-1004.2002']",./output/11215168.pdf/citedby/10.1128~AAC.46.4.996-1004.2002
10.1021/ja963036t,"Englund, J., , Antiviral therapy of influenza, Seminars in Pediatric Infectious Diseases, 2002",cited-by,10.1053/spid.2002.122999,Antiviral therapy of influenza,"[['Janet', 'A.', 'Englund']]",Seminars in Pediatric Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1045187002500571', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187002500571']",./output/11215168.pdf/citedby/10.1053~spid.2002.122999
10.1021/ja963036t,"Williams, S., Davies, G., , Protein–carbohydrate interactions: learning lessons from nature, Trends in Biotechnology, 2001",cited-by,10.1016/S0167-7799(01)01699-7,Protein–carbohydrate interactions: learning lessons from nature,"[['Spencer', 'J.', 'Williams'], ['Gideon', 'J.', 'Davies']]",Trends in Biotechnology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0167779901016997', u'http://linkinghub.elsevier.com/retrieve/pii/S0167779901016997']",
10.1021/ja963036t,"Wang, B., Dwyer, D., Blyth, C., et. al, Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections, Antiviral Research, 2010",cited-by,10.1016/j.antiviral.2010.04.002,Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections,"[['Bin', '', 'Wang'], ['Dominic', 'E.', 'Dwyer'], ['Christopher', 'C.', 'Blyth'], ['Maly', '', 'Soedjono'], ['Haijing', '', 'Shi'], ['Alison', '', 'Kesson'], ['Mala', '', 'Ratnamohan'], ['Ken', '', 'McPhie'], ['Anthony', 'L.', 'Cunningham'], ['Nitin', 'K.', 'Saksena']]",Antiviral Research,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0166354210005723', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354210005723']",
10.1021/ja963036t,"Hung, H., Tseng, C., Yang, J., et. al, Aurintricarboxylic acid inhibits influenza virus neuraminidase, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.10.006,Aurintricarboxylic acid inhibits influenza virus neuraminidase,"[['Hui-Chen', '', 'Hung'], ['Ching-Ping', '', 'Tseng'], ['Jinn-Moon', '', 'Yang'], ['Yi-Wei', '', 'Ju'], ['Sung-Nain', '', 'Tseng'], ['Yen-Fu', '', 'Chen'], ['Yu-Sheng', '', 'Chao'], ['Hsing-Pang', '', 'Hsieh'], ['Shin-Ru', '', 'Shih'], ['John', 'T.-A.', 'Hsu']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208004300', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208004300']",
10.1021/ja963036t,"Lagoja, I., Clercq, E., , Anti-influenza virus agents: Synthesis and mode of action, Medicinal Research Reviews, 2008",cited-by,10.1002/med.20096,Anti-influenza virus agents: Synthesis and mode of action,"[['Irene', 'M.', 'Lagoja'], ['Erik', 'De', 'Clercq']]",Medicinal Research Reviews,2008,[u'http://doi.wiley.com/10.1002/med.20096'],./output/11215168.pdf/citedby/10.1002~med.20096
10.1021/ja963036t,"Chutinimitkul, S., Suwannakarn, K., Chieochansin, T., et. al, H5N1 Oseltamivir-resistance detection by real-time PCR using two high sensitivity labeled TaqMan probes, Journal of Virological Methods, 2007",cited-by,10.1016/j.jviromet.2006.09.007,H5N1 Oseltamivir-resistance detection by real-time PCR using two high sensitivity labeled TaqMan probes,"[['Salin', '', 'Chutinimitkul'], ['Kamol', '', 'Suwannakarn'], ['Thaweesak', '', 'Chieochansin'], ['Le', 'Quynh', 'Mai'], ['Sudarat', '', 'Damrongwatanapokin'], ['Arunee', '', 'Chaisingh'], ['Alongkorn', '', 'Amonsin'], ['Olfert', '', 'Landt'], ['Thaweesak', '', 'Songserm'], ['Apiradee', '', 'Theamboonlers'], ['Yong', '', 'Poovorawan']]",Journal of Virological Methods,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0166093406003302', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093406003302']",
10.1021/ja963036t,"McKimm-Breschkin, J., , Management of Influenza Virus Infections with Neuraminidase Inhibitors, Treatments in Respiratory Medicine, 2005",cited-by,10.2165/00151829-200504020-00004,Management of Influenza Virus Infections with Neuraminidase Inhibitors,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Treatments in Respiratory Medicine,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00151829-200504020-00004'],
10.1021/ja963036t,"Magden, J., Kääriäinen, L., Ahola, T., , Inhibitors of virus replication: recent developments and prospects, Applied Microbiology and Biotechnology, 2005",cited-by,10.1007/s00253-004-1783-3,Inhibitors of virus replication: recent developments and prospects,"[['Julia', '', 'Magden'], ['Leevi', '', 'K\xc3\xa4\xc3\xa4ri\xc3\xa4inen'], ['Tero', '', 'Ahola']]",Applied Microbiology and Biotechnology,2005,"[u'http://www.springerlink.com/content/kcuwdwknb57f5buy', u'http://www.springerlink.com/index/kcuwdwknb57f5buy.pdf', u'http://www.springerlink.com/index/10.1007/s00253-004-1783-3', u'http://www.springerlink.com/index/pdf/10.1007/s00253-004-1783-3']",./output/11215168.pdf/citedby/10.1007~s00253-004-1783-3
10.1021/ja963036t,"Aramini, J., Ma, L., Krug, R., et. al, Structures of influenza A proteins and insights into antiviral drug targets, Nature Structural & Molecular Biology, 2010",cited-by,10.1038/nsmb.1779,Structures of influenza A proteins and insights into antiviral drug targets,"[['James', 'M', 'Aramini'], ['Li-Chung', '', 'Ma'], ['Robert', 'M', 'Krug'], ['Eddy', '', 'Arnold'], ['Kalyan', '', 'Das']]",Nature Structural & Molecular Biology,2010,"[u'http://www.nature.com/doifinder/10.1038/nsmb.1779', u'http://dx.doi.org/10.1038/nsmb.1779']",./output/11215168.pdf/citedby/10.1038~nsmb.1779
10.1021/ja963036t,"Collins, P., Haire, L., Lin, Y., et. al, Structural basis for oseltamivir resistance of influenza viruses, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.07.017,Structural basis for oseltamivir resistance of influenza viruses,"[['P.', 'J.', 'Collins'], ['L.', 'F.', 'Haire'], ['Y.', 'P.', 'Lin'], ['J.', '', 'Liua'], ['R.', 'J.', 'Russell'], ['P.', 'A.', 'Walker'], ['S.', 'R.', 'Martin'], ['R.', 'S.', 'Daniels'], ['V.', '', 'Gregory'], ['J.', 'J.', 'Skehel'], ['S.', 'J.', 'Gamblin'], ['A.', 'J.', 'Hay']]",Vaccine,2009,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-51.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X09010299', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-53.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09010299']",./output/11215168.pdf/citedby/10.1016~j.vaccine.2009.07.017
10.1021/ja963036t,"Gloster, T., Davies, G., , Glycosidase inhibition: assessing mimicry of the transition state, Organic & Biomolecular Chemistry, 2010",cited-by,10.1039/b915870g,Glycosidase inhibition: assessing mimicry of the transition state,"[['Tracey', 'M.', 'Gloster'], ['Gideon', 'J.', 'Davies']]",Organic & Biomolecular Chemistry,2010,[u'http://xlink.rsc.org/?DOI=b915870g'],./output/11215168.pdf/citedby/10.1039~b915870g
10.1021/ja963036t,"Yamatsugu, K., Yin, L., Kamijo, S., et. al, A Synthesis of Tamiflu by Using a Barium-Catalyzed Asymmetric Diels-Alder-Type Reaction, Angewandte Chemie-international Edition, 2009",cited-by,10.1002/anie.200804777,A Synthesis of Tamiflu by Using a Barium-Catalyzed Asymmetric Diels-Alder-Type Reaction,"[['Kenzo', '', 'Yamatsugu'], ['Liang', '', 'Yin'], ['Shin', '', 'Kamijo'], ['Yasuaki', '', 'Kimura'], ['Motomu', '', 'Kanai'], ['Masakatsu', '', 'Shibasaki']]",Angewandte Chemie-international Edition,2009,[u'http://doi.wiley.com/10.1002/anie.200804777'],./output/11215168.pdf/citedby/10.1002~anie.200804777
10.1021/ja963036t,"Gibson, J., Thomas, P., Thomas, J., et. al, Benzene-Free Synthesis of Phenol, Angewandte Chemie-international Edition, 2001",cited-by,10.1002/1521-3773(20010518)40:10<1945::AID-ANIE1945>3.0.CO;2-5,Benzene-Free Synthesis of Phenol,"[['James', 'M.', 'Gibson'], ['Phillip', 'S.', 'Thomas'], ['Joshua', 'D.', 'Thomas'], ['Jessica', 'L.', 'Barker'], ['Sunil', 'S.', 'Chandran'], ['Mason', 'K.', 'Harrup'], ['Karen', 'M.', 'Draths'], ['John', 'W.', 'Frost']]",Angewandte Chemie-international Edition,2001,[u'http://doi.wiley.com/10.1002/1521-3773%2820010518%2940%3A10%3C1945%3A%3AAID-ANIE1945%3E3.0.CO%3B2-5'],
10.1021/ja963036t,"Du, Q., Huang, R., Wei, Y., et. al, Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design, Journal of Computational Chemistry, 2009",cited-by,10.1002/jcc.21056,Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design,"[['Qi-Shi', '', 'Du'], ['Ri-bo', '', 'Huang'], ['Yu-tuo', '', 'Wei'], ['Zong-wen', '', 'Pang'], ['Li-qin', '', 'Du'], ['Kuo-chen', '', 'Chou']]",Journal of Computational Chemistry,2009,"[u'http://doi.wiley.com/10.1002/jcc.21056', u'http://www.informatik.uni-trier.de/~ley/db/journals/jcc/jcc30.html#DuHWPDC09', u'http://dx.doi.org/10.1002/jcc.21056']",./output/11215168.pdf/citedby/10.1002~jcc.21056
10.1021/ja963036t,"Sullivan, B., Carrera, I., Drouin, M., et. al, Symmetry-Based Design for the Chemoenzymatic Synthesis of Oseltamivir (Tamiflu) from Ethyl Benzoate, Angewandte Chemie-international Edition, 2009",cited-by,10.1002/anie.200901345,Symmetry-Based Design for the Chemoenzymatic Synthesis of Oseltamivir (Tamiflu) from Ethyl Benzoate,"[['Bradford', '', 'Sullivan'], ['Ignacio', '', 'Carrera'], ['Melissa', '', 'Drouin'], ['Tomas', '', 'Hudlicky']]",Angewandte Chemie-international Edition,2009,"[u'http://www.brocku.ca/chemistry/faculty/Hudlicky/ACIE-2009,48,23,4229-4231.pdf', u'http://doi.wiley.com/10.1002/anie.200901345']",./output/11215168.pdf/citedby/10.1002~anie.200901345
10.1021/ja963036t,"Abe, S., Ishihara, K., Adachi, M., et. al, Professional oral care reduces influenza infection in elderly, Archives of Gerontology and Geriatrics, 2006",cited-by,10.1016/j.archger.2005.10.004,Professional oral care reduces influenza infection in elderly,"[['Shu', '', 'Abe'], ['Kazuyuki', '', 'Ishihara'], ['Mieko', '', 'Adachi'], ['Hidetada', '', 'Sasaki'], ['Kouko', '', 'Tanaka'], ['Katsuji', '', 'Okuda']]",Archives of Gerontology and Geriatrics,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0167494305001330', u'http://linkinghub.elsevier.com/retrieve/pii/S0167494305001330']",
10.1021/ja963036t,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004'],
10.1021/ja963036t,"Johansson, L., Lindskog, A., Silfversparre, G., et. al, Shikimic acid production by a modified strain ofE. coli (W3110.shik1) under phosphate-limited and carbon-limited conditions, Biotechnology and Bioengineering, 2005",cited-by,10.1002/bit.20546,Shikimic acid production by a modified strain ofE. coli (W3110.shik1) under phosphate-limited and carbon-limited conditions,"[['Louise', '', 'Johansson'], ['Anna', '', 'Lindskog'], ['Gustav', '', 'Silfversparre'], ['Christian', '', 'Cimander'], ['Kristian', 'Fog', 'Nielsen'], ['Gunnar', '', 'Lid\xc3\xa9n']]",Biotechnology and Bioengineering,2005,[u'http://doi.wiley.com/10.1002/bit.20546'],./output/11215168.pdf/citedby/10.1002~bit.20546
10.1021/ja963036t,"Karlsson, K., , Pathogen-Host Protein-Carbohydrate Interactions as the Basis of Important Infections, , 0",cited-by,10.1007/978-1-4615-1267-7_28,Pathogen-Host Protein-Carbohydrate Interactions as the Basis of Important Infections,"[['Karl-Anders', '', 'Karlsson']]",,0,"[u'http://www.springerlink.com/index/mr111226p7m17337.pdf', u'http://www.springerlink.com/content/mr111226p7m17337']",./output/11215168.pdf/citedby/10.1007~978-1-4615-1267-7_28
10.1021/ja963036t,"Mihajlovic, M., Mitrasinovic, P., , Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs), Molecular Simulation, 2009",cited-by,10.1080/08927020802430752,Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs),"[['Marija', 'L.', 'Mihajlovic'], ['Petar', 'M.', 'Mitrasinovic']]",Molecular Simulation,2009,"[u'http://www.informaworld.com/openurl?genre=article&doi=10.1080/08927020802430752&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3', u'http://dx.doi.org/10.1080/08927020802430752']",./output/11215168.pdf/citedby/10.1080~08927020802430752
10.1021/ja963036t,"Morrissey, B., Streamer, M., Downard, K., , Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry, Journal of Virological Methods, 2007",cited-by,10.1016/j.jviromet.2007.05.015,Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry,"[['Bethny', '', 'Morrissey'], ['Margaret', '', 'Streamer'], ['Kevin', 'M.', 'Downard']]",Journal of Virological Methods,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0166093407001796', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093407001796']",
10.1021/ja963036t,"Armstrong, K., Tidor, B., Cheng, A., , Optimal Charges in Lead Progression:  A Structure-Based Neuraminidase Case Study, Journal of Medicinal Chemistry, 2006",cited-by,10.1021/jm051105l,Optimal Charges in Lead Progression:  A Structure-Based Neuraminidase Case Study,"[['Kathryn', 'A.', 'Armstrong'], ['Bruce', '', 'Tidor'], ['Alan', 'C.', 'Cheng']]",Journal of Medicinal Chemistry,2006,"[u'http://people.brandeis.edu/~acheng/publications/2006_JMC_ChargeOptNeuraminidase.pdf', u'http://pubs.acs.org/doi/abs/10.1021/jm051105l']",./output/11215168.pdf/citedby/10.1021~jm051105l
10.1021/ja963036t,"Masuda, T., Yoshida, S., Arai, M., et. al, Synthesis and Anti-influenza Evaluation of Polyvalent Sialidase Inhibitors Bearing 4-Guanidino-Neu5Ac2en Derivatives, Chemical & Pharmaceutical Bulletin, 2003",cited-by,10.1248/cpb.51.1386,Synthesis and Anti-influenza Evaluation of Polyvalent Sialidase Inhibitors Bearing 4-Guanidino-Neu5Ac2en Derivatives,"[['Takeshi', '', 'Masuda'], ['Shuku', '', 'Yoshida'], ['Masami', '', 'Arai'], ['Satoru', '', 'Kaneko'], ['Makoto', '', 'Yamashita'], ['Takeshi', '', 'Honda']]",Chemical & Pharmaceutical Bulletin,2003,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/cpb/51.1386?from=CrossRef'],./output/11215168.pdf/citedby/10.1248~cpb.51.1386
10.1021/ja963036t,"Krug, R., Aramini, J., , Emerging antiviral targets for influenza A virus, Trends in Pharmacological Sciences, 2009",cited-by,10.1016/j.tips.2009.03.002,Emerging antiviral targets for influenza A virus,"[['Robert', 'M.', 'Krug'], ['James', 'M.', 'Aramini']]",Trends in Pharmacological Sciences,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0165614709000558', u'http://linkinghub.elsevier.com/retrieve/pii/S0165614709000558']",
10.1021/ja963036t,"Song, J., Park, K., Lee, K., et. al, Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives, Antiviral Research, 2007",cited-by,10.1016/j.antiviral.2007.07.001,Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives,"[['Jae', 'Min', 'Song'], ['Ki', 'Duk', 'Park'], ['Kwang', 'Hee', 'Lee'], ['Young', 'Ho', 'Byun'], ['Ju', 'Hee', 'Park'], ['Sung', 'Han', 'Kim'], ['Jae', 'Hong', 'Kim'], ['Baik', 'Lin', 'Seong']]",Antiviral Research,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0166354207003713', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354207003713']",
10.1021/ja963036t,"Abed, Y., Boivin, G., , Treatment of respiratory virus infections, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.01.006,Treatment of respiratory virus infections,"[['Yacine', '', 'Abed'], ['Guy', '', 'Boivin']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016635420600026X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420600026X']",
11215168.pdf,"Klenk, H.-D., and R. Rott. 1988. The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34:247–280.",references,NOT found in MAS
11215168.pdf,"Langmuir, A. D., T. D. Worthen, J. Solomon, C. G. Ray, and E. Peterson. 1985. Thucydides syndrome. A new hypothesis for the cause of the plague of Athens. N. Engl. J. Med. 313:1027–1030.",references,10.1056/NEJM198510173131618,The Thucydides Syndrome: A New Hypothesis for the Cause of the Plague of Athens,"[[u'Alexander', u'D.', u'Langmuir'], [u'Thomas', u'D.', u'Worthen'], [u'Jon', u'', u'Solomon'], [u'C.', u'George', u'Ray'], [u'Eskild', u'', u'Petersen']]",New England Journal of Medicine,1985,[u'http://www.nejm.org/doi/abs/10.1056/NEJM198510173131618'],./output/11215168.pdf/10.1056~NEJM198510173131618
10.1056/NEJM198510173131618,"Drancourt, M., Raoult, D., , Molecular insights into the history of plague, Microbes and Infection, 2002",cited-by,10.1016/S1286-4579(01)01515-5,Molecular insights into the history of plague,"[['Michel', '', 'Drancourt'], ['Didier', '', 'Raoult']]",Microbes and Infection,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1286457901015155', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457901015155']",
10.1056/NEJM198510173131618,"Monto, A., , Epidemiology of influenza, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.07.066,Epidemiology of influenza,"[['Arnold', 'S.', 'Monto']]",Vaccine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08010219', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08010219']",
10.1056/NEJM198510173131618,"Papagrigorakis, M., Yapijakis, C., Synodinos, P., et. al, DNA examination of ancient dental pulp incriminates typhoid fever as a probable cause of the Plague of Athens, International Journal of Infectious Diseases, 2006",cited-by,10.1016/j.ijid.2005.09.001,DNA examination of ancient dental pulp incriminates typhoid fever as a probable cause of the Plague of Athens,"[['Manolis', 'J.', 'Papagrigorakis'], ['Christos', '', 'Yapijakis'], ['Philippos', 'N.', 'Synodinos'], ['Effie', '', 'Baziotopoulou-Valavani']]",International Journal of Infectious Diseases,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1201971205001785', u'http://forum.openu.ac.il/opus/static/binaries/forum/bank192\\typhoidfever-greece_0.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971205001785']",./output/11215168.pdf/citedby/10.1016~j.ijid.2005.09.001
10.1056/NEJM198510173131618,"Durack, D., Littman, R., Benitez, R., et. al, Hellenic holocaust: a historical clinico-pathologic conference, American Journal of Medicine, 2000",cited-by,10.1016/S0002-9343(00)00521-0,Hellenic holocaust: a historical clinico-pathologic conference,"[['David', 'T', 'Durack'], ['Robert', 'J', 'Littman'], ['R.', 'Michael', 'Benitez'], ['Philip', 'A', 'Mackowiak']]",American Journal of Medicine,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0002934300005210', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934300005210']",
10.1056/NEJM198510173131618,"Eisenberg, E., , Case Study: Oseltamivir: An Orally Bioavailable Ester Prodrug of Oseltamivir Carboxylate, , 0",cited-by,10.1007/978-0-387-49785-3_50,Case Study: Oseltamivir: An Orally Bioavailable Ester Prodrug of Oseltamivir Carboxylate,"[['Eugene', 'J.', 'Eisenberg']]",,0,"[u'http://www.springerlink.com/index/qp8122385lu86756.pdf', u'http://www.springerlink.com/content/qp8122385lu86756']",./output/11215168.pdf/citedby/10.1007~978-0-387-49785-3_50
10.1056/NEJM198510173131618,"Cleri, D., Marton, R., Rabbat, M., et. al, Pneumonia Caused by Yersinia pestis : Plague Pneumonia, , 0",cited-by,10.1007/0-306-46834-4_49,Pneumonia Caused by Yersinia pestis : Plague Pneumonia,"[['Dennis', 'James', 'Cleri'], ['Randy', '', 'Marton'], ['Mohammed', '', 'Rabbat'], ['John', '', 'Vernaleo']]",,0,"[u'http://www.springerlink.com/index/x88g6470707n853h.pdf', u'http://www.springerlink.com/content/x88g6470707n853h']",./output/11215168.pdf/citedby/10.1007~0-306-46834-4_49
11215168.pdf,"Laver, W. G., P. M. Colman, R. G. Webster, V. S. Hinshaw, and G. M. Air. 1984. Influenza virus neuraminidase with hemagglutinin activity. Virology 137:314–323.",references,NOT found in MAS
11215168.pdf,"Leinweber, F.-J. 1987. Possible physiological roles of carboxylic ester hydrolases. Drug Metab. Dispos. 16:425–428.",references,10.3109/03602538708994129,Possible Physiological Roles of Carboxylic Ester Hydrolases,"[[u'Franz-Josef', u'', u'Leinweber']]",Drug Metabolism Reviews,1987,[u'http://www.informapharmascience.com/doi/abs/10.3109/03602538708994129'],./output/11215168.pdf/10.3109~03602538708994129
10.3109/03602538708994129,"Satoh, T., Hosokawa, M., , THE MAMMALIAN CARBOXYLESTERASES: From Molecules to Functions, Annual Review of Pharmacology and Toxicology, 1998",cited-by,10.1146/annurev.pharmtox.38.1.257,THE MAMMALIAN CARBOXYLESTERASES: From Molecules to Functions,"[['Tetsuo', '', 'Satoh'], ['Masakiyo', '', 'Hosokawa']]",Annual Review of Pharmacology and Toxicology,1998,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.pharmtox.38.1.257'],./output/11215168.pdf/citedby/10.1146~annurev.pharmtox.38.1.257
10.3109/03602538708994129,"Thummel, K., Kunze, K., Shen, D., , Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction, Advanced Drug Delivery Reviews, 1997",cited-by,10.1016/S0169-409X(97)00039-2,Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction,"[['Kenneth', 'E.', 'Thummel'], ['Kent', 'L.', 'Kunze'], ['Danny', 'D.', 'Shen']]",Advanced Drug Delivery Reviews,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X97000392', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X97000392']",
10.3109/03602538708994129,"BERTICAT, C., BOQUIEN, G., RAYMOND, M., et. al, Insecticide resistance genes induce a mating competition cost in Culex pipiens mosquitoes, Genetics Research, 2002",cited-by,10.1017/S001667230100547X,Insecticide resistance genes induce a mating competition cost in Culex pipiens mosquitoes,"[['CLAIRE', '', 'BERTICAT'], ['GR\xc3\x89GOIRE', '', 'BOQUIEN'], ['MICHEL', '', 'RAYMOND'], ['CHRISTINE', '', 'CHEVILLON']]",Genetics Research,2002,"[u'http://gemi.mpl.ird.fr/PDF/Berticat.GenRes.2002%20.pdf', u'http://gemi.mpl.ird.fr/SiteSGASS/Chevillon/2002%20reprint23.pdf', u'http://www.journals.cambridge.org/abstract_S001667230100547X']",./output/11215168.pdf/citedby/10.1017~S001667230100547X
10.3109/03602538708994129,"Hyne, R., Maher, W., , Invertebrate biomarkers: links to toxicosis that predict population decline, Ecotoxicology and Environmental Safety, 2003",cited-by,10.1016/S0147-6513(02)00119-7,Invertebrate biomarkers: links to toxicosis that predict population decline,"[['Ross', 'V', 'Hyne'], ['William', 'A', 'Maher']]",Ecotoxicology and Environmental Safety,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0147651302001197', u'http://linkinghub.elsevier.com/retrieve/pii/S0147651302001197']",
10.3109/03602538708994129,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.3109/03602538708994129,"Lavis, L., Chao, T., Raines, R., , Fluorogenic Label for Biomolecular Imaging, Acs Chemical Biology, 2006",cited-by,10.1021/cb600132m,Fluorogenic Label for Biomolecular Imaging,"[['Luke', 'D.', 'Lavis'], ['Tzu-Yuan', '', 'Chao'], ['Ronald', 'T.', 'Raines']]",Acs Chemical Biology,2006,"[u'https://www.biochem.wisc.edu/faculty/raines/lab/pdfs/Lavis2006a.pdf', u'http://pubs.acs.org/doi/abs/10.1021/cb600132m']",./output/11215168.pdf/citedby/10.1021~cb600132m
10.3109/03602538708994129,"Liederer, B., Borchardt, R., , Enzymes involved in the bioconversion of ester-based prodrugs, Journal of Pharmaceutical Sciences, 2006",cited-by,10.1002/jps.20542,Enzymes involved in the bioconversion of ester-based prodrugs,"[['Bianca', 'M.', 'Liederer'], ['Ronald', 'T.', 'Borchardt']]",Journal of Pharmaceutical Sciences,2006,[u'http://doi.wiley.com/10.1002/jps.20542'],./output/11215168.pdf/citedby/10.1002~jps.20542
10.3109/03602538708994129,"Minagawa, T., Kohno, Y., Suwa, T., et. al, Species differences in hydrolysis of isocarbacyclin methyl ester (TEI9090) by blood esterases, Biochemical Pharmacology, 1995",cited-by,10.1016/0006-2952(95)00071-7,Species differences in hydrolysis of isocarbacyclin methyl ester (TEI9090) by blood esterases,"[['Toshiya', '', 'Minagawa'], ['Yoshiro', '', 'Kohno'], ['Toshio', '', 'Suwa'], ['Akira', '', 'Tsuji']]",Biochemical Pharmacology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0006295295000717', u'http://linkinghub.elsevier.com/retrieve/pii/0006295295000717']",
10.3109/03602538708994129,"Bodor, N., Buchwald, P., , Soft drug design: General principles and recent applications, Medicinal Research Reviews, 2000",cited-by,10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X,Soft drug design: General principles and recent applications,"[['Nicholas', '', 'Bodor'], ['Peter', '', 'Buchwald']]",Medicinal Research Reviews,2000,[u'http://doi.wiley.com/10.1002/%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X'],
10.3109/03602538708994129,"Homola, E., Chang, E., , Distribution and Regulation of Esterases That Hydrolyze Methyl Farnesoate in Homarus americanusand Other Crustaceans, General and Comparative Endocrinology, 1997",cited-by,10.1006/gcen.1996.6850,Distribution and Regulation of Esterases That Hydrolyze Methyl Farnesoate in Homarus americanusand Other Crustaceans,"[['Ellen', '', 'Homola'], ['Ernest', 'S.', 'Chang']]",General and Comparative Endocrinology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0016648096968501', u'http://linkinghub.elsevier.com/retrieve/pii/S0016648096968501']",
10.3109/03602538708994129,"Ericsson, H., Tholander, B., Regårdh, C., , In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man, European Journal of Pharmaceutical Sciences, 1999",cited-by,10.1016/S0928-0987(98)00058-X,"In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man","[['H.', '', 'Ericsson'], ['B.', '', 'Tholander'], ['C.', 'G.', 'Reg\xc3\xa5rdh']]",European Journal of Pharmaceutical Sciences,1999,"[u'http://www.sciencedirect.com/science/article/pii/S092809879800058X', u'http://linkinghub.elsevier.com/retrieve/pii/S092809879800058X']",
10.3109/03602538708994129,"ALEXSON, S., MENTLEIN, R., WERNSTEDT, C., et. al, Isolation and characterization of microsomal acyl-CoA thioesterase. A member of the rat liver microsomal carboxylesterase multi-gene family, European Journal of Biochemistry, 1993",cited-by,10.1111/j.1432-1033.1993.tb17973.x,Isolation and characterization of microsomal acyl-CoA thioesterase. A member of the rat liver microsomal carboxylesterase multi-gene family,"[['Stefan', 'E. H.', 'ALEXSON'], ['Rolf', '', 'MENTLEIN'], ['Christer', '', 'WERNSTEDT'], ['Ulf', '', 'HELLMAN']]",European Journal of Biochemistry,1993,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1432-1033.1993.tb17973.x'],./output/11215168.pdf/citedby/10.1111~j.1432-1033.1993.tb17973.x
10.3109/03602538708994129,"Dolinsky, V., Gilham, D., Hatch, G., et. al, Regulation of triacylglycerol hydrolase expression by dietary fatty acids and peroxisomal proliferator-activated receptors, Biochimica Et Biophysica Acta-molecular and Cell Biology of Lipids, 2003",cited-by,10.1016/j.bbalip.2003.09.007,Regulation of triacylglycerol hydrolase expression by dietary fatty acids and peroxisomal proliferator-activated receptors,"[['Vernon', 'W.', 'Dolinsky'], ['Dean', '', 'Gilham'], ['Grant', 'M.', 'Hatch'], ['Luis', 'B.', 'Agellon'], ['Richard', '', 'Lehner'], ['Dennis', 'E.', 'Vance']]",Biochimica Et Biophysica Acta-molecular and Cell Biology of Lipids,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1388198103001628', u'http://linkinghub.elsevier.com/retrieve/pii/S1388198103001628']",
10.3109/03602538708994129,"Holmes, R., Cox, L., VandeBerg, J., , Mammalian carboxylesterase 5: Comparative biochemistry and genomics, Comparative Biochemistry and Physiology D-genomics & Proteomics, 2008",cited-by,10.1016/j.cbd.2008.05.002,Mammalian carboxylesterase 5: Comparative biochemistry and genomics,"[['Roger', 'S.', 'Holmes'], ['Laura', 'A.', 'Cox'], ['John', 'L.', 'VandeBerg']]",Comparative Biochemistry and Physiology D-genomics & Proteomics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1744117X08000373', u'http://linkinghub.elsevier.com/retrieve/pii/S1744117X08000373']",
10.3109/03602538708994129,"Krakovičová, H., Etrych, T., Ulbrich, K., , HPMA-based polymer conjugates with drug combination, European Journal of Pharmaceutical Sciences, 2009",cited-by,10.1016/j.ejps.2009.03.011,HPMA-based polymer conjugates with drug combination,"[['Hana', '', 'Krakovi\xc4\x8dov\xc3\xa1'], ['Tom\xc3\xa1\xc5\xa1', '', 'Etrych'], ['Karel', '', 'Ulbrich']]",European Journal of Pharmaceutical Sciences,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0928098709001110', u'http://linkinghub.elsevier.com/retrieve/pii/S0928098709001110']",
10.3109/03602538708994129,"SOHASKEY, C., BARBOUR, A., , Esterases in Serum-Containing Growth Media Counteract Chloramphenicol Acetyltransferase Activity In Vitro, , 1999",cited-by,14156078Esterases in Serum-Containing Growth Media Counteract Chloramphenicol Acetyltransferase Activity In Vitro,Esterases in Serum-Containing Growth Media Counteract Chloramphenicol Acetyltransferase Activity In Vitro,"[['CHARLES', 'D.', 'SOHASKEY'], ['ALAN', 'G.', 'BARBOUR']]",,1999,[u'http://aac.asm.org/cgi/reprint/43/3/655.pdf'],./output/11215168.pdf/citedby/14156078Esterases in Serum-Containing Growth Media Counteract Chloramphenicol Acetyltransferase Activity In Vitro
10.3109/03602538708994129,"Poole, M., Bridgers, K., Alexson, S., et. al, Altered expression of the carboxylesterases ES4 and ES10 by peroxisome proliferator chemicals, Toxicology, 2001",cited-by,10.1016/S0300-483X(01)00416-4,Altered expression of the carboxylesterases ES4 and ES10 by peroxisome proliferator chemicals,"[['Michele', '', 'Poole'], ['Kristie', '', 'Bridgers'], ['Stefan', 'E. H.', 'Alexson'], ['J.', 'Christopher', 'Corton']]",Toxicology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0300483X01004164', u'http://linkinghub.elsevier.com/retrieve/pii/S0300483X01004164']",
10.3109/03602538708994129,"Parker, A., Pinot, F., Grant, D., et. al, Regulation of mouse liver microsomal esterases by clofibrate and sexual hormones, Biochemical Pharmacology, 1996",cited-by,10.1016/S0006-2952(95)02254-6,Regulation of mouse liver microsomal esterases by clofibrate and sexual hormones,"[['Anthony', 'G.', 'Parker'], ['Franck', '', 'Pinot'], ['David', 'F.', 'Grant'], ['Jimmy', '', 'Spearow'], ['Bruce', 'D.', 'Hammock']]",Biochemical Pharmacology,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0006295295022546', u'http://linkinghub.elsevier.com/retrieve/pii/S0006295295022546']",
10.3109/03602538708994129,"Gershater, M., Edwards, R., , Regulating biological activity in plants with carboxylesterases, Plant Science, 2007",cited-by,10.1016/j.plantsci.2007.08.008,Regulating biological activity in plants with carboxylesterases,"[['Markus', 'C.', 'Gershater'], ['Robert', '', 'Edwards']]",Plant Science,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0168945207002385', u'http://linkinghub.elsevier.com/retrieve/pii/S0168945207002385']",
10.3109/03602538708994129,"Bodor, N., Buchwald, P., , Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites, Molecular Biotechnology, 2004",cited-by,10.1385/MB:26:2:123,Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites,"[['Nicholas', '', 'Bodor'], ['Peter', '', 'Buchwald']]",Molecular Biotechnology,2004,"[u'http://www.springerlink.com/index/21187v66h4x47188.pdf', u'http://www.springerlink.com/content/21187v66h4x47188', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1385/MB:26:2:123', u'http://www.springerlink.com/index/pdf/10.1385/MB:26:2:123']",
10.3109/03602538708994129,"Miller, A., Scott, D., Chacko, T., et. al, Expression and Partial Purification of a Recombinant Secretory Form of Human Liver Carboxylesterase, Protein Expression and Purification, 1999",cited-by,10.1006/prep.1999.1121,Expression and Partial Purification of a Recombinant Secretory Form of Human Liver Carboxylesterase,"[['Amanda', 'D.', 'Miller'], ['David', 'F.', 'Scott'], ['Terry', 'L.', 'Chacko'], ['Donald', 'M.', 'Maxwell'], ['John', 'J.', 'Schlager'], ['Kenneth', 'D.', 'Lanclos']]",Protein Expression and Purification,1999,"[u'http://www.sciencedirect.com/science/article/pii/S104659289991121X', u'http://linkinghub.elsevier.com/retrieve/pii/S104659289991121X']",
10.3109/03602538708994129,"Feng, P., Ruff, T., Rangwala, S., et. al, Engineering Plant Resistance to Thiazopyr Herbicide via Expression of a Novel Esterase Deactivation Enzyme, Pesticide Biochemistry and Physiology, 1997",cited-by,10.1006/pest.1997.2312,Engineering Plant Resistance to Thiazopyr Herbicide via Expression of a Novel Esterase Deactivation Enzyme,"[['Paul', 'C. C', 'Feng'], ['Thomas', 'G', 'Ruff'], ['Shaukat', 'H', 'Rangwala'], ['Sudabathula', 'R', 'Rao']]",Pesticide Biochemistry and Physiology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0048357597923129', u'http://linkinghub.elsevier.com/retrieve/pii/S0048357597923129']",
10.3109/03602538708994129,"Holmes, R., Glenn, J., VandeBerg, J., et. al, Baboon carboxylesterases 1 and 2: sequences, structures and phylogenetic relationships with human and other primate carboxylesterases, Journal of Medical Primatology, 2009",cited-by,10.1111/j.1600-0684.2008.00315.x,"Baboon carboxylesterases 1 and 2: sequences, structures and phylogenetic relationships with human and other primate carboxylesterases","[['Roger', 'S.', 'Holmes'], ['Jeremy', 'P.', 'Glenn'], ['John', 'L.', 'VandeBerg'], ['Laura', 'A.', 'Cox']]",Journal of Medical Primatology,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1600-0684.2008.00315.x'],
10.3109/03602538708994129,"SOHASKEY, C., BARBOUR, A., , Spirochaeta aurantia Has Diacetyl Chloramphenicol Esterase Activity, Journal of Bacteriology, 2000",cited-by,10.1128/JB.182.7.1930-1934.2000,Spirochaeta aurantia Has Diacetyl Chloramphenicol Esterase Activity,"[['CHARLES', 'D.', 'SOHASKEY'], ['ALAN', 'G.', 'BARBOUR']]",Journal of Bacteriology,2000,"[u'http://jb.asm.org/cgi/reprint/182/7/1930.pdf', u'http://jb.asm.org/cgi/doi/10.1128/JB.182.7.1930-1934.2000']",./output/11215168.pdf/citedby/10.1128~JB.182.7.1930-1934.2000
10.3109/03602538708994129,"MARSHALL, J., ABDEL-RAHMAN, S., JOHNSON, K., et. al, Rifapentine pharmacokinetics in adolescents, Pediatric Infectious Disease Journal, 1999",cited-by,10.1097/00006454-199910000-00009,Rifapentine pharmacokinetics in adolescents,"[['JAMES', 'D.', 'MARSHALL'], ['SUSAN', '', 'ABDEL-RAHMAN'], ['KATHY', '', 'JOHNSON'], ['RALPH', 'E.', 'KAUFFMAN'], ['GREGORY', 'L.', 'KEARNS']]",Pediatric Infectious Disease Journal,1999,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-199910000-00009'],
10.3109/03602538708994129,"Holmes, R., Wright, M., Laulederkind, S., et. al, Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins, Mammalian Genome, 2010",cited-by,10.1007/s00335-010-9284-4,"Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins","[['Roger', 'S.', 'Holmes'], ['Matthew', 'W.', 'Wright'], ['Stanley', 'J. F.', 'Laulederkind'], ['Laura', 'A.', 'Cox'], ['Masakiyo', '', 'Hosokawa'], ['Teruko', '', 'Imai'], ['Shun', '', 'Ishibashi'], ['Richard', '', 'Lehner'], ['Masao', '', 'Miyazaki'], ['Everett', 'J.', 'Perkins'], ['Phillip', 'M.', 'Potter'], ['Matthew', 'R.', 'Redinbo'], ['Jacques', '', 'Robert'], ['Tetsuo', '', 'Satoh'], ['Tetsuro', '', 'Yamashita'], ['Bingfan', '', 'Yan'], ['Tsuyoshi', '', 'Yokoi'], ['Rudolf', '', 'Zechner'], ['Lois', 'J.', 'Maltais']]",Mammalian Genome,2010,"[u'http://www.springerlink.com/content/3u444727545g5463', u'http://www.springerlink.com/index/3u444727545g5463.pdf']",./output/11215168.pdf/citedby/10.1007~s00335-010-9284-4
10.3109/03602538708994129,"Holmes, R., Cox, L., VandeBerg, J., , Bovine carboxylesterases: Evidence for two CES1 and five families of CES genes on chromosome 18, Comparative Biochemistry and Physiology D-genomics & Proteomics, 2009",cited-by,10.1016/j.cbd.2008.09.002,Bovine carboxylesterases: Evidence for two CES1 and five families of CES genes on chromosome 18,"[['Roger', 'S.', 'Holmes'], ['Laura', 'A.', 'Cox'], ['John', 'L.', 'VandeBerg']]",Comparative Biochemistry and Physiology D-genomics & Proteomics,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1744117X08000610', u'http://linkinghub.elsevier.com/retrieve/pii/S1744117X08000610']",
10.3109/03602538708994129,"Holmes, R., Cox, L., VandeBerg, J., , Horse carboxylesterases: Evidence for six CES1 and four families of CES genes on chromosome 3, Comparative Biochemistry and Physiology D-genomics & Proteomics, 2009",cited-by,10.1016/j.cbd.2008.10.004,Horse carboxylesterases: Evidence for six CES1 and four families of CES genes on chromosome 3,"[['Roger', 'S.', 'Holmes'], ['Laura', 'A.', 'Cox'], ['John', 'L.', 'VandeBerg']]",Comparative Biochemistry and Physiology D-genomics & Proteomics,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1744117X08000828', u'http://linkinghub.elsevier.com/retrieve/pii/S1744117X08000828']",
10.3109/03602538708994129,"Holmes, R., Cox, L., VandeBerg, J., , A new class of mammalian carboxylesterase CES6, Comparative Biochemistry and Physiology D-genomics & Proteomics, 2009",cited-by,10.1016/j.cbd.2009.03.002,A new class of mammalian carboxylesterase CES6,"[['Roger', 'S.', 'Holmes'], ['Laura', 'A.', 'Cox'], ['John', 'L.', 'VandeBerg']]",Comparative Biochemistry and Physiology D-genomics & Proteomics,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1744117X09000306', u'http://linkinghub.elsevier.com/retrieve/pii/S1744117X09000306']",
10.3109/03602538708994129,"Gyermek, L., , Development of ultra short-acting muscle relaxant agents: History, research strategies, and challenges, Medicinal Research Reviews, 2005",cited-by,10.1002/med.20036,"Development of ultra short-acting muscle relaxant agents: History, research strategies, and challenges","[['Laszlo', '', 'Gyermek']]",Medicinal Research Reviews,2005,[u'http://doi.wiley.com/10.1002/med.20036'],./output/11215168.pdf/citedby/10.1002~med.20036
10.3109/03602538708994129,"Wakselman, M., Cerutti, I., Chany, C., , Antitumor protection induced in mice by fatty acid conjugates: Alkyl butyrates and poly(ethylene glycol) dibutyrates, International Journal of Cancer, 1990",cited-by,10.1002/ijc.2910460323,Antitumor protection induced in mice by fatty acid conjugates: Alkyl butyrates and poly(ethylene glycol) dibutyrates,"[['Michel', '', 'Wakselman'], ['Italina', '', 'Cerutti'], ['Charles', '', 'Chany']]",International Journal of Cancer,1990,[u'http://doi.wiley.com/10.1002/ijc.2910460323'],./output/11215168.pdf/citedby/10.1002~ijc.2910460323
10.3109/03602538708994129,"Holmes, R., Cox, L., VandeBerg, J., , Mammalian carboxylesterase 3: comparative genomics and proteomics, Genetica, 2010",cited-by,10.1007/s10709-010-9438-z,Mammalian carboxylesterase 3: comparative genomics and proteomics,"[['Roger', 'S.', 'Holmes'], ['Laura', 'A.', 'Cox'], ['John', 'L.', 'VandeBerg']]",Genetica,2010,"[u'http://www.springerlink.com/index/226740215343371h.pdf', u'http://www.springerlink.com/content/226740215343371h', u'http://www.springerlink.com/index/10.1007/s10709-010-9438-z', u'http://www.springerlink.com/index/pdf/10.1007/s10709-010-9438-z']",./output/11215168.pdf/citedby/10.1007~s10709-010-9438-z
10.3109/03602538708994129,"Li, Q., Du, Y., Yuan, H., et. al, Synthesis of Lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system, European Journal of Pharmaceutical Sciences, 2010",cited-by,10.1016/j.ejps.2010.08.004,Synthesis of Lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system,"[['Qian', '', 'Li'], ['Yong-Zhong', '', 'Du'], ['Hong', '', 'Yuan'], ['Xing-Guo', '', 'Zhang'], ['Jing', '', 'Miao'], ['Fu-De', '', 'Cui'], ['Fu-Qiang', '', 'Hu']]",European Journal of Pharmaceutical Sciences,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0928098710003015', u'http://linkinghub.elsevier.com/retrieve/pii/S0928098710003015']",
10.3109/03602538708994129,"Diaz-Droguett, D., Espinoza, R., Fuenzalida, V., , Copper nanoparticles grown under hydrogen: Study of the surface oxide, Applied Surface Science, 2011",cited-by,10.1016/j.apsusc.2010.12.082,Copper nanoparticles grown under hydrogen: Study of the surface oxide,"[['D.', 'E.', 'Diaz-Droguett'], ['R.', '', 'Espinoza'], ['V.', 'M.', 'Fuenzalida']]",Applied Surface Science,2011,[u'http://www.sciencedirect.com/science/article/pii/S0169433210018118'],
10.3109/03602538708994129,"Kostková, H., Etrych, T., Říhová, B., et. al, Synergistic effect of HPMA copolymer-bound doxorubicin and dexamethasone in vivo on mouse lymphomas, Journal of Bioactive and Compatible Polymers, 2011",cited-by,10.1177/0883911511406326,Synergistic effect of HPMA copolymer-bound doxorubicin and dexamethasone in vivo on mouse lymphomas,"[['Hana', '', 'Kostkov\xc3\xa1'], ['Tom\xc3\xa1\xc5\xa1', '', 'Etrych'], ['Blanka', '', '\xc5\x98\xc3\xadhov\xc3\xa1'], ['Karel', '', 'Ulbrich']]",Journal of Bioactive and Compatible Polymers,2011,[u'http://dx.doi.org/10.1177/0883911511406326'],./output/11215168.pdf/citedby/10.1177~0883911511406326
10.3109/03602538708994129,"Peng, Y., Shao, X., Hose, G., et. al, Dimethoate, fenvalerate and their mixture affects Hylyphantes graminicola (Araneae: Linyphiidae) adults and their unexposed offspring, Agricultural and Forest Entomology, 2010",cited-by,10.1111/j.1461-9563.2010.00481.x,"Dimethoate, fenvalerate and their mixture affects Hylyphantes graminicola (Araneae: Linyphiidae) adults and their unexposed offspring","[['Yu', '', 'Peng'], ['Xiao-li', '', 'Shao'], ['Grant', 'C.', 'Hose'], ['Feng-xiang', '', 'Liu'], ['Jian', '', 'Chen']]",Agricultural and Forest Entomology,2010,[u'http://doi.wiley.com/10.1111/j.1461-9563.2010.00481.x'],./output/11215168.pdf/citedby/10.1111~j.1461-9563.2010.00481.x
10.3109/03602538708994129,"Buchwald, P., , Computer-aided retrometabolic drug design: soft drugs, Expert Opinion on Drug Discovery, 2007",cited-by,10.1517/17460441.2.7.923,Computer-aided retrometabolic drug design: soft drugs,"[['Peter', '', 'Buchwald']]",Expert Opinion on Drug Discovery,2007,[u'http://www.expertopin.com/doi/abs/10.1517/17460441.2.7.923'],./output/11215168.pdf/citedby/10.1517~17460441.2.7.923
10.3109/03602538708994129,"Watanabe, K., Matsunaga, T., Kimura, T., et. al, Stereospecific and Regioselective Hydrolysis of Cannabinoid Esters by ES46.5K, an Esterase from Mouse Hepatic Microsomes, and Its Differences from Carboxylesterases of Rabbit and Porcine Liver, Biological & Pharmaceutical Bulletin, 2005",cited-by,10.1248/bpb.28.1743,"Stereospecific and Regioselective Hydrolysis of Cannabinoid Esters by ES46.5K, an Esterase from Mouse Hepatic Microsomes, and Its Differences from Carboxylesterases of Rabbit and Porcine Liver","[['Kazuhito', '', 'Watanabe'], ['Tamihide', '', 'Matsunaga'], ['Toshiyuki', '', 'Kimura'], ['Tatsuya', '', 'Funahashi'], ['Satoshi', '', 'Yamaori'], ['Yukihiro', '', 'Shoyama'], ['Ikuo', '', 'Yamamoto']]",Biological & Pharmaceutical Bulletin,2005,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/28.1743?from=CrossRef'],./output/11215168.pdf/citedby/10.1248~bpb.28.1743
10.3109/03602538708994129,"Barron, M., Charron, K., Stott, W., et. al, Tissue carboxylesterase activity of rainbow trout, Environmental Toxicology and Chemistry, 1999",cited-by,10.1002/etc.5620181117,Tissue carboxylesterase activity of rainbow trout,"[['Mace', 'G.', 'Barron'], ['Kem', 'A.', 'Charron'], ['William', 'T.', 'Stott'], ['Stephanie', 'E.', 'Duvall']]",Environmental Toxicology and Chemistry,1999,[u'http://doi.wiley.com/10.1002/etc.5620181117'],./output/11215168.pdf/citedby/10.1002~etc.5620181117
10.3109/03602538708994129,"Zimmerman, C., Johnson, K., , Etretinate absorption in thein situ perfused intestinal lumen: Preliminary studies in the rat, Biopharmaceutics & Drug Disposition, 1991",cited-by,10.1002/bdd.2510120106,Etretinate absorption in thein situ perfused intestinal lumen: Preliminary studies in the rat,"[['Cheryl', 'L.', 'Zimmerman'], ['Kenneth', 'E.', 'Johnson']]",Biopharmaceutics & Drug Disposition,1991,[u'http://doi.wiley.com/10.1002/bdd.2510120106'],./output/11215168.pdf/citedby/10.1002~bdd.2510120106
10.3109/03602538708994129,", List of Member Companies, , 0",cited-by,5109662List of Member Companies,List of Member Companies,[],,0,"[u'http://www.epa.gov/opptintr/chemrtk/pubs/summaries/aroterhc/c13972rt.pdf', u'http://www.epa.gov/chemrtk/pubs/summaries/aroterhc/c13972rt.pdf', u'http://iaspub.epa.gov/oppthpv/document_api.download?file=c13972tp.pdf', u'http://iaspub.epa.gov/oppthpv/document_api.download?file=9-9-2004-c12965rt.pdf', u'http://iaspub.epa.gov/oppthpv/document_api.download?file=c13972rt-6302005.pdf', u'http://www.epa.gov/oppt/chemrtk/pubs/summaries/aroterhc/c13972tp.pdf', u'http://www.epa.gov/hpv/pubs/summaries/aroterhc/c13972rt.pdf', u'http://www.epa.gov/hpv/pubs/summaries/terprial/c12965rt.pdf', u'http://www.epa.gov/opptintr/chemrtk/pubs/summaries/terprial/c12965rt.pdf', u'http://www.epa.gov/oppt/chemrtk/pubs/summaries/ionederv/c13660rt.pdf', u'http://www.epa.gov/opptintr/chemrtk/pubs/summaries/ionederv/c13660rt.pdf', u'http://www.epa.gov/hpv/pubs/summaries/aroterhc/c13972tp.pdf', u'http://www.epa.gov/hpv/pubs/summaries/ionederv/c13660rt.pdf', u'http://www.epa.gov/chemrtk/pubs/summaries/ionederv/c13660rt.pdf', u'http://www.epa.gov/oppt/chemrtk/pubs/summaries/terprial/c12965rt.pdf', u'http://www.epa.gov/chemrtk/pubs/summaries/aroterhc/c13972tp.pdf', u'http://www.epa.gov/oppt/chemrtk/pubs/summaries/aroterhc/c13972rt.pdf', u'http://www.epa.gov/opptintr/chemrtk/pubs/summaries/aroterhc/c13972tp.pdf', u'http://www.epa.gov/chemrtk/pubs/summaries/terprial/c12965rt.pdf', u'http://iaspub.epa.gov/oppthpv/document_api.download?FILE=201-16029A.pdf']",./output/11215168.pdf/citedby/5109662List of Member Companies
10.3109/03602538708994129,"Dhareshwar, S., Stella, V., , Prodrugs of Alcohols and Phenols, , 0",cited-by,10.1007/978-0-387-49785-3_21,Prodrugs of Alcohols and Phenols,"[['Sundeep', 'S.', 'Dhareshwar'], ['Valentino', 'J.', 'Stella']]",,0,"[u'http://www.springerlink.com/index/l667506l322ru73j.pdf', u'http://www.springerlink.com/content/l667506l322ru73j']",./output/11215168.pdf/citedby/10.1007~978-0-387-49785-3_21
10.3109/03602538708994129,"Eisenberg, E., , Case Study: Oseltamivir: An Orally Bioavailable Ester Prodrug of Oseltamivir Carboxylate, , 0",cited-by,10.1007/978-0-387-49785-3_50,Case Study: Oseltamivir: An Orally Bioavailable Ester Prodrug of Oseltamivir Carboxylate,"[['Eugene', 'J.', 'Eisenberg']]",,0,"[u'http://www.springerlink.com/index/qp8122385lu86756.pdf', u'http://www.springerlink.com/content/qp8122385lu86756']",./output/11215168.pdf/citedby/10.1007~978-0-387-49785-3_50
11215168.pdf,"Liu, C., M. C. Eichelberger, R. W. Compans, and G. M. Air. 1995. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 69:1099–1106.",references,"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","[[u'CHONGGUANG', u'', u'LIU'], [u'MARYNA', u'C.', u'EICHELBERGER'], [u'RICHARD', u'W.', u'COMPANS']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/2/1099.pdf'],./output/11215168.pdf/13908139
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Lama, J., Mangasarian, A., Trono, D., , Cell-surface expression of CD4 reduces HIV1 infectivity by blocking Env incorporation in a Nef and Vpu-inhibitable manner, Current Biology, 1999",cited-by,10.1016/S0960-9822(99)80284-X,Cell-surface expression of CD4 reduces HIV1 infectivity by blocking Env incorporation in a Nef and Vpu-inhibitable manner,"[['Juan', '', 'Lama'], ['Aram', '', 'Mangasarian'], ['Didier', '', 'Trono']]",Current Biology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S096098229980284X', u'http://linkinghub.elsevier.com/retrieve/pii/S096098229980284X']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Ross, T., Oran, A., Cullen, B., , Inhibition of HIV1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein, Current Biology, 1999",cited-by,10.1016/S0960-9822(99)80283-8,Inhibition of HIV1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein,"[['Ted', 'M.', 'Ross'], ['Alp', 'E.', 'Oran'], ['Bryan', 'R.', 'Cullen']]",Current Biology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0960982299802838', u'http://linkinghub.elsevier.com/retrieve/pii/S0960982299802838']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Olsen, C., , The emergence of novel swine influenza viruses in North America, Virus Research, 2002",cited-by,10.1016/S0168-1702(02)00027-8,The emergence of novel swine influenza viruses in North America,"[['Christopher', 'W.', 'Olsen']]",Virus Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168170202000278', u'http://birdflubook.com/resources/Olsen199.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-10.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-28.pdf', u'http://www.uaeh.edu.mx/influenza/contenido/documentos/expertos/review.pdf', u'http://fazd.tamu.edu/flulitfolder/Emergence%20of%20Novel%20Swine%20Flu%20in%20North%20America.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170202000278']",./output/11215168.pdf/citedby/10.1016~S0168-1702(02)00027-8
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Asano, N., , Glycosidase inhibitors: update and perspectives on practical use, Glycobiology, 2003",cited-by,10.1093/glycob/cwg090,Glycosidase inhibitors: update and perspectives on practical use,"[['Naoki', '', 'Asano']]",Glycobiology,2003,"[u'http://glycob.oxfordjournals.org/cgi/reprint/cwg090v1.pdf', u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/cwg090']",./output/11215168.pdf/citedby/10.1093~glycob~cwg090
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Nayak, D., Hui, E., Barman, S., , Assembly and budding of influenza virus, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.08.012,Assembly and budding of influenza virus,"[['Debi', 'P.', 'Nayak'], ['Eric', 'Ka-Wai', 'Hui'], ['Subrata', '', 'Barman']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204003235', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204003235']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Karlsson, K., , Microbial recognition of target-cell glycoconjugates, Current Opinion in Structural Biology, 1995",cited-by,10.1016/0959-440X(95)80054-9,Microbial recognition of target-cell glycoconjugates,"[['Karl-Anders', '', 'Karlsson']]",Current Opinion in Structural Biology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0959440X95800549', u'http://linkinghub.elsevier.com/retrieve/pii/0959440X95800549']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","MITNAUL, L., MATROSOVICH, M., CASTRUCCI, M., et. al, Balanced Hemagglutinin and Neuraminidase Activities Are Critical for Efficient Replication of Influenza A Virus, Journal of Virology, 2000",cited-by,10.1128/JVI.74.13.6015-6020.2000,Balanced Hemagglutinin and Neuraminidase Activities Are Critical for Efficient Replication of Influenza A Virus,"[['LYNDON', 'J.', 'MITNAUL'], ['MIKHAIL', 'N.', 'MATROSOVICH'], ['MARIA', 'R.', 'CASTRUCCI'], ['ALEXANDER', 'B.', 'TUZIKOV'], ['NIKOLAI', 'V.', 'BOVIN'], ['DARWYN', '', 'KOBASA'], ['YOSHIHIRO', '', 'KAWAOKA']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/13/6015.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.13.6015-6020.2000']",./output/11215168.pdf/citedby/10.1128~JVI.74.13.6015-6020.2000
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","GOVORKOVA, E., LENEVA, I., GOLOUBEVA, O., et. al, Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.10.2723-2732.2001,"Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses","[['ELENA', 'A.', 'GOVORKOVA'], ['IRINA', 'A.', 'LENEVA'], ['OLGA', 'G.', 'GOLOUBEVA'], ['KAREN', '', 'BUSH'], ['ROBERT', 'G.', 'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/10/2723.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.10.2723-2732.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.10.2723-2732.2001
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","GAROFF, H., HEWSON, R., OPSTELTEN, D., , Virus Maturation by Budding, , 1998",cited-by,11582143Virus Maturation by Budding,Virus Maturation by Budding,"[['HENRIK', '', 'GAROFF'], ['ROGER', '', 'HEWSON'], ['DIRK-JAN', 'E.', 'OPSTELTEN']]",,1998,[u'http://mmbr.asm.org/cgi/reprint/62/4/1171.pdf'],./output/11215168.pdf/citedby/11582143Virus Maturation by Budding
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","WAGNER, R., WOLFF, T., HERWIG, A., et. al, Interdependence of Hemagglutinin Glycosylation and Neuraminidase as Regulators of Influenza Virus Growth: a Study by Reverse Genetics, Journal of Virology, 2000",cited-by,10.1128/JVI.74.14.6316-6323.2000,Interdependence of Hemagglutinin Glycosylation and Neuraminidase as Regulators of Influenza Virus Growth: a Study by Reverse Genetics,"[['RALF', '', 'WAGNER'], ['THORSTEN', '', 'WOLFF'], ['ASTRID', '', 'HERWIG'], ['STEPHAN', '', 'PLESCHKA'], ['HANS-DIETER', '', 'KLENK']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/14/6316.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.14.6316-6323.2000']",./output/11215168.pdf/citedby/10.1128~JVI.74.14.6316-6323.2000
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","GUBAREVA, L., BETHELL, R., HART, G., et. al, Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en, , 1996",cited-by,6119882Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en,Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en,"[['L.', 'V.', 'GUBAREVA'], ['R.', '', 'BETHELL'], ['G.', 'J.', 'HART'], ['K.', 'G.', 'MURTI'], ['C.', 'R.', 'PENN'], ['ANDR.', 'G.', 'WEBSTER']]",,1996,[u'http://jvi.asm.org/cgi/reprint/70/3/1818.pdf'],./output/11215168.pdf/citedby/6119882Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","GUBAREVA, L., ROBINSON, M., BETHELL, R., et. al, Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en, , 1997",cited-by,13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"[['LARISA', 'V.', 'GUBAREVA'], ['MATTHEW', 'J.', 'ROBINSON'], ['RICHARD', 'C.', 'BETHELL'], ['ANDROBERT', 'G.', 'WEBSTER']]",,1997,[u'http://jvi.asm.org/cgi/reprint/71/5/3385.pdf'],./output/11215168.pdf/citedby/13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/11215168.pdf/citedby/7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","ENAMI, M., ENAMI, A., , Influenza Virus Hemagglutinin and Neuraminidase Glycoproteins Stimulate the Membrane Association of the Matrix Protein, , 1996",cited-by,14162832Influenza Virus Hemagglutinin and Neuraminidase Glycoproteins Stimulate the Membrane Association of the Matrix Protein,Influenza Virus Hemagglutinin and Neuraminidase Glycoproteins Stimulate the Membrane Association of the Matrix Protein,"[['MASAYOSHI', '', 'ENAMI'], ['ANDKAZUE', '', 'ENAMI']]",,1996,[u'http://jvi.asm.org/cgi/reprint/70/10/6653.pdf'],./output/11215168.pdf/citedby/14162832Influenza Virus Hemagglutinin and Neuraminidase Glycoproteins Stimulate the Membrane Association of the Matrix Protein
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","CHEN, B., GANDHI, R., , CD4 Down-Modulation during Infection of Human T Cells with Human Immunodeficiency Virus Type 1 Involves Independent Activities ofvpu,env, andnef, , 1996",cited-by,"5799560CD4 Down-Modulation during Infection of Human T Cells with Human Immunodeficiency Virus Type 1 Involves Independent Activities ofvpu,env, andnef","CD4 Down-Modulation during Infection of Human T Cells with Human Immunodeficiency Virus Type 1 Involves Independent Activities ofvpu,env, andnef","[['BENJAMIN', 'K.', 'CHEN'], ['RAJESH', 'T.', 'GANDHI']]",,1996,"[u'http://authors.library.caltech.edu/2768/1/CHEjvir96.pdf', u'http://jvi.asm.org/cgi/reprint/70/9/6044.pdf']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","MITNAUL, L., CASTRUCCI, M., MURTI, K., et. al, The Cytoplasmic Tail of Influenza A Virus Neuraminidase (NA) Affects NA Incorporation into Virions, Virion Morphology, and Virulence in Mice but Is Not Essential for Virus Replication, , 1996",cited-by,"6661825The Cytoplasmic Tail of Influenza A Virus Neuraminidase (NA) Affects NA Incorporation into Virions, Virion Morphology, and Virulence in Mice but Is Not Essential for Virus Replication","The Cytoplasmic Tail of Influenza A Virus Neuraminidase (NA) Affects NA Incorporation into Virions, Virion Morphology, and Virulence in Mice but Is Not Essential for Virus Replication","[['LYNDON', 'J.', 'MITNAUL'], ['MARIA', 'R.', 'CASTRUCCI'], ['K.', 'GOPAL', 'MURTI'], ['ANDYOSHIHIRO', '', 'KAWAOKA']]",,1996,[u'http://jvi.asm.org/cgi/reprint/70/2/873.pdf'],
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf'],./output/11215168.pdf/citedby/11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","AVALOS, R., YU, Z., NAYAK, A., , Association of Influenza Virus NP and M1 Proteins with Cellular Cytoskeletal Elements in Influenza Virus-Infected Cells, , 1997",cited-by,11330716Association of Influenza Virus NP and M1 Proteins with Cellular Cytoskeletal Elements in Influenza Virus-Infected Cells,Association of Influenza Virus NP and M1 Proteins with Cellular Cytoskeletal Elements in Influenza Virus-Infected Cells,"[['ROY', 'T.', 'AVALOS'], ['ZHONG', '', 'YU'], ['ANDDEBI', 'P.', 'NAYAK']]",,1997,"[u'http://jvi.asm.org/cgi/reprint/71/4/2947.pdf', u'http://jvi.highwire.org/cgi/reprint/71/4/2947.pdf']",./output/11215168.pdf/citedby/11330716Association of Influenza Virus NP and M1 Proteins with Cellular Cytoskeletal Elements in Influenza Virus-Infected Cells
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Morris, S., Price, G., Barnett, J., et. al, Role of neuraminidase in influenza virus-induced apoptosis, , 1999",cited-by,6297657Role of neuraminidase in influenza virus-induced apoptosis,Role of neuraminidase in influenza virus-induced apoptosis,"[['Susan', 'J.', 'Morris'], ['Graeme', 'E.', 'Price'], ['Jacqueline', 'M.', 'Barnett'], ['Steven', 'A.', 'Hiscox'], ['Harry', '', 'Smith'], ['Clive', '', 'Sweet']]",,1999,[u'http://vir.sgmjournals.org/cgi/reprint/80/1/137.pdf'],./output/11215168.pdf/citedby/6297657Role of neuraminidase in influenza virus-induced apoptosis
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Skoging, U., Vihinen, M., Nilsson, L., et. al, Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid, Structure, 1996",cited-by,10.1016/S0969-2126(96)00058-5,Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid,"[['Ulrica', '', 'Skoging'], ['Mauno', '', 'Vihinen'], ['Lennart', '', 'Nilsson'], ['Peter', '', 'Liljestr\xc3\xb6m']]",Structure,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0969212696000585', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212696000585']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Baigent, S., McCauley, J., , Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture, Virus Research, 2001",cited-by,10.1016/S0168-1702(01)00272-6,Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture,"[['Susan', 'J', 'Baigent'], ['John', 'W', 'McCauley']]",Virus Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168170201002726', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170201002726']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","SMEE, D., HUFFMAN, J., MORRISON, A., et. al, Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.743-748.2001,Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities,"[['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['ANN', 'C.', 'MORRISON'], ['DALE', 'L.', 'BARNARD'], ['ROBERT', 'W.', 'SIDWELL']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://journals.pasteur.ac.ir/AAC01/45(3)/743.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.743-748.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.3.743-748.2001
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Itzstein, M., , The war against influenza: discovery and development of sialidase inhibitors, Nature Reviews Drug Discovery, 2007",cited-by,10.1038/nrd2400,The war against influenza: discovery and development of sialidase inhibitors,"[['Mark', 'von', 'Itzstein']]",Nature Reviews Drug Discovery,2007,"[u'http://dx.doi.org/10.1038/nrd2400', u'http://www.nature.com/doifinder/10.1038/nrd2400']",./output/11215168.pdf/citedby/10.1038~nrd2400
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Hulse, D., Webster, R., Russell, R., et. al, Molecular Determinants within the Surface Proteins Involved in the Pathogenicity of H5N1 Influenza Viruses in Chickens, Journal of Virology, 2004",cited-by,10.1128/JVI.78.18.9954-9964.2004,Molecular Determinants within the Surface Proteins Involved in the Pathogenicity of H5N1 Influenza Viruses in Chickens,"[['Diane', 'J.', 'Hulse'], ['Robert', 'G.', 'Webster'], ['Rupert', 'J.', 'Russell'], ['Daniel', 'R.', 'Perez']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/18/9954.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/66.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.18.9954-9964.2004']",./output/11215168.pdf/citedby/10.1128~JVI.78.18.9954-9964.2004
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Ferraris, O., Lina, B., , Mutations of neuraminidase implicated in neuraminidase inhibitors resistance, Journal of Clinical Virology, 2008",cited-by,10.1016/j.jcv.2007.10.020,Mutations of neuraminidase implicated in neuraminidase inhibitors resistance,"[['Olivier', '', 'Ferraris'], ['Bruno', '', 'Lina']]",Journal of Clinical Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1386653207003903', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653207003903']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Wei, D., Du, Q., Sun, H., et. al, Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands, Biochemical and Biophysical Research Communications, 2006",cited-by,10.1016/j.bbrc.2006.03.210,Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands,"[['Dong-Qing', '', 'Wei'], ['Qi-Shi', '', 'Du'], ['Hao', '', 'Sun'], ['Kuo-Chen', '', 'Chou']]",Biochemical and Biophysical Research Communications,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0006291X06007716', u'http://people.virginia.edu/~fc8b/kchou/new/paper/BBRC_H5N1_2006.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0006291X06007716']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","BAUER, P., BRONSON, R., FUNG, S., et. al, Genetic and Structural Analysis of a Virulence Determinant in Polyomavirus VP1, , 1995",cited-by,14019107Genetic and Structural Analysis of a Virulence Determinant in Polyomavirus VP1,Genetic and Structural Analysis of a Virulence Determinant in Polyomavirus VP1,"[['PAUL', 'H.', 'BAUER'], ['ROD', 'T.', 'BRONSON'], ['SHUI', 'C.', 'FUNG'], ['ROBERT', '', 'FREUND'], ['THILO', '', 'STEHLE'], ['STEPHEN', 'C.', 'HARRISON'], ['ANDTHOMAS', 'L.', 'BENJAMIN']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/12/7925.pdf'],./output/11215168.pdf/citedby/14019107Genetic and Structural Analysis of a Virulence Determinant in Polyomavirus VP1
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Barman, S., Adhikary, L., Chakrabarti, A., et. al, Role of Transmembrane Domain and Cytoplasmic Tail Amino Acid Sequences of Influenza A Virus Neuraminidase in Raft Association and Virus Budding, Journal of Virology, 2004",cited-by,10.1128/JVI.78.10.5258-5269.2004,Role of Transmembrane Domain and Cytoplasmic Tail Amino Acid Sequences of Influenza A Virus Neuraminidase in Raft Association and Virus Budding,"[['Subrata', '', 'Barman'], ['Lopa', '', 'Adhikary'], ['Alok', 'K.', 'Chakrabarti'], ['Carl', '', 'Bernas'], ['Yoshihiro', '', 'Kawaoka'], ['Debi', 'P.', 'Nayak']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/10/5258.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.10.5258-5269.2004']",./output/11215168.pdf/citedby/10.1128~JVI.78.10.5258-5269.2004
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Ferraris, O., Kessler, N., Lina, B., , Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice, Antiviral Research, 2005",cited-by,10.1016/j.antiviral.2005.07.004,Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice,"[['O.', '', 'Ferraris'], ['N.', '', 'Kessler'], ['B.', '', 'Lina']]",Antiviral Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205001427', u'http://birdflubook.com/resources/0Ferrarisxxx.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205001427']",./output/11215168.pdf/citedby/10.1016~j.antiviral.2005.07.004
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Stray, S., Cummings, R., Air, G., , Influenza virus infection of desialylated cells, Glycobiology, 2000",cited-by,10.1093/glycob/10.7.649,Influenza virus infection of desialylated cells,"[['Stephen', 'J.', 'Stray'], ['Richard', 'D.', 'Cummings'], ['Gillian', 'M.', 'Air']]",Glycobiology,2000,"[u'http://glycob.oxfordjournals.org/cgi/reprint/10/7/649.pdf', u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/10.7.649']",./output/11215168.pdf/citedby/10.1093~glycob~10.7.649
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Schmitt, A., Lamb, R., , Influenza Virus Assembly and Budding at the Viral Budozone, Advances in Virus Research, 2005",cited-by,10.1016/S0065-3527(05)64012-2,Influenza Virus Assembly and Budding at the Viral Budozone,"[['Anthony', 'P.', 'Schmitt'], ['Robert', 'A.', 'Lamb']]",Advances in Virus Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0065352705640122', u'http://linkinghub.elsevier.com/retrieve/pii/S0065352705640122']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","MENA, I., VIVO, A., PEREZ, E., et. al, Rescue of a Synthetic Chloramphenicol Acetyltransferase RNA into Influenza Virus-Like Particles Obtained from Recombinant Plasmids, , 1996",cited-by,14230293Rescue of a Synthetic Chloramphenicol Acetyltransferase RNA into Influenza Virus-Like Particles Obtained from Recombinant Plasmids,Rescue of a Synthetic Chloramphenicol Acetyltransferase RNA into Influenza Virus-Like Particles Obtained from Recombinant Plasmids,"[['IGNACIO', '', 'MENA'], ['AMPARO', '', 'VIVO'], ['ESPERANZA', '', 'PEREZ'], ['ANDAGUSTIN', '', 'PORTELA'], ['Biologia', '', 'Celular']]",,1996,[u'http://jvi.asm.org/cgi/reprint/70/8/5016.pdf'],./output/11215168.pdf/citedby/14230293Rescue of a Synthetic Chloramphenicol Acetyltransferase RNA into Influenza Virus-Like Particles Obtained from Recombinant Plasmids
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Yang, P., Bansal, A., Liu, C., et. al, Hemagglutinin Specificity and Neuraminidase Coding Capacity of Neuraminidase-Deficient Influenza Viruses, Virology, 1997",cited-by,10.1006/viro.1996.8421,Hemagglutinin Specificity and Neuraminidase Coding Capacity of Neuraminidase-Deficient Influenza Viruses,"[['Ping', '', 'Yang'], ['Anju', '', 'Bansal'], ['Chongguang', '', 'Liu'], ['Gillian', 'M', 'Air']]",Virology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0042682296984214', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682296984214']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","HUGHES, M., MATROSOVICH, M., RODGERS, M., et. al, Influenza A Viruses Lacking Sialidase Activity Can Undergo Multiple Cycles of Replication in Cell Culture, Eggs, or Mice, Journal of Virology, 2000",cited-by,10.1128/JVI.74.11.5206-5212.2000,"Influenza A Viruses Lacking Sialidase Activity Can Undergo Multiple Cycles of Replication in Cell Culture, Eggs, or Mice","[['MARK', 'T.', 'HUGHES'], ['MIKHAIL', '', 'MATROSOVICH'], ['M.', 'ELIZABETH', 'RODGERS'], ['MARTHA', '', 'MCGREGOR'], ['YOSHIHIRO', '', 'KAWAOKA']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/11/5206.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.11.5206-5212.2000']",./output/11215168.pdf/citedby/10.1128~JVI.74.11.5206-5212.2000
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Shinya, K., Fujii, Y., Ito, H., et. al, Characterization of a Neuraminidase-Deficient Influenza A Virus as a Potential Gene Delivery Vector and a Live Vaccine, Journal of Virology, 2004",cited-by,10.1128/JVI.78.6.3083-3088.2004,Characterization of a Neuraminidase-Deficient Influenza A Virus as a Potential Gene Delivery Vector and a Live Vaccine,"[['Kyoko', '', 'Shinya'], ['Yutaka', '', 'Fujii'], ['Hiroshi', '', 'Ito'], ['Toshihiro', '', 'Ito'], ['Yoshihiro', '', 'Kawaoka']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/6/3083.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.6.3083-3088.2004']",./output/11215168.pdf/citedby/10.1128~JVI.78.6.3083-3088.2004
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","BANTIA, S., GHATE, A., ANANTH, S., et. al, Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140, , 1998",cited-by,13869212Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140,Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140,"[['SHANTA', '', 'BANTIA'], ['ANITA', 'A.', 'GHATE'], ['SANDYA', 'L.', 'ANANTH'], ['Y.', 'SUDHAKAR', 'BABU'], ['GILLIAN', 'M.', 'AIR'], ['GERALD', 'M.', 'WALSH']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/4/801.pdf'],./output/11215168.pdf/citedby/13869212Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Mishin, V., Novikov, D., Hayden, F., et. al, Effect of Hemagglutinin Glycosylation on Influenza Virus Susceptibility to Neuraminidase Inhibitors, Journal of Virology, 2005",cited-by,10.1128/JVI.79.19.12416-12424.2005,Effect of Hemagglutinin Glycosylation on Influenza Virus Susceptibility to Neuraminidase Inhibitors,"[['Vasiliy', 'P.', 'Mishin'], ['Dmitri', '', 'Novikov'], ['Frederick', 'G.', 'Hayden'], ['Larisa', 'V.', 'Gubareva']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/19/12416.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.19.12416-12424.2005']",./output/11215168.pdf/citedby/10.1128~JVI.79.19.12416-12424.2005
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Macdonald, S., Watson, K., Cameron, R., et. al, Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4542-4549.2004,Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen,"[['Simon', 'J. F.', 'Macdonald'], ['Keith', 'G.', 'Watson'], ['Rachel', '', 'Cameron'], ['David', 'K.', 'Chalmers'], ['Derek', 'A.', 'Demaine'], ['Rob', 'J.', 'Fenton'], ['David', '', 'Gower'], ['J.', 'Nicole', 'Hamblin'], ['Stephanie', '', 'Hamilton'], ['Graham', 'J.', 'Hart'], ['Graham', 'G. A.', 'Inglis'], ['Betty', '', 'Jin'], ['Haydn', 'T.', 'Jones'], ['Darryl', 'B.', 'McConnell'], ['Andy', 'M.', 'Mason'], ['Van', '', 'Nguyen'], ['Ian', 'J.', 'Owens'], ['Nigel', '', 'Parry'], ['Phillip', 'A.', 'Reece'], ['Stephen', 'E.', 'Shanahan'], ['Donna', '', 'Smith'], ['Wen-Yang', '', 'Wu'], ['Simon', 'P.', 'Tucker']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4542.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4542-4549.2004']",./output/11215168.pdf/citedby/10.1128~AAC.48.12.4542-4549.2004
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","DeMarco, M., Woods, R., , Structural glycobiology: A game of snakes and ladders, Glycobiology, 2008",cited-by,10.1093/glycob/cwn026,Structural glycobiology: A game of snakes and ladders,"[['Mari', 'L', 'DeMarco'], ['Robert', 'J', 'Woods']]",Glycobiology,2008,"[u'http://glycob.oxfordjournals.org/cgi/reprint/cwn026v1.pdf', u'http://glycob.oxfordjournals.org/cgi/reprint/18/6/426.pdf', u'http://www.glycob.oxfordjournals.org/cgi/doi/10.1093/glycob/cwn026']",./output/11215168.pdf/citedby/10.1093~glycob~cwn026
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Ohuchi, M., Asaoka, N., Sakai, T., et. al, Roles of neuraminidase in the initial stage of influenza virus infection, Microbes and Infection, 2006",cited-by,10.1016/j.micinf.2005.12.008,Roles of neuraminidase in the initial stage of influenza virus infection,"[['Masanobu', '', 'Ohuchi'], ['Naoko', '', 'Asaoka'], ['Tatsuya', '', 'Sakai'], ['Reiko', '', 'Ohuchi']]",Microbes and Infection,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1286457906000189', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457906000189']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Porotto, M., Murrell, M., Greengard, O., et. al, Influence of the Human Parainfluenza Virus 3 Attachment Protein's Neuraminidase Activity on Its Capacity To Activate the Fusion Protein, Journal of Virology, 2005",cited-by,10.1128/JVI.79.4.2383-2392.2005,Influence of the Human Parainfluenza Virus 3 Attachment Protein's Neuraminidase Activity on Its Capacity To Activate the Fusion Protein,"[['Matteo', '', 'Porotto'], ['Matthew', '', 'Murrell'], ['Olga', '', 'Greengard'], ['Anne', '', 'Moscona']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/4/2383.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.4.2383-2392.2005']",./output/11215168.pdf/citedby/10.1128~JVI.79.4.2383-2392.2005
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Tsuchiya, E., Sugawara, K., Hongo, S., et. al, Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule, , 0",cited-by,12051678Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule,Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule,"[['Emi', '', 'Tsuchiya'], ['Kanetsu', '', 'Sugawara'], ['Seiji', '', 'Hongo'], ['Yoko', '', 'Matsuzaki'], ['Yasushi', '', 'Muraki'], ['Zhu-Nan', '', 'Li']]",,0,[],
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Kang, S., Song, J., Quan, F., et. al, Influenza vaccines based on virus-like particles, Virus Research, 2009",cited-by,10.1016/j.virusres.2009.04.005,Influenza vaccines based on virus-like particles,"[['Sang-Moo', '', 'Kang'], ['Jae-Min', '', 'Song'], ['Fu-Shi', '', 'Quan'], ['Richard', 'W.', 'Compans']]",Virus Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0168170209001415', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170209001415']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Mena, I., Castillo, M., Vivo, A., , Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins, , 1999",cited-by,5349095Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins,Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins,"[['Ignacio', '', 'Mena'], ['Mar', '', 'Castillo'], ['Amparo', '', 'Vivo']]",,1999,"[u'http://vir.sgmjournals.org/cgi/reprint/80/7/1635.pdf', u'http://jgv.sgmjournals.org/cgi/reprint/80/7/1635.pdf']",./output/11215168.pdf/citedby/5349095Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Lee, K., Seong, B., , The position 4 nucleotide at the 3« end of the influenza virus neuraminidase vRNA is involved in temporal regulation of transcription and replication of neuraminidase RNAs and affects the repertoire of influenza virus surface antigens, , 0",cited-by,11833489The position 4 nucleotide at the 3« end of the influenza virus neuraminidase vRNA is involved in temporal regulation of transcription and replication of neuraminidase RNAs and affects the repertoire of influenza virus surface antigens,The position 4 nucleotide at the 3« end of the influenza virus neuraminidase vRNA is involved in temporal regulation of transcription and replication of neuraminidase RNAs and affects the repertoire of influenza virus surface antigens,"[['Kwang-Hee', '', 'Lee'], ['Baik', 'L.', 'Seong']]",,0,[u'http://vir.sgmjournals.org/cgi/reprint/79/8/1923.pdf'],
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Gulati, U., Wu, W., Gulati, S., et. al, Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses, Virology, 2005",cited-by,10.1016/j.virol.2005.05.009,Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses,"[['Upma', '', 'Gulati'], ['Wenxin', '', 'Wu'], ['Shelly', '', 'Gulati'], ['Kshama', '', 'Kumari'], ['Joseph', 'L.', 'Waner'], ['Gillian', 'M.', 'Air']]",Virology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S004268220500293X', u'http://linkinghub.elsevier.com/retrieve/pii/S004268220500293X']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Stray, S., Air, G., , Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis, Virus Research, 2001",cited-by,10.1016/S0168-1702(01)00260-X,Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis,"[['Stephen', 'J', 'Stray'], ['Gillian', 'M', 'Air']]",Virus Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S016817020100260X', u'http://linkinghub.elsevier.com/retrieve/pii/S016817020100260X']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Jr., J., Alviano, D., Silva, M., et. al, Characterization of Sialidase from an Influenza A (H3N2) Virus Strain: Kinetic Parameters and Substrate Specificity, Intervirology, 2003",cited-by,10.1159/000072428,Characterization of Sialidase from an Influenza A (H3N2) Virus Strain: Kinetic Parameters and Substrate Specificity,"[['Jos\xc3\xa9', 'Fran\xc3\xa7a de Barros', 'Jr.'], ['Daniela', 'Sales', 'Alviano'], ['Maria', 'Helena da', 'Silva'], ['Marcia', 'Dutra', 'Wigg'], ['Celuta', 'Sales', 'Alviano'], ['Roland', '', 'Schauer'], ['Jos\xc3\xa9', 'Nelson dos Santos Silva', 'Couceiro']]",Intervirology,2003,"[u'http://www.online.karger.com/doi/10.1159/000072428', u'http://www.karger.com/doi/10.1159/000072428']",./output/11215168.pdf/citedby/10.1159~000072428
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","OH, S., EICHELBERGER, M., , Polarization of Allogeneic T-Cell Responses by Influenza Virus-Infected Dendritic Cells, Journal of Virology, 2000",cited-by,10.1128/JVI.74.17.7738-7744.2000,Polarization of Allogeneic T-Cell Responses by Influenza Virus-Infected Dendritic Cells,"[['SANGKON', '', 'OH'], ['MARYNA', 'C.', 'EICHELBERGER']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/17/7738.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.17.7738-7744.2000']",./output/11215168.pdf/citedby/10.1128~JVI.74.17.7738-7744.2000
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Hatakeyama, S., Sakai-Tagawa, Y., Kiso, M., et. al, Enhanced Expression of an 2,6Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase Inhibitor, , 2005",cited-by,"6784417Enhanced Expression of an 2,6Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase Inhibitor","Enhanced Expression of an 2,6Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase Inhibitor","[['Shuji', '', 'Hatakeyama'], ['Yuko', '', 'Sakai-Tagawa'], ['Maki', '', 'Kiso'], ['Hideo', '', 'Goto'], ['Chiharu', '', 'Kawakami'], ['Keiko', '', 'Mitamura'], ['Norio', '', 'Sugaya'], ['Yasuo', '', 'Suzuki'], ['Yoshihiro', '', 'Kawaoka']]",,2005,[u'http://jcm.asm.org/cgi/reprint/43/8/4139.pdf'],
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","CHEUNG, T., POON, L., , Biology of Influenza A Virus, Annals of The New York Academy of Sciences, 2007",cited-by,10.1196/annals.1408.001,Biology of Influenza A Virus,"[['TIMOTHY', 'K. W.', 'CHEUNG'], ['LEO', 'L. M.', 'POON']]",Annals of The New York Academy of Sciences,2007,[u'http://blackwell-synergy.com/doi/abs/10.1196/annals.1408.001'],
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Barman, S., Adhikary, L., Kawaoka, Y., et. al, Influenza A Virus Hemagglutinin Containing Basolateral Localization Signal Does Not Alter the Apical Budding of a Recombinant Influenza A Virus in Polarized MDCK Cells, Virology, 2003",cited-by,10.1006/viro.2002.1731,Influenza A Virus Hemagglutinin Containing Basolateral Localization Signal Does Not Alter the Apical Budding of a Recombinant Influenza A Virus in Polarized MDCK Cells,"[['Subrata', '', 'Barman'], ['Lopa', '', 'Adhikary'], ['Yoshihiro', '', 'Kawaoka'], ['Debi', 'P.', 'Nayak']]",Virology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0042682202917319', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682202917319']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","HUGHES, M., MCGREGOR, M., SUZUKI, T., et. al, Adaptation of Influenza A Viruses to Cells Expressing Low Levels of Sialic Acid Leads to Loss of Neuraminidase Activity, Journal of Virology, 2001",cited-by,10.1128/JVI.75.8.3766-3770.2001,Adaptation of Influenza A Viruses to Cells Expressing Low Levels of Sialic Acid Leads to Loss of Neuraminidase Activity,"[['MARK', 'T.', 'HUGHES'], ['MARTHA', '', 'MCGREGOR'], ['TAKASHI', '', 'SUZUKI'], ['YASUO', '', 'SUZUKI'], ['YOSHIHIRO', '', 'KAWAOKA']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/8/3766.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.8.3766-3770.2001']",./output/11215168.pdf/citedby/10.1128~JVI.75.8.3766-3770.2001
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Walter, M., Fiedler, C., Grassl, R., et. al, Structure of the Receptor-Binding Protein of Bacteriophage Det7: a Podoviral Tail Spike in a Myovirus, Journal of Virology, 2008",cited-by,10.1128/JVI.01641-07,Structure of the Receptor-Binding Protein of Bacteriophage Det7: a Podoviral Tail Spike in a Myovirus,"[['Monika', '', 'Walter'], ['Christian', '', 'Fiedler'], ['Renate', '', 'Grassl'], ['Manfred', '', 'Biebl'], ['Reinhard', '', 'Rachel'], ['X.', 'Lois', 'Hermo-Parrado'], ['Antonio', 'L.', 'Llamas-Saiz'], ['Robert', '', 'Seckler'], ['Stefan', '', 'Miller'], ['Mark', 'J. van', 'Raaij']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01641-07', u'http://jvi.asm.org/cgi/reprint/82/5/2265.pdf']",./output/11215168.pdf/citedby/10.1128~JVI.01641-07
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Wu, W., Air, G., , Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to α2,8-linked sialic acid, Virology, 2004",cited-by,10.1016/j.virol.2004.05.013,"Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to α2,8-linked sialic acid","[['Wenxin', '', 'Wu'], ['Gillian', 'M.', 'Air']]",Virology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0042682204003307', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682204003307']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Gubareva, L., Nedyalkova, M., Novikov, D., et. al, A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site, , 2002",cited-by,6949716A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site,A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site,"[['Larisa', 'V.', 'Gubareva'], ['Marina', 'S.', 'Nedyalkova'], ['Dmitri', 'V.', 'Novikov'], ['K.', 'Gopal', 'Murti'], ['Erich', '', 'Hoffmann'], ['Frederick', 'G.', 'Hayden']]",,2002,[u'http://vir.sgmjournals.org/cgi/reprint/83/11/2683.pdf'],./output/11215168.pdf/citedby/6949716A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Watanabe, S., Imai, M., Ohara, Y., et. al, Influenza B Virus BM2 Protein Is Transported through the trans-Golgi Network as an Integral Membrane Protein, Journal of Virology, 2003",cited-by,10.1128/JVI.77.19.10630-10637.2003,Influenza B Virus BM2 Protein Is Transported through the trans-Golgi Network as an Integral Membrane Protein,"[['Shinji', '', 'Watanabe'], ['Masaki', '', 'Imai'], ['Yoshiro', '', 'Ohara'], ['Takato', '', 'Odagiri']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/19/10630.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.19.10630-10637.2003']",./output/11215168.pdf/citedby/10.1128~JVI.77.19.10630-10637.2003
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Solorzano, A., Zheng, H., Fodor, E., et. al, Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice, , 0",cited-by,11088220Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice,Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice,"[['Alicia', '', 'Solorzano'], ['Hongyong', '', 'Zheng'], ['Ervin', '', 'Fodor'], ['George', 'G.', 'Brownlee'], ['Peter', '', 'Palese'], ['Adolfo', '', 'Garci']]",,0,[u'http://vir.sgmjournals.org/cgi/reprint/81/3/737.pdf'],./output/11215168.pdf/citedby/11088220Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Yongkiettrakul, S., Boonyapakron, K., Jongkaewwattana, A., et. al, Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain, Journal of Virological Methods, 2009",cited-by,10.1016/j.jviromet.2008.10.025,Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain,"[['S.', '', 'Yongkiettrakul'], ['K.', '', 'Boonyapakron'], ['A.', '', 'Jongkaewwattana'], ['A.', '', 'Wanitchang'], ['U.', '', 'Leartsakulpanich'], ['P.', '', 'Chitnumsub'], ['L.', '', 'Eurwilaichitr'], ['Y.', '', 'Yuthavong']]",Journal of Virological Methods,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166093408003789', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093408003789']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","KREMPL, C., HERRLER, G., , Sialic Acid Binding Activity of Transmissible Gastroenteritis Coronavirus Affects Sedimentation Behavior of Virions and Solubilized Glycoproteins, Journal of Virology, 2001",cited-by,10.1128/JVI.75.2.844-849.2001,Sialic Acid Binding Activity of Transmissible Gastroenteritis Coronavirus Affects Sedimentation Behavior of Virions and Solubilized Glycoproteins,"[['CHRISTINE', '', 'KREMPL'], ['GEORG', '', 'HERRLER']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/2/844.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.2.844-849.2001']",./output/11215168.pdf/citedby/10.1128~JVI.75.2.844-849.2001
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","PRINCE, G., OTTOLINI, M., MOSCONA, A., , Contribution of the Human Parainfluenza Virus Type 3 HN-Receptor Interaction to Pathogenesis In Vivo, Journal of Virology, 2001",cited-by,10.1128/JVI.75.24.12446-12451.2001,Contribution of the Human Parainfluenza Virus Type 3 HN-Receptor Interaction to Pathogenesis In Vivo,"[['GREGORY', 'A.', 'PRINCE'], ['MARTIN', 'G.', 'OTTOLINI'], ['ANNE', '', 'MOSCONA']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/24/12446.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.24.12446-12451.2001']",./output/11215168.pdf/citedby/10.1128~JVI.75.24.12446-12451.2001
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Bosch, V., Kramer, B., Pfeiffer, T., et. al, Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors, , 0",cited-by,11124978Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors,Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors,"[['Valerie', '', 'Bosch'], ['Beatrice', '', 'Kramer'], ['Tanya', '', 'Pfeiffer'], ['Lilian', '', 'Sta'], ['David', 'A.', 'Steinhauer']]",,0,[u'http://vir.sgmjournals.org/cgi/reprint/82/10/2485.pdf'],
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Shtyrya, Y., Mochalova, L., Voznova, G., et. al, Adjustment of receptor-binding and neuraminidase substrate specificties in avian–human reassortant influenza viruses, Glycoconjugate Journal, 2009",cited-by,10.1007/s10719-008-9169-x,Adjustment of receptor-binding and neuraminidase substrate specificties in avian–human reassortant influenza viruses,"[['Yulia', '', 'Shtyrya'], ['Larisa', '', 'Mochalova'], ['Galina', '', 'Voznova'], ['Irina', '', 'Rudneva'], ['Aleksandr', '', 'Shilov'], ['Nikolai', '', 'Kaverin'], ['Nicolai', '', 'Bovin']]",Glycoconjugate Journal,2009,"[u'http://www.springerlink.com/index/n8600j6n6303451t.pdf', u'http://www.springerlink.com/content/n8600j6n6303451t', u'http://www.springerlink.com/index/10.1007/s10719-008-9169-x', u'http://www.springerlink.com/index/pdf/10.1007/s10719-008-9169-x']",./output/11215168.pdf/citedby/10.1007~s10719-008-9169-x
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Englund, L., Segerstad, C., , Two avian H10 influenza A virus strains with different pathogenicity for mink (Mustela vison), Archives of Virology, 1998",cited-by,10.1007/s007050050321,Two avian H10 influenza A virus strains with different pathogenicity for mink (Mustela vison),"[['L.', '', 'Englund'], ['C.', 'H\xc3\xa5rd af', 'Segerstad']]",Archives of Virology,1998,"[u'http://www.springerlink.com/content/cq16hahetvp6hwfq', u'http://www.springerlink.com/index/cq16hahetvp6hwfq.pdf', u'http://www.lib.cau.edu.cn/qlga/37a.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s007050050321', u'http://www.springerlink.com/index/pdf/10.1007/s007050050321']",./output/11215168.pdf/citedby/10.1007~s007050050321
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Kang, S., Pushko, P., Bright, R., et. al, Influenza Virus-Like Particles as Pandemic Vaccines, , 0",cited-by,10.1007/978-3-540-92165-3_14,Influenza Virus-Like Particles as Pandemic Vaccines,"[['S.', 'M.', 'Kang'], ['P.', '', 'Pushko'], ['R.', 'A.', 'Bright'], ['G.', '', 'Smith'], ['R.', 'W.', 'Compans']]",,0,"[u'http://www.springerlink.com/content/v020651282368468', u'http://www.springerlink.com/index/v020651282368468.pdf']",./output/11215168.pdf/citedby/10.1007~978-3-540-92165-3_14
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Gulati, S., Smith, D., Air, G., , Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses, Virology Journal, 2009",cited-by,10.1186/1743-422X-6-22,Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses,"[['Shelly', '', 'Gulati'], ['David', 'F', 'Smith'], ['Gillian', 'M', 'Air']]",Virology Journal,2009,"[u'http://www.biomedcentral.com/content/pdf/1743-422X-6-22.pdf', u'http://www.virologyj.com/content/6/1/22', u'http://www.springerlink.com/content/u1n3w82j47m83057', u'http://www.springerlink.com/index/u1n3w82j47m83057.pdf']",./output/11215168.pdf/citedby/10.1186~1743-422X-6-22
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Venkatramani, L., Bochkareva, E., Lee, J., et. al, An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA–Antibody Complex, Journal of Molecular Biology, 2006",cited-by,10.1016/j.jmb.2005.11.061,An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA–Antibody Complex,"[['Lalitha', '', 'Venkatramani'], ['Elena', '', 'Bochkareva'], ['Janis', 'T.', 'Lee'], ['Upma', '', 'Gulati'], ['W.', 'Graeme', 'Laver'], ['Alexey', '', 'Bochkarev'], ['Gillian', 'M.', 'Air']]",Journal of Molecular Biology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0022283605014646', u'http://linkinghub.elsevier.com/retrieve/pii/S0022283605014646']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Ferraris, O., Kessler, N., Valette, M., et. al, Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.05.050,Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005,"[['Olivier', '', 'Ferraris'], ['Nicole', '', 'Kessler'], ['Martine', '', 'Valette'], ['Bruno', '', 'Lina']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06006384', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06006384']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Gravel, C., Li, C., Wang, J., et. al, Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.06.075,Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences,"[['Caroline', '', 'Gravel'], ['Changgui', '', 'Li'], ['Junzhi', '', 'Wang'], ['Anwar', 'M.', 'Hashem'], ['Bozena', '', 'Jaentschke'], ['Kang-wei', '', 'Xu'], ['Barry', '', 'Lorbetskie'], ['Genevieve', '', 'Gingras'], ['Yves', '', 'Aubin'], ['Garry', 'Van', 'Domselaar'], ['Michel', '', 'Girard'], ['Runtao', '', 'He'], ['Xuguang', '', 'Li']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10009035', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10009035']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Ghate, A., Air, G., , Influenza Type B Neuraminidase Can Replace the Function of Type A Neuraminidase, Virology, 1999",cited-by,10.1006/viro.1999.9936,Influenza Type B Neuraminidase Can Replace the Function of Type A Neuraminidase,"[['Anita', 'A.', 'Ghate'], ['Gillian', 'M.', 'Air']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299999361', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299999361']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Wyde, P., , Chemotherapy of respiratory viruses: prospects and challenges, Drug Resistance Updates, 1999",cited-by,10.1054/drup.1999.0091,Chemotherapy of respiratory viruses: prospects and challenges,"[['Philip', 'R.', 'Wyde']]",Drug Resistance Updates,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1368764699900912', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764699900912']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Sylte, M., Suarez, D., , Influenza Neuraminidase as a Vaccine Antigen, , 0",cited-by,10.1007/978-3-540-92165-3_12,Influenza Neuraminidase as a Vaccine Antigen,"[['Matthew', 'J.', 'Sylte'], ['David', 'L.', 'Suarez']]",,0,"[u'http://www.springerlink.com/index/g23374h0j3315635.pdf', u'http://www.springerlink.com/content/g23374h0j3315635']",./output/11215168.pdf/citedby/10.1007~978-3-540-92165-3_12
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Jo, S., Kawaguchi, A., Takizawa, N., et. al, Involvement of vesicular trafficking system in membrane targeting of the progeny influenza virus genome, Microbes and Infection, 2010",cited-by,10.1016/j.micinf.2010.06.011,Involvement of vesicular trafficking system in membrane targeting of the progeny influenza virus genome,"[['Shuichi', '', 'Jo'], ['Atsushi', '', 'Kawaguchi'], ['Naoki', '', 'Takizawa'], ['Yuko', '', 'Morikawa'], ['Fumitaka', '', 'Momose'], ['Kyosuke', '', 'Nagata']]",Microbes and Infection,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1286457910001747', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457910001747']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Hashem, A., Flaman, A., Farnsworth, A., et. al, Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases, PLOS One, 2009",cited-by,10.1371/journal.pone.0008350.t001,Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases,"[['Anwar', 'M.', 'Hashem'], ['Anathea', 'S.', 'Flaman'], ['Aaron', '', 'Farnsworth'], ['Earl', 'G.', 'Brown'], ['Gary', 'Van', 'Domselaar'], ['Runtao', '', 'He'], ['Xuguang', '', 'Li']]",PLOS One,2009,"[u'http://www.med.uottawa.ca/bmi/assets/documents/dr%20brown/dr_brown11.pdf', u'http://www.medicine.uottawa.ca/bmi/assets/documents/dr%20brown/dr_brown11.pdf', u'http://dx.plos.org/10.1371/journal.pone.0008350', u'http://dx.plos.org/10.1371/journal.pone.0008350.g001', u'http://dx.plos.org/10.1371/journal.pone.0008350.g002', u'http://dx.plos.org/10.1371/journal.pone.0008350.g003', u'http://dx.plos.org/10.1371/journal.pone.0008350.g004', u'http://dx.plos.org/10.1371/journal.pone.0008350.g005', u'http://dx.plos.org/10.1371/journal.pone.0008350.g006', u'http://dx.plos.org/10.1371/journal.pone.0008350.g007', u'http://dx.plos.org/10.1371/journal.pone.0008350.g008', u'http://dx.plos.org/10.1371/journal.pone.0008350.g009', u'http://dx.plos.org/10.1371/journal.pone.0008350.g010', u'http://dx.plos.org/10.1371/journal.pone.0008350.t001']",./output/11215168.pdf/citedby/10.1371~journal.pone.0008350.t001
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2008.11.014,"Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273608003842', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273608003842']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Lee, J., Air, G., , Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal antibody Mem5, Virology, 2006",cited-by,10.1016/j.virol.2005.10.014,Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal antibody Mem5,"[['Janis', 'T.', 'Lee'], ['Gillian', 'M.', 'Air']]",Virology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0042682205006513', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682205006513']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Jindrák, L., Grubhoffer, L., , Animal virus receptors, Folia Microbiologica, 1999",cited-by,10.1007/BF02816247,Animal virus receptors,"[['L.', '', 'Jindr\xc3\xa1k'], ['L.', '', 'Grubhoffer']]",Folia Microbiologica,1999,"[u'http://www.springerlink.com/content/h733003335912242', u'http://www.springerlink.com/index/h733003335912242.pdf', u'http://www.springerlink.com/index/10.1007/BF02816247', u'http://www.springerlink.com/index/pdf/10.1007/BF02816247']",./output/11215168.pdf/citedby/10.1007~BF02816247
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Gerantes, L., Kessler, N., Thomas, G., et. al, Simultaneous purification of influenza haemagglutinin and neuraminidase proteins by immunochromatography, Journal of Virological Methods, 1996",cited-by,10.1016/0166-0934(96)02006-X,Simultaneous purification of influenza haemagglutinin and neuraminidase proteins by immunochromatography,"[['L.', '', 'Gerantes'], ['N.', '', 'Kessler'], ['G.', '', 'Thomas'], ['M.', '', 'Aymard']]",Journal of Virological Methods,1996,"[u'http://www.sciencedirect.com/science/article/pii/016609349602006X', u'http://linkinghub.elsevier.com/retrieve/pii/016609349602006X']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Müller, A., Markussen, T., Drabløs, F., et. al, Structural and functional analysis of the hemagglutinin-esterase of infectious salmon anaemia virus, Virus Research, 2010",cited-by,10.1016/j.virusres.2010.03.020,Structural and functional analysis of the hemagglutinin-esterase of infectious salmon anaemia virus,"[['Anita', '', 'M\xc3\xbcller'], ['Turhan', '', 'Markussen'], ['Finn', '', 'Drabl\xc3\xb8s'], ['Tor', '', 'Gj\xc3\xb8en'], ['Trond', '\xc3\x98.', 'J\xc3\xb8rgensen'], ['Stein', 'Tore', 'Solem'], ['Siri', '', 'Mjaaland']]",Virus Research,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0168170210001231', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170210001231']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Nimmanpipug, P., Jitonnom, J., Ngaojampa, C., et. al, A computational H5N1 neuraminidase model and its binding to commercial drugs, Molecular Simulation, 2007",cited-by,10.1080/08927020701255862,A computational H5N1 neuraminidase model and its binding to commercial drugs,"[['P.', '', 'Nimmanpipug'], ['J.', '', 'Jitonnom'], ['C.', '', 'Ngaojampa'], ['S.', '', 'Hannongbua'], ['V.', 'S.', 'Lee']]",Molecular Simulation,2007,"[u'http://www.informaworld.com/openurl?genre=article&doi=10.1080/08927020701255862&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3', u'http://dx.doi.org/10.1080/08927020701255862']",./output/11215168.pdf/citedby/10.1080~08927020701255862
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Lee, C., Kim, S., Lee, K., et. al, Neuraminidase Inhibitors from Reynoutria elliptica, Archives of Pharmacal Research, 2003",cited-by,10.1007/BF02976693,Neuraminidase Inhibitors from Reynoutria elliptica,"[['Chu-Hyun', '', 'Lee'], ['Sang-ln', '', 'Kim'], ['Kyung-Bok', '', 'Lee'], ['Yung-Choon', '', 'Yoo'], ['Si-Young', '', 'Ryu'], ['Kyung-Sik', '', 'Song']]",Archives of Pharmacal Research,2003,"[u'http://www.springerlink.com/content/ntw8n37421083574', u'http://www.springerlink.com/index/ntw8n37421083574.pdf', u'http://www.springerlink.com/index/10.1007/BF02976693', u'http://www.springerlink.com/index/pdf/10.1007/BF02976693']",./output/11215168.pdf/citedby/10.1007~BF02976693
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Wagner, R., Feldmann, A., Wolff, T., et. al, Hemagglutinin and neuraminidase as determinants of influenza virus pathogenicity, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00381-8,Hemagglutinin and neuraminidase as determinants of influenza virus pathogenicity,"[['Ralf', '', 'Wagner'], ['Anke', '', 'Feldmann'], ['Thorsten', '', 'Wolff'], ['Stephan', '', 'Pleschka'], ['Wolfgang', '', 'Garten'], ['Hans-Dieter', '', 'Klenk']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003818', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003818']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Nedyalkova, M., Hayden, F., Webster, R., et. al, Accumulation of segment 6 sgRNAs of influenza A viruses in the presence of neuraminidase inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00398-3,Accumulation of segment 6 sgRNAs of influenza A viruses in the presence of neuraminidase inhibitors,"[['Marina', 'S', 'Nedyalkova'], ['Frederick', 'G', 'Hayden'], ['Robert', 'G', 'Webster'], ['Larisa', 'V', 'Gubareva']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003983', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003983']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Ho, K., Klenk, H., Herrler, G., , Inactivation of inhibitors by the receptor-destroying enzyme of influenza C virus, , 0",cited-by,11138560Inactivation of inhibitors by the receptor-destroying enzyme of influenza C virus,Inactivation of inhibitors by the receptor-destroying enzyme of influenza C virus,"[['Katja', '', 'Ho'], ['Hans-Dieter', '', 'Klenk'], ['Georg', '', 'Herrler']]",,0,[u'http://vir.sgmjournals.org/cgi/reprint/78/3/567.pdf'],./output/11215168.pdf/citedby/11138560Inactivation of inhibitors by the receptor-destroying enzyme of influenza C virus
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Thangavel, R., Reed, A., Norcross, E., et. al, ""Boom"" and ""Bust"" cycles in virus growth suggest multiple selective forces in influenza a evolution, Virology Journal, 2011",cited-by,10.1186/1743-422X-8-180,"""Boom"" and ""Bust"" cycles in virus growth suggest multiple selective forces in influenza a evolution","[['Rajagowthamee', 'R', 'Thangavel'], ['Aisha', '', 'Reed'], ['Erin', 'W', 'Norcross'], ['Sherrina', 'N', 'Dixon'], ['Mary', 'E', 'Marquart'], ['Stephen', 'J', 'Stray']]",Virology Journal,2011,"[u'http://www.springerlink.com/content/h822446508102746', u'http://www.springerlink.com/index/h822446508102746.pdf']",./output/11215168.pdf/citedby/10.1186~1743-422X-8-180
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Zhang, P., Zhao, J., Qin, Y., et. al, Stability and migration property of helium and self defects in vanadium and V–4Cr–4Ti alloy by first-principles, Journal of Nuclear Materials, 2011",cited-by,10.1016/j.jnucmat.2011.03.031,Stability and migration property of helium and self defects in vanadium and V–4Cr–4Ti alloy by first-principles,"[['Pengbo', '', 'Zhang'], ['Jijun', '', 'Zhao'], ['Ying', '', 'Qin'], ['Bin', '', 'Wen']]",Journal of Nuclear Materials,2011,"[u'http://www.sciencedirect.com/science/article/pii/S0022311511002996', u'http://adsabs.harvard.edu/abs/2011JNuM..413...90Z']",./output/11215168.pdf/citedby/10.1016~j.jnucmat.2011.03.031
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Xu, Z., Li, H., Luo, H., et. al, Graphite nanosheets doped with Fe, Ni, and N, synthesized in one step, and their unique magnetic performance, Solid State Communications, 2011",cited-by,10.1016/j.ssc.2011.01.020,"Graphite nanosheets doped with Fe, Ni, and N, synthesized in one step, and their unique magnetic performance","[['Zhanwei', '', 'Xu'], ['Hejun', '', 'Li'], ['Huijuan', '', 'Luo'], ['Huihui', '', 'Sun'], ['Qinglin', '', 'Zhang'], ['Gaoxiang', '', 'Cao'], ['Kezhi', '', 'Li']]",Solid State Communications,2011,"[u'http://www.sciencedirect.com/science/article/pii/S0038109811000494', u'http://adsabs.harvard.edu/abs/2011SSCom.151..643X']",./output/11215168.pdf/citedby/10.1016~j.ssc.2011.01.020
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Lynning, K., Jacobsen, A., , Grasping the spirit in nature: Anschauung in Ørsted’s epistemology of science and beauty, Studies in History and Philosophy of Science, 2011",cited-by,10.1016/j.shpsa.2010.11.018,Grasping the spirit in nature: Anschauung in Ørsted’s epistemology of science and beauty,"[['Kristine', 'Hays', 'Lynning'], ['Anja', 'Skaar', 'Jacobsen']]",Studies in History and Philosophy of Science,2011,[u'http://www.sciencedirect.com/science/article/pii/S003936811000097X'],
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Li, J., Dohna, H., Cardona, C., et. al, Emergence and Genetic Variation of Neuraminidase Stalk Deletions in Avian Influenza Viruses, PLOS One, 2011",cited-by,10.1371/journal.pone.0014722,Emergence and Genetic Variation of Neuraminidase Stalk Deletions in Avian Influenza Viruses,"[['Jinling', '', 'Li'], ['Heinrich', 'Zu', 'Dohna'], ['Carol', 'J.', 'Cardona'], ['Joy', '', 'Miller'], ['Tim', 'E.', 'Carpenter'], ['Maciej', 'F.', 'Boni']]",PLOS One,2011,"[u'http://adsabs.harvard.edu/abs/2011PLoSO...6E4722L', u'http://dx.doi.org/10.1371/journal.pone.0014722']",./output/11215168.pdf/citedby/10.1371~journal.pone.0014722
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Weight, A., Haldar, J., Cienfuegos, L., et. al, Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus, Journal of Pharmaceutical Sciences, 2010",cited-by,10.1002/jps.22338,Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus,"[['Alisha', 'K.', 'Weight'], ['Jayanta', '', 'Haldar'], ['Luis', '\xc3\x81lvarez de', 'Cienfuegos'], ['Larisa', 'V.', 'Gubareva'], ['Terrence', 'M.', 'Tumpey'], ['Jianzhu', '', 'Chen'], ['Alexander', 'M.', 'Klibanov']]",Journal of Pharmaceutical Sciences,2010,[u'http://doi.wiley.com/10.1002/jps.22338'],./output/11215168.pdf/citedby/10.1002~jps.22338
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2009.04.014,"Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273609001345', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273609001345']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Li, Y., Zhou, B., Wang, R., , Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1, Journal of Molecular Graphics & Modelling, 2009",cited-by,10.1016/j.jmgm.2009.07.001,Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1,"[['Yan', '', 'Li'], ['Bingcheng', '', 'Zhou'], ['Renxiao', '', 'Wang']]",Journal of Molecular Graphics & Modelling,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1093326309000783', u'http://linkinghub.elsevier.com/retrieve/pii/S1093326309000783']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Zhou, H., Yu, Z., Hu, Y., et. al, The Special Neuraminidase Stalk-Motif Responsible for Increased Virulence and Pathogenesis of H5N1 Influenza A Virus, PLOS One, 2009",cited-by,10.1371/journal.pone.0006277,The Special Neuraminidase Stalk-Motif Responsible for Increased Virulence and Pathogenesis of H5N1 Influenza A Virus,"[['Hongbo', '', 'Zhou'], ['Zhengjun', '', 'Yu'], ['Yong', '', 'Hu'], ['Jiagang', '', 'Tu'], ['Wei', '', 'Zou'], ['Yaping', '', 'Peng'], ['Jiping', '', 'Zhu'], ['Yongtao', '', 'Li'], ['Anding', '', 'Zhang'], ['Ziniu', '', 'Yu'], ['Zhiping', '', 'Ye'], ['Huanchun', '', 'Chen'], ['Meilin', '', 'Jin'], ['Darren', 'P.', 'Martin']]",PLOS One,2009,"[u'http://adsabs.harvard.edu/abs/2009PLoSO...4.6277Z', u'http://dx.doi.org/10.1371/journal.pone.0006277']",./output/11215168.pdf/citedby/10.1371~journal.pone.0006277
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Hashem, A., Flaman, A., Farnsworth, A., et. al, Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases, PLOS One, 2009",cited-by,10.1371/journal.pone.0008350,Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases,"[['Anwar', 'M.', 'Hashem'], ['Anathea', 'S.', 'Flaman'], ['Aaron', '', 'Farnsworth'], ['Earl', 'G.', 'Brown'], ['Gary', 'van', 'Domselaar'], ['Runtao', '', 'He'], ['Xuguang', '', 'Li'], ['Rosemary', 'Jeanne', 'Redfield']]",PLOS One,2009,"[u'http://dx.doi.org/10.1371/journal.pone.0008350', u'http://adsabs.harvard.edu/abs/2009PLoSO...4.8350H']",./output/11215168.pdf/citedby/10.1371~journal.pone.0008350
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Mori, I., Liu, B., Kimura, Y., , Influenza A virus derived from persistently virus-infected cells shows attenuated cytotoxicity in cultured cells but virulent pathogenicity in mice, Microbial Pathogenesis, 2008",cited-by,10.1016/j.micpath.2007.11.005,Influenza A virus derived from persistently virus-infected cells shows attenuated cytotoxicity in cultured cells but virulent pathogenicity in mice,"[['Isamu', '', 'Mori'], ['Beixing', '', 'Liu'], ['Yoshinobu', '', 'Kimura']]",Microbial Pathogenesis,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0882401007001556', u'http://linkinghub.elsevier.com/retrieve/pii/S0882401007001556']",
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737'],
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Júnior, J., Barros, F., Santos, J., et. al, Receptor-binding variants of H3N2 influenza A viruses: characterization of their sialidase activity towards different substrates, , 2004",cited-by,6694082Receptor-binding variants of H3N2 influenza A viruses: characterization of their sialidase activity towards different substrates,Receptor-binding variants of H3N2 influenza A viruses: characterization of their sialidase activity towards different substrates,"[['Jos\xc3\xa9', '', 'J\xc3\xbanior'], ['Fran\xc3\xa7a', 'de', 'Barros'], ['Jos\xc3\xa9', 'Nelson dos', 'Santos'], ['Silva', '', 'Couceiro']]",,2004,[u'http://www.cienciasmedicasbiologicas.ufba.br/pdf_3_1/vol_3_1_02.pdf'],./output/11215168.pdf/citedby/6694082Receptor-binding variants of H3N2 influenza A viruses: characterization of their sialidase activity towards different substrates
"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Lee, J., Air, G., , Contacts between Influenza Virus N9 Neuraminidase and Monoclonal Antibody NC10, Virology, 2002",cited-by,10.1006/viro.2002.1564,Contacts between Influenza Virus N9 Neuraminidase and Monoclonal Antibody NC10,"[['Janis', 'T.', 'Lee'], ['Gillian', 'M.', 'Air']]",Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0042682202915643', u'http://linkinghub.elsevier.com/retrieve/doi/10.1006/viro.2002.1564']",
11215168.pdf,"Lui, K. J., and A. P. Kendal. 1987. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am. J. Public Health 77:712–716.",references,10.2105/AJPH.77.6.712,Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985,"[[u'K', u'J', u'Lui'], [u'A', u'P', u'Kendal']]",American Journal of Public Health,1987,[u'http://www.ajph.org/cgi/doi/10.2105/AJPH.77.6.712'],./output/11215168.pdf/10.2105~AJPH.77.6.712
10.2105/AJPH.77.6.712,"Nichol, K., Wuorenma, J., Sternberg, T., , Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens, , 1998",cited-by,"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","[['Kristin', 'L.', 'Nichol'], ['J.', '', 'Wuorenma'], ['T.', 'von', 'Sternberg']]",,1998,"[u'http://archinte.highwire.org/cgi/reprint/158/16/1769.pdf', u'http://archinte.ama-assn.org/cgi/reprint/158/16/1769.pdf']","./output/11215168.pdf/citedby/13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens"
10.2105/AJPH.77.6.712,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']","./output/11215168.pdf/citedby/13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008"
10.2105/AJPH.77.6.712,"Donald, R., Baken, L., Nelson, A., et. al, Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients, American Journal of Preventive Medicine, 1999",cited-by,10.1016/S0749-3797(98)00159-7,Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients,"[['Roderick', 'Mac', 'Donald'], ['Leslie', '', 'Baken'], ['Andrew', '', 'Nelson'], ['Kristin', 'L.', 'Nichol']]",American Journal of Preventive Medicine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0749379798001597', u'http://linkinghub.elsevier.com/retrieve/pii/S0749379798001597']",
10.2105/AJPH.77.6.712,"Glezen, W., , Emerging Infections: Pandemic Influenza, , 0",cited-by,5797503Emerging Infections: Pandemic Influenza,Emerging Infections: Pandemic Influenza,"[['W.', 'Paul', 'Glezen']]",,0,[u'http://epirev.oxfordjournals.org/cgi/reprint/18/1/64.pdf'],./output/11215168.pdf/citedby/5797503Emerging Infections: Pandemic Influenza
10.2105/AJPH.77.6.712,"Nichol, K., Baken, L., Nelson, A., , Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease, , 1999",cited-by,"5884544Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease","Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease","[['Kristin', 'L.', 'Nichol'], ['Leslie', '', 'Baken'], ['Andrew', '', 'Nelson']]",,1999,"[u'http://www.separ.es/guia_epoc/gecarp/gepubli/publdoc/041-040-nicholkl-relation-between-influenza-vaccination-and-outpatient-visits.pdf', u'http://www.taiss.com/gepoc/gecarp/gepubli/publdoc/041-040-nicholkl-relation-between-influenza-vaccination-and-outpatient-visits.pdf']","./output/11215168.pdf/citedby/5884544Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease"
10.2105/AJPH.77.6.712,"Cox, R., Brokstad, K., Ogra, P., , Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines, Scandinavian Journal of Immunology, 2004",cited-by,10.1111/j.0300-9475.2004.01382.x,"Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines","[['R.', 'J.', 'Cox'], ['K.', 'A.', 'Brokstad'], ['P.', '', 'Ogra']]",Scandinavian Journal of Immunology,2004,"[u'http://biologie.univ-mrs.fr/upload/p270/3_La_grippe.pdf', u'http://cmbi.bjmu.cn/news/report/2005/flu/54.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.0300-9475.2004.01382.x']",./output/11215168.pdf/citedby/10.1111~j.0300-9475.2004.01382.x
10.2105/AJPH.77.6.712,"Simonsen, L., , The global impact of influenza on morbidity and mortality, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00099-7,The global impact of influenza on morbidity and mortality,"[['Lone', '', 'Simonsen']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99000997', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-20.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99000997']",./output/11215168.pdf/citedby/10.1016~S0264-410X(99)00099-7
10.2105/AJPH.77.6.712,"Salgado, C., Farr, B., Hall, K., et. al, Influenza in the acute hospital setting, Lancet Infectious Diseases, 2002",cited-by,10.1016/S1473-3099(02)00221-9,Influenza in the acute hospital setting,"[['Cassandra', 'D', 'Salgado'], ['Barry', 'M', 'Farr'], ['Keri', 'K', 'Hall'], ['Frederick', 'G', 'Hayden']]",Lancet Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1473309902002219', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309902002219', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/preparedness/preparedness-13.pdf']",./output/11215168.pdf/citedby/10.1016~S1473-3099(02)00221-9
10.2105/AJPH.77.6.712,"Simonsen, L., Reichert, T., Viboud, C., et. al, Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population, , 0",cited-by,6234833Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population,Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population,"[['Lone', '', 'Simonsen'], ['Thomas', 'A.', 'Reichert'], ['Cecile', '', 'Viboud'], ['William', 'C.', 'Blackwelder'], ['Robert', 'J.', 'Taylor'], ['Mark', 'A.', 'Miller']]",,0,"[u'http://origem.info/FIC/pdf/Simonson%20et%20al%20Impact%20of%20Influ_Arch%20Intern%20Med%2005.pdf', u'http://archinte.ama-assn.org/cgi/reprint/165/3/265.pdf']",./output/11215168.pdf/citedby/6234833Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population
10.2105/AJPH.77.6.712,"Podda, A., , The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine, Vaccine, 2001",cited-by,10.1016/S0264-410X(00)00499-0,The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine,"[['Audino', '', 'Podda']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X00004990', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X00004990']",
10.2105/AJPH.77.6.712,"Carrat, F., Flahault, A., , Influenza vaccine: The challenge of antigenic drift, Vaccine, 2007",cited-by,10.1016/j.vaccine.2007.07.027,Influenza vaccine: The challenge of antigenic drift,"[['F.', '', 'Carrat'], ['A.', '', 'Flahault']]",Vaccine,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X07008328', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X07008328']",
10.2105/AJPH.77.6.712,"Reichert, T., Simonsen, L., Sharma, A., et. al, Influenza and the Winter Increase in Mortality in the United States, 1959-1999, , 2004",cited-by,"6891767Influenza and the Winter Increase in Mortality in the United States, 1959-1999","Influenza and the Winter Increase in Mortality in the United States, 1959-1999","[['Thomas', 'A.', 'Reichert'], ['Lone', '', 'Simonsen'], ['Ashutosh', '', 'Sharma'], ['Scott', 'A.', 'Pardo'], ['David', 'S.', 'Fedson'], ['Mark', 'A.', 'Miller']]",,2004,[u'http://aje.oxfordjournals.org/cgi/reprint/160/5/492.pdf'],"./output/11215168.pdf/citedby/6891767Influenza and the Winter Increase in Mortality in the United States, 1959-1999"
10.2105/AJPH.77.6.712,"Cox, N., Fukuda, K., , INFLUENZA, Science, 1925",cited-by,10.1126/science.62.1609.0xii-s,INFLUENZA,"[['Nancy', 'J.', 'Cox'], ['Keiji', '', 'Fukuda']]",Science,1925,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/surveillance/surveillance-20.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-8.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-45.pdf', u'http://www.sciencemag.org/cgi/doi/10.1126/science.62.1609.0xii-s', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-11.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-17.pdf']",./output/11215168.pdf/citedby/10.1126~science.62.1609.0xii-s
10.2105/AJPH.77.6.712,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/11215168.pdf/citedby/7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
10.2105/AJPH.77.6.712,"Tsui, F., Wagner, M., Dato, V., , Value of ICD9Coded Chief Complaints for Detection of Epidemics, , 2001",cited-by,4058308Value of ICD9Coded Chief Complaints for Detection of Epidemics,Value of ICD9Coded Chief Complaints for Detection of Epidemics,"[['Fu-Chiang', '', 'Tsui'], ['Michael', 'M.', 'Wagner'], ['Virginia', '', 'Dato']]",,2001,[u'http://rods.health.pitt.edu/LIBRARY/AMIA2001Tsui.pdf'],./output/11215168.pdf/citedby/4058308Value of ICD9Coded Chief Complaints for Detection of Epidemics
10.2105/AJPH.77.6.712,"Donato, S., Granoff, D., Minutello, M., et. al, Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00138-3,Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly,"[['S', 'De', 'Donato'], ['D', '', 'Granoff'], ['M', '', 'Minutello'], ['G', '', 'Lecchi'], ['M', '', 'Faccini'], ['M', '', 'Agnello'], ['F', '', 'Senatore'], ['P', '', 'Verweij'], ['B', '', 'Fritzell'], ['A', '', 'Podda']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99001383', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99001383']",
10.2105/AJPH.77.6.712,"SPRENGER, M., MULDER, P., BEYER, W., et. al, Impact of influenza on mortality in relation to age and underlying disease, 1967-1989, International Journal of Epidemiology, 1993",cited-by,10.1093/ije/22.2.334,"Impact of influenza on mortality in relation to age and underlying disease, 1967-1989","[['MARC', 'J W', 'SPRENGER'], ['PAUL', 'G H', 'MULDER'], ['WALTER', 'E P', 'BEYER'], ['ROEL', 'VAN', 'STRIK'], ['NIC', '', 'MASUREL']]",International Journal of Epidemiology,1993,"[u'http://publishing.eur.nl/ir/repub/asset/15009/OA_8505193.pdf', u'http://ije.oxfordjournals.org/cgi/doi/10.1093/ije/22.2.334']",./output/11215168.pdf/citedby/10.1093~ije~22.2.334
10.2105/AJPH.77.6.712,"Bowles, S., Lee, W., Simor, A., et. al, Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999â2000, Journal of The American Geriatrics Society, 2002",cited-by,10.1046/j.1532-5415.2002.50153.x,"Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999â2000","[['Susan', 'K.', 'Bowles'], ['Wayne', '', 'Lee'], ['Andrew', 'E.', 'Simor'], ['Mary', '', 'Vearncombe'], ['Mark', '', 'Loeb'], ['Susan', '', 'Tamblyn'], ['Margaret', '', 'Fearon'], ['Yan', '', 'Li'], ['Allison', '', 'McGeer']]",Journal of The American Geriatrics Society,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2002.50153.x'],
10.2105/AJPH.77.6.712,"SMEE, D., HUFFMAN, J., MORRISON, A., et. al, Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.743-748.2001,Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities,"[['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['ANN', 'C.', 'MORRISON'], ['DALE', 'L.', 'BARNARD'], ['ROBERT', 'W.', 'SIDWELL']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://journals.pasteur.ac.ir/AAC01/45(3)/743.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.743-748.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.3.743-748.2001
10.2105/AJPH.77.6.712,"Lee, P., Matchar, D., Clements, D., et. al, Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults, , 2002",cited-by,5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,"[['Patrick', 'Y.', 'Lee'], ['David', 'B.', 'Matchar'], ['Dennis', 'A.', 'Clements'], ['Joel', '', 'Huber'], ['John', 'D.', 'Hamilton'], ['Eric', 'D.', 'Peterson']]",,2002,[u'http://www.pforster.ch/yvaccin/DocumVaccinInfluenzaBAG/Lee_2002.pdf'],./output/11215168.pdf/citedby/5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults
10.2105/AJPH.77.6.712,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.2105/AJPH.77.6.712,"Walker, F., Singleton, J., Lu, P., et. al, Influenza Vaccination of Healthcare Workers in the United States, 1989‐2002 , Infection Control and Hospital Epidemiology, 2006",cited-by,10.1086/501538,"Influenza Vaccination of Healthcare Workers in the United States, 1989‐2002 ","[['Frances', 'J.', 'Walker'], ['James', 'A.', 'Singleton'], ['Pengjun', '', 'Lu'], ['Karen', 'G.', 'Wooten'], ['Raymond', 'A.', 'Strikas']]",Infection Control and Hospital Epidemiology,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501538'],./output/11215168.pdf/citedby/10.1086~501538
10.2105/AJPH.77.6.712,"Kouides, R., Bennett, N., Lewis, B., et. al, Performance-based physician reimbursement and influenza immunization rates in the elderly, American Journal of Preventive Medicine, 1998",cited-by,10.1016/S0749-3797(97)00028-7,Performance-based physician reimbursement and influenza immunization rates in the elderly,"[['Ruth', 'W.', 'Kouides'], ['Nancy', 'M.', 'Bennett'], ['Bonnie', '', 'Lewis'], ['Joseph', 'D.', 'Cappuccio'], ['William', 'H.', 'Barker'], ['F.', 'Marc', 'LaForce']]",American Journal of Preventive Medicine,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0749379797000287', u'http://linkinghub.elsevier.com/retrieve/pii/S0749379797000287']",
10.2105/AJPH.77.6.712,"Conne, P., Gauthey, L., Vernet, P., et. al, Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients, Vaccine, 1997",cited-by,10.1016/S0264-410X(97)00087-X,Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients,"[['Pierre', '', 'Conne'], ['Laurent', '', 'Gauthey'], ['Philippe', '', 'Vernet'], ['Beat', '', 'Althaus'], ['John', 'U.', 'Que'], ['Beatriz', '', 'Finkel'], ['Reinhard', '', 'Gl\xc3\xbcck']]",Vaccine,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X9700087X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X9700087X']",
10.2105/AJPH.77.6.712,"Banzhoff, A., Nacci, P., Podda, A., , A New MF59-Adjuvanted Influenza Vaccine Enhances the Immune Response in the Elderly with Chronic Diseases: Results from an Immunogenicity Meta-Analysis, Gerontology, 2003",cited-by,10.1159/000069172,A New MF59-Adjuvanted Influenza Vaccine Enhances the Immune Response in the Elderly with Chronic Diseases: Results from an Immunogenicity Meta-Analysis,"[['Angelika', '', 'Banzhoff'], ['Pantaleo', '', 'Nacci'], ['Audino', '', 'Podda']]",Gerontology,2003,"[u'http://www.online.karger.com/doi/10.1159/000069172', u'http://www.karger.com/doi/10.1159/000069172']",./output/11215168.pdf/citedby/10.1159~000069172
10.2105/AJPH.77.6.712,"Fedson, D., Hannoun, C., Leese, J., et. al, Influenza vaccination in 18 developed countries, 1980–1992, Vaccine, 1995",cited-by,10.1016/0264-410X(94)00041-K,"Influenza vaccination in 18 developed countries, 1980–1992","[['David', 'S.', 'Fedson'], ['Claude', '', 'Hannoun'], ['Jane', '', 'Leese'], ['Marc', 'J. W.', 'Sprenger'], ['Alan', 'W.', 'Hampson'], ['Klaus', '', 'Bro-J\xc3\xb8rgensen'], ['Ann-Marie', '', 'Ahlbom'], ['Hanne', '', 'N\xc3\xb8kleby'], ['Martti', '', 'Valle'], ['Olafur', '', 'Olafsson'], ['Fracisco', 'Salmeron', 'Garcia'], ['Richard', '', 'Gugelman'], ['Helena', 'Rebelo de', 'Andrade'], ['Ren\xc3\xa9', '', 'Snacken'], ['Franz', '', 'Ambrosch'], ['Isabella', '', 'Donatelli']]",Vaccine,1995,"[u'http://www.sciencedirect.com/science/article/pii/0264410X9400041K', u'http://linkinghub.elsevier.com/retrieve/pii/0264410X9400041K']",
10.2105/AJPH.77.6.712,"Cox, N., Fukuda, K., , INFLUENZA, Infectious Disease Clinics of North America, 1998",cited-by,10.1016/S0891-5520(05)70406-2,INFLUENZA,"[['Nancy', 'J.', 'Cox'], ['Keiji', '', 'Fukuda']]",Infectious Disease Clinics of North America,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0891552005704062', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552005704062']",./output/11215168.pdf/citedby/10.1016~S0891-5520(05)70406-2
10.2105/AJPH.77.6.712,"LeVine, A., Koeningsknecht, V., Stark, J., , Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice, Journal of Virological Methods, 2001",cited-by,10.1016/S0166-0934(01)00287-7,Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice,"[['Ann', 'Marie', 'LeVine'], ['Vincent', '', 'Koeningsknecht'], ['James', 'M', 'Stark']]",Journal of Virological Methods,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166093401002877', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093401002877']",
10.2105/AJPH.77.6.712,"Honkanen, P., Keistinen, T., Kivela, S., , Factors associated with influenza vaccination coverage among the elderly:role of health care personnel, Public Health, 1996",cited-by,10.1016/S0033-3506(96)80070-9,Factors associated with influenza vaccination coverage among the elderly:role of health care personnel,"[['P.', 'O.', 'Honkanen'], ['T', '', 'Keistinen'], ['S-L', '', 'Kivela']]",Public Health,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0033350696800709', u'http://linkinghub.elsevier.com/retrieve/pii/S0033350696800709']",
10.2105/AJPH.77.6.712,"Bryant, K., Stover, B., Cain, L., et. al, Improving Influenza Immunization Rates Among Healthcare Workers Caring for High‐Risk Pediatric Patients, Infection Control and Hospital Epidemiology, 2004",cited-by,10.1086/502319,Improving Influenza Immunization Rates Among Healthcare Workers Caring for High‐Risk Pediatric Patients,"[['Kristina', 'A.', 'Bryant'], ['Beth', '', 'Stover'], ['Linda', '', 'Cain'], ['Gail', 'L.', 'Levine'], ['Jane', '', 'Siegel'], ['William', 'R.', 'Jarvis']]",Infection Control and Hospital Epidemiology,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502319'],./output/11215168.pdf/citedby/10.1086~502319
10.2105/AJPH.77.6.712,"Williamson, G., Hudson, G., , A monitoring system for detecting aberrations in public health surveillance reports, Statistics in Medicine, 1999",cited-by,10.1002/(SICI)1097-0258(19991215)18:23<3283::AID-SIM316>3.0.CO;2-Z,A monitoring system for detecting aberrations in public health surveillance reports,"[['G.', 'David', 'Williamson'], ['Ginner', 'Weatherby', 'Hudson']]",Statistics in Medicine,1999,"[u'http://sisla06.samsi.info/ndhs/ad/Papers/WilliamsonHudson1999.pdf', u'http://doi.wiley.com/10.1002/%28SICI%291097-0258%2819991215%2918%3A23%3C3283%3A%3AAID-SIM316%3E3.3.CO%3B2-Q', u'http://doi.wiley.com/10.1002/%28SICI%291097-0258%2819991215%2918%3A23%3C3283%3A%3AAID-SIM316%3E3.0.CO%3B2-Z']",
10.2105/AJPH.77.6.712,"Hindiyeh, M., Goulding, C., Morgan, H., et. al, Evaluation of BioStar® FLU OIA® assay for rapid detection of influenza A and B viruses in respiratory specimens, Journal of Clinical Virology, 2000",cited-by,10.1016/S1386-6532(00)00081-0,Evaluation of BioStar® FLU OIA® assay for rapid detection of influenza A and B viruses in respiratory specimens,"[['M', '', 'Hindiyeh'], ['C', '', 'Goulding'], ['H', '', 'Morgan'], ['B', '', 'Kenyon'], ['J', '', 'Langer'], ['L', '', 'Fox'], ['G', '', 'Dean'], ['D', '', 'Woolstenhulme'], ['A', '', 'Turnbow'], ['E', '', 'Billetdeaux'], ['S', '', 'Shakib'], ['C', '', 'Gordon'], ['A', '', 'Powers'], ['G', '', 'Vardeny'], ['M', '', 'Johnson'], ['L', '', 'Skodack-Jones'], ['K', '', 'Carroll']]",Journal of Clinical Virology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1386653200000810', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653200000810']",
10.2105/AJPH.77.6.712,"Greene, S., Ionides, E., Wilson, M., , Patterns of Influenza-associated Mortality among US Elderly by Geographic Region and Virus Subtype, 1968-1998, , 2006",cited-by,"6720079Patterns of Influenza-associated Mortality among US Elderly by Geographic Region and Virus Subtype, 1968-1998","Patterns of Influenza-associated Mortality among US Elderly by Geographic Region and Virus Subtype, 1968-1998","[['Sharon', 'K.', 'Greene'], ['Edward', 'L.', 'Ionides'], ['Mark', 'L.', 'Wilson']]",,2006,[],
10.2105/AJPH.77.6.712,"HODGE, L., MARINARO, M., JONES, H., et. al, Immunoglobulin A (IgA) Responses and IgE-Associated Inflammation along the Respiratory Tract after Mucosal but Not Systemic Immunization, Infection and Immunity, 2001",cited-by,10.1128/IAI.69.4.2328-2338.2001,Immunoglobulin A (IgA) Responses and IgE-Associated Inflammation along the Respiratory Tract after Mucosal but Not Systemic Immunization,"[['LISA', 'M.', 'HODGE'], ['MARIAROSARIA', '', 'MARINARO'], ['HARLAN', 'P.', 'JONES'], ['JERRY', 'R.', 'MCGHEE'], ['HIROSHI', '', 'KIYONO'], ['JERRY', 'W.', 'SIMECKA']]",Infection and Immunity,2001,"[u'http://iai.asm.org/cgi/reprint/69/4/2328.pdf', u'http://iai.asm.org/cgi/doi/10.1128/IAI.69.4.2328-2338.2001']",./output/11215168.pdf/citedby/10.1128~IAI.69.4.2328-2338.2001
10.2105/AJPH.77.6.712,"Barker, W., Borisute, H., Cox, C., , A Study of the Impact of Influenza on the Functional Status of Frail Older People, , 1998",cited-by,13387369A Study of the Impact of Influenza on the Functional Status of Frail Older People,A Study of the Impact of Influenza on the Functional Status of Frail Older People,"[['William', 'H.', 'Barker'], ['Hannah', '', 'Borisute'], ['Christopher', '', 'Cox']]",,1998,[u'http://archinte.ama-assn.org/cgi/reprint/158/6/645.pdf'],./output/11215168.pdf/citedby/13387369A Study of the Impact of Influenza on the Functional Status of Frail Older People
10.2105/AJPH.77.6.712,", Influenza-attributable deaths, Canada 1990–1999, Epidemiology and Infection, 2007",cited-by,10.1017/S0950268807007923,"Influenza-attributable deaths, Canada 1990–1999",[],Epidemiology and Infection,2007,[u'http://www.journals.cambridge.org/abstract_S0950268807007923'],./output/11215168.pdf/citedby/10.1017~S0950268807007923
10.2105/AJPH.77.6.712,"Stamboulian, D., Bonvehí, P., Nacinovich, F., et. al, INFLUENZA, Infectious Disease Clinics of North America, 2000",cited-by,10.1016/S0891-5520(05)70222-1,INFLUENZA,"[['Daniel', '', 'Stamboulian'], ['Pablo', 'E.', 'Bonveh\xc3\xad'], ['Francisco', 'M.', 'Nacinovich'], ['Nancy', '', 'Cox']]",Infectious Disease Clinics of North America,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0891552005702221', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552005702221']",./output/11215168.pdf/citedby/10.1016~S0891-5520(05)70222-1
10.2105/AJPH.77.6.712,"Stroup, D., Thacker, S., Herndon, J., , Application of multiple time series analysis to the estimation of pneumonia and influenza mortality by age 1962–1983, Statistics in Medicine, 1988",cited-by,10.1002/sim.4780071006,Application of multiple time series analysis to the estimation of pneumonia and influenza mortality by age 1962–1983,"[['Donna', 'F.', 'Stroup'], ['Stephen', 'B.', 'Thacker'], ['Joy', 'L.', 'Herndon']]",Statistics in Medicine,1988,[u'http://doi.wiley.com/10.1002/sim.4780071006'],./output/11215168.pdf/citedby/10.1002~sim.4780071006
10.2105/AJPH.77.6.712,"Cox, N., Brammer, T., Regnery, H., , Influenza: Global surveillance for epidemic and pandemic variants, European Journal of Epidemiology, 1994",cited-by,10.1007/BF01719678,Influenza: Global surveillance for epidemic and pandemic variants,"[['Nancy', 'J.', 'Cox'], ['T.', 'Lynnette', 'Brammer'], ['Helen', 'L.', 'Regnery']]",European Journal of Epidemiology,1994,"[u'http://www.springerlink.com/content/mw98k16352742421', u'http://www.springerlink.com/index/mw98k16352742421.pdf', u'http://www.springerlink.com/index/10.1007/BF01719678', u'http://www.springerlink.com/index/pdf/10.1007/BF01719678']",./output/11215168.pdf/citedby/10.1007~BF01719678
10.2105/AJPH.77.6.712,"Aoki, F., Doucette, K., , Oseltamivir: a clinical and pharmacological perspective, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.10.1671,Oseltamivir: a clinical and pharmacological perspective,"[['Fred', 'Y', 'Aoki'], ['Karen', 'E', 'Doucette']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.10.1671'],./output/11215168.pdf/citedby/10.1517~14656566.2.10.1671
10.2105/AJPH.77.6.712,"Tomoda, T., Morita, H., Kurashige, T., et. al, Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response, Vaccine, 1995",cited-by,10.1016/0264-410X(95)93134-U,"Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response","[['Takashi', '', 'Tomoda'], ['Hideo', '', 'Morita'], ['Takanobu', '', 'Kurashige'], ['Hunein', 'F.', 'Maassab']]",Vaccine,1995,"[u'http://www.sciencedirect.com/science/article/pii/0264410X9593134U', u'http://linkinghub.elsevier.com/retrieve/pii/0264410X9593134U']",
10.2105/AJPH.77.6.712,"Rizzo, C., Viboud, C., Montomoli, E., et. al, Influenza-related mortality in the Italian elderly: No decline associated with increasing vaccination coverage, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.06.052,Influenza-related mortality in the Italian elderly: No decline associated with increasing vaccination coverage,"[['Caterina', '', 'Rizzo'], ['C\xc3\xa9cile', '', 'Viboud'], ['Emanuele', '', 'Montomoli'], ['Lone', '', 'Simonsen'], ['Mark', 'A.', 'Miller']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0600764X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0600764X']",
10.2105/AJPH.77.6.712,"Snacken, R., Lion, J., CASTEREN, V., et. al, Five years of sentinel surveillance of acute respiratory infections (1985–1990): The benefits of an influenza early warning system, European Journal of Epidemiology, 1992",cited-by,10.1007/BF00146364,Five years of sentinel surveillance of acute respiratory infections (1985–1990): The benefits of an influenza early warning system,"[['R.', '', 'Snacken'], ['J.', '', 'Lion'], ['V.', 'VAN', 'CASTEREN'], ['R.', '', 'Cornelis'], ['F.', '', 'Yane'], ['M.', '', 'Mombaerts'], ['W.', '', 'Aelvoet'], ['A.', '', 'Stroobant']]",European Journal of Epidemiology,1992,"[u'http://www.springerlink.com/index/r73514k7417k2596.pdf', u'http://www.springerlink.com/content/r73514k7417k2596', u'http://www.springerlink.com/index/10.1007/BF00146364', u'http://www.springerlink.com/index/pdf/10.1007/BF00146364']",./output/11215168.pdf/citedby/10.1007~BF00146364
10.2105/AJPH.77.6.712,"Mostashari, F., Fine, A., Das, D., et. al, Use of Ambulance Dispatch Data as an Early Warning System for Communitywide Influenzalike Illness, New York City, , 2003",cited-by,"6427444Use of Ambulance Dispatch Data as an Early Warning System for Communitywide Influenzalike Illness, New York City","Use of Ambulance Dispatch Data as an Early Warning System for Communitywide Influenzalike Illness, New York City","[['Farzad', '', 'Mostashari'], ['Annie', '', 'Fine'], ['Debjani', '', 'Das'], ['John', '', 'Adams'], ['Marcelle', '', 'Layton']]",,2003,[u'http://www.syndromic.org/syndromicconference/2002/Supplementpdf/Mostashari.pdf'],
10.2105/AJPH.77.6.712,"Poland, G., Rottinghaus, S., Jacobson, R., , Influenza vaccines: a review and rationale for use in developed and underdeveloped countries, Vaccine, 2001",cited-by,10.1016/S0264-410X(00)00448-5,Influenza vaccines: a review and rationale for use in developed and underdeveloped countries,"[['Gregory', 'A.', 'Poland'], ['Scott', 'T.', 'Rottinghaus'], ['Robert', 'M.', 'Jacobson']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X00004485', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X00004485']",
10.2105/AJPH.77.6.712,"Fukuda, K., O'Mara, D., Singleton, J., , How the Delayed Distribution of Influenza Vaccine Created Shortages in 2000 and 2001, , 2002",cited-by,14135101How the Delayed Distribution of Influenza Vaccine Created Shortages in 2000 and 2001,How the Delayed Distribution of Influenza Vaccine Created Shortages in 2000 and 2001,"[['Keiji', '', 'Fukuda'], ['Dennis', '', ""O'Mara""], ['James', 'A.', 'Singleton']]",,2002,[u'http://www.ptcommunity.com/ptjournal/fulltext/27/5/ptj2705235.pdf'],./output/11215168.pdf/citedby/14135101How the Delayed Distribution of Influenza Vaccine Created Shortages in 2000 and 2001
10.2105/AJPH.77.6.712,"Nichol, K., , Live attenuated influenza virus vaccines: new options for the prevention of influenza, Vaccine, 2001",cited-by,10.1016/S0264-410X(01)00143-8,Live attenuated influenza virus vaccines: new options for the prevention of influenza,"[['Kristin', 'L.', 'Nichol']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X01001438', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X01001438']",
10.2105/AJPH.77.6.712,"Oshitani, H., Saito, R., Seki, N., et. al, Influenza Vaccination Levels and Influenza‐Like Illness in Long‐Term–Care Facilities for Elderly People in Niigata, Japan, During an Influenza A (H3N2) Epidemic, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501725,"Influenza Vaccination Levels and Influenza‐Like Illness in Long‐Term–Care Facilities for Elderly People in Niigata, Japan, During an Influenza A (H3N2) Epidemic","[['Hitoshi', '', 'Oshitani'], ['Reiko', '', 'Saito'], ['Nao', '', 'Seki'], ['Naohito', '', 'Tanabe'], ['Osamu', '', 'Yamazaki'], ['Seiji', '', 'Hayashi'], ['Hiroshi', '', 'Suzuki']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501725'],./output/11215168.pdf/citedby/10.1086~501725
10.2105/AJPH.77.6.712,"Thompson, W., Weintraub, E., Dhankhar, P., et. al, Estimates of US influenza-associated deaths made using four different methods, Influenza and Other Respiratory Viruses, 2009",cited-by,10.1111/j.1750-2659.2009.00073.x,Estimates of US influenza-associated deaths made using four different methods,"[['William', 'W.', 'Thompson'], ['Eric', '', 'Weintraub'], ['Praveen', '', 'Dhankhar'], ['Po-Yung', '', 'Cheng'], ['Lynnette', '', 'Brammer'], ['Martin', 'I.', 'Meltzer'], ['Joseph', 'S.', 'Bresee'], ['David', 'K.', 'Shay']]",Influenza and Other Respiratory Viruses,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1750-2659.2009.00073.x'],
10.2105/AJPH.77.6.712,"Dab, W., Quenel, P., Cohen, J., et. al, A new influenza surveillance system in France: The Ile-De-France “GROG”. 2. Validity of indicators (1984–1989), European Journal of Epidemiology, 1991",cited-by,10.1007/BF00218667,A new influenza surveillance system in France: The Ile-De-France “GROG”. 2. Validity of indicators (1984–1989),"[['W.', '', 'Dab'], ['P.', '', 'Quenel'], ['J.', 'M.', 'Cohen'], ['C.', '', 'Hannoun']]",European Journal of Epidemiology,1991,"[u'http://www.springerlink.com/index/w55860up50576618.pdf', u'http://www.springerlink.com/content/w55860up50576618', u'http://www.springerlink.com/index/10.1007/BF00218667', u'http://www.springerlink.com/index/pdf/10.1007/BF00218667']",./output/11215168.pdf/citedby/10.1007~BF00218667
10.2105/AJPH.77.6.712,"Monto, A., , Epidemiology of influenza, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.07.066,Epidemiology of influenza,"[['Arnold', 'S.', 'Monto']]",Vaccine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08010219', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08010219']",
10.2105/AJPH.77.6.712,"Viboud, C., Tam, T., Fleming, D., et. al, 1951 Influenza Epidemic, England and Wales, Canada, and the United States, , 2006",cited-by,"141884001951 Influenza Epidemic, England and Wales, Canada, and the United States","1951 Influenza Epidemic, England and Wales, Canada, and the United States","[['C\xc3\xa9cile', '', 'Viboud'], ['Theresa', '', 'Tam'], ['Douglas', '', 'Fleming'], ['Mark', 'A', 'Miller'], ['Lone', '', 'Simonsen']]",,2006,[u'http://www.cdc.gov/ncidod/eid/vol12no04/pdfs/05-0695.pdf'],"./output/11215168.pdf/citedby/141884001951 Influenza Epidemic, England and Wales, Canada, and the United States"
10.2105/AJPH.77.6.712,"Zucs, P., Buchholz, U., Haas, W., et. al, Influenza associated excess mortality in Germany, 1985 – 2001, Emerging Themes in Epidemiology, 2005",cited-by,10.1186/1742-7622-2-6,"Influenza associated excess mortality in Germany, 1985 – 2001","[['Phillip', '', 'Zucs'], ['Udo', '', 'Buchholz'], ['Walter', '', 'Haas'], ['Helmut', '', 'Uphoff']]",Emerging Themes in Epidemiology,2005,"[u'http://www.springerlink.com/index/pk303u81h3321865.pdf', u'http://www.springerlink.com/content/pk303u81h3321865', u'http://www.ete-online.com/content/2/1/6', u'http://www.biomedcentral.com/content/pdf/1742-7622-2-6.pdf']",./output/11215168.pdf/citedby/10.1186~1742-7622-2-6
10.2105/AJPH.77.6.712,"Neuzil, K., Maynard, C., Griffin, M., et. al, Winter Respiratory Viruses and Health Care Use: A Population‐Based Study in the Northwest United States, Clinical Infectious Diseases, 2003",cited-by,10.1086/375604,Winter Respiratory Viruses and Health Care Use: A Population‐Based Study in the Northwest United States,"[['Kathleen', 'M.', 'Neuzil'], ['Charles', '', 'Maynard'], ['Marie', 'R.', 'Griffin'], ['Patrick', '', 'Heagerty']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/375604'],./output/11215168.pdf/citedby/10.1086~375604
10.2105/AJPH.77.6.712,"Hannoun, C., Dab, W., Cohen, J., , A new influenza surveillance system in France: The Ile-De-France “GROG”. I. Principles and methodology, European Journal of Epidemiology, 1989",cited-by,10.1007/BF00144828,A new influenza surveillance system in France: The Ile-De-France “GROG”. I. Principles and methodology,"[['C.', '', 'Hannoun'], ['W.', '', 'Dab'], ['J.', 'M.', 'Cohen']]",European Journal of Epidemiology,1989,"[u'http://www.springerlink.com/index/u4212638l2gm1303.pdf', u'http://www.springerlink.com/content/u4212638l2gm1303', u'http://www.springerlink.com/index/10.1007/BF00144828', u'http://www.springerlink.com/index/pdf/10.1007/BF00144828']",./output/11215168.pdf/citedby/10.1007~BF00144828
10.2105/AJPH.77.6.712,"Kohut, M., Lee, W., Martin, A., et. al, The exercise-induced enhancement of influenza immunity is mediated in part by improvements in psychosocial factors in older adults, Brain Behavior and Immunity, 2005",cited-by,10.1016/j.bbi.2004.12.002,The exercise-induced enhancement of influenza immunity is mediated in part by improvements in psychosocial factors in older adults,"[['M.', 'L.', 'Kohut'], ['W.', '', 'Lee'], ['A.', '', 'Martin'], ['B.', '', 'Arnston'], ['D.', 'W.', 'Russell'], ['P.', '', 'Ekkekakis'], ['K.', 'J.', 'Yoon'], ['A.', '', 'Bishop'], ['J.', 'E.', 'Cunnick']]",Brain Behavior and Immunity,2005,"[u'http://www.public.iastate.edu/~ekkekaki/pdfs/kohut_et_al_2005_bbi.pdf', u'http://www.sciencedirect.com/science/article/pii/S0889159104001552', u'http://linkinghub.elsevier.com/retrieve/pii/S0889159104001552']",./output/11215168.pdf/citedby/10.1016~j.bbi.2004.12.002
10.2105/AJPH.77.6.712,"Lee, V., Phua, K., Chen, M., et. al, Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore, , 0",cited-by,"12330234Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore","Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore","[['Vernon', 'J.', 'Lee'], ['Kai', 'Hong', 'Phua'], ['Mark', 'I.', 'Chen'], ['Angela', '', 'Chow'], ['Stefan', '', 'Ma'], ['Kee', 'Tai', 'Goh'], ['Yee', 'Sin', 'Leo']]",,0,[u'http://www.spp.nus.edu.sg/Handler.ashx?path=Data/Site/SiteDocuments/wp/2006/wp06-04.pdf'],"./output/11215168.pdf/citedby/12330234Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore"
10.2105/AJPH.77.6.712,"Fiore, A., Bridges, C., Cox, N., , Seasonal Influenza Vaccines, , 0",cited-by,10.1007/978-3-540-92165-3_3,Seasonal Influenza Vaccines,"[['Anthony', 'E.', 'Fiore'], ['Carolyn', 'B.', 'Bridges'], ['Nancy', 'J.', 'Cox']]",,0,"[u'http://www.springerlink.com/index/l157756160304643.pdf', u'http://www.springerlink.com/content/l157756160304643']",./output/11215168.pdf/citedby/10.1007~978-3-540-92165-3_3
10.2105/AJPH.77.6.712,"Choi, K., Yu, H., Wilson, M., , Spatiotemporal statistical analysis of influenza mortality risk in the State of California during the period 1997–2001, Stochastic Environmental Research and Risk Assessment, 2008",cited-by,10.1007/s00477-007-0168-4,Spatiotemporal statistical analysis of influenza mortality risk in the State of California during the period 1997–2001,"[['Kyung-Mee', '', 'Choi'], ['Hwa-Lung', '', 'Yu'], ['Mark', 'L.', 'Wilson']]",Stochastic Environmental Research and Risk Assessment,2008,"[u'http://www.springerlink.com/content/l4l37035745h8273', u'http://www.springerlink.com/index/l4l37035745h8273.pdf', u'http://www.springerlink.com/index/10.1007/s00477-007-0168-4', u'http://www.springerlink.com/index/pdf/10.1007/s00477-007-0168-4']",./output/11215168.pdf/citedby/10.1007~s00477-007-0168-4
10.2105/AJPH.77.6.712,"Pachucki, C., , Rapid tests for influenza, Current Infectious Disease Reports, 2005",cited-by,10.1007/s11908-005-0033-x,Rapid tests for influenza,"[['Constance', 'T.', 'Pachucki']]",Current Infectious Disease Reports,2005,"[u'http://www.springerlink.com/content/0383227661823303', u'http://www.springerlink.com/index/0383227661823303.pdf', u'http://www.springerlink.com/index/pdf/10.1007/s11908-005-0033-x', u'http://www.springerlink.com/index/10.1007/s11908-005-0033-x']",./output/11215168.pdf/citedby/10.1007~s11908-005-0033-x
10.2105/AJPH.77.6.712,"Bennink, J., Palmore, T., , The promise of siRNAs for the treatment of influenza, Trends in Molecular Medicine, 2004",cited-by,10.1016/j.molmed.2004.10.004,The promise of siRNAs for the treatment of influenza,"[['Jack', 'R.', 'Bennink'], ['Tara', 'N.', 'Palmore']]",Trends in Molecular Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S147149140400262X', u'http://linkinghub.elsevier.com/retrieve/pii/S147149140400262X']",
10.2105/AJPH.77.6.712,"Saito, R., Suzuki, H., Oshitani, H., et. al, The Effectiveness of Influenza Vaccine Against Influenza A (H3N2) Virus Infections in Nursing Homes in Niigata, Japan, During the 1998–1999 and 1999–2000 Seasons, Infection Control and Hospital Epidemiology, 2002",cited-by,10.1086/502011,"The Effectiveness of Influenza Vaccine Against Influenza A (H3N2) Virus Infections in Nursing Homes in Niigata, Japan, During the 1998–1999 and 1999–2000 Seasons","[['Reiko', '', 'Saito'], ['Hiroshi', '', 'Suzuki'], ['Hitoshi', '', 'Oshitani'], ['Takatsugu', '', 'Sakai'], ['Nao', '', 'Seki'], ['Naohito', '', 'Tanabe']]",Infection Control and Hospital Epidemiology,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502011'],./output/11215168.pdf/citedby/10.1086~502011
10.2105/AJPH.77.6.712,"Merkel, P., Caputo, G., , Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate, Journal of General Internal Medicine, 1994",cited-by,10.1007/BF02599008,Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate,"[['Peter', 'A.', 'Merkel'], ['G.', 'Craig', 'Caputo']]",Journal of General Internal Medicine,1994,"[u'http://www.springerlink.com/content/g1935365h32621n3', u'http://www.springerlink.com/index/g1935365h32621n3.pdf', u'http://www.springerlink.com/index/10.1007/BF02599008', u'http://www.springerlink.com/index/pdf/10.1007/BF02599008']",./output/11215168.pdf/citedby/10.1007~BF02599008
10.2105/AJPH.77.6.712,"Menec, V., MacWilliam, L., Aoki, F., , Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents, , 0",cited-by,"11896331Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents","Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents","[['Verena', 'H.', 'Menec'], ['Leonard', '', 'MacWilliam'], ['Fred', 'Y.', 'Aoki']]",,0,[u'http://biomed.gerontologyjournals.org/cgi/reprint/57/10/M629.pdf'],
10.2105/AJPH.77.6.712,"Pelat, C., Boëlle, P., Cowling, B., et. al, Online detection and quantification of epidemics, BMC Medical Informatics and Decision Making, 2007",cited-by,10.1186/1472-6947-7-29,Online detection and quantification of epidemics,"[['Camille', '', 'Pelat'], ['Pierre-Yves', '', 'Bo\xc3\xablle'], ['Benjamin', 'J', 'Cowling'], ['Fabrice', '', 'Carrat'], ['Antoine', '', 'Flahault'], ['S\xc3\xa9verine', '', 'Ansart'], ['Alain-Jacques', '', 'Valleron']]",BMC Medical Informatics and Decision Making,2007,"[u'http://www.springerlink.com/content/h4r3g0048267j405', u'http://www.biomedcentral.com/1472-6947/7/29', u'http://www.biomedcentral.com/content/pdf/1472-6947-7-29.pdf', u'http://www.springerlink.com/index/h4r3g0048267j405.pdf']",./output/11215168.pdf/citedby/10.1186~1472-6947-7-29
10.2105/AJPH.77.6.712,"Silka, P., Geiderman, J., Goldberg, J., et. al, Demand on ED resources during periods of widespread influenza activity, American Journal of Emergency Medicine, 2003",cited-by,10.1016/j.ajem.2003.08.011,Demand on ED resources during periods of widespread influenza activity,"[['Paul', 'A', 'Silka'], ['Joel', 'M', 'Geiderman'], ['Joshua', 'B', 'Goldberg'], ['Linda', 'Park', 'Kim']]",American Journal of Emergency Medicine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0735675703001992', u'http://linkinghub.elsevier.com/retrieve/pii/S0735675703001992']",./output/11215168.pdf/citedby/10.1016~j.ajem.2003.08.011
10.2105/AJPH.77.6.712,"Nichol, K., , Long-term success with the national health objective for influenza vaccination, Journal of General Internal Medicine, 1992",cited-by,10.1007/BF02599197,Long-term success with the national health objective for influenza vaccination,"[['Kristin', 'L.', 'Nichol']]",Journal of General Internal Medicine,1992,"[u'http://www.springerlink.com/content/93547266u853l70v', u'http://www.springerlink.com/index/93547266u853l70v.pdf', u'http://www.springerlink.com/index/10.1007/BF02599197', u'http://www.springerlink.com/index/pdf/10.1007/BF02599197']",./output/11215168.pdf/citedby/10.1007~BF02599197
10.2105/AJPH.77.6.712,"Talbot, H., Poehling, K., Williams, J., et. al, Influenza in older adults: Impact of vaccination of school children, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.01.108,Influenza in older adults: Impact of vaccination of school children,"[['H.', 'Keipp', 'Talbot'], ['Katherine', 'A.', 'Poehling'], ['John', 'V.', 'Williams'], ['Yuwei', '', 'Zhu'], ['Qingxia', '', 'Chen'], ['Paul', '', 'McNabb'], ['Kathryn', 'M.', 'Edwards'], ['Marie', 'R.', 'Griffin']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09001716', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09001716']",
10.2105/AJPH.77.6.712,"Humair, J., Buchs, C., Stalder, H., , Promoting influenza vaccination of elderly patients in primary care, , 2002",cited-by,6705299Promoting influenza vaccination of elderly patients in primary care,Promoting influenza vaccination of elderly patients in primary care,"[['Jean-Paul', '', 'Humair'], ['Cristina', 'Rizzi', 'Buchs'], ['Hans', '', 'Stalder']]",,2002,[u'http://fampra.oxfordjournals.org/cgi/reprint/19/4/383.pdf'],./output/11215168.pdf/citedby/6705299Promoting influenza vaccination of elderly patients in primary care
10.2105/AJPH.77.6.712,"LaForce, C., Man, C., Henderson, F., et. al, Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial, Clinical Therapeutics, 2007",cited-by,10.1016/j.clinthera.2007.08.023,"Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","[['Craig', '', 'LaForce'], ['Choy', 'Y.', 'Man'], ['Frederick', 'W.', 'Henderson'], ['Janet', 'E.', 'McElhaney'], ['Frank', 'C.', 'Hampel'], ['Robert', '', 'Bettis'], ['Laila', '', 'Kudule'], ['Julia', '', 'Harris'], ['Philip', '', 'Yates'], ['Margaret', '', 'Tisdale'], ['Alison', '', 'Webster']]",Clinical Therapeutics,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0149291807002585', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291807002585']",
10.2105/AJPH.77.6.712,"McGeer, A., Lee, W., Loeb, M., et. al, Adverse Effects of Amantadine and Oseltamivir Used During Respiratory Outbreaks in a Center for Developmentally Disabled Adults, Infection Control and Hospital Epidemiology, 2004",cited-by,10.1086/502326,Adverse Effects of Amantadine and Oseltamivir Used During Respiratory Outbreaks in a Center for Developmentally Disabled Adults,"[['Allison', 'J.', 'McGeer'], ['Wayne', '', 'Lee'], ['Mark', '', 'Loeb'], ['Andrew', 'E.', 'Simor'], ['Margaret', '', 'McArthur'], ['Karen', '', 'Green'], ['Jonathan', 'Hayfron', 'Benjamin'], ['Charles', '', 'Gardner']]",Infection Control and Hospital Epidemiology,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502326'],./output/11215168.pdf/citedby/10.1086~502326
10.2105/AJPH.77.6.712,"Hak, E., Loon, S., Buskens, E., et. al, Design of the Dutch Prevention of Influenza, Surveillance and Management (PRISMA) study, Vaccine, 2003",cited-by,10.1016/S0264-410X(02)00520-0,"Design of the Dutch Prevention of Influenza, Surveillance and Management (PRISMA) study","[['E.', '', 'Hak'], ['S.', 'van', 'Loon'], ['E.', '', 'Buskens'], ['G.', 'A. van', 'Essen'], ['D.', 'de', 'Bakker'], ['M.', 'A. J. B.', 'Tacken'], ['B.', 'A. van', 'Hout'], ['D.', 'E.', 'Grobbee'], ['Th.', 'J. M', 'Verheij']]",Vaccine,2003,"[u'http://nvl002.nivel.nl/postprint/pppp1426.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X02005200', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02005200']",./output/11215168.pdf/citedby/10.1016~S0264-410X(02)00520-0
10.2105/AJPH.77.6.712,"Davis, M., Taubert, K., Brown, D., et. al, Influenza Vaccination as Secondary Prevention for Cardiovascular Disease A Science Advisory From the American Heart Association/ American College of Cardiology Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Association of Critical Care Nurses, the American Association of Heart Failure Nurses, the American Diabetes Association, the Association of Black Cardiologists, Inc., the Heart Failure Society of America, and the Preventive Cardiovascular Nurses Association. The American Academy of Nurse Practitioners supports the recommendations of this scientific advisory. This science advisory is consistent with the recommendations of the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices, , 2006",cited-by,"11843843Influenza Vaccination as Secondary Prevention for Cardiovascular Disease A Science Advisory From the American Heart Association/ American College of Cardiology Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Association of Critical Care Nurses, the American Association of Heart Failure Nurses, the American Diabetes Association, the Association of Black Cardiologists, Inc., the Heart Failure Society of America, and the Preventive Cardiovascular Nurses Association. The American Academy of Nurse Practitioners supports the recommendations of this scientific advisory. This science advisory is consistent with the recommendations of the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices","Influenza Vaccination as Secondary Prevention for Cardiovascular Disease A Science Advisory From the American Heart Association/ American College of Cardiology Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Association of Critical Care Nurses, the American Association of Heart Failure Nurses, the American Diabetes Association, the Association of Black Cardiologists, Inc., the Heart Failure Society of America, and the Preventive Cardiovascular Nurses Association. The American Academy of Nurse Practitioners supports the recommendations of this scientific advisory. This science advisory is consistent with the recommendations of the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices","[['Matthew', 'M.', 'Davis'], ['Kathryn', '', 'Taubert'], ['David', 'W.', 'Brown'], ['George', 'A.', 'Mensah'], ['Larry', 'M.', 'Baddour'], ['Sandra', '', 'Dunbar'], ['Harlan', 'M.', 'Krumholz']]",,2006,"[u'http://www.acc.org/qualityandscience/clinical/pdfs/fluadvisorycorrected.pdf', u'http://content.onlinejacc.org/cgi/reprint/48/7/1498.pdf', u'http://www.acc.org/qualityandscience/clinical/pdfs/Flu%20vaccine%20for%20CVD.9.08.06.pdf']",
10.2105/AJPH.77.6.712,"Rose, G., Cooper, C., , Fluarix™, inactivated split-virus influenza vaccine, Expert Opinion on Biological Therapy, 2006",cited-by,10.1517/14712598.6.3.301,"Fluarix™, inactivated split-virus influenza vaccine","[['G', 'W', 'Rose'], ['C', 'L', 'Cooper']]",Expert Opinion on Biological Therapy,2006,[u'http://informahealthcare.com/doi/abs/10.1517/14712598.6.3.301'],./output/11215168.pdf/citedby/10.1517~14712598.6.3.301
10.2105/AJPH.77.6.712,"Davis, M., Taubert, K., Brown, D., et. al, Influenza Vaccination as Secondary Prevention for Cardiovascular Disease, Journal of The American College of Cardiology, 2006",cited-by,10.1016/j.jacc.2006.09.004,Influenza Vaccination as Secondary Prevention for Cardiovascular Disease,"[['Matthew', 'M.', 'Davis'], ['Kathryn', '', 'Taubert'], ['David', 'W.', 'Brown'], ['George', 'A.', 'Mensah'], ['Larry', 'M.', 'Baddour'], ['Sandra', '', 'Dunbar'], ['Harlan', 'M.', 'Krumholz']]",Journal of The American College of Cardiology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0735109706022200', u'http://linkinghub.elsevier.com/retrieve/pii/S0735109706022200']",
10.2105/AJPH.77.6.712,"Simor, A., , Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?, Infection Control and Hospital Epidemiology, 2002",cited-by,10.1086/501971,Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?,"[['Andrew', '', 'Simor']]",Infection Control and Hospital Epidemiology,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501971'],./output/11215168.pdf/citedby/10.1086~501971
10.2105/AJPH.77.6.712,"Wilson, D., Lester, R., Taylor, A., et. al, Prevalence of influenza immunisation in Australia and suggestions for future targeting of campaigns, Sozial-und Praventivmedizin, 2002",cited-by,10.1007/BF01318390,Prevalence of influenza immunisation in Australia and suggestions for future targeting of campaigns,"[['David', '', 'Wilson'], ['Rosemary', '', 'Lester'], ['Anne', '', 'Taylor'], ['Tiffany', '', 'Gill'], ['Eleonora', 'Dal', 'Grande'], ['John', '', 'Litt'], ['Ann', '', 'Kempe'], ['Margaret', '', 'Campbell'], ['Nan', '', 'Miller'], ['Gay', '', 'Rixon'], ['Jo', '', 'Schell'], ['Brenda', '', 'White'], ['Sandra', '', 'Klason']]",Sozial-und Praventivmedizin,2002,"[u'http://www.springerlink.com/content/r0x365800r31g608', u'http://www.springerlink.com/index/r0x365800r31g608.pdf', u'http://www.springerlink.com/index/10.1007/BF01318390', u'http://www.springerlink.com/index/pdf/10.1007/BF01318390']",./output/11215168.pdf/citedby/10.1007~BF01318390
10.2105/AJPH.77.6.712,"GAUTHEY, L., CHAMOT, E., LAREQUI, T., et. al, Influenza vaccination coverage in the geriatric population of the State of Geneva, Switzerland, , 2010",cited-by,"6243174Influenza vaccination coverage in the geriatric population of the State of Geneva, Switzerland","Influenza vaccination coverage in the geriatric population of the State of Geneva, Switzerland","[['LAURENT', '', 'GAUTHEY'], ['ERIC', '', 'CHAMOT'], ['TANYA', '', 'LAREQUI'], ['CLAUDE', 'FRANCOIS', 'ROBERT']]",,2010,[u'http://eurpub.oxfordjournals.org/cgi/reprint/9/1/36.pdf'],"./output/11215168.pdf/citedby/6243174Influenza vaccination coverage in the geriatric population of the State of Geneva, Switzerland"
10.2105/AJPH.77.6.712,"Wilder-Smith, A., , Infectious Respiratory Illnesses and their Impact on Healthcare Workers: A Review, , 2005",cited-by,6419464Infectious Respiratory Illnesses and their Impact on Healthcare Workers: A Review,Infectious Respiratory Illnesses and their Impact on Healthcare Workers: A Review,"[['A', '', 'Wilder-Smith']]",,2005,[u'http://www.annals.edu.sg/pdf200502/LowJGH.pdf'],./output/11215168.pdf/citedby/6419464Infectious Respiratory Illnesses and their Impact on Healthcare Workers: A Review
10.2105/AJPH.77.6.712,"Sato, M., Saito, R., Tanabe, N., et. al, Antibody Response to Influenza Vaccination in Nursing Home Residents and Healthcare Workers During Four Successive Seasons in Niigata, Japan, Infection Control and Hospital Epidemiology, 2005",cited-by,10.1086/502509,"Antibody Response to Influenza Vaccination in Nursing Home Residents and Healthcare Workers During Four Successive Seasons in Niigata, Japan","[['Mizuho', '', 'Sato'], ['Reiko', '', 'Saito'], ['Naohito', '', 'Tanabe'], ['Makoto', '', 'Nishikawa'], ['Asami', '', 'Sasaki'], ['Fumitake', '', 'Gejyo'], ['Hiroshi', '', 'Suzuki']]",Infection Control and Hospital Epidemiology,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502509'],./output/11215168.pdf/citedby/10.1086~502509
10.2105/AJPH.77.6.712,"Monto, A., , Global burden of influenza: what we know and what we need to know, International Congress Series, 2004",cited-by,10.1016/j.ics.2004.02.049,Global burden of influenza: what we know and what we need to know,"[['Arnold', 'S.', 'Monto']]",International Congress Series,2004,"[u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/103.pdf', u'http://www.sciencedirect.com/science/article/pii/S0531513104001803', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513104001803']",
10.2105/AJPH.77.6.712,"Parry, M., Grant, B., Iton, A., et. al, Influenza Vaccination: A Collaborative Effort to Improve the Health of the Community, Infection Control and Hospital Epidemiology, 2004",cited-by,10.1086/502322,Influenza Vaccination: A Collaborative Effort to Improve the Health of the Community,"[['Michael', 'F.', 'Parry'], ['Brenda', '', 'Grant'], ['Anthony', '', 'Iton'], ['Patricia', 'D.', 'Parry'], ['Diane', '', 'Baranowsky']]",Infection Control and Hospital Epidemiology,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502322'],./output/11215168.pdf/citedby/10.1086~502322
10.2105/AJPH.77.6.712,"Toscani, L., Gauthey, L., Robert, C., , The information network of senior citizens in Geneva, Switzerland, and progress in flu vaccination coverage between 1991 and 2000, Vaccine, 2003",cited-by,10.1016/S0264-410X(02)00411-5,"The information network of senior citizens in Geneva, Switzerland, and progress in flu vaccination coverage between 1991 and 2000","[['Letizia', '', 'Toscani'], ['Laurent', '', 'Gauthey'], ['Claude-Fran\xc3\xa7ois', '', 'Robert']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02004115', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02004115']",
10.2105/AJPH.77.6.712,"Monto, A., Fendrick, A., , Developments in Influenza Prevention and Treatment: A Managed Care Perspective, Disease Management & Health Outcomes, 2000",cited-by,10.2165/00115677-200007050-00001,Developments in Influenza Prevention and Treatment: A Managed Care Perspective,"[['Arnold', 'S.', 'Monto'], ['A.', 'Mark', 'Fendrick']]",Disease Management & Health Outcomes,2000,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00115677-200007050-00001', u'http://diseasemanagement.adisonline.com/pt/re/dmo/pdfhandler.00115677-200007050-00001.pdf', u'http://diseasemanagement.adisonline.com/pt/re/dmo/fulltext.00115677-200007050-00001.htm']",
10.2105/AJPH.77.6.712,"Stamboulian, D., Bonvehı́, P., Nacinovich, F., et. al, Immunization against influenza in the elderly: the Argentinian experience, 1993–1997, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00106-1,"Immunization against influenza in the elderly: the Argentinian experience, 1993–1997","[['Daniel', '', 'Stamboulian'], ['Pablo', 'E', 'Bonveh\xc4\xb1\xcc\x81'], ['Francisco', 'M', 'Nacinovich'], ['Ricardo', 'W', 'R\xc3\xbcttimann']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99001061', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99001061']",
10.2105/AJPH.77.6.712,"Jackson, M., , Confounding by Season in Ecologic Studies of Seasonal Exposures and Outcomes: Examples From Estimates of Mortality Due to Influenza, Annals of Epidemiology, 2009",cited-by,10.1016/j.annepidem.2009.06.009,Confounding by Season in Ecologic Studies of Seasonal Exposures and Outcomes: Examples From Estimates of Mortality Due to Influenza,"[['Michael', 'L.', 'Jackson']]",Annals of Epidemiology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1047279709001744', u'http://linkinghub.elsevier.com/retrieve/pii/S1047279709001744']",
10.2105/AJPH.77.6.712,"Deguchi, Y., Takasugi, Y., , Efficacy of influenza vaccine in the elderly: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic for the elderly in nursing homes, International Journal of Clinical & Laboratory Research, 2000",cited-by,10.1007/s005990070025,Efficacy of influenza vaccine in the elderly: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic for the elderly in nursing homes,"[['Y.', '', 'Deguchi'], ['Y.', '', 'Takasugi']]",International Journal of Clinical & Laboratory Research,2000,"[u'http://www.springerlink.com/index/9nbw7nw3lguf9vwr.pdf', u'http://www.springerlink.com/content/9nbw7nw3lguf9vwr', u'http://www.springerlink.com/index/10.1007/s005990070025', u'http://www.springerlink.com/index/pdf/10.1007/s005990070025']",./output/11215168.pdf/citedby/10.1007~s005990070025
10.2105/AJPH.77.6.712,"Hjorth, R., Bonde, G., Piner, E., et. al, The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse, Vaccine, 1997",cited-by,10.1016/S0264-410X(97)00216-8,The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse,"[['Richard', 'N.', 'Hjorth'], ['Geraldine', 'M.', 'Bonde'], ['Elizabeth', 'D.', 'Piner'], ['Kenneth', 'M.', 'Goldberg'], ['Mark', 'H.', 'Levner']]",Vaccine,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X97002168', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X97002168']",
10.2105/AJPH.77.6.712,"Lee, C., Lee, K., Jung, M., et. al, Rate of Influenza Vaccination and Its Adverse Reactions Seen in Health Care Personnel in a Single Tertiary Hospital in Korea, , 2008",cited-by,6209683Rate of Influenza Vaccination and Its Adverse Reactions Seen in Health Care Personnel in a Single Tertiary Hospital in Korea,Rate of Influenza Vaccination and Its Adverse Reactions Seen in Health Care Personnel in a Single Tertiary Hospital in Korea,"[['Chang-Seop', '', 'Lee'], ['Kang-Hyu', '', 'Lee'], ['Min-Hee', '', 'Jung'], ['Heung-Bum', '', 'Lee']]",,2008,"[u'http://www.nih.go.jp/JJID/61/457.pdf', u'http://www0.nih.go.jp/JJID/61/457.pdf']",./output/11215168.pdf/citedby/6209683Rate of Influenza Vaccination and Its Adverse Reactions Seen in Health Care Personnel in a Single Tertiary Hospital in Korea
10.2105/AJPH.77.6.712,"Foppa, I., , Revised estimates of influenza-associated excess mortality, United States, 1995 through 2005, Emerging Themes in Epidemiology, 2008",cited-by,10.1186/1742-7622-5-26,"Revised estimates of influenza-associated excess mortality, United States, 1995 through 2005","[['Ivo', 'M', 'Foppa']]",Emerging Themes in Epidemiology,2008,"[u'http://www.springerlink.com/index/ep28v5676nhk677v.pdf', u'http://www.biomedcentral.com/content/pdf/1742-7622-5-26.pdf', u'http://www.ete-online.com/content/5/1/26', u'http://www.springerlink.com/content/ep28v5676nhk677v']",./output/11215168.pdf/citedby/10.1186~1742-7622-5-26
10.2105/AJPH.77.6.712,"Mallia, P., Johnston, S., , Influenza infection and COPD, International Journal of Copd, 2007",cited-by,10.2147/copd.2007.2.1.55,Influenza infection and COPD,"[['Patrick', '', 'Mallia'], ['Sebastian', 'L', 'Johnston']]",International Journal of Copd,2007,[u'http://www.atypon-link.com/DMP/doi/abs/10.2147/copd.2007.2.1.55'],
10.2105/AJPH.77.6.712,"Hanessian, S., , Structure-Based Organic Synthesis of Drug Prototypes: A Personal Odyssey, Chemmedchem, 2006",cited-by,10.1002/cmdc.200600203,Structure-Based Organic Synthesis of Drug Prototypes: A Personal Odyssey,"[['Stephen', '', 'Hanessian']]",Chemmedchem,2006,[u'http://doi.wiley.com/10.1002/cmdc.200600203'],./output/11215168.pdf/citedby/10.1002~cmdc.200600203
10.2105/AJPH.77.6.712,"Shorr, A., , Preventing Pneumonia: The Role for Pneumococcal and Influenza Vaccines, Clinics in Chest Medicine, 2005",cited-by,10.1016/j.ccm.2004.10.003,Preventing Pneumonia: The Role for Pneumococcal and Influenza Vaccines,"[['Andrew', 'F.', 'Shorr']]",Clinics in Chest Medicine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0272523104000917', u'http://linkinghub.elsevier.com/retrieve/pii/S0272523104000917']",./output/11215168.pdf/citedby/10.1016~j.ccm.2004.10.003
10.2105/AJPH.77.6.712,"Wyde, P., , Chemotherapy of respiratory viruses: prospects and challenges, Drug Resistance Updates, 1999",cited-by,10.1054/drup.1999.0091,Chemotherapy of respiratory viruses: prospects and challenges,"[['Philip', 'R.', 'Wyde']]",Drug Resistance Updates,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1368764699900912', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764699900912']",
10.2105/AJPH.77.6.712,"Menec, V., Bruce, S., MacWilliam, L., , Exploring Reasons for Bed Pressures in Winnipeg Acute Care Hospitals, Canadian Journal on Aging-revue Canadienne Du Vieillissement, 2005",cited-by,10.1353/cja.2005.0051,Exploring Reasons for Bed Pressures in Winnipeg Acute Care Hospitals,"[['Verena', 'H.', 'Menec'], ['Sharon', '', 'Bruce'], ['Leonard', '', 'MacWilliam']]",Canadian Journal on Aging-revue Canadienne Du Vieillissement,2005,[u'http://www.journals.cambridge.org/abstract_S0714980800004153'],./output/11215168.pdf/citedby/10.1353~cja.2005.0051
10.2105/AJPH.77.6.712,"Pachucki, C., Khurshid, M., Nawrocki, J., , Utility of Reverse Transcriptase PCR for Rapid Diagnosis of Influenza A Virus Infection and Detection of Amantadine-Resistant Influenza A Virus Isolates, , 2004",cited-by,6794196Utility of Reverse Transcriptase PCR for Rapid Diagnosis of Influenza A Virus Infection and Detection of Amantadine-Resistant Influenza A Virus Isolates,Utility of Reverse Transcriptase PCR for Rapid Diagnosis of Influenza A Virus Infection and Detection of Amantadine-Resistant Influenza A Virus Isolates,"[['Constance', 'T.', 'Pachucki'], ['M.', 'Aijaz', 'Khurshid'], ['John', '', 'Nawrocki']]",,2004,[u'http://jcm.asm.org/cgi/reprint/42/6/2796.pdf'],
10.2105/AJPH.77.6.712,"Blitz, S., Cram, P., Chernew, M., et. al, Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients With Influenza-Like Illness: What a Difference a Day Makes, , 2002",cited-by,5529074Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients With Influenza-Like Illness: What a Difference a Day Makes,Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients With Influenza-Like Illness: What a Difference a Day Makes,"[['Susan', 'G.', 'Blitz'], ['Peter', '', 'Cram'], ['Michael', 'E.', 'Chernew'], ['Arnold', 'S.', 'Monto'], ['A.', 'Mark', 'Fendrick']]",,2002,[u'http://www.ajmc.com/media/pdf/AJMC2002marBlitz221_227.pdf'],./output/11215168.pdf/citedby/5529074Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients With Influenza-Like Illness: What a Difference a Day Makes
10.2105/AJPH.77.6.712,"Brownstein, A., Roizen, M., , A compelling rationale for using preoperative visits to complete adult immunizations, Journal of Clinical Anesthesia, 1998",cited-by,10.1016/S0952-8180(98)00040-3,A compelling rationale for using preoperative visits to complete adult immunizations,"[['Alice', 'B', 'Brownstein'], ['Michael', 'F', 'Roizen']]",Journal of Clinical Anesthesia,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0952818098000403', u'http://linkinghub.elsevier.com/retrieve/pii/S0952818098000403']",./output/11215168.pdf/citedby/10.1016~S0952-8180(98)00040-3
10.2105/AJPH.77.6.712,"Gauthey, L., Toscani, L., Schira, J., , Vaccination contre la grippe en Suisse, Sozial-und Praventivmedizin, 1997",cited-by,10.1007/BF01365164,Vaccination contre la grippe en Suisse,"[['Laurent', '', 'Gauthey'], ['Letizia', '', 'Toscani'], ['Jean-Claude', '', 'Schira']]",Sozial-und Praventivmedizin,1997,"[u'http://www.springerlink.com/index/t72m33568286j782.pdf', u'http://www.springerlink.com/content/t72m33568286j782']",./output/11215168.pdf/citedby/10.1007~BF01365164
10.2105/AJPH.77.6.712,"Abbasi, S., Gruber, W., Edwards, K., et. al, The HA1 of cold-adapted influenza B vaccine is not altered during replication in human vaccinees, Virus Research, 1995",cited-by,10.1016/0168-1702(95)00097-6,The HA1 of cold-adapted influenza B vaccine is not altered during replication in human vaccinees,"[['Seema', '', 'Abbasi'], ['William', '', 'Gruber'], ['Kathryn', '', 'Edwards'], ['Larisa', '', 'Gubareva'], ['Robert', 'G.', 'Webster'], ['Yoshihiro', '', 'Kawaoka']]",Virus Research,1995,"[u'http://www.sciencedirect.com/science/article/pii/0168170295000976', u'http://linkinghub.elsevier.com/retrieve/pii/0168170295000976']",
11215168.pdf,"Mendel, D. B., C. Y. Tai, P. Escarpe, W.-X. Li, C. U. Kim, M. A. Williams, W. Lew, L. Zhang, N. Bischofberger, J. H. Huffman, R. W. Sidwell, and M. S. Chen. 1997. GS 4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B viruses in vitro. Antivir. Res. 34: A73. (Abstract 111.)",references,10.1016/S0166-3542(97)83251-2,GS 4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B viruses in vitro,"[[u'D.', u'B.', u'Mendel'], [u'C.', u'Y.', u'Tai'], [u'P.', u'A.', u'Escarpe'], [u'W.-X.', u'', u'Li'], [u'C.', u'U.', u'Kim'], [u'M.', u'A.', u'Williams'], [u'W.', u'', u'Lew'], [u'L.', u'', u'Zhang'], [u'N.', u'', u'Bischofberger'], [u'J.', u'H.', u'Huffman'], [u'R.', u'W.', u'Sidwell'], [u'M.', u'S.', u'Chen']]",Antiviral Research,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0166354297832512', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354297832512']",
10.1016/S0166-3542(97)83251-2,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.1016/S0166-3542(97)83251-2,"Leneva, I., Roberts, N., Govorkova, E., et. al, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00123-6,The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses,"[['Irina', 'A.', 'Leneva'], ['Noel', '', 'Roberts'], ['Elena', 'A.', 'Govorkova'], ['Olga', 'G.', 'Goloubeva'], ['Robert', 'G.', 'Webster']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001236', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001236']",
10.1016/S0166-3542(97)83251-2,"Oxford, J., Bossuyt, S., Balasingam, S., et. al, Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors, Clinical Microbiology and Infection, 2003",cited-by,10.1046/j.1469-0691.2003.00564.x,Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors,"[['J.', 'S.', 'Oxford'], ['S.', '', 'Bossuyt'], ['S.', '', 'Balasingam'], ['A.', '', 'Mann'], ['P.', '', 'Novelli'], ['R.', '', 'Lambkin']]",Clinical Microbiology and Infection,2003,"[u'http://birdflubook.com/resources/Oxford1.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1469-0691.2003.00564.x']",./output/11215168.pdf/citedby/10.1046~j.1469-0691.2003.00564.x
10.1016/S0166-3542(97)83251-2,"Tisdale, M., , Influenza M2 Ion-Channel and Neuraminidase Inhibitors, , 0",cited-by,10.1007/978-1-59745-180-2_31,Influenza M2 Ion-Channel and Neuraminidase Inhibitors,"[['Margaret', '', 'Tisdale']]",,0,"[u'http://www.springerlink.com/content/th812t5r62661uh4', u'http://www.springerlink.com/index/th812t5r62661uh4.pdf']",./output/11215168.pdf/citedby/10.1007~978-1-59745-180-2_31
11215168.pdf,"Mendel, D. B., C. Y. Tai, P. A. Escarpe, W. Li, R. W. Sidwell, J. H. Huffman, C. Sweet, K. J. Jakeman, J. Merson, S. A. Lacy, W. Lew, M. A. Williams, L. Zhang, M. S. Chen, N. Bischofberger, and C. U. Kim. 1998. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob. Agents Chemother. 42:640–646. 20a.National Institutes of Health. 1986. Guide for the care and use of laboratory animals. NIH publication 86-23. National Institutes of Health, Bethesda, Md.",references,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[[u'DIRK', u'B.', u'MENDEL'], [u'CHUN', u'Y.', u'TAI'], [u'PAUL', u'A.', u'ESCARPE'], [u'WEIXING', u'', u'LI'], [u'ROBERT', u'W.', u'SIDWELL'], [u'JOHN', u'H.', u'HUFFMAN'], [u'CLIVE', u'', u'SWEET'], [u'KENNETH', u'J.', u'JAKEMAN'], [u'JAMES', u'', u'MERSON'], [u'STEVEN', u'A.', u'LACY'], [u'WILLARD', u'', u'LEW'], [u'MATTHEW', u'A.', u'WILLIAMS'], [u'LIJUN', u'', u'ZHANG'], [u'MING', u'S.', u'CHEN'], [u'NORBERT', u'', u'BISCHOFBERGER'], [u'CHOUNG', u'U.', u'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/11215168.pdf/7023591
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']","./output/11215168.pdf/citedby/13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Palese, P., , Influenza: old and new threats, Nature Medicine, 2004",cited-by,10.1038/nm1141,Influenza: old and new threats,"[['Peter', '', 'Palese']]",Nature Medicine,2004,"[u'http://www.nature.com/doifinder/10.1038/nm1141', u'http://dx.doi.org/10.1038/nm1141']",./output/11215168.pdf/citedby/10.1038~nm1141
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"McKimm-Breschkin, J., , Resistance of influenza viruses to neuraminidase inhibitors — a review, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00103-0,Resistance of influenza viruses to neuraminidase inhibitors — a review,"[['Jennifer', 'L.', 'McKimm-Breschkin']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001030', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-14.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001030']",./output/11215168.pdf/citedby/10.1016~S0166-3542(00)00103-0
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Ives, J., Carr, J., Mendel, D., et. al, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(02)00053-0,The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo,"[['J.', 'A. L.', 'Ives'], ['J.', 'A.', 'Carr'], ['D.', 'B.', 'Mendel'], ['C.', 'Y.', 'Tai'], ['R.', '', 'Lambkin'], ['L.', '', 'Kelly'], ['J.', 'S.', 'Oxford'], ['F.', 'G.', 'Hayden'], ['N.', 'A.', 'Roberts']]",Antiviral Research,2002,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-20.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354202000530', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-21.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354202000530']",./output/11215168.pdf/citedby/10.1016~S0166-3542(02)00053-0
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"GOVORKOVA, E., LENEVA, I., GOLOUBEVA, O., et. al, Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.10.2723-2732.2001,"Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses","[['ELENA', 'A.', 'GOVORKOVA'], ['IRINA', 'A.', 'LENEVA'], ['OLGA', 'G.', 'GOLOUBEVA'], ['KAREN', '', 'BUSH'], ['ROBERT', 'G.', 'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/10/2723.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.10.2723-2732.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.10.2723-2732.2001
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Clercq, E., , Strategies in the design of antiviral drugs, Nature Reviews Drug Discovery, 2002",cited-by,10.1038/nrd703,Strategies in the design of antiviral drugs,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2002,"[u'http://dx.doi.org/10.1038/nrd703', u'http://www.nature.com/doifinder/10.1038/nrd703']",./output/11215168.pdf/citedby/10.1038~nrd703
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x'],
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf'],./output/11215168.pdf/citedby/11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Herlocher, M., Carr, J., Ives, J., et. al, Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00214-5,Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets,"[['M.', 'L', 'Herlocher'], ['J', '', 'Carr'], ['J', '', 'Ives'], ['S', '', 'Elias'], ['R', '', 'Truscon'], ['N', '', 'Roberts'], ['A.', 'S', 'Monto']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201002145', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201002145']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Govorkova, E., Ilyushina, N., Boltz, D., et. al, Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza Virus, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01312-06,Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza Virus,"[['Elena', 'A.', 'Govorkova'], ['Natalia', 'A.', 'Ilyushina'], ['David', 'A.', 'Boltz'], ['Alan', '', 'Douglas'], ['Neziha', '', 'Yilmaz'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/4/1414.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01312-06']",./output/11215168.pdf/citedby/10.1128~AAC.01312-06
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Mishin, V., Hayden, F., Gubareva, L., , Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.11.4515-4520.2005,Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors,"[['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Larisa', 'V.', 'Gubareva']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/11/4515.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.11.4515-4520.2005']",./output/11215168.pdf/citedby/10.1128~AAC.49.11.4515-4520.2005
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Furuta, Y., Takahashi, K., Fukuda, Y., et. al, In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.977-981.2002,In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705,"[['Y.', '', 'Furuta'], ['K.', '', 'Takahashi'], ['Y.', '', 'Fukuda'], ['M.', '', 'Kuno'], ['T.', '', 'Kamiyama'], ['K.', '', 'Kozaki'], ['N.', '', 'Nomura'], ['H.', '', 'Egawa'], ['S.', '', 'Minami'], ['Y.', '', 'Watanabe'], ['H.', '', 'Narita'], ['K.', '', 'Shiraki']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://journals.pasteur.ac.ir/aac02/46(4)/977.pdf', u'http://aac.asm.org/cgi/reprint/46/4/977.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.977-981.2002']",./output/11215168.pdf/citedby/10.1128~AAC.46.4.977-981.2002
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Bantia, S., Parker, C., Ananth, S., et. al, Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1162-1167.2001,Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir,"[['S.', '', 'Bantia'], ['C.', 'D.', 'Parker'], ['S.', 'L.', 'Ananth'], ['L.', 'L.', 'Horn'], ['K.', '', 'Andries'], ['P.', '', 'Chand'], ['P.', 'L.', 'Kotian'], ['A.', '', 'Dehghani'], ['Y.', '', 'El-Kattan'], ['T.', '', 'Lin'], ['T.', 'L.', 'Hutchison'], ['J.', 'A.', 'Montgomery'], ['D.', 'L.', 'Kellog'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://faculty.tamu-commerce.edu/fmiskevich/Bsc-597MAMB/Bantia-%20anti-influenza%20drug%20design.pdf', u'http://aac.asm.org/cgi/reprint/45/4/1162.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1162-1167.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.4.1162-1167.2001
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Leneva, I., Roberts, N., Govorkova, E., et. al, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00123-6,The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses,"[['Irina', 'A.', 'Leneva'], ['Noel', '', 'Roberts'], ['Elena', 'A.', 'Govorkova'], ['Olga', 'G.', 'Goloubeva'], ['Robert', 'G.', 'Webster']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001236', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001236']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Malakhov, M., Aschenbrenner, L., Smee, D., et. al, Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.50.4.1470-1479.2006,Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection,"[['Michael', 'P.', 'Malakhov'], ['Laura', 'M.', 'Aschenbrenner'], ['Donald', 'F.', 'Smee'], ['Miles', 'K.', 'Wandersee'], ['Robert', 'W.', 'Sidwell'], ['Larisa', 'V.', 'Gubareva'], ['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Do', 'Hyong', 'Kim'], ['Alice', '', 'Ing'], ['Erin', 'R.', 'Campbell'], ['Mang', '', 'Yu'], ['Fang', '', 'Fang']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/4/1470.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.50.4.1470-1479.2006']",./output/11215168.pdf/citedby/10.1128~AAC.50.4.1470-1479.2006
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"NOYOLA, D., CLARK, B., O'DONNELL, F., et. al, Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens, , 2000",cited-by,"13918606Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","[['DANIEL', 'E.', 'NOYOLA'], ['BRUCE', '', 'CLARK'], ['FREDERICK', 'T.', ""O'DONNELL""], ['ROBERT', 'L.', 'ATMAR'], ['JEWEL', '', 'GREER'], ['GAIL', 'J.', 'DEMMLER']]",,2000,[u'http://jcm.asm.org/cgi/reprint/38/3/1161.pdf'],
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Govorkova, E., Fang, H., Tan, M., et. al, Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4855-4863.2004,Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells,"[['Elena', 'A.', 'Govorkova'], ['Hong-Bin', '', 'Fang'], ['Ming', '', 'Tan'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4855.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4855-4863.2004']",./output/11215168.pdf/citedby/10.1128~AAC.48.12.4855-4863.2004
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Rameix-Welti, M., Agou, F., Buchy, P., et. al, Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00645-06,Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir,"[['M.', 'A.', 'Rameix-Welti'], ['F.', '', 'Agou'], ['P.', '', 'Buchy'], ['S.', '', 'Mardy'], ['J.', 'T.', 'Aubin'], ['M.', '', 'Veron'], ['S.', 'van der', 'Werf'], ['N.', '', 'Naffakh']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://www.ctcd.edu/science/tanderson/documents/OseltamivirSensitivityH5N1.pdf', u'http://aac.asm.org/cgi/reprint/50/11/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00645-06']",./output/11215168.pdf/citedby/10.1128~AAC.00645-06
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Kati, W., Montgomery, D., Carrick, R., et. al, In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.1014-1021.2002,"In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication","[['Warren', 'M.', 'Kati'], ['Debra', '', 'Montgomery'], ['Robert', '', 'Carrick'], ['Larisa', '', 'Gubareva'], ['Clarence', '', 'Maring'], ['Keith', '', 'McDaniel'], ['Kevin', '', 'Steffy'], ['Akhteruzzaman', '', 'Molla'], ['Frederick', '', 'Hayden'], ['Dale', '', 'Kempf'], ['William', '', 'Kohlbrenner']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/1014.pdf', u'http://journals.pasteur.ac.ir/AAC02/46(4)/1014.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.1014-1021.2002']",./output/11215168.pdf/citedby/10.1128~AAC.46.4.1014-1021.2002
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sidwell, R., Barnard, D., Day, C., et. al, Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01051-06,Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice,"[['Robert', 'W.', 'Sidwell'], ['Dale', 'L.', 'Barnard'], ['Craig', 'W.', 'Day'], ['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['John', 'D.', 'Morrey'], ['Yousuke', '', 'Furuta']]",Antimicrobial Agents and Chemotherapy,2007,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.01051-06'],./output/11215168.pdf/citedby/10.1128~AAC.01051-06
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"SIDWELL, R., SMEE, D., HUFFMAN, J., et. al, In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.749-757.2001,In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201,"[['ROBERT', 'W.', 'SIDWELL'], ['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['DALE', 'L.', 'BARNARD'], ['KEVIN', 'W.', 'BAILEY'], ['JOHN', 'D.', 'MORREY'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/3/749.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.749-757.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.3.749-757.2001
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Molla, A., Kati, W., Carrick, R., et. al, In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675, Journal of Virology, 2002",cited-by,10.1128/JVI.76.11.5380-5386.2002,"In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675","[['Akhteruzzaman', '', 'Molla'], ['Warren', '', 'Kati'], ['Robert', '', 'Carrick'], ['Kevin', '', 'Steffy'], ['Yan', '', 'Shi'], ['Debra', '', 'Montgomery'], ['Nanette', '', 'Gusick'], ['Vincent', 'S.', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['Teresa', 'I.', 'Ng'], ['Clarence', '', 'Maring'], ['Dale', 'J.', 'Kempf'], ['William', '', 'Kohlbrenner']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/11/5380.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.11.5380-5386.2002']",./output/11215168.pdf/citedby/10.1128~JVI.76.11.5380-5386.2002
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf'],./output/11215168.pdf/citedby/6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Noah, D., Krug, R., , Influenza Virus Virulence and Its Molecular Determinants, Advances in Virus Research, 2005",cited-by,10.1016/S0065-3527(05)65004-X,Influenza Virus Virulence and Its Molecular Determinants,"[['Diana', 'L.', 'Noah'], ['Robert', 'M.', 'Krug']]",Advances in Virus Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S006535270565004X', u'http://linkinghub.elsevier.com/retrieve/pii/S006535270565004X']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Laver, W., Bischofberger, N., Webster, R., , The Origin and Control of Pandemic Influenza, , 2000",cited-by,10259737The Origin and Control of Pandemic Influenza,The Origin and Control of Pandemic Influenza,"[['W.', 'Graeme', 'Laver'], ['Norbert', '', 'Bischofberger'], ['Robert', 'G.', 'Webster']]",,2000,"[u'http://birdflubook.com/resources/LAVER173.pdf', u'http://muse.jhu.edu/about/publishers.html/journals/perspectives_in_biology_and_medicine/v043/43.2laver.html']",./output/11215168.pdf/citedby/10259737The Origin and Control of Pandemic Influenza
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Yun, N., Linde, N., Zacks, M., et. al, Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1), Virology, 2008",cited-by,10.1016/j.virol.2007.12.029,"Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)","[['Nadezhda', 'E.', 'Yun'], ['Nathaniel', 'S.', 'Linde'], ['Michele', 'A.', 'Zacks'], ['Ian', 'G.', 'Barr'], ['Aeron', 'C.', 'Hurt'], ['Jeanon', 'N.', 'Smith'], ['Natallia', '', 'Dziuba'], ['Michael', 'R.', 'Holbrook'], ['Lifang', '', 'Zhang'], ['John', 'M.', 'Kilpatrick'], ['C.', 'Shane', 'Arnold'], ['Slobodan', '', 'Paessler']]",Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0042682207008562', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682207008562']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Alymova, I., Taylor, G., Takimoto, T., et. al, Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.5.1495-1502.2004,Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo,"[['Irina', 'V.', 'Alymova'], ['Garry', '', 'Taylor'], ['Toru', '', 'Takimoto'], ['Tsu-Hsing', '', 'Lin'], ['Pooran', '', 'Chand'], ['Y.', 'Sudhakara', 'Babu'], ['Chenghong', '', 'Li'], ['Xiaoping', '', 'Xiong'], ['Allen', '', 'Portner']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/5/1495.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.5.1495-1502.2004', u'http://aac.highwire.org/cgi/reprint/48/5/1495.pdf']",./output/11215168.pdf/citedby/10.1128~AAC.48.5.1495-1502.2004
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Schentag, J., Hill, G., Chu, T., et. al, Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects, Journal of Clinical Pharmacology, 2007",cited-by,10.1177/0091270007299761,Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects,"[['Jerome', 'J.', 'Schentag'], ['George', '', 'Hill'], ['Tom', '', 'Chu'], ['Craig', 'R.', 'Rayner']]",Journal of Clinical Pharmacology,2007,"[u'http://www.jclinpharm.org/cgi/doi/10.1177/0091270007299761', u'http://dx.doi.org/10.1177/0091270007299761']",./output/11215168.pdf/citedby/10.1177~0091270007299761
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sweet, C., Jakeman, K., Bush, K., et. al, Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.996-1004.2002,Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection,"[['Clive', '', 'Sweet'], ['Kenneth', 'J.', 'Jakeman'], ['Karen', '', 'Bush'], ['Pamela', 'C.', 'Wagaman'], ['Linda', 'A.', 'Mckown'], ['Anthony', 'J.', 'Streeter'], ['Daksha', '', 'Desai-Krieger'], ['Pooran', '', 'Chand'], ['Yarlagadda', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/996.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.996-1004.2002']",./output/11215168.pdf/citedby/10.1128~AAC.46.4.996-1004.2002
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Hung, H., Tseng, C., Yang, J., et. al, Aurintricarboxylic acid inhibits influenza virus neuraminidase, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.10.006,Aurintricarboxylic acid inhibits influenza virus neuraminidase,"[['Hui-Chen', '', 'Hung'], ['Ching-Ping', '', 'Tseng'], ['Jinn-Moon', '', 'Yang'], ['Yi-Wei', '', 'Ju'], ['Sung-Nain', '', 'Tseng'], ['Yen-Fu', '', 'Chen'], ['Yu-Sheng', '', 'Chao'], ['Hsing-Pang', '', 'Hsieh'], ['Shin-Ru', '', 'Shih'], ['John', 'T.-A.', 'Hsu']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208004300', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208004300']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Jackson, D., Barclay, W., Zurcher, T., , Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations, , 2005",cited-by,6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,"[['David', '', 'Jackson'], ['Wendy', '', 'Barclay'], ['Thomas', '', 'Zurcher']]",,2005,[u'http://jac.oxfordjournals.org/cgi/reprint/55/2/162.pdf'],./output/11215168.pdf/citedby/6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Robson, R., Buttimore, A., Lynn, K., et. al, The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis, , 2006",cited-by,10077451The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,"[['Richard', '', 'Robson'], ['Adrian', '', 'Buttimore'], ['Kelvin', '', 'Lynn'], ['Mike', '', 'Brewster'], ['Penelope', '', 'Ward']]",,2006,"[u'http://www.kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://ndt.oxfordjournals.org/cgi/reprint/21/9/2556.pdf']",./output/11215168.pdf/citedby/10077451The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Smee, D., Sidwell, R., Morrison, A., et. al, Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00168-1,Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201,"[['Donald', 'F', 'Smee'], ['Robert', 'W', 'Sidwell'], ['Ann', 'C', 'Morrison'], ['Kevin', 'W', 'Bailey'], ['Ellen', 'Z', 'Baum'], ['Linh', '', 'Ly'], ['Pamela', 'C', 'Wagaman']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001681', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001681']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Dreitlein, W., Maratos, J., Brocavich, J., , Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, 2001",cited-by,10.1016/S0149-2918(01)80042-4,Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza,"[['William', 'B.', 'Dreitlein'], ['Julia', '', 'Maratos'], ['Joseph', '', 'Brocavich']]",Clinical Therapeutics,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0149291801800424', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291801800424']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Holodniy, M., Penzak, S., Straight, T., et. al, Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00047-08,Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid,"[['Mark', '', 'Holodniy'], ['Scott', 'R.', 'Penzak'], ['Timothy', 'M.', 'Straight'], ['Richard', 'T.', 'Davey'], ['Kelvin', 'K.', 'Lee'], ['Matthew', 'Bidwell', 'Goetz'], ['Dennis', 'W.', 'Raisch'], ['Francesca', '', 'Cunningham'], ['Emil', 'T.', 'Lin'], ['Noemi', '', 'Olivo'], ['Lawrence', 'R.', 'Deyton']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/9/3013.pdf', u'http://www.apuabrasil.org.br/arquivos/influenza25.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00047-08']",./output/11215168.pdf/citedby/10.1128~AAC.00047-08
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Krug, R., Aramini, J., , Emerging antiviral targets for influenza A virus, Trends in Pharmacological Sciences, 2009",cited-by,10.1016/j.tips.2009.03.002,Emerging antiviral targets for influenza A virus,"[['Robert', 'M.', 'Krug'], ['James', 'M.', 'Aramini']]",Trends in Pharmacological Sciences,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0165614709000558', u'http://linkinghub.elsevier.com/retrieve/pii/S0165614709000558']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Smee, D., Bailey, K., Wong, M., et. al, Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N, Antiviral Research, 2008",cited-by,10.1016/j.antiviral.2008.06.003,Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N,"[['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Barry', 'R.', 'O\xe2\x80\x99Keefe'], ['Kirk', 'R.', 'Gustafson'], ['Vasiliy', 'P.', 'Mishin'], ['Larisa', 'V.', 'Gubareva']]",Antiviral Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208003239', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208003239']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Myc, A., Anderson, M., Jr, J., , Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents, Journal of Virological Methods, 1999",cited-by,10.1016/S0166-0934(98)00150-5,Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents,"[['Andrzej', '', 'Myc'], ['Marie', 'J', 'Anderson'], ['James', 'R Baker', 'Jr']]",Journal of Virological Methods,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166093498001505', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093498001505']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Itzstein, M., Thomson, R., , Anti-Influenza Drugs: The Development of Sialidase Inhibitors, , 0",cited-by,10.1007/978-3-540-79086-0_5,Anti-Influenza Drugs: The Development of Sialidase Inhibitors,"[['Mark', 'von', 'Itzstein'], ['Robin', '', 'Thomson']]",,0,"[u'http://www.springerlink.com/index/q7q766196t171341.pdf', u'http://www.springerlink.com/content/q7q766196t171341']",./output/11215168.pdf/citedby/10.1007~978-3-540-79086-0_5
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Jancel, T., Penzak, S., , Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia, Seminars in Hematology, 2009",cited-by,10.1053/j.seminhematol.2009.03.004,"Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia","[['Timothy', '', 'Jancel'], ['Scott', 'R.', 'Penzak']]",Seminars in Hematology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0037196309000596', u'http://linkinghub.elsevier.com/retrieve/pii/S0037196309000596']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Brewster, M., Smith, J., Dutkowski, R., et. al, Active metabolite from Tamiflu ® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.05.080,"Active metabolite from Tamiflu ® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study","[['M.', '', 'Brewster'], ['J.', 'R.', 'Smith'], ['R.', '', 'Dutkowski'], ['R.', '', 'Robson']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06006396', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06006396']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Carroll, T., Matzinger, S., Genesca, M., et. al, Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1, , 0",cited-by,12122205Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1,Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1,"[['Timothy', 'D.', 'Carroll'], ['Shannon', 'R.', 'Matzinger'], ['Meritxell', '', 'Genesca'], ['Linda', '', 'Fritts'], ['Roxana', '', 'Colon'], ['Michael', 'B.', 'McChesney'], ['Christopher', 'J.', 'Miller']]",,0,[u'http://www.jimmunol.org/cgi/reprint/180/4/2385.pdf'],./output/11215168.pdf/citedby/12122205Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"SAWABUCHI, T., SUZUKI, S., IWASE, K., et. al, Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza, Respirology, 2009",cited-by,10.1111/j.1440-1843.2009.01639.x,Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza,"[['Takako', '', 'SAWABUCHI'], ['Satoshi', '', 'SUZUKI'], ['Kazuhiro', '', 'IWASE'], ['Chika', '', 'ITO'], ['Dai', '', 'MIZUNO'], ['Hajime', '', 'TOGARI'], ['Isamu', '', 'WATANABE'], ['Sadiqur', 'R.', 'TALUKDER'], ['Junji', '', 'CHIDA'], ['Hiroshi', '', 'KIDO']]",Respirology,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1440-1843.2009.01639.x'],
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Kulkarni, A., Weiss, A., Iyer, S., , Glycan-based high-affinity ligands for toxins and pathogen receptors, Medicinal Research Reviews, 2010",cited-by,10.1002/med.20196,Glycan-based high-affinity ligands for toxins and pathogen receptors,"[['Ashish', 'A.', 'Kulkarni'], ['Alison', 'A.', 'Weiss'], ['Suri', 'S.', 'Iyer']]",Medicinal Research Reviews,2010,[u'http://doi.wiley.com/10.1002/med.20196'],./output/11215168.pdf/citedby/10.1002~med.20196
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2008.11.014,"Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273608003842', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273608003842']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sauerbrei, A., Haertl, A., Brandstaedt, A., et. al, Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors, Medical Microbiology and Immunology, 2006",cited-by,10.1007/s00430-005-0002-x,Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors,"[['A.', '', 'Sauerbrei'], ['A.', '', 'Haertl'], ['A.', '', 'Brandstaedt'], ['M.', '', 'Schmidtke'], ['P.', '', 'Wutzler']]",Medical Microbiology and Immunology,2006,"[u'http://www.springerlink.com/content/m37932425096l606', u'http://www.springerlink.com/index/m37932425096l606.pdf', u'http://www.springerlink.com/index/10.1007/s00430-005-0002-x', u'http://www.springerlink.com/index/pdf/10.1007/s00430-005-0002-x']",./output/11215168.pdf/citedby/10.1007~s00430-005-0002-x
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Oxford, J., , Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza, Influenza and Other Respiratory Viruses, 2007",cited-by,10.1111/j.1750-2659.2006.00006.x,Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza,"[['John', 'S.', 'Oxford']]",Influenza and Other Respiratory Viruses,2007,[u'http://doi.wiley.com/10.1111/j.1750-2659.2006.00006.x'],./output/11215168.pdf/citedby/10.1111~j.1750-2659.2006.00006.x
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Lu, F., Tseng, S., Li, M., et. al, In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid, Archives of Virology, 2002",cited-by,10.1007/s705-002-8319-5,In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid,"[['F.-J.', '', 'Lu'], ['S.-N.', '', 'Tseng'], ['M.-L.', '', 'Li'], ['S.-R.', '', 'Shih']]",Archives of Virology,2002,"[u'http://www.springerlink.com/content/ajvvqnn6jcjmg9bc', u'http://www.springerlink.com/index/ajvvqnn6jcjmg9bc.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s705-002-8319-5', u'http://www.springerlink.com/index/pdf/10.1007/s705-002-8319-5']",./output/11215168.pdf/citedby/10.1007~s705-002-8319-5
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sidwell, R., , A consideration of animal models used for study of influenza virus inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00388-0,A consideration of animal models used for study of influenza virus inhibitors,"[['Robert', 'W', 'Sidwell']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003880', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003880']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Xu, Z., Li, H., Luo, H., et. al, Graphite nanosheets doped with Fe, Ni, and N, synthesized in one step, and their unique magnetic performance, Solid State Communications, 2011",cited-by,10.1016/j.ssc.2011.01.020,"Graphite nanosheets doped with Fe, Ni, and N, synthesized in one step, and their unique magnetic performance","[['Zhanwei', '', 'Xu'], ['Hejun', '', 'Li'], ['Huijuan', '', 'Luo'], ['Huihui', '', 'Sun'], ['Qinglin', '', 'Zhang'], ['Gaoxiang', '', 'Cao'], ['Kezhi', '', 'Li']]",Solid State Communications,2011,"[u'http://www.sciencedirect.com/science/article/pii/S0038109811000494', u'http://adsabs.harvard.edu/abs/2011SSCom.151..643X']",./output/11215168.pdf/citedby/10.1016~j.ssc.2011.01.020
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Welliver, R., Monto, A., Carewicz, O., , Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in, , 2010",cited-by,13851601Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,"[['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz']]",,2010,[u'http://jama.ama-assn.org/cgi/reprint/285/6/748.pdf'],./output/11215168.pdf/citedby/13851601Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Lindemann, L., Jacobsen, H., Schuhbauer, D., et. al, In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu ®) and active metabolite, European Journal of Pharmacology, 2010",cited-by,10.1016/j.ejphar.2009.11.020,In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu ®) and active metabolite,"[['Lothar', '', 'Lindemann'], ['Helmut', '', 'Jacobsen'], ['Diana', '', 'Schuhbauer'], ['Frederic', '', 'Knoflach'], ['Silvia', '', 'Gatti'], ['Joseph', 'G.', 'Wettstein'], ['Hansruedi', '', 'Loetscher'], ['Tom', '', 'Chu'], ['Martin', '', 'Ebeling'], ['James', 'C.', 'Paulson'], ['Eric', '', 'Prinssen'], ['Manfred', '', 'Brockhaus']]",European Journal of Pharmacology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0014299909010358', u'http://linkinghub.elsevier.com/retrieve/pii/S0014299909010358']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Fusco, D., Liu, X., Savage, C., et. al, Echinacea purpurea aerial extract alters course of influenza infection in mice, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.03.047,Echinacea purpurea aerial extract alters course of influenza infection in mice,"[['Dahlene', '', 'Fusco'], ['Xinyan', '', 'Liu'], ['Caroline', '', 'Savage'], ['Ying', '', 'Taur'], ['Weilie', '', 'Xiao'], ['Edward', '', 'Kennelly'], ['Jianda', '', 'Yuan'], ['Barrie', '', 'Cassileth'], ['Mirella', '', 'Salvatore'], ['Genovefa', 'A.', 'Papanicolaou']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10004470', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10004470']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"West, M., Hanigan, M., , γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells, Archives of Biochemistry and Biophysics, 2010",cited-by,10.1016/j.abb.2010.08.019,γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells,"[['Matthew', 'B.', 'West'], ['Marie', 'H.', 'Hanigan']]",Archives of Biochemistry and Biophysics,2010,[u'http://www.sciencedirect.com/science/article/pii/S0003986110003656'],
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"D'Andrea, I., Santarelli, S., Alleva, E., et. al, P.1.f.004 Communal nest reduces vulnerability to depression-like behaviour and enhances brain dopamine function in adult male mice, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70412-0,P.1.f.004 Communal nest reduces vulnerability to depression-like behaviour and enhances brain dopamine function in adult male mice,"[['I.', '', ""D'Andrea""], ['S.', '', 'Santarelli'], ['E.', '', 'Alleva'], ['I.', '', 'Branchi']]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10704120'],
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Meltzer, H., Karayal, O., Miceli, J., et. al, P.3.c.051 The effect of ziprasidone on the QTc interval when used in combination with lithium, valproate or lamotrigine, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70721-5,"P.3.c.051 The effect of ziprasidone on the QTc interval when used in combination with lithium, valproate or lamotrigine","[['H.', '', 'Meltzer'], ['O.', 'N.', 'Karayal'], ['J.', '', 'Miceli'], ['S.', '', 'Kolluri'], ['C.', '', ""O'Gorman""]]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10707215'],
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Kissi, Y., Laaroussi, M., Gaabout, S., et. al, P.3.e.007 Sexual activity and marital relationships in Tunisian schizophrenic patients: comparison with healthy controls, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70762-8,P.3.e.007 Sexual activity and marital relationships in Tunisian schizophrenic patients: comparison with healthy controls,"[['Y.', 'El', 'Kissi'], ['M.', '', 'Laaroussi'], ['S.', '', 'Gaabout'], ['M.', '', 'Ayachi'], ['J.', '', 'Nakhli'], ['B.', 'Ben Hadj', 'Ali']]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10707628'],
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2009.04.014,"Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273609001345', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273609001345']",
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737'],
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Lipatov, A., Govorkova, E., Webby, R., et. al, MINIREVIEW Influenza: Emergence and Control, , 2004",cited-by,12108822MINIREVIEW Influenza: Emergence and Control,MINIREVIEW Influenza: Emergence and Control,"[['Aleksandr', 'S.', 'Lipatov'], ['Elena', 'A.', 'Govorkova'], ['Richard', 'J.', 'Webby'], ['Hiroichi', '', 'Ozaki'], ['Malik', '', 'Peiris'], ['Yi', '', 'Guan'], ['Leo', '', 'Poon'], ['Robert', 'G.', 'Webster']]",,2004,"[u'http://jvi.highwire.org/cgi/reprint/78/17/8951.pdf', u'http://jvi.asm.org/cgi/reprint/78/17/8951.pdf']",./output/11215168.pdf/citedby/12108822MINIREVIEW Influenza: Emergence and Control
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Massarella, J., He, G., Dorr, A., et. al, The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers, Journal of Clinical Pharmacology, 2000",cited-by,10.1177/009127000004000804,The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers,"[['Joseph', 'W.', 'Massarella'], ['George', 'Z.', 'He'], ['Albert', '', 'Dorr'], ['Keith', '', 'Nieforth'], ['Penelope', '', 'Ward'], ['Andy', '', 'Brown']]",Journal of Clinical Pharmacology,2000,[u'http://dx.doi.org/10.1177/009127000004000804'],
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Leitzke, S., , Die Therapie der Influenza mit Neuraminidase-Inhibitoren, Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz, 1999",cited-by,10.1007/s001030050275,Die Therapie der Influenza mit Neuraminidase-Inhibitoren,"[['S.', '', 'Leitzke']]",Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz,1999,"[u'http://www.springerlink.com/content/aubc4t0cmtk1megk', u'http://www.springerlink.com/index/aubc4t0cmtk1megk.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s001030050275', u'http://www.springerlink.com/index/pdf/10.1007/s001030050275']",./output/11215168.pdf/citedby/10.1007~s001030050275
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf'],./output/11215168.pdf/citedby/12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Pleschka, S., Ludwig, S., Wolff, T., et. al, Anti-viral approaches against influenza viruses, , 0",cited-by,10.1007/978-0-387-31047-3_5,Anti-viral approaches against influenza viruses,"[['Stephan', '', 'Pleschka'], ['Stephan', '', 'Ludwig'], ['Thorsten', '', 'Wolff'], ['Oliver', '', 'Planz']]",,0,"[u'http://www.springerlink.com/index/um10454n7482018j.pdf', u'http://www.springerlink.com/content/um10454n7482018j']",./output/11215168.pdf/citedby/10.1007~978-0-387-31047-3_5
11215168.pdf,"Palese, P., and R. W. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J. Gen. Virol. 33:159–163.",references,10.1099/0022-1317-33-1-159,"Inhibition of Influenza Virus Replication in Tissue Culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of Action","[[u'P.', u'', u'Palese'], [u'R.', u'W.', u'Compans']]",Journal of General Virology,1976,[u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-33-1-159'],./output/11215168.pdf/10.1099~0022-1317-33-1-159
10.1099/0022-1317-33-1-159,"Palese, P., , Influenza: old and new threats, Nature Medicine, 2004",cited-by,10.1038/nm1141,Influenza: old and new threats,"[['Peter', '', 'Palese']]",Nature Medicine,2004,"[u'http://www.nature.com/doifinder/10.1038/nm1141', u'http://dx.doi.org/10.1038/nm1141']",./output/11215168.pdf/citedby/10.1038~nm1141
10.1099/0022-1317-33-1-159,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']",./output/11215168.pdf/citedby/5346198Neuraminidase Inhibitors for Influenza
10.1099/0022-1317-33-1-159,"LIU, C., EICHELBERGER, M., COMPANS, R., , Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding, , 1995",cited-by,"13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding","[['CHONGGUANG', '', 'LIU'], ['MARYNA', 'C.', 'EICHELBERGER'], ['RICHARD', 'W.', 'COMPANS']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/2/1099.pdf'],"./output/11215168.pdf/citedby/13908139Influenza Type A Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding"
10.1099/0022-1317-33-1-159,"WAGNER, R., WOLFF, T., HERWIG, A., et. al, Interdependence of Hemagglutinin Glycosylation and Neuraminidase as Regulators of Influenza Virus Growth: a Study by Reverse Genetics, Journal of Virology, 2000",cited-by,10.1128/JVI.74.14.6316-6323.2000,Interdependence of Hemagglutinin Glycosylation and Neuraminidase as Regulators of Influenza Virus Growth: a Study by Reverse Genetics,"[['RALF', '', 'WAGNER'], ['THORSTEN', '', 'WOLFF'], ['ASTRID', '', 'HERWIG'], ['STEPHAN', '', 'PLESCHKA'], ['HANS-DIETER', '', 'KLENK']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/14/6316.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.14.6316-6323.2000']",./output/11215168.pdf/citedby/10.1128~JVI.74.14.6316-6323.2000
10.1099/0022-1317-33-1-159,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/11215168.pdf/citedby/7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
10.1099/0022-1317-33-1-159,"Colman, P., , Influenza virus neuraminidase: Structure, antibodies, and inhibitors, Protein Science, 1994",cited-by,10.1002/pro.5560031007,"Influenza virus neuraminidase: Structure, antibodies, and inhibitors","[['P.', 'M.', 'Colman']]",Protein Science,1994,[u'http://doi.wiley.com/10.1002/pro.5560031007'],./output/11215168.pdf/citedby/10.1002~pro.5560031007
10.1099/0022-1317-33-1-159,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf'],./output/11215168.pdf/citedby/11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071
10.1099/0022-1317-33-1-159,"Sidwell, R., Huffman, J., Barnard, D., et. al, Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor, Antiviral Research, 1998",cited-by,10.1016/S0166-3542(97)00065-X,"Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor","[['Robert', 'W.', 'Sidwell'], ['John', 'H.', 'Huffman'], ['Dale', 'L.', 'Barnard'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Ann', '', 'Morrison'], ['Timothy', '', 'Syndergaard'], ['Choung', 'U.', 'Kim']]",Antiviral Research,1998,"[u'http://www.sciencedirect.com/science/article/pii/S016635429700065X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635429700065X']",
10.1099/0022-1317-33-1-159,"Gubareva, L., Webster, R., Hayden, F., , Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00192-9,Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay,"[['Larisa', 'V.', 'Gubareva'], ['Robert', 'G.', 'Webster'], ['Frederick', 'G.', 'Hayden']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001929', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001929']",
10.1099/0022-1317-33-1-159,"Morris, S., Price, G., Barnett, J., et. al, Role of neuraminidase in influenza virus-induced apoptosis, , 1999",cited-by,6297657Role of neuraminidase in influenza virus-induced apoptosis,Role of neuraminidase in influenza virus-induced apoptosis,"[['Susan', 'J.', 'Morris'], ['Graeme', 'E.', 'Price'], ['Jacqueline', 'M.', 'Barnett'], ['Steven', 'A.', 'Hiscox'], ['Harry', '', 'Smith'], ['Clive', '', 'Sweet']]",,1999,[u'http://vir.sgmjournals.org/cgi/reprint/80/1/137.pdf'],./output/11215168.pdf/citedby/6297657Role of neuraminidase in influenza virus-induced apoptosis
10.1099/0022-1317-33-1-159,"MCKIMM-BRESCHKIN, J., BLICK, T., SAHASRABUDHE, A., et. al, Generation and Characterization of Variants of NWS/G70C Influenza Virus after In Vitro Passage in 4-Amino-Neu5Ac2en and 4-Guanidino-Neu5Ac2en, , 1996",cited-by,13518261Generation and Characterization of Variants of NWS/G70C Influenza Virus after In Vitro Passage in 4-Amino-Neu5Ac2en and 4-Guanidino-Neu5Ac2en,Generation and Characterization of Variants of NWS/G70C Influenza Virus after In Vitro Passage in 4-Amino-Neu5Ac2en and 4-Guanidino-Neu5Ac2en,"[['JENNIFER', 'L.', 'MCKIMM-BRESCHKIN'], ['TONY', 'J.', 'BLICK'], ['ANJALI', '', 'SAHASRABUDHE'], ['TAK', '', 'TIONG'], ['DEIDRE', '', 'MARSHALL'], ['GRAHAM', 'J.', 'HART'], ['RICHARD', 'C.', 'BETHELL'], ['ANDCHARLES', 'R.', 'PENN'], ['Glaxo', '', 'Wellcome']]",,1996,"[u'http://aac.highwire.org/cgi/reprint/40/1/40.pdf', u'http://aac.asm.org/cgi/reprint/40/1/40.pdf']",./output/11215168.pdf/citedby/13518261Generation and Characterization of Variants of NWS~G70C Influenza Virus after In Vitro Passage in 4-Amino-Neu5Ac2en and 4-Guanidino-Neu5Ac2en
10.1099/0022-1317-33-1-159,"Palese, P., García-Sastre, A., , Influenza vaccines: present and future, Journal of Clinical Investigation, 2002",cited-by,10.1172/JCI15999,Influenza vaccines: present and future,"[['Peter', '', 'Palese'], ['Adolfo', '', 'Garc\xc3\xada-Sastre']]",Journal of Clinical Investigation,2002,[u'http://www.jci.org/articles/view/15999'],./output/11215168.pdf/citedby/10.1172~JCI15999
10.1099/0022-1317-33-1-159,"SMEE, D., HUFFMAN, J., MORRISON, A., et. al, Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.743-748.2001,Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities,"[['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['ANN', 'C.', 'MORRISON'], ['DALE', 'L.', 'BARNARD'], ['ROBERT', 'W.', 'SIDWELL']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://journals.pasteur.ac.ir/AAC01/45(3)/743.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.743-748.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.3.743-748.2001
10.1099/0022-1317-33-1-159,"Itzstein, M., , The war against influenza: discovery and development of sialidase inhibitors, Nature Reviews Drug Discovery, 2007",cited-by,10.1038/nrd2400,The war against influenza: discovery and development of sialidase inhibitors,"[['Mark', 'von', 'Itzstein']]",Nature Reviews Drug Discovery,2007,"[u'http://dx.doi.org/10.1038/nrd2400', u'http://www.nature.com/doifinder/10.1038/nrd2400']",./output/11215168.pdf/citedby/10.1038~nrd2400
10.1099/0022-1317-33-1-159,"MCKIMM-BRESCHKIN, J., SAHASRABUDHE, A., BLICK, T., et. al, Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors, , 1998",cited-by,13896013Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,"[['JENNIFER', 'L.', 'MCKIMM-BRESCHKIN'], ['ANJALI', '', 'SAHASRABUDHE'], ['TONY', 'J.', 'BLICK'], ['MANDY', '', 'MCDONALD'], ['PETER', 'M.', 'COLMAN'], ['GRAHAM', 'J.', 'HART'], ['RICHARD', 'C.', 'BETHELL'], ['JOSEPH', 'N.', 'VARGHESE']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/3/2456.pdf'],./output/11215168.pdf/citedby/13896013Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors
10.1099/0022-1317-33-1-159,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.1099/0022-1317-33-1-159,"Leneva, I., Roberts, N., Govorkova, E., et. al, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00123-6,The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses,"[['Irina', 'A.', 'Leneva'], ['Noel', '', 'Roberts'], ['Elena', 'A.', 'Govorkova'], ['Olga', 'G.', 'Goloubeva'], ['Robert', 'G.', 'Webster']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001236', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001236']",
10.1099/0022-1317-33-1-159,"Hayden, F., , Antivirals for influenza: Historical perspectives and lessons learned, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.05.016,Antivirals for influenza: Historical perspectives and lessons learned,"[['Frederick', 'G.', 'Hayden']]",Antiviral Research,2006,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-10.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354206001653', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206001653']",./output/11215168.pdf/citedby/10.1016~j.antiviral.2006.05.016
10.1099/0022-1317-33-1-159,"Barman, S., Adhikary, L., Chakrabarti, A., et. al, Role of Transmembrane Domain and Cytoplasmic Tail Amino Acid Sequences of Influenza A Virus Neuraminidase in Raft Association and Virus Budding, Journal of Virology, 2004",cited-by,10.1128/JVI.78.10.5258-5269.2004,Role of Transmembrane Domain and Cytoplasmic Tail Amino Acid Sequences of Influenza A Virus Neuraminidase in Raft Association and Virus Budding,"[['Subrata', '', 'Barman'], ['Lopa', '', 'Adhikary'], ['Alok', 'K.', 'Chakrabarti'], ['Carl', '', 'Bernas'], ['Yoshihiro', '', 'Kawaoka'], ['Debi', 'P.', 'Nayak']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/10/5258.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.10.5258-5269.2004']",./output/11215168.pdf/citedby/10.1128~JVI.78.10.5258-5269.2004
10.1099/0022-1317-33-1-159,"Kati, W., Montgomery, D., Carrick, R., et. al, In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.1014-1021.2002,"In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication","[['Warren', 'M.', 'Kati'], ['Debra', '', 'Montgomery'], ['Robert', '', 'Carrick'], ['Larisa', '', 'Gubareva'], ['Clarence', '', 'Maring'], ['Keith', '', 'McDaniel'], ['Kevin', '', 'Steffy'], ['Akhteruzzaman', '', 'Molla'], ['Frederick', '', 'Hayden'], ['Dale', '', 'Kempf'], ['William', '', 'Kohlbrenner']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/1014.pdf', u'http://journals.pasteur.ac.ir/AAC02/46(4)/1014.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.1014-1021.2002']",./output/11215168.pdf/citedby/10.1128~AAC.46.4.1014-1021.2002
10.1099/0022-1317-33-1-159,"Bouvier, N., Palese, P., , The biology of influenza viruses, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.07.039,The biology of influenza viruses,"[['Nicole', 'M.', 'Bouvier'], ['Peter', '', 'Palese']]",Vaccine,2008,"[u'http://www3.botany.ubc.ca/biol430/influenza%20biology.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X08009377', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08009377']",
10.1099/0022-1317-33-1-159,"Kaverin, N., Gambaryan, A., Bovin, N., et. al, Postreassortment Changes in Influenza A Virus Hemagglutinin Restoring HA–NA Functional Match, Virology, 1998",cited-by,10.1006/viro.1998.9119,Postreassortment Changes in Influenza A Virus Hemagglutinin Restoring HA–NA Functional Match,"[['N.', 'V.', 'Kaverin'], ['A.', 'S.', 'Gambaryan'], ['N.', 'V.', 'Bovin'], ['I.', 'A.', 'Rudneva'], ['A.', 'A.', 'Shilov'], ['O.', 'M.', 'Khodova'], ['N.', 'L.', 'Varich'], ['B.', 'V.', 'Sinitsin'], ['N.', 'V.', 'Makarova'], ['E.', 'A.', 'Kropotkina']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S004268229899119X', u'http://linkinghub.elsevier.com/retrieve/pii/S004268229899119X']",
10.1099/0022-1317-33-1-159,"Steel, J., Lowen, A., Pena, L., et. al, Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza, Journal of Virology, 2009",cited-by,10.1128/JVI.01920-08,Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza,"[['John', '', 'Steel'], ['Anice', 'C.', 'Lowen'], ['Lindomar', '', 'Pena'], ['Matthew', '', 'Angel'], ['Alicia', '', 'Solorzano'], ['Randy', '', 'Albrecht'], ['Daniel', 'R.', 'Perez'], ['A.', '', 'Garcia-Sastre'], ['Peter', '', 'Palese']]",Journal of Virology,2009,"[u'http://jvi.asm.org/cgi/reprint/83/4/1742.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01920-08']",./output/11215168.pdf/citedby/10.1128~JVI.01920-08
10.1099/0022-1317-33-1-159,"GREENGARD, O., POLTORATSKAIA, N., LEIKINA, E., et. al, The Anti-Influenza Virus Agent 4-GU-DANA (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA, Journal of Virology, 2000",cited-by,10.1128/JVI.74.23.11108-11114.2000,The Anti-Influenza Virus Agent 4-GU-DANA (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA,"[['OLGA', '', 'GREENGARD'], ['NATALIA', '', 'POLTORATSKAIA'], ['EVGENIA', '', 'LEIKINA'], ['JOSHUA', '', 'ZIMMERBERG'], ['ANNE', '', 'MOSCONA']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/23/11108.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.23.11108-11114.2000']",./output/11215168.pdf/citedby/10.1128~JVI.74.23.11108-11114.2000
10.1099/0022-1317-33-1-159,"Molla, A., Kati, W., Carrick, R., et. al, In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675, Journal of Virology, 2002",cited-by,10.1128/JVI.76.11.5380-5386.2002,"In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675","[['Akhteruzzaman', '', 'Molla'], ['Warren', '', 'Kati'], ['Robert', '', 'Carrick'], ['Kevin', '', 'Steffy'], ['Yan', '', 'Shi'], ['Debra', '', 'Montgomery'], ['Nanette', '', 'Gusick'], ['Vincent', 'S.', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['Teresa', 'I.', 'Ng'], ['Clarence', '', 'Maring'], ['Dale', 'J.', 'Kempf'], ['William', '', 'Kohlbrenner']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/11/5380.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.11.5380-5386.2002']",./output/11215168.pdf/citedby/10.1128~JVI.76.11.5380-5386.2002
10.1099/0022-1317-33-1-159,"Shinya, K., Fujii, Y., Ito, H., et. al, Characterization of a Neuraminidase-Deficient Influenza A Virus as a Potential Gene Delivery Vector and a Live Vaccine, Journal of Virology, 2004",cited-by,10.1128/JVI.78.6.3083-3088.2004,Characterization of a Neuraminidase-Deficient Influenza A Virus as a Potential Gene Delivery Vector and a Live Vaccine,"[['Kyoko', '', 'Shinya'], ['Yutaka', '', 'Fujii'], ['Hiroshi', '', 'Ito'], ['Toshihiro', '', 'Ito'], ['Yoshihiro', '', 'Kawaoka']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/6/3083.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.6.3083-3088.2004']",./output/11215168.pdf/citedby/10.1128~JVI.78.6.3083-3088.2004
10.1099/0022-1317-33-1-159,"Singer, A., Nunn, M., Gould, E., et. al, Potential Risks Associated with the Proposed Widespread Use of Tamiflu, Environmental Health Perspectives, 2006",cited-by,10.1289/ehp.9574,Potential Risks Associated with the Proposed Widespread Use of Tamiflu,"[['Andrew', 'C.', 'Singer'], ['Miles', 'A.', 'Nunn'], ['Ernest', 'A.', 'Gould'], ['Andrew', 'C.', 'Johnson']]",Environmental Health Perspectives,2006,[u'http://www.ehponline.org/ambra-doi-resolver/10.1289/ehp.9574'],
10.1099/0022-1317-33-1-159,"Macdonald, S., Watson, K., Cameron, R., et. al, Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4542-4549.2004,Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen,"[['Simon', 'J. F.', 'Macdonald'], ['Keith', 'G.', 'Watson'], ['Rachel', '', 'Cameron'], ['David', 'K.', 'Chalmers'], ['Derek', 'A.', 'Demaine'], ['Rob', 'J.', 'Fenton'], ['David', '', 'Gower'], ['J.', 'Nicole', 'Hamblin'], ['Stephanie', '', 'Hamilton'], ['Graham', 'J.', 'Hart'], ['Graham', 'G. A.', 'Inglis'], ['Betty', '', 'Jin'], ['Haydn', 'T.', 'Jones'], ['Darryl', 'B.', 'McConnell'], ['Andy', 'M.', 'Mason'], ['Van', '', 'Nguyen'], ['Ian', 'J.', 'Owens'], ['Nigel', '', 'Parry'], ['Phillip', 'A.', 'Reece'], ['Stephen', 'E.', 'Shanahan'], ['Donna', '', 'Smith'], ['Wen-Yang', '', 'Wu'], ['Simon', 'P.', 'Tucker']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4542.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4542-4549.2004']",./output/11215168.pdf/citedby/10.1128~AAC.48.12.4542-4549.2004
10.1099/0022-1317-33-1-159,"Porotto, M., Murrell, M., Greengard, O., et. al, Inhibition of Parainfluenza Virus Type 3 and Newcastle Disease Virus Hemagglutinin-Neuraminidase Receptor Binding: Effect of Receptor Avidity and Steric Hindrance at the Inhibitor Binding Sites, Journal of Virology, 2004",cited-by,10.1128/JVI.78.24.13911-13919.2004,Inhibition of Parainfluenza Virus Type 3 and Newcastle Disease Virus Hemagglutinin-Neuraminidase Receptor Binding: Effect of Receptor Avidity and Steric Hindrance at the Inhibitor Binding Sites,"[['Matteo', '', 'Porotto'], ['Matthew', '', 'Murrell'], ['Olga', '', 'Greengard'], ['Michael', 'C.', 'Lawrence'], ['J.', 'L.', 'McKimm-Breschkin'], ['Anne', '', 'Moscona']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/24/13911.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.24.13911-13919.2004']",./output/11215168.pdf/citedby/10.1128~JVI.78.24.13911-13919.2004
10.1099/0022-1317-33-1-159,"Fanning, T., Reid, A., Taubenberger, J., , Influenza A Virus Neuraminidase: Regions of the Protein Potentially Involved in Virus–Host Interactions, Virology, 2000",cited-by,10.1006/viro.2000.0578,Influenza A Virus Neuraminidase: Regions of the Protein Potentially Involved in Virus–Host Interactions,"[['Thomas', 'G.', 'Fanning'], ['Ann', 'H.', 'Reid'], ['Jeffery', 'K.', 'Taubenberger']]",Virology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0042682200905786', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682200905786']",
10.1099/0022-1317-33-1-159,"DeMarco, M., Woods, R., , Structural glycobiology: A game of snakes and ladders, Glycobiology, 2008",cited-by,10.1093/glycob/cwn026,Structural glycobiology: A game of snakes and ladders,"[['Mari', 'L', 'DeMarco'], ['Robert', 'J', 'Woods']]",Glycobiology,2008,"[u'http://glycob.oxfordjournals.org/cgi/reprint/cwn026v1.pdf', u'http://glycob.oxfordjournals.org/cgi/reprint/18/6/426.pdf', u'http://www.glycob.oxfordjournals.org/cgi/doi/10.1093/glycob/cwn026']",./output/11215168.pdf/citedby/10.1093~glycob~cwn026
10.1099/0022-1317-33-1-159,"McKay, T., Patel, M., Pickles, R., et. al, Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors, Gene Therapy, 2006",cited-by,10.1038/sj.gt.3302715,Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors,"[['T', '', 'McKay'], ['M', '', 'Patel'], ['R', 'J', 'Pickles'], ['L', 'G', 'Johnson'], ['J', 'C', 'Olsen']]",Gene Therapy,2006,"[u'http://dx.doi.org/10.1038/sj.gt.3302715', u'http://www.nature.com/doifinder/10.1038/sj.gt.3302715']",./output/11215168.pdf/citedby/10.1038~sj.gt.3302715
10.1099/0022-1317-33-1-159,"Porotto, M., Murrell, M., Greengard, O., et. al, Influence of the Human Parainfluenza Virus 3 Attachment Protein's Neuraminidase Activity on Its Capacity To Activate the Fusion Protein, Journal of Virology, 2005",cited-by,10.1128/JVI.79.4.2383-2392.2005,Influence of the Human Parainfluenza Virus 3 Attachment Protein's Neuraminidase Activity on Its Capacity To Activate the Fusion Protein,"[['Matteo', '', 'Porotto'], ['Matthew', '', 'Murrell'], ['Olga', '', 'Greengard'], ['Anne', '', 'Moscona']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/4/2383.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.4.2383-2392.2005']",./output/11215168.pdf/citedby/10.1128~JVI.79.4.2383-2392.2005
10.1099/0022-1317-33-1-159,"Baigent, S., Bethell, R., McCauley, J., , Genetic Analysis Reveals That Both Haemagglutinin and Neuraminidase Determine the Sensitivity of Naturally Occurring Avian Influenza Viruses to Zanamivir in Vitro, Virology, 1999",cited-by,10.1006/viro.1999.9931,Genetic Analysis Reveals That Both Haemagglutinin and Neuraminidase Determine the Sensitivity of Naturally Occurring Avian Influenza Viruses to Zanamivir in Vitro,"[['S.', 'J.', 'Baigent'], ['R.', 'C.', 'Bethell'], ['J.', 'W.', 'McCauley']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299999312', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299999312']",
10.1099/0022-1317-33-1-159,"Bouvier, N., Lowen, A., Palese, P., , Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol, Journal of Virology, 2008",cited-by,10.1128/JVI.01226-08,Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol,"[['Nicole', 'M.', 'Bouvier'], ['Anice', 'C.', 'Lowen'], ['Peter', '', 'Palese']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/20/10052.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01226-08']",./output/11215168.pdf/citedby/10.1128~JVI.01226-08
10.1099/0022-1317-33-1-159,"Villar, E., Barroso, I., , Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview, Glycoconjugate Journal, 2006",cited-by,10.1007/s10719-006-5433-0,Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview,"[['Enrique', '', 'Villar'], ['Isabel', 'Mu\xc3\xb1oz', 'Barroso']]",Glycoconjugate Journal,2006,"[u'http://www.springerlink.com/content/n549v716hp2mr30p', u'http://www.springerlink.com/index/n549v716hp2mr30p.pdf', u'http://www.springerlink.com/index/10.1007/s10719-006-5433-0', u'http://www.springerlink.com/index/pdf/10.1007/s10719-006-5433-0']",./output/11215168.pdf/citedby/10.1007~s10719-006-5433-0
10.1099/0022-1317-33-1-159,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']",
10.1099/0022-1317-33-1-159,"Nagai, T., Moriguchi, R., Suzuki, Y., et. al, Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis, Antiviral Research, 1995",cited-by,10.1016/0166-3542(94)00062-D,"Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis","[['Takayuki', '', 'Nagai'], ['Ryozo', '', 'Moriguchi'], ['Yujiro', '', 'Suzuki'], ['Tsuyoshi', '', 'Tomimori'], ['Haruki', '', 'Yamada']]",Antiviral Research,1995,"[u'http://www.sciencedirect.com/science/article/pii/016635429400062D', u'http://linkinghub.elsevier.com/retrieve/pii/016635429400062D']",
10.1099/0022-1317-33-1-159,"Smee, D., Sidwell, R., , Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza, Expert Opinion on Investigational Drugs, 2002",cited-by,10.1517/13543784.11.6.859,"Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza","[['Donald', 'F', 'Smee'], ['Robert', 'W', 'Sidwell']]",Expert Opinion on Investigational Drugs,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.11.6.859'],./output/11215168.pdf/citedby/10.1517~13543784.11.6.859
10.1099/0022-1317-33-1-159,"Varghese, J., , Development of neuraminidase inhibitors as anti-influenza virus drugs, Drug Development Research, 1999",cited-by,10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6,Development of neuraminidase inhibitors as anti-influenza virus drugs,"[['Joseph', 'N.', 'Varghese']]",Drug Development Research,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291098-2299%28199903/04%2946%3A3/4%3C176%3A%3AAID-DDR4%3E3.0.CO%3B2-6'],
10.1099/0022-1317-33-1-159,"Wang, B., Quan, F., Kang, S., et. al, Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses, Journal of Virology, 2008",cited-by,10.1128/JVI.01076-08,Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses,"[['Bao-Zhong', '', 'Wang'], ['Fu-Shi', '', 'Quan'], ['Sang-Moo', '', 'Kang'], ['Jadranka', '', 'Bozja'], ['Ioanna', '', 'Skountzou'], ['Richard', 'W.', 'Compans']]",Journal of Virology,2008,"[u'http://www.cri.ulaval.ca/fileadmin/CRI/Chercheurs/Cours/DLeclerc/Flagellin_incorporation_into_VLP.pdf', u'http://jvi.asm.org/cgi/reprint/82/23/11813.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01076-08']",./output/11215168.pdf/citedby/10.1128~JVI.01076-08
10.1099/0022-1317-33-1-159,"Jr, J., Michaelis, M., Doerr, H., , The threat of avian influenza A (H5N1). Part III: antiviral therapy, Medical Microbiology and Immunology, 2007",cited-by,10.1007/s00430-007-0048-z,The threat of avian influenza A (H5N1). Part III: antiviral therapy,"[['Jindrich', 'Cinatl', 'Jr'], ['Martin', '', 'Michaelis'], ['Hans', 'W.', 'Doerr']]",Medical Microbiology and Immunology,2007,"[u'http://www.springerlink.com/index/41xpm470518281m7.pdf', u'http://www.springerlink.com/content/41xpm470518281m7', u'http://www.springerlink.com/index/10.1007/s00430-007-0048-z', u'http://www.springerlink.com/index/pdf/10.1007/s00430-007-0048-z']",./output/11215168.pdf/citedby/10.1007~s00430-007-0048-z
10.1099/0022-1317-33-1-159,"CHEUNG, T., POON, L., , Biology of Influenza A Virus, Annals of The New York Academy of Sciences, 2007",cited-by,10.1196/annals.1408.001,Biology of Influenza A Virus,"[['TIMOTHY', 'K. W.', 'CHEUNG'], ['LEO', 'L. M.', 'POON']]",Annals of The New York Academy of Sciences,2007,[u'http://blackwell-synergy.com/doi/abs/10.1196/annals.1408.001'],
10.1099/0022-1317-33-1-159,"Rudneva, I., Kovaleva, V., Varich, N., et. al, Influenza A virus reassortants with surface glycoprotein genes of the avian parent viruses: effects of HA and NA gene combinations on virus aggregation, Archives of Virology, 1993",cited-by,10.1007/BF01313781,Influenza A virus reassortants with surface glycoprotein genes of the avian parent viruses: effects of HA and NA gene combinations on virus aggregation,"[['I.', 'A.', 'Rudneva'], ['V.', 'P.', 'Kovaleva'], ['N.', 'L.', 'Varich'], ['V.', 'R.', 'Farashyan'], ['L.', 'V.', 'Gubareva'], ['S.', 'S.', 'Yamnikova'], ['I.', 'A.', 'Popova'], ['V.', 'P.', 'Presnova'], ['N.', 'V.', 'Kaverin']]",Archives of Virology,1993,"[u'http://www.springerlink.com/index/p8gnvu85w75v0213.pdf', u'http://www.springerlink.com/content/p8gnvu85w75v0213', u'http://www.springerlink.com/index/10.1007/BF01313781', u'http://www.springerlink.com/index/pdf/10.1007/BF01313781']",./output/11215168.pdf/citedby/10.1007~BF01313781
10.1099/0022-1317-33-1-159,"Gubareva, L., Nedyalkova, M., Novikov, D., et. al, A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site, , 2002",cited-by,6949716A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site,A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site,"[['Larisa', 'V.', 'Gubareva'], ['Marina', 'S.', 'Nedyalkova'], ['Dmitri', 'V.', 'Novikov'], ['K.', 'Gopal', 'Murti'], ['Erich', '', 'Hoffmann'], ['Frederick', 'G.', 'Hayden']]",,2002,[u'http://vir.sgmjournals.org/cgi/reprint/83/11/2683.pdf'],./output/11215168.pdf/citedby/6949716A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site
10.1099/0022-1317-33-1-159,"Taubenberger, J., , The virulence of the 1918 pandemic influenza virus: unraveling the enigma, , 0",cited-by,10.1007/3-211-29981-5_9,The virulence of the 1918 pandemic influenza virus: unraveling the enigma,"[['J.', 'K.', 'Taubenberger']]",,0,"[u'http://www.springerlink.com/content/nt45442057g28674', u'http://www.springerlink.com/index/nt45442057g28674.pdf']",./output/11215168.pdf/citedby/10.1007~3-211-29981-5_9
10.1099/0022-1317-33-1-159,"Bennink, J., Palmore, T., , The promise of siRNAs for the treatment of influenza, Trends in Molecular Medicine, 2004",cited-by,10.1016/j.molmed.2004.10.004,The promise of siRNAs for the treatment of influenza,"[['Jack', 'R.', 'Bennink'], ['Tara', 'N.', 'Palmore']]",Trends in Molecular Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S147149140400262X', u'http://linkinghub.elsevier.com/retrieve/pii/S147149140400262X']",
10.1099/0022-1317-33-1-159,"Machado, A., Naffakh, N., Werf, S., et. al, Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter, Virology, 2003",cited-by,10.1016/S0042-6822(03)00289-7,Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter,"[['Alexandre', 'Vieira', 'Machado'], ['Nadia', '', 'Naffakh'], ['Sylvie', 'van der', 'Werf'], ['Nicolas', '', 'Escriou']]",Virology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0042682203002897', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682203002897']",
10.1099/0022-1317-33-1-159,"Ruigrok, R., Hirst, E., Hay, A., , The Specific Inhibition of Influenza A Virus Maturation by Amantadine: An Electron Microscopic Examination, Journal of General Virology, 1991",cited-by,10.1099/0022-1317-72-1-191,The Specific Inhibition of Influenza A Virus Maturation by Amantadine: An Electron Microscopic Examination,"[['R.', 'W. H.', 'Ruigrok'], ['E.', 'M. A.', 'Hirst'], ['A.', 'J.', 'Hay']]",Journal of General Virology,1991,"[u'http://vir.sgmjournals.org/cgi/reprint/72/1/191.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-72-1-191']",./output/11215168.pdf/citedby/10.1099~0022-1317-72-1-191
10.1099/0022-1317-33-1-159,"Solorzano, A., Zheng, H., Fodor, E., et. al, Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice, , 0",cited-by,11088220Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice,Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice,"[['Alicia', '', 'Solorzano'], ['Hongyong', '', 'Zheng'], ['Ervin', '', 'Fodor'], ['George', 'G.', 'Brownlee'], ['Peter', '', 'Palese'], ['Adolfo', '', 'Garci']]",,0,[u'http://vir.sgmjournals.org/cgi/reprint/81/3/737.pdf'],./output/11215168.pdf/citedby/11088220Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice
10.1099/0022-1317-33-1-159,"Masuda, T., Yoshida, S., Arai, M., et. al, Synthesis and Anti-influenza Evaluation of Polyvalent Sialidase Inhibitors Bearing 4-Guanidino-Neu5Ac2en Derivatives, Chemical & Pharmaceutical Bulletin, 2003",cited-by,10.1248/cpb.51.1386,Synthesis and Anti-influenza Evaluation of Polyvalent Sialidase Inhibitors Bearing 4-Guanidino-Neu5Ac2en Derivatives,"[['Takeshi', '', 'Masuda'], ['Shuku', '', 'Yoshida'], ['Masami', '', 'Arai'], ['Satoru', '', 'Kaneko'], ['Makoto', '', 'Yamashita'], ['Takeshi', '', 'Honda']]",Chemical & Pharmaceutical Bulletin,2003,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/cpb/51.1386?from=CrossRef'],
10.1099/0022-1317-33-1-159,"KREMPL, C., HERRLER, G., , Sialic Acid Binding Activity of Transmissible Gastroenteritis Coronavirus Affects Sedimentation Behavior of Virions and Solubilized Glycoproteins, Journal of Virology, 2001",cited-by,10.1128/JVI.75.2.844-849.2001,Sialic Acid Binding Activity of Transmissible Gastroenteritis Coronavirus Affects Sedimentation Behavior of Virions and Solubilized Glycoproteins,"[['CHRISTINE', '', 'KREMPL'], ['GEORG', '', 'HERRLER']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/2/844.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.2.844-849.2001']",./output/11215168.pdf/citedby/10.1128~JVI.75.2.844-849.2001
10.1099/0022-1317-33-1-159,"Abed, Y., Boivin, G., , Treatment of respiratory virus infections, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.01.006,Treatment of respiratory virus infections,"[['Yacine', '', 'Abed'], ['Guy', '', 'Boivin']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016635420600026X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420600026X']",
10.1099/0022-1317-33-1-159,"Ilyushina, N., Rudneva, I., Shilov, A., et. al, Postreassortment changes in a model system: HA–NA adjustment in an H3N2 avian–human reassortant influenza virus, Archives of Virology, 2005",cited-by,10.1007/s00705-005-0490-4,Postreassortment changes in a model system: HA–NA adjustment in an H3N2 avian–human reassortant influenza virus,"[['N.', 'A.', 'Ilyushina'], ['I.', 'A.', 'Rudneva'], ['A.', 'A.', 'Shilov'], ['H.-D.', '', 'Klenk'], ['N.', 'V.', 'Kaverin']]",Archives of Virology,2005,"[u'http://www.springerlink.com/index/g40766068781hk48.pdf', u'http://www.springerlink.com/content/g40766068781hk48', u'http://www.springerlink.com/index/10.1007/s00705-005-0490-4', u'http://www.springerlink.com/index/pdf/10.1007/s00705-005-0490-4']",./output/11215168.pdf/citedby/10.1007~s00705-005-0490-4
10.1099/0022-1317-33-1-159,"Selamat, A., Omatu, S., , Neural networks for web page classification based on augmented PCA, , 2003",cited-by,10.1109/IJCNN.2003.1223679,Neural networks for web page classification based on augmented PCA,"[['Ali', '', 'Selamat'], ['Sigeru', '', 'Omatu']]",,2003,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1223679', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01223679']",./output/11215168.pdf/citedby/10.1109~IJCNN.2003.1223679
10.1099/0022-1317-33-1-159,"Colman, P., , Zanamivir: an influenza virus neuraminidase inhibitor, Expert Review of Anti-infective Therapy, 2005",cited-by,10.1586/14787210.3.2.191,Zanamivir: an influenza virus neuraminidase inhibitor,"[['PM', '', 'Colman']]",Expert Review of Anti-infective Therapy,2005,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.3.2.191'],
10.1099/0022-1317-33-1-159,"Itzstein, M., Thomson, R., , Anti-Influenza Drugs: The Development of Sialidase Inhibitors, , 0",cited-by,10.1007/978-3-540-79086-0_5,Anti-Influenza Drugs: The Development of Sialidase Inhibitors,"[['Mark', 'von', 'Itzstein'], ['Robin', '', 'Thomson']]",,0,"[u'http://www.springerlink.com/index/q7q766196t171341.pdf', u'http://www.springerlink.com/content/q7q766196t171341']",./output/11215168.pdf/citedby/10.1007~978-3-540-79086-0_5
10.1099/0022-1317-33-1-159,"Wang, G., , Recent advances in the discovery and development of anti-influenza drugs, Expert Opinion on Therapeutic Patents, 2002",cited-by,10.1517/13543776.12.6.845,Recent advances in the discovery and development of anti-influenza drugs,"[['Gary', 'T', 'Wang']]",Expert Opinion on Therapeutic Patents,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.12.6.845'],./output/11215168.pdf/citedby/10.1517~13543776.12.6.845
10.1099/0022-1317-33-1-159,"Oladele, S., Abdu, P., Nok, A., et. al, Effect of some inhibitors on neuraminidase of Newcastle disease virus Kudu 113 strain, , 0",cited-by,10218546Effect of some inhibitors on neuraminidase of Newcastle disease virus Kudu 113 strain,Effect of some inhibitors on neuraminidase of Newcastle disease virus Kudu 113 strain,"[['Sunday', 'Blessing', 'Oladele'], ['Paul', '', 'Abdu'], ['Andrew', 'Jonathan', 'Nok'], ['King', '', 'Akpofure'], ['Nelson', '', 'Esievo'], ['Nicodemus', 'Maashin', 'Useh']]",,0,[u'http://www.vef.hr/vetarhiv/papers/72-4/oladele.pdf'],./output/11215168.pdf/citedby/10218546Effect of some inhibitors on neuraminidase of Newcastle disease virus Kudu 113 strain
10.1099/0022-1317-33-1-159,"Meunier, I., Pillet, S., Simonsen, J., et. al, Influenza pathogenesis: Lessons learned from animal studies with H5N1, H1N1 Spanish, and pandemic H1N1 2009 influenza, Critical Care Medicine, 2010",cited-by,10.1097/CCM.0b013e3181c8b4d5,"Influenza pathogenesis: Lessons learned from animal studies with H5N1, H1N1 Spanish, and pandemic H1N1 2009 influenza","[['Isabelle', '', 'Meunier'], ['St\xc3\xa9phane', '', 'Pillet'], ['J.', 'Neil', 'Simonsen'], ['Veronika', 'von', 'Messling']]",Critical Care Medicine,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-201004001-00003'],
10.1099/0022-1317-33-1-159,"Gravel, C., Li, C., Wang, J., et. al, Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.06.075,Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences,"[['Caroline', '', 'Gravel'], ['Changgui', '', 'Li'], ['Junzhi', '', 'Wang'], ['Anwar', 'M.', 'Hashem'], ['Bozena', '', 'Jaentschke'], ['Kang-wei', '', 'Xu'], ['Barry', '', 'Lorbetskie'], ['Genevieve', '', 'Gingras'], ['Yves', '', 'Aubin'], ['Garry', 'Van', 'Domselaar'], ['Michel', '', 'Girard'], ['Runtao', '', 'He'], ['Xuguang', '', 'Li']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10009035', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10009035']",
10.1099/0022-1317-33-1-159,"Winter, C., Herrler, G., Neumann, U., , Infection of the tracheal epithelium by infectious bronchitis virus is sialic acid dependent, Microbes and Infection, 2008",cited-by,10.1016/j.micinf.2007.12.009,Infection of the tracheal epithelium by infectious bronchitis virus is sialic acid dependent,"[['Christine', '', 'Winter'], ['Georg', '', 'Herrler'], ['Ulrich', '', 'Neumann']]",Microbes and Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1286457907003917', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457907003917']",
10.1099/0022-1317-33-1-159,"Wyde, P., , Chemotherapy of respiratory viruses: prospects and challenges, Drug Resistance Updates, 1999",cited-by,10.1054/drup.1999.0091,Chemotherapy of respiratory viruses: prospects and challenges,"[['Philip', 'R.', 'Wyde']]",Drug Resistance Updates,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1368764699900912', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764699900912']",
10.1099/0022-1317-33-1-159,"BASLER, C., GARCIA-SASTRE, A., PALESE, P., , Mutation of Neuraminidase Cysteine Residues Yields Temperature-Sensitive Influenza Viruses, , 0",cited-by,11212716Mutation of Neuraminidase Cysteine Residues Yields Temperature-Sensitive Influenza Viruses,Mutation of Neuraminidase Cysteine Residues Yields Temperature-Sensitive Influenza Viruses,"[['CHRISTOPHER', 'F.', 'BASLER'], ['ADOLFO', '', 'GARCIA-SASTRE'], ['PETER', '', 'PALESE']]",,0,[u'http://jvi.asm.org/cgi/reprint/73/10/8095.pdf'],./output/11215168.pdf/citedby/11212716Mutation of Neuraminidase Cysteine Residues Yields Temperature-Sensitive Influenza Viruses
10.1099/0022-1317-33-1-159,"Horst, D., Vermeylen, S., , Spatial scale and social impacts of biofuel production, Biomass & Bioenergy, 2011",cited-by,10.1016/j.biombioe.2010.11.029,Spatial scale and social impacts of biofuel production,"[['Dan', 'van der', 'Horst'], ['Saskia', '', 'Vermeylen']]",Biomass & Bioenergy,2011,[u'http://www.sciencedirect.com/science/article/pii/S0961953410004204'],
10.1099/0022-1317-33-1-159,"Fourment, M., Wood, J., Gibbs, A., et. al, Evolutionary dynamics of the N1 neuraminidases of the main lineages of influenza A viruses, Molecular Phylogenetics and Evolution, 2010",cited-by,10.1016/j.ympev.2010.04.039,Evolutionary dynamics of the N1 neuraminidases of the main lineages of influenza A viruses,"[['Mathieu', '', 'Fourment'], ['Jeffrey', 'T.', 'Wood'], ['Adrian', 'J.', 'Gibbs'], ['Mark', 'J.', 'Gibbs']]",Molecular Phylogenetics and Evolution,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1055790310002058', u'http://linkinghub.elsevier.com/retrieve/pii/S1055790310002058']",
10.1099/0022-1317-33-1-159,"Hashem, A., Flaman, A., Farnsworth, A., et. al, Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases, PLOS One, 2009",cited-by,10.1371/journal.pone.0008350.t001,Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases,"[['Anwar', 'M.', 'Hashem'], ['Anathea', 'S.', 'Flaman'], ['Aaron', '', 'Farnsworth'], ['Earl', 'G.', 'Brown'], ['Gary', 'Van', 'Domselaar'], ['Runtao', '', 'He'], ['Xuguang', '', 'Li']]",PLOS One,2009,"[u'http://www.med.uottawa.ca/bmi/assets/documents/dr%20brown/dr_brown11.pdf', u'http://www.medicine.uottawa.ca/bmi/assets/documents/dr%20brown/dr_brown11.pdf', u'http://dx.plos.org/10.1371/journal.pone.0008350', u'http://dx.plos.org/10.1371/journal.pone.0008350.g001', u'http://dx.plos.org/10.1371/journal.pone.0008350.g002', u'http://dx.plos.org/10.1371/journal.pone.0008350.g003', u'http://dx.plos.org/10.1371/journal.pone.0008350.g004', u'http://dx.plos.org/10.1371/journal.pone.0008350.g005', u'http://dx.plos.org/10.1371/journal.pone.0008350.g006', u'http://dx.plos.org/10.1371/journal.pone.0008350.g007', u'http://dx.plos.org/10.1371/journal.pone.0008350.g008', u'http://dx.plos.org/10.1371/journal.pone.0008350.g009', u'http://dx.plos.org/10.1371/journal.pone.0008350.g010', u'http://dx.plos.org/10.1371/journal.pone.0008350.t001']",./output/11215168.pdf/citedby/10.1371~journal.pone.0008350.t001
10.1099/0022-1317-33-1-159,"Adamo, J., Liu, T., Schmeisser, F., et. al, Optimizing Viral Protein Yield of Influenza Virus Strain A/Vietnam/1203/2004 by Modification of the Neuraminidase Gene, Journal of Virology, 2009",cited-by,10.1128/JVI.02391-08,Optimizing Viral Protein Yield of Influenza Virus Strain A/Vietnam/1203/2004 by Modification of the Neuraminidase Gene,"[['Joan', 'E.', 'Adamo'], ['Teresa', '', 'Liu'], ['Falko', '', 'Schmeisser'], ['Zhiping', '', 'Ye']]",Journal of Virology,2009,"[u'http://jvi.asm.org/cgi/reprint/83/9/4023.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02391-08']",./output/11215168.pdf/citedby/10.1128~JVI.02391-08
10.1099/0022-1317-33-1-159,"Chand, P., , Recent advances in the discovery and synthesis of neuraminidase inhibitors, Expert Opinion on Therapeutic Patents, 2005",cited-by,10.1517/13543776.15.8.1009,Recent advances in the discovery and synthesis of neuraminidase inhibitors,"[['Pooran', '', 'Chand']]",Expert Opinion on Therapeutic Patents,2005,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.15.8.1009'],./output/11215168.pdf/citedby/10.1517~13543776.15.8.1009
10.1099/0022-1317-33-1-159,"McSwiggen, J., Seth, S., , A potential treatment for pandemic influenza using siRNAs targeting conserved regions of influenza A, Expert Opinion on Biological Therapy, 2008",cited-by,10.1517/14712598.8.3.299,A potential treatment for pandemic influenza using siRNAs targeting conserved regions of influenza A,"[['James', 'A', 'McSwiggen'], ['Shaguna', '', 'Seth']]",Expert Opinion on Biological Therapy,2008,[u'http://informahealthcare.com/doi/abs/10.1517/14712598.8.3.299'],./output/11215168.pdf/citedby/10.1517~14712598.8.3.299
10.1099/0022-1317-33-1-159,"Mori, I., Dong, L., Liu, B., et. al, Fetal calf serum inhibits virus genome expression in Madin-Darby canine kidney cells persistently infected with influenza A virus, Medical Microbiology and Immunology, 2008",cited-by,10.1007/s00430-007-0054-1,Fetal calf serum inhibits virus genome expression in Madin-Darby canine kidney cells persistently infected with influenza A virus,"[['Isamu', '', 'Mori'], ['Li', '', 'Dong'], ['Beixing', '', 'Liu'], ['Yoshinobu', '', 'Kimura']]",Medical Microbiology and Immunology,2008,"[u'http://www.springerlink.com/index/d6vm0967571736t8.pdf', u'http://www.springerlink.com/content/d6vm0967571736t8', u'http://www.springerlink.com/index/10.1007/s00430-007-0054-1', u'http://www.springerlink.com/index/pdf/10.1007/s00430-007-0054-1']",./output/11215168.pdf/citedby/10.1007~s00430-007-0054-1
10.1099/0022-1317-33-1-159,"Fleming, D., , Zanamivir in the treatment of influenza, Expert Opinion on Pharmacotherapy, 2003",cited-by,10.1517/14656566.4.5.799,Zanamivir in the treatment of influenza,"[['Douglas', 'M', 'Fleming']]",Expert Opinion on Pharmacotherapy,2003,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.4.5.799'],./output/11215168.pdf/citedby/10.1517~14656566.4.5.799
10.1099/0022-1317-33-1-159,"Lee, C., Kim, S., Lee, K., et. al, Neuraminidase Inhibitors from Reynoutria elliptica, Archives of Pharmacal Research, 2003",cited-by,10.1007/BF02976693,Neuraminidase Inhibitors from Reynoutria elliptica,"[['Chu-Hyun', '', 'Lee'], ['Sang-ln', '', 'Kim'], ['Kyung-Bok', '', 'Lee'], ['Yung-Choon', '', 'Yoo'], ['Si-Young', '', 'Ryu'], ['Kyung-Sik', '', 'Song']]",Archives of Pharmacal Research,2003,"[u'http://www.springerlink.com/content/ntw8n37421083574', u'http://www.springerlink.com/index/ntw8n37421083574.pdf', u'http://www.springerlink.com/index/10.1007/BF02976693', u'http://www.springerlink.com/index/pdf/10.1007/BF02976693']",./output/11215168.pdf/citedby/10.1007~BF02976693
10.1099/0022-1317-33-1-159,"Meloni, D., Monaci, R., Rombi, E., et. al, Synthesis and characterization of MCM-22 zeolites for the N 2O oxidation of benzene to phenol, Studies in Surface Science and Catalysis, 2002",cited-by,10.1016/S0167-2991(02)80025-8,Synthesis and characterization of MCM-22 zeolites for the N 2O oxidation of benzene to phenol,"[['D.', '', 'Meloni'], ['R.', '', 'Monaci'], ['E.', '', 'Rombi'], ['C.', '', 'Guimon'], ['H.', '', 'Martinez'], ['I.', '', 'Fechete'], ['E.', '', 'Dumitriu']]",Studies in Surface Science and Catalysis,2002,[u'http://www.sciencedirect.com/science/article/pii/S0167299102800258'],
10.1099/0022-1317-33-1-159,"Wagner, R., Feldmann, A., Wolff, T., et. al, Hemagglutinin and neuraminidase as determinants of influenza virus pathogenicity, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00381-8,Hemagglutinin and neuraminidase as determinants of influenza virus pathogenicity,"[['Ralf', '', 'Wagner'], ['Anke', '', 'Feldmann'], ['Thorsten', '', 'Wolff'], ['Stephan', '', 'Pleschka'], ['Wolfgang', '', 'Garten'], ['Hans-Dieter', '', 'Klenk']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003818', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003818']",
10.1099/0022-1317-33-1-159,"Khare, M., Sharland, M., , Influenza, Expert Opinion on Pharmacotherapy, 2000",cited-by,10.1517/14656566.1.3.367,Influenza,"[['Milind', 'D', 'Khare'], ['Mike', '', 'Sharland']]",Expert Opinion on Pharmacotherapy,2000,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.1.3.367'],./output/11215168.pdf/citedby/10.1517~14656566.1.3.367
10.1099/0022-1317-33-1-159,"Barrêre, B., Driguez, P., Maudrin, J., et. al, A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture, Archives of Virology, 1997",cited-by,10.1007/s007050050166,A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture,"[['B.', '', 'Barr\xc3\xaare'], ['P.', 'A.', 'Driguez'], ['J.', '', 'Maudrin'], ['A.', '', 'Doutheau'], ['M.', '', 'Aymard'], ['G.', '', 'Quash']]",Archives of Virology,1997,"[u'http://www.springerlink.com/content/r3fu5b17wfftj306', u'http://www.springerlink.com/index/r3fu5b17wfftj306.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s007050050166', u'http://www.springerlink.com/index/pdf/10.1007/s007050050166']",./output/11215168.pdf/citedby/10.1007~s007050050166
10.1099/0022-1317-33-1-159,"Saunders, J., Cameron, J., , Recent developments in the design of antiviral agents, Medicinal Research Reviews, 1995",cited-by,10.1002/med.2610150604,Recent developments in the design of antiviral agents,"[['John', '', 'Saunders'], ['Janet', 'M.', 'Cameron']]",Medicinal Research Reviews,1995,[u'http://doi.wiley.com/10.1002/med.2610150604'],./output/11215168.pdf/citedby/10.1002~med.2610150604
10.1099/0022-1317-33-1-159,"Colacino, J., Staschke, K., Laver, W., , Approaches and strategies for the treatment of influenza virus infections, , 0",cited-by,11571009Approaches and strategies for the treatment of influenza virus infections,Approaches and strategies for the treatment of influenza virus infections,"[['Joseph', 'M', 'Colacino'], ['Kirk', 'A', 'Staschke'], ['W', 'Graeme', 'Laver']]",,0,[u'http://arbidol.org/Approaches-and-strategies-for-the-treatment-of-influenza.pdf'],./output/11215168.pdf/citedby/11571009Approaches and strategies for the treatment of influenza virus infections
10.1099/0022-1317-33-1-159,"Xu, J., Davis, C., Christman, M., et. al, Evolutionary History and Phylodynamics of Influenza A and B Neuraminidase (NA) Genes Inferred from Large-Scale Sequence Analyses, PLOS One, 2012",cited-by,10.1371/journal.pone.0038665,Evolutionary History and Phylodynamics of Influenza A and B Neuraminidase (NA) Genes Inferred from Large-Scale Sequence Analyses,"[['Jianpeng', '', 'Xu'], ['C.', 'Todd', 'Davis'], ['Mary', 'C.', 'Christman'], ['Pierre', '', 'Rivailler'], ['Haizhen', '', 'Zhong'], ['Ruben', 'O.', 'Donis'], ['Guoqing', '', 'Lu']]",PLOS One,2012,[u'http://dx.doi.org/10.1371/journal.pone.0038665'],./output/11215168.pdf/citedby/10.1371~journal.pone.0038665
10.1099/0022-1317-33-1-159,"Wang, Z., Li, H., Guo, X., et. al, Growth characteristics of topological insulator Bi 2Se 3 films on different substrates, Journal of Crystal Growth, 2011",cited-by,10.1016/j.jcrysgro.2011.08.029,Growth characteristics of topological insulator Bi 2Se 3 films on different substrates,"[['Z.', 'Y.', 'Wang'], ['H.', 'D.', 'Li'], ['X.', '', 'Guo'], ['W.', 'K.', 'Ho'], ['M.', 'H.', 'Xie']]",Journal of Crystal Growth,2011,[u'http://www.sciencedirect.com/science/article/pii/S0022024811007123'],
10.1099/0022-1317-33-1-159,"Abed, Y., Pizzorno, A., Bouhy, X., et. al, Role of Permissive Neuraminidase Mutations in Influenza A/Brisbane/59/2007-like (H1N1) Viruses, PLOS Pathogens, 2011",cited-by,10.1371/journal.ppat.1002431,Role of Permissive Neuraminidase Mutations in Influenza A/Brisbane/59/2007-like (H1N1) Viruses,"[['Yacine', '', 'Abed'], ['Andr\xc3\xa9s', '', 'Pizzorno'], ['Xavier', '', 'Bouhy'], ['Guy', '', 'Boivin']]",PLOS Pathogens,2011,[u'http://dx.doi.org/10.1371/journal.ppat.1002431'],./output/11215168.pdf/citedby/10.1371~journal.ppat.1002431
10.1099/0022-1317-33-1-159,"Yavarian, J., Mokhtari-Azad, T., Nadji, S., et. al, Analysis of the Hemagglutinin and Neuraminidase Genes of Human Influenza A/H3N2 Viruses Circulating in Iran between 2005 and 2007: Antigenic and Phylogenetic Relationships to Vaccine Strains, Intervirology, 2010",cited-by,10.1159/000273211,Analysis of the Hemagglutinin and Neuraminidase Genes of Human Influenza A/H3N2 Viruses Circulating in Iran between 2005 and 2007: Antigenic and Phylogenetic Relationships to Vaccine Strains,"[['J.', '', 'Yavarian'], ['T.', '', 'Mokhtari-Azad'], ['S.', 'A.', 'Nadji'], ['H.', '', 'Zeraati'], ['M.', '', 'Naseri']]",Intervirology,2010,"[u'http://www.karger.com/doi/10.1159/000273211', u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000273211']",./output/11215168.pdf/citedby/10.1159~000273211
10.1099/0022-1317-33-1-159,"Hashem, A., Flaman, A., Farnsworth, A., et. al, Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases, PLOS One, 2009",cited-by,10.1371/journal.pone.0008350,Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases,"[['Anwar', 'M.', 'Hashem'], ['Anathea', 'S.', 'Flaman'], ['Aaron', '', 'Farnsworth'], ['Earl', 'G.', 'Brown'], ['Gary', 'van', 'Domselaar'], ['Runtao', '', 'He'], ['Xuguang', '', 'Li'], ['Rosemary', 'Jeanne', 'Redfield']]",PLOS One,2009,"[u'http://dx.doi.org/10.1371/journal.pone.0008350', u'http://adsabs.harvard.edu/abs/2009PLoSO...4.8350H']",./output/11215168.pdf/citedby/10.1371~journal.pone.0008350
10.1099/0022-1317-33-1-159,"Thathaisong, U., Kulkeaw, K., Srimanote, P., et. al, Human Monoclonal Single Chain Anti bodies (HuScFv) that Bind to the Poly merase Proteins of Influenza A Virus, , 2008",cited-by,5903142Human Monoclonal Single Chain Anti bodies (HuScFv) that Bind to the Poly merase Proteins of Influenza A Virus,Human Monoclonal Single Chain Anti bodies (HuScFv) that Bind to the Poly merase Proteins of Influenza A Virus,"[['Umaporn', '', 'Thathaisong'], ['Kasem', '', 'Kulkeaw'], ['Potjanee', '', 'Srimanote'], ['Thaweesak', '', 'Songserm'], ['Pongsri', '', 'Tongtawe'], ['Pramuan', '', 'Tapchaisri'], ['Wanpen', '', 'Chaicumpa']]",,2008,[u'http://www.allergythai.org/APJAI2008/March%202008/MS1684%20final2%208May08.pdf'],./output/11215168.pdf/citedby/5903142Human Monoclonal Single Chain Anti bodies (HuScFv) that Bind to the Poly merase Proteins of Influenza A Virus
10.1099/0022-1317-33-1-159,"Ghadiri, M., Kwan, C., Ding, Y., , Chapter 14 Analysis of Milling and the Role of Feed Properties, , 2007",cited-by,10.1016/S0167-3785(07)12017-0,Chapter 14 Analysis of Milling and the Role of Feed Properties,"[['Mojtaba', '', 'Ghadiri'], ['Chih', 'Chi', 'Kwan'], ['Yulong', '', 'Ding']]",,2007,[u'http://www.sciencedirect.com/science/article/pii/S0167378507120170'],
10.1099/0022-1317-33-1-159,"Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737'],
10.1099/0022-1317-33-1-159,"Daubeney, P., Nugent, A., Cheung, M., et. al, Characteristics of children with dilated cardiomyopathy who develop persisting cardiac dysfunction, Heart Lung and Circulation, 2003",cited-by,10.1046/j.1443-9506.2003.03374.x,Characteristics of children with dilated cardiomyopathy who develop persisting cardiac dysfunction,"[['Piers', '', 'Daubeney'], ['Alan', '', 'Nugent'], ['Michael', '', 'Cheung'], ['Patty', '', 'Chondros'], ['Andrew', '', 'Davis'], ['John', '', 'Carlin'], ['Robert', '', 'Weintraub']]",Heart Lung and Circulation,2003,[u'http://www.sciencedirect.com/science/article/pii/S1443950603903374'],
10.1099/0022-1317-33-1-159,"Pleschka, S., Ludwig, S., Wolff, T., et. al, Anti-viral approaches against influenza viruses, , 0",cited-by,10.1007/978-0-387-31047-3_5,Anti-viral approaches against influenza viruses,"[['Stephan', '', 'Pleschka'], ['Stephan', '', 'Ludwig'], ['Thorsten', '', 'Wolff'], ['Oliver', '', 'Planz']]",,0,"[u'http://www.springerlink.com/index/um10454n7482018j.pdf', u'http://www.springerlink.com/content/um10454n7482018j']",./output/11215168.pdf/citedby/10.1007~978-0-387-31047-3_5
10.1099/0022-1317-33-1-159,"Wagner, R., Feldmann, A., Wolff, T., et. al, The Role of Hemagglutinin and Neuraminidase in Influenza Virus Pathogenicity, , 0",cited-by,10.1007/0-306-47650-9_12,The Role of Hemagglutinin and Neuraminidase in Influenza Virus Pathogenicity,"[['Ralf', '', 'Wagner'], ['Anke', '', 'Feldmann'], ['Thorsten', '', 'Wolff'], ['Stephan', '', 'Pleschka'], ['Wolfgang', '', 'Garten'], ['Hans-Dieter', '', 'Klenk']]",,0,"[u'http://www.springerlink.com/content/xg97860r8u060008', u'http://www.springerlink.com/index/xg97860r8u060008.pdf']",./output/11215168.pdf/citedby/10.1007~0-306-47650-9_12
11215168.pdf,"Palese, P., K. Tobita, M. Ueda, and R. W. Compans. 1974. Characterization of temperature sensitive influenza virus mutants. Virology 61:397–410.",references,NOT found in MAS
11215168.pdf,"Potier, M., L. Mameli, M. Be ´lisle, L. Dallaire, and S. B. Melanc ¸on. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl␣-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287–296.",references,NOT found in MAS
11215168.pdf,"Quon, C. Y., K. Mai, G. Patil, and H. F. Stampfli. 1988. Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Drug Metab. Dispos. 16:425–428.",references,NOT found in MAS
11215168.pdf,"Roerig, D. L., K. J. Kotrly, C. A. Dawson, S. B. Ahlf, J. F. Gualtieri, and J. P. Kampine. 1989. First-pass uptake of verapamil, diazepam, and thiopental in 652 LI ET AL. ANTIMICROB. AGENTS CHEMOTHER. on September 2, by UNIVERSITY OF NEW SOUTH WALES http://aac.asm.org/ Downloaded from the human lung. Anesth. Analg. 69:461–466.",references,10.1213/00000539-198910000-00007,"First-Pass Uptake of Verapamil, Diazepam, and Thiopental in the Human Lung","[[u'David', u'L.', u'Roerig'], [u'Karel', u'J.', u'Kotrly'], [u'Christopher', u'A.', u'Dawson'], [u'Susan', u'B.', u'Ahlf'], [u'John', u'F.', u'Gualtieri'], [u'John', u'P.', u'Kampine']]",Anesthesia and Analgesia,1989,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00000539-198910000-00007'],
10.1213/00000539-198910000-00007,"Krejcie, T., Jacquez, J., Avram, M., et. al, Use of parallel erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs, Journal of Pharmacokinetics and Biopharmaceutics, 1996",cited-by,10.1007/BF02353481,Use of parallel erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs,"[['T.', 'C.', 'Krejcie'], ['J.', 'A.', 'Jacquez'], ['M.', 'J.', 'Avram'], ['C.', 'U.', 'Niemann'], ['C.', 'A.', 'Shanks'], ['T.', 'K.', 'Henthorn']]",Journal of Pharmacokinetics and Biopharmaceutics,1996,"[u'http://www.springerlink.com/content/uu07lr583867r658', u'http://www.springerlink.com/index/uu07lr583867r658.pdf', u'http://www.springerlink.com/index/10.1007/BF02353481', u'http://www.springerlink.com/index/pdf/10.1007/BF02353481']",./output/11215168.pdf/citedby/10.1007~BF02353481
10.1213/00000539-198910000-00007,"Upton, R., Doolette, D., , KINETIC ASPECTS OF DRUG DISPOSITION IN THE LUNGS, Clinical and Experimental Pharmacology and Physiology, 1999",cited-by,10.1046/j.1440-1681.1999.03048.x,KINETIC ASPECTS OF DRUG DISPOSITION IN THE LUNGS,"[['Rn', '', 'Upton'], ['Dj', '', 'Doolette']]",Clinical and Experimental Pharmacology and Physiology,1999,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1681.1999.03048.x'],./output/11215168.pdf/citedby/10.1046~j.1440-1681.1999.03048.x
10.1213/00000539-198910000-00007,"Kietzmann, D., Foth, H., Geng, W., et. al, Transpulmonary disposition of prilocaine, mepivacaine, and bupivacaine in humans in the course of epidural anaesthesia, Acta Anaesthesiologica Scandinavica, 1995",cited-by,10.1111/j.1399-6576.1995.tb04192.x,"Transpulmonary disposition of prilocaine, mepivacaine, and bupivacaine in humans in the course of epidural anaesthesia","[['D.', '', 'Kietzmann'], ['H.', '', 'Foth'], ['W.', 'P.', 'Geng'], ['J.', '', 'Rathgeber'], ['U.', '', 'GundertRemy'], ['D.', '', 'Kettler']]",Acta Anaesthesiologica Scandinavica,1995,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1399-6576.1995.tb04192.x'],
10.1213/00000539-198910000-00007,"Huang, Y., Upton, R., Mather, L., et. al, An assessment of methods for sampling blood to characterize rapidly changing blood drug concentrations, Journal of Pharmaceutical Sciences, 1991",cited-by,10.1002/jps.2600800909,An assessment of methods for sampling blood to characterize rapidly changing blood drug concentrations,"[['Yi', 'Fei', 'Huang'], ['Richard', 'N.', 'Upton'], ['Laurence', 'E.', 'Mather'], ['William', 'B.', 'Runciman']]",Journal of Pharmaceutical Sciences,1991,[u'http://doi.wiley.com/10.1002/jps.2600800909'],./output/11215168.pdf/citedby/10.1002~jps.2600800909
10.1213/00000539-198910000-00007,"Upton, R., Runciman, W., Mather, L., , Regional pharmacokinetics II. Experimental methods, Biopharmaceutics & Drug Disposition, 1990",cited-by,10.1002/bdd.2510110902,Regional pharmacokinetics II. Experimental methods,"[['Richard', 'N.', 'Upton'], ['William', 'B.', 'Runciman'], ['Laurence', 'E.', 'Mather']]",Biopharmaceutics & Drug Disposition,1990,[u'http://doi.wiley.com/10.1002/bdd.2510110902'],./output/11215168.pdf/citedby/10.1002~bdd.2510110902
10.1213/00000539-198910000-00007,"Wet, C., Moss, J., , METABOLIC FUNCTIONS OF THE LUNG, Anesthesiology Clinics of North America, 1998",cited-by,10.1016/S0889-8537(05)70013-4,METABOLIC FUNCTIONS OF THE LUNG,"[['Charl', 'de', 'Wet'], ['Jonathan', '', 'Moss']]",Anesthesiology Clinics of North America,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0889853705700134', u'http://linkinghub.elsevier.com/retrieve/pii/S0889853705700134']",./output/11215168.pdf/citedby/10.1016~S0889-8537(05)70013-4
10.1213/00000539-198910000-00007,"Ludbrook, G., Upton, R., Grant, C., et. al, A Compartmental Analysis of the Pharmacokinetics of Propofol in Sheep, Journal of Pharmacokinetics and Pharmacodynamics, 1999",cited-by,10.1023/A:1020903315017,A Compartmental Analysis of the Pharmacokinetics of Propofol in Sheep,"[['Guy', 'L.', 'Ludbrook'], ['Richard', 'N.', 'Upton'], ['Cliff', '', 'Grant'], ['Alison', '', 'Martinez']]",Journal of Pharmacokinetics and Pharmacodynamics,1999,"[u'http://www.springerlink.com/index/g12900k52r008832.pdf', u'http://www.springerlink.com/content/g12900k52r008832']",./output/11215168.pdf/citedby/10.1023~A:1020903315017
10.1213/00000539-198910000-00007,"Weiss, M., , Errors in Clearance Estimation After Bolus Injection and Arterial Sampling: Nonexistence of a Central Compartment, Journal of Pharmacokinetics and Pharmacodynamics, 1997",cited-by,10.1023/A:1025788214777,Errors in Clearance Estimation After Bolus Injection and Arterial Sampling: Nonexistence of a Central Compartment,"[['Michael', '', 'Weiss']]",Journal of Pharmacokinetics and Pharmacodynamics,1997,"[u'http://www.springerlink.com/content/p3656202w0q766r5', u'http://www.springerlink.com/index/p3656202w0q766r5.pdf']",./output/11215168.pdf/citedby/10.1023~A:1025788214777
10.1213/00000539-198910000-00007,"Banks, H., Holm, K., Wanner, N., et. al, A mathematical model for the first-pass dynamics of antibiotics acting on the cardiovascular system, Mathematical and Computer Modelling, 2009",cited-by,10.1016/j.mcm.2009.02.007,A mathematical model for the first-pass dynamics of antibiotics acting on the cardiovascular system,"[['H.', 'T.', 'Banks'], ['Kathleen', '', 'Holm'], ['Nathan', 'C.', 'Wanner'], ['Ariel', '', 'Cintr\xc3\xb3n-Arias'], ['Grace', 'M.', 'Kepler'], ['Jeffrey', 'D.', 'Wetherington']]",Mathematical and Computer Modelling,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0895717709000703', u'http://faculty.etsu.edu/cintronarias/my_pblctns/banks_holm09.pdf', u'http://www.ncsu.edu/crsc/reports/ftp/pdf/crsc-tr08-25.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0895717709000703', u'http://dx.doi.org/10.1016/j.mcm.2009.02.007', u'http://www.informatik.uni-trier.de/~ley/db/journals/mcm/mcm50.html#BanksHWCKW09']",./output/11215168.pdf/citedby/10.1016~j.mcm.2009.02.007
10.1213/00000539-198910000-00007,"Shahiwala, A., Misra, A., , Pulmonary absorption of liposomal levonorgestrel, Aaps Pharmscitech, 2004",cited-by,10.1007/BF02830581,Pulmonary absorption of liposomal levonorgestrel,"[['Aliasgar', '', 'Shahiwala'], ['Ambikanandan', '', 'Misra']]",Aaps Pharmscitech,2004,[u'http://www.springerlink.com/index/10.1007/BF02830581'],./output/11215168.pdf/citedby/10.1007~BF02830581
10.1213/00000539-198910000-00007,"Huang, Y., Upton, R., , An estimate of the rate of direct drug diffusion from the surface of heart and kidney—implications for their representation as compartments, Biopharmaceutics & Drug Disposition, 1993",cited-by,10.1002/bdd.2510140802,An estimate of the rate of direct drug diffusion from the surface of heart and kidney—implications for their representation as compartments,"[['Yi', 'Fei', 'Huang'], ['Richard', 'N.', 'Upton']]",Biopharmaceutics & Drug Disposition,1993,[u'http://doi.wiley.com/10.1002/bdd.2510140802'],./output/11215168.pdf/citedby/10.1002~bdd.2510140802
11215168.pdf,"Ryan, D. M., J. Ticehurst, and M. H. Dempsey. 1995. GG167 (4-guanidino2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets. Antimicrob. Agents Chemother. 39:2583–2584.",references,"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","[[u'D.', u'MICHAEL', u'RYAN'], [u'JULIA', u'', u'TICEHURST'], [u'ANDMARIA', u'H.', u'DEMPSEY'], [u'Glaxo', u'', u'Wellcome']]",,1995,"[u'http://aac.asm.org/cgi/reprint/39/11/2583.pdf', u'http://aac.highwire.org/cgi/reprint/39/11/2583.pdf']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']","./output/11215168.pdf/citedby/13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008"
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Kelm, S., Schauer, R., , Sialic Acids in Molecular and Cellular Interactions, International Review of Cytology-a Survey of Cell Biology, 1997",cited-by,10.1016/S0074-7696(08)62127-0,Sialic Acids in Molecular and Cellular Interactions,"[['S\xc3\xb8rge', '', 'Kelm'], ['Roland', '', 'Schauer']]",International Review of Cytology-a Survey of Cell Biology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0074769608621270', u'http://linkinghub.elsevier.com/retrieve/pii/S0074769608621270']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","GUBAREVA, L., ROBINSON, M., BETHELL, R., et. al, Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en, , 1997",cited-by,13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"[['LARISA', 'V.', 'GUBAREVA'], ['MATTHEW', 'J.', 'ROBINSON'], ['RICHARD', 'C.', 'BETHELL'], ['ANDROBERT', 'G.', 'WEBSTER']]",,1997,[u'http://jvi.asm.org/cgi/reprint/71/5/3385.pdf'],
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/11215168.pdf/citedby/7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf'],./output/11215168.pdf/citedby/11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Barnett, J., Lewis, A., Cadman, A., et. al, Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies, Antimicrobial Agents and Chemotherapy, 2000",cited-by,10.1128/AAC.44.1.78-87.2000,Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies,"[['J.', 'M.', 'Barnett'], ['A.', 'P.', 'Lewis'], ['A.', '', 'Cadman'], ['D.', '', 'Gor'], ['M.', '', 'Dempsey'], ['M.', '', 'Walters'], ['A.', '', 'Candlin'], ['M.', '', 'Tisdale'], ['Groot', 'de', 'R'], ['P.', 'J.', 'Morley'], ['I.', 'J.', 'Owens'], ['G.', 'F.', 'Rimmelzwaan'], ['R.', 'J.', 'Fenton'], ['E.', 'C. J.', 'Claas'], ['A.', 'D. M. E.', 'Osterhaus']]",Antimicrobial Agents and Chemotherapy,2000,"[u'http://aac.asm.org/cgi/reprint/44/1/78.pdf', u'http://publishing.eur.nl/ir/repub/asset/9217/10602727.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.44.1.78-87.2000']",./output/11215168.pdf/citedby/10.1128~AAC.44.1.78-87.2000
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Sidwell, R., Huffman, J., Barnard, D., et. al, Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor, Antiviral Research, 1998",cited-by,10.1016/S0166-3542(97)00065-X,"Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor","[['Robert', 'W.', 'Sidwell'], ['John', 'H.', 'Huffman'], ['Dale', 'L.', 'Barnard'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Ann', '', 'Morrison'], ['Timothy', '', 'Syndergaard'], ['Choung', 'U.', 'Kim']]",Antiviral Research,1998,"[u'http://www.sciencedirect.com/science/article/pii/S016635429700065X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635429700065X']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Morris, S., Price, G., Barnett, J., et. al, Role of neuraminidase in influenza virus-induced apoptosis, , 1999",cited-by,6297657Role of neuraminidase in influenza virus-induced apoptosis,Role of neuraminidase in influenza virus-induced apoptosis,"[['Susan', 'J.', 'Morris'], ['Graeme', 'E.', 'Price'], ['Jacqueline', 'M.', 'Barnett'], ['Steven', 'A.', 'Hiscox'], ['Harry', '', 'Smith'], ['Clive', '', 'Sweet']]",,1999,[u'http://vir.sgmjournals.org/cgi/reprint/80/1/137.pdf'],./output/11215168.pdf/citedby/6297657Role of neuraminidase in influenza virus-induced apoptosis
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Bantia, S., Parker, C., Ananth, S., et. al, Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1162-1167.2001,Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir,"[['S.', '', 'Bantia'], ['C.', 'D.', 'Parker'], ['S.', 'L.', 'Ananth'], ['L.', 'L.', 'Horn'], ['K.', '', 'Andries'], ['P.', '', 'Chand'], ['P.', 'L.', 'Kotian'], ['A.', '', 'Dehghani'], ['Y.', '', 'El-Kattan'], ['T.', '', 'Lin'], ['T.', 'L.', 'Hutchison'], ['J.', 'A.', 'Montgomery'], ['D.', 'L.', 'Kellog'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://faculty.tamu-commerce.edu/fmiskevich/Bsc-597MAMB/Bantia-%20anti-influenza%20drug%20design.pdf', u'http://aac.asm.org/cgi/reprint/45/4/1162.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1162-1167.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.4.1162-1167.2001
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Baigent, S., Bethell, R., McCauley, J., , Genetic Analysis Reveals That Both Haemagglutinin and Neuraminidase Determine the Sensitivity of Naturally Occurring Avian Influenza Viruses to Zanamivir in Vitro, Virology, 1999",cited-by,10.1006/viro.1999.9931,Genetic Analysis Reveals That Both Haemagglutinin and Neuraminidase Determine the Sensitivity of Naturally Occurring Avian Influenza Viruses to Zanamivir in Vitro,"[['S.', 'J.', 'Baigent'], ['R.', 'C.', 'Bethell'], ['J.', 'W.', 'McCauley']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299999312', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299999312']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","CASS, L., GUNAWARDENA, K., MACMAHON, M., et. al, Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir, Respiratory Medicine, 2000",cited-by,10.1053/rmed.1999.0718,Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir,"[['L.', 'M. R.', 'CASS'], ['K.', 'A.', 'GUNAWARDENA'], ['M.', 'M.', 'MACMAHON'], ['A.', '', 'BYE']]",Respiratory Medicine,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0954611199907187', u'http://linkinghub.elsevier.com/retrieve/pii/S0954611199907187']",./output/11215168.pdf/citedby/10.1053~rmed.1999.0718
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","FENTON, R., MORLEY, P., OWENS, I., et. al, Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract, , 1999",cited-by,"14046363Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract","Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract","[['ROBERT', 'J.', 'FENTON'], ['PETER', 'J.', 'MORLEY'], ['IAN', 'J.', 'OWENS'], ['DAVID', '', 'GOWER'], ['SIMON', '', 'PARRY'], ['LEE', '', 'CROSSMAN'], ['TONY', '', 'WONG'], ['Glaxo', '', 'Wellcome']]",,1999,[u'http://aac.asm.org/cgi/reprint/43/11/2642.pdf'],
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Romanova, J., Katinger, D., Ferko, B., et. al, Live cold-adapted influenza A vaccine produced in Vero cell line, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.02.032,Live cold-adapted influenza A vaccine produced in Vero cell line,"[['Julia', '', 'Romanova'], ['Dietmar', '', 'Katinger'], ['Boris', '', 'Ferko'], ['Brigitta', '', 'Vcelar'], ['Sabine', '', 'Sereinig'], ['Oleg', '', 'Kuznetsov'], ['Marina', '', 'Stukova'], ['Marjana', '', 'Erofeeva'], ['Oleg', '', 'Kiselev'], ['Hermann', '', 'Katinger'], ['Andrej', '', 'Egorov']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204001315', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001315']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Itzstein, M., Thomson, R., , Anti-Influenza Drugs: The Development of Sialidase Inhibitors, , 0",cited-by,10.1007/978-3-540-79086-0_5,Anti-Influenza Drugs: The Development of Sialidase Inhibitors,"[['Mark', 'von', 'Itzstein'], ['Robin', '', 'Thomson']]",,0,"[u'http://www.springerlink.com/index/q7q766196t171341.pdf', u'http://www.springerlink.com/content/q7q766196t171341']",./output/11215168.pdf/citedby/10.1007~978-3-540-79086-0_5
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Peng, A., Hussey, E., Rosolowski, B., et. al, Pharmacokinetics and tolerability of a single inhaled dose of zanamivir in children, Current Therapeutic Research-clinical and Experimental, 2000",cited-by,10.1016/S0011-393X(00)88495-7,Pharmacokinetics and tolerability of a single inhaled dose of zanamivir in children,"[['Amy', 'W.', 'Peng'], ['Elizabeth', 'K.', 'Hussey'], ['Bonnie', '', 'Rosolowski'], ['Jeffrey', 'L.', 'Blumer']]",Current Therapeutic Research-clinical and Experimental,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0011393X00884957', u'http://linkinghub.elsevier.com/retrieve/pii/S0011393X00884957']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Wyde, P., , Chemotherapy of respiratory viruses: prospects and challenges, Drug Resistance Updates, 1999",cited-by,10.1054/drup.1999.0091,Chemotherapy of respiratory viruses: prospects and challenges,"[['Philip', 'R.', 'Wyde']]",Drug Resistance Updates,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1368764699900912', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764699900912']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Jong, M., Boucher, C., Cooper, D., et. al, Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies, Antiviral Research, 1997",cited-by,10.1016/S0166-3542(97)00020-X,Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies,"[['Menno', 'D. de', 'Jong'], ['Charles', 'A. B.', 'Boucher'], ['David', 'A.', 'Cooper'], ['George', 'J.', 'Galasso'], ['Brian', '', 'Gazzard'], ['Joep', 'M. A.', 'Lange'], ['Julio', 'S.', 'Montaner'], ['Douglas', 'D.', 'Richman'], ['Howard', 'C.', 'Thomas']]",Antiviral Research,1997,"[u'http://www.sciencedirect.com/science/article/pii/S016635429700020X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635429700020X']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","WERLING, D., , The clinical significance of sialoderiveratives in the search for novel means of antipathogen therapy, Equine Veterinary Journal, 2010",cited-by,10.2746/042516406778400600,The clinical significance of sialoderiveratives in the search for novel means of antipathogen therapy,"[['D.', '', 'WERLING']]",Equine Veterinary Journal,2010,"[u'http://blackwell-synergy.com/doi/abs/10.2746/042516406778400600', u'http://www.ingentaconnect.com/content/evj/evj/2006/00000038/00000005/art00002']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Sidwell, R., , A consideration of animal models used for study of influenza virus inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00388-0,A consideration of animal models used for study of influenza virus inhibitors,"[['Robert', 'W', 'Sidwell']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003880', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003880']",
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Colacino, J., Staschke, K., Laver, W., , Approaches and strategies for the treatment of influenza virus infections, , 0",cited-by,11571009Approaches and strategies for the treatment of influenza virus infections,Approaches and strategies for the treatment of influenza virus infections,"[['Joseph', 'M', 'Colacino'], ['Kirk', 'A', 'Staschke'], ['W', 'Graeme', 'Laver']]",,0,[u'http://arbidol.org/Approaches-and-strategies-for-the-treatment-of-influenza.pdf'],./output/11215168.pdf/citedby/11571009Approaches and strategies for the treatment of influenza virus infections
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737'],
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Leitzke, S., , Die Therapie der Influenza mit Neuraminidase-Inhibitoren, Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz, 1999",cited-by,10.1007/s001030050275,Die Therapie der Influenza mit Neuraminidase-Inhibitoren,"[['S.', '', 'Leitzke']]",Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz,1999,"[u'http://www.springerlink.com/content/aubc4t0cmtk1megk', u'http://www.springerlink.com/index/aubc4t0cmtk1megk.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s001030050275', u'http://www.springerlink.com/index/pdf/10.1007/s001030050275']",./output/11215168.pdf/citedby/10.1007~s001030050275
"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","Nishida, S., Sato, T., , Two mechanisms for motion perception in the human visual system, , 1992",cited-by,10.1109/ROMAN.1992.253872,Two mechanisms for motion perception in the human visual system,"[['S.', '', 'Nishida'], ['T.', '', 'Sato']]",,1992,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=253872', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00253872']",./output/11215168.pdf/citedby/10.1109~ROMAN.1992.253872
11215168.pdf,"Ryan, D. M., J. Ticehurst, M. H. Dempsey, and C. R. Penn. 1994. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob. Agents Chemother. 38:2270– 2275.",references,NOT found in MAS
11215168.pdf,"Sidwell, R. W., J. H. Huffman, D. L. Barnard, K. W. Bailey, M.-H. Wong, A. Morrison, T. Syndergaard, and C. U. Kim. 1997. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Antiviral Res., in press.",references,10.1016/S0166-3542(97)00065-X,"Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor","[[u'Robert', u'W.', u'Sidwell'], [u'John', u'H.', u'Huffman'], [u'Dale', u'L.', u'Barnard'], [u'Kevin', u'W.', u'Bailey'], [u'Min-Hui', u'', u'Wong'], [u'Ann', u'', u'Morrison'], [u'Timothy', u'', u'Syndergaard'], [u'Choung', u'U.', u'Kim']]",Antiviral Research,1998,"[u'http://www.sciencedirect.com/science/article/pii/S016635429700065X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635429700065X']",
10.1016/S0166-3542(97)00065-X,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']","./output/11215168.pdf/citedby/13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008"
10.1016/S0166-3542(97)00065-X,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']",
10.1016/S0166-3542(97)00065-X,"Suzuki, Y., , Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza Viruses, Biological & Pharmaceutical Bulletin, 2005",cited-by,10.1248/bpb.28.399,Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza Viruses,"[['Yasuo', '', 'Suzuki']]",Biological & Pharmaceutical Bulletin,2005,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/28.399?from=CrossRef'],./output/11215168.pdf/citedby/10.1248~bpb.28.399
10.1016/S0166-3542(97)00065-X,"GOVORKOVA, E., LENEVA, I., GOLOUBEVA, O., et. al, Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.10.2723-2732.2001,"Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses","[['ELENA', 'A.', 'GOVORKOVA'], ['IRINA', 'A.', 'LENEVA'], ['OLGA', 'G.', 'GOLOUBEVA'], ['KAREN', '', 'BUSH'], ['ROBERT', 'G.', 'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/10/2723.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.10.2723-2732.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.10.2723-2732.2001
10.1016/S0166-3542(97)00065-X,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],
10.1016/S0166-3542(97)00065-X,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf'],./output/11215168.pdf/citedby/11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071
10.1016/S0166-3542(97)00065-X,"Zambon, M., Hayden, F., , Position statement: global neuraminidase inhibitor susceptibility network, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00124-3,Position statement: global neuraminidase inhibitor susceptibility network,"[['Maria', '', 'Zambon'], ['Frederick', 'G.', 'Hayden']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001243', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001243']",
10.1016/S0166-3542(97)00065-X,"SMEE, D., HUFFMAN, J., MORRISON, A., et. al, Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.743-748.2001,Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities,"[['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['ANN', 'C.', 'MORRISON'], ['DALE', 'L.', 'BARNARD'], ['ROBERT', 'W.', 'SIDWELL']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://journals.pasteur.ac.ir/AAC01/45(3)/743.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.743-748.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.3.743-748.2001
10.1016/S0166-3542(97)00065-X,"Bantia, S., Parker, C., Ananth, S., et. al, Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1162-1167.2001,Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir,"[['S.', '', 'Bantia'], ['C.', 'D.', 'Parker'], ['S.', 'L.', 'Ananth'], ['L.', 'L.', 'Horn'], ['K.', '', 'Andries'], ['P.', '', 'Chand'], ['P.', 'L.', 'Kotian'], ['A.', '', 'Dehghani'], ['Y.', '', 'El-Kattan'], ['T.', '', 'Lin'], ['T.', 'L.', 'Hutchison'], ['J.', 'A.', 'Montgomery'], ['D.', 'L.', 'Kellog'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://faculty.tamu-commerce.edu/fmiskevich/Bsc-597MAMB/Bantia-%20anti-influenza%20drug%20design.pdf', u'http://aac.asm.org/cgi/reprint/45/4/1162.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1162-1167.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.4.1162-1167.2001
10.1016/S0166-3542(97)00065-X,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.1016/S0166-3542(97)00065-X,"Smee, D., Bailey, K., Wong, M., et. al, Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00159-0,Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice,"[['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Robert', 'W.', 'Sidwell']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001590', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001590']",
10.1016/S0166-3542(97)00065-X,"Leneva, I., Roberts, N., Govorkova, E., et. al, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00123-6,The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses,"[['Irina', 'A.', 'Leneva'], ['Noel', '', 'Roberts'], ['Elena', 'A.', 'Govorkova'], ['Olga', 'G.', 'Goloubeva'], ['Robert', 'G.', 'Webster']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001236', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001236']",
10.1016/S0166-3542(97)00065-X,"NOYOLA, D., CLARK, B., O'DONNELL, F., et. al, Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens, , 2000",cited-by,"13918606Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","[['DANIEL', 'E.', 'NOYOLA'], ['BRUCE', '', 'CLARK'], ['FREDERICK', 'T.', ""O'DONNELL""], ['ROBERT', 'L.', 'ATMAR'], ['JEWEL', '', 'GREER'], ['GAIL', 'J.', 'DEMMLER']]",,2000,[u'http://jcm.asm.org/cgi/reprint/38/3/1161.pdf'],
10.1016/S0166-3542(97)00065-X,"Govorkova, E., Fang, H., Tan, M., et. al, Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4855-4863.2004,Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells,"[['Elena', 'A.', 'Govorkova'], ['Hong-Bin', '', 'Fang'], ['Ming', '', 'Tan'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4855.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4855-4863.2004']",./output/11215168.pdf/citedby/10.1128~AAC.48.12.4855-4863.2004
10.1016/S0166-3542(97)00065-X,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']",
10.1016/S0166-3542(97)00065-X,"Sidwell, R., Barnard, D., Day, C., et. al, Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01051-06,Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice,"[['Robert', 'W.', 'Sidwell'], ['Dale', 'L.', 'Barnard'], ['Craig', 'W.', 'Day'], ['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['John', 'D.', 'Morrey'], ['Yousuke', '', 'Furuta']]",Antimicrobial Agents and Chemotherapy,2007,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.01051-06'],./output/11215168.pdf/citedby/10.1128~AAC.01051-06
10.1016/S0166-3542(97)00065-X,"Sidwell, R., Bailey, K., Wong, M., et. al, In vitro and in vivo influenza virus-inhibitory effects of viramidine, Antiviral Research, 2005",cited-by,10.1016/j.antiviral.2005.06.003,In vitro and in vivo influenza virus-inhibitory effects of viramidine,"[['Robert', 'W.', 'Sidwell'], ['K.', 'W.', 'Bailey'], ['M.-H.', '', 'Wong'], ['D.', 'L.', 'Barnard'], ['D.', 'F.', 'Smee']]",Antiviral Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S016635420500121X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420500121X']",
10.1016/S0166-3542(97)00065-X,"SIDWELL, R., SMEE, D., HUFFMAN, J., et. al, In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.749-757.2001,In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201,"[['ROBERT', 'W.', 'SIDWELL'], ['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['DALE', 'L.', 'BARNARD'], ['KEVIN', 'W.', 'BAILEY'], ['JOHN', 'D.', 'MORREY'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/3/749.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.749-757.2001']",./output/11215168.pdf/citedby/10.1128~AAC.45.3.749-757.2001
10.1016/S0166-3542(97)00065-X,"Kawai, N., Ikematsu, H., Iwaki, N., et. al, A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003–2004 and 2004–2005 Influenza Seasons, Clinical Infectious Diseases, 2006",cited-by,10.1086/505868,A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003–2004 and 2004–2005 Influenza Seasons,"[['Naoki', '', 'Kawai'], ['Hideyuki', '', 'Ikematsu'], ['Norio', '', 'Iwaki'], ['Tetsunari', '', 'Maeda'], ['Ietaka', '', 'Satoh'], ['Nobuo', '', 'Hirotsu'], ['Seizaburo', '', 'Kashiwagi']]",Clinical Infectious Diseases,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/505868'],./output/11215168.pdf/citedby/10.1086~505868
10.1016/S0166-3542(97)00065-X,"Kawai, N., Ikematsu, H., Iwaki, N., et. al, Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002–2003 Influenza Season, Clinical Infectious Diseases, 2005",cited-by,10.1086/429241,Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002–2003 Influenza Season,"[['Naoki', '', 'Kawai'], ['Hideyuki', '', 'Ikematsu'], ['Norio', '', 'Iwaki'], ['Ietaka', '', 'Satoh'], ['Takashi', '', 'Kawashima'], ['Tetsunari', '', 'Maeda'], ['Kiyomitsu', '', 'Miyachi'], ['Nobuo', '', 'Hirotsu'], ['Takeshi', '', 'Shigematsu'], ['Seizaburo', '', 'Kashiwagi']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/429241'],./output/11215168.pdf/citedby/10.1086~429241
10.1016/S0166-3542(97)00065-X,"Molla, A., Kati, W., Carrick, R., et. al, In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675, Journal of Virology, 2002",cited-by,10.1128/JVI.76.11.5380-5386.2002,"In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675","[['Akhteruzzaman', '', 'Molla'], ['Warren', '', 'Kati'], ['Robert', '', 'Carrick'], ['Kevin', '', 'Steffy'], ['Yan', '', 'Shi'], ['Debra', '', 'Montgomery'], ['Nanette', '', 'Gusick'], ['Vincent', 'S.', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['Teresa', 'I.', 'Ng'], ['Clarence', '', 'Maring'], ['Dale', 'J.', 'Kempf'], ['William', '', 'Kohlbrenner']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/11/5380.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.11.5380-5386.2002']",./output/11215168.pdf/citedby/10.1128~JVI.76.11.5380-5386.2002
10.1016/S0166-3542(97)00065-X,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf'],./output/11215168.pdf/citedby/6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts
10.1016/S0166-3542(97)00065-X,"Aoki, F., Doucette, K., , Oseltamivir: a clinical and pharmacological perspective, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.10.1671,Oseltamivir: a clinical and pharmacological perspective,"[['Fred', 'Y', 'Aoki'], ['Karen', 'E', 'Doucette']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.10.1671'],./output/11215168.pdf/citedby/10.1517~14656566.2.10.1671
10.1016/S0166-3542(97)00065-X,"Lu, X., Jin, X., Lee, A., et. al, DAS181, A Novel Sialidase Fusion Protein, Protects Mice from Lethal Avian Influenza H5N1 Virus Infection, Journal of Infectious Diseases, 2007",cited-by,10.1086/522609,"DAS181, A Novel Sialidase Fusion Protein, Protects Mice from Lethal Avian Influenza H5N1 Virus Infection","[['Xiuhua', '', 'Lu'], ['Xiaoping', '', 'Jin'], ['Alice', '', 'Lee'], ['Stephen', '', 'Hawley'], ['Mang', '', 'Yu'], ['Fang', '', 'Fang']]",Journal of Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/522609'],./output/11215168.pdf/citedby/10.1086~522609
10.1016/S0166-3542(97)00065-X,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']",
10.1016/S0166-3542(97)00065-X,"Jackson, D., Barclay, W., Zurcher, T., , Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations, , 2005",cited-by,6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,"[['David', '', 'Jackson'], ['Wendy', '', 'Barclay'], ['Thomas', '', 'Zurcher']]",,2005,[u'http://jac.oxfordjournals.org/cgi/reprint/55/2/162.pdf'],./output/11215168.pdf/citedby/6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations
10.1016/S0166-3542(97)00065-X,"Boltz, D., Ilyushina, N., Arnold, C., et. al, Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice, Antiviral Research, 2008",cited-by,10.1016/j.antiviral.2008.05.012,Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice,"[['David', 'A.', 'Boltz'], ['Natalia', 'A.', 'Ilyushina'], ['C.', 'Shane', 'Arnold'], ['Y.', 'Sudhakar', 'Babu'], ['Robert', 'G.', 'Webster'], ['Elena', 'A.', 'Govorkova']]",Antiviral Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208003185', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208003185']",
10.1016/S0166-3542(97)00065-X,"Sidwell, R., Smee, D., Huffman, J., et. al, Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00149-8,"Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201","[['Robert', 'W', 'Sidwell'], ['Donald', 'F', 'Smee'], ['John', 'H', 'Huffman'], ['Dale', 'L', 'Barnard'], ['John', 'D', 'Morrey'], ['Kevin', 'W', 'Bailey'], ['W.-C', '', 'Feng'], ['Y.', 'S', 'Babu'], ['Karen', '', 'Bush']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001498', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001498']",
10.1016/S0166-3542(97)00065-X,"FENTON, R., MORLEY, P., OWENS, I., et. al, Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract, , 1999",cited-by,"14046363Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract","Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract","[['ROBERT', 'J.', 'FENTON'], ['PETER', 'J.', 'MORLEY'], ['IAN', 'J.', 'OWENS'], ['DAVID', '', 'GOWER'], ['SIMON', '', 'PARRY'], ['LEE', '', 'CROSSMAN'], ['TONY', '', 'WONG'], ['Glaxo', '', 'Wellcome']]",,1999,[u'http://aac.asm.org/cgi/reprint/43/11/2642.pdf'],
10.1016/S0166-3542(97)00065-X,"Barrera, C., Reyes-Terán, G., , Influenza: Forecast for a Pandemic, Archives of Medical Research, 2005",cited-by,10.1016/j.arcmed.2005.05.002,Influenza: Forecast for a Pandemic,"[['Claudia', 'Alvarado de la', 'Barrera'], ['Gustavo', '', 'Reyes-Ter\xc3\xa1n']]",Archives of Medical Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0188440905001876', u'http://linkinghub.elsevier.com/retrieve/pii/S0188440905001876']",
10.1016/S0166-3542(97)00065-X,"Reyes-Teran, G., , Influenza: Forecast for a Pandemic, , 2005",cited-by,5508018Influenza: Forecast for a Pandemic,Influenza: Forecast for a Pandemic,"[['Gustavo', '', 'Reyes-Teran']]",,2005,"[u'http://birdflubook.com/resources/0barrera628.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-32.pdf']",./output/11215168.pdf/citedby/5508018Influenza: Forecast for a Pandemic
10.1016/S0166-3542(97)00065-X,"Hidari, K., Tsujii, E., Hiroi, J., et. al, In Vitro and in Vivo Inhibitory Effects of Disodium Cromoglycate on Influenza Virus Infection, Biological & Pharmaceutical Bulletin, 2004",cited-by,10.1248/bpb.27.825,In Vitro and in Vivo Inhibitory Effects of Disodium Cromoglycate on Influenza Virus Infection,"[['Kazuya', 'I. P. J.', 'Hidari'], ['Eisaku', '', 'Tsujii'], ['Jun', '', 'Hiroi'], ['Eriko', '', 'Mano'], ['Akihiko', '', 'Miyatake'], ['Daisei', '', 'Miyamoto'], ['Takashi', '', 'Suzuki'], ['Yasuo', '', 'Suzuki']]",Biological & Pharmaceutical Bulletin,2004,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/27.825?from=CrossRef'],./output/11215168.pdf/citedby/10.1248~bpb.27.825
10.1016/S0166-3542(97)00065-X,"Hidari, K., Murata, T., Yoshida, K., et. al, Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection, Glycobiology, 2008",cited-by,10.1093/glycob/cwn067,"Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection","[['Kazuya', 'I P J', 'Hidari'], ['Takeomi', '', 'Murata'], ['Kazuhiro', '', 'Yoshida'], ['Yoshiharu', '', 'Takahashi'], ['Yo-hei', '', 'Minamijima'], ['Yoshinobu', '', 'Miwa'], ['Satoshi', '', 'Adachi'], ['Makoto', '', 'Ogata'], ['Taiichi', '', 'Usui'], ['Yasuo', '', 'Suzuki'], ['Takashi', '', 'Suzuki']]",Glycobiology,2008,"[u'http://glycob.oxfordjournals.org/cgi/reprint/18/10/779.pdf', u'http://www.glycob.oxfordjournals.org/cgi/doi/10.1093/glycob/cwn067']",./output/11215168.pdf/citedby/10.1093~glycob~cwn067
10.1016/S0166-3542(97)00065-X,"Whitley, R., , The role of oseltamivir in the treatment and prevention of influenza in children, Expert Opinion on Drug Metabolism & Toxicology, 2007",cited-by,10.1517/17425225.3.5.755,The role of oseltamivir in the treatment and prevention of influenza in children,"[['Richard', 'J', 'Whitley']]",Expert Opinion on Drug Metabolism & Toxicology,2007,[u'http://www.expertopin.com/doi/abs/10.1517/17425225.3.5.755'],./output/11215168.pdf/citedby/10.1517~17425225.3.5.755
10.1016/S0166-3542(97)00065-X,"Liu, J., Mei, W., Xu, A., et. al, Synthesis, characterization and antiviral activity against influenza virus of a series of novel manganese-substituted rare earth borotungstates heteropolyoxometalates, Antiviral Research, 2004",cited-by,10.1016/j.antiviral.2003.12.004,"Synthesis, characterization and antiviral activity against influenza virus of a series of novel manganese-substituted rare earth borotungstates heteropolyoxometalates","[['Jie', '', 'Liu'], ['Wen-Jie', '', 'Mei'], ['An-Wu', '', 'Xu'], ['Cai-Ping', '', 'Tan'], ['Shuo', '', 'Shi'], ['Liang-Nian', '', 'Ji']]",Antiviral Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0166354203003000', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354203003000']",
10.1016/S0166-3542(97)00065-X,"Smee, D., Bailey, K., Sidwell, R., , Comparative Effects of Cidofovir and Cyclic HPMPC on Lethal Cowpox and Vaccinia Virus Respiratory Infections in Mice, Chemotherapy, 2003",cited-by,10.1159/000070618,Comparative Effects of Cidofovir and Cyclic HPMPC on Lethal Cowpox and Vaccinia Virus Respiratory Infections in Mice,"[['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Robert', 'W.', 'Sidwell']]",Chemotherapy,2003,"[u'http://www.karger.com/doi/10.1159/000070618', u'http://www.online.karger.com/doi/10.1159/000070618']",./output/11215168.pdf/citedby/10.1159~000070618
10.1016/S0166-3542(97)00065-X,"Miyamoto, D., Hasegawa, S., Sriwilaijaroen, N., et. al, Clarithromycin Inhibits Progeny Virus Production from Human Influenza Virus-Infected Host Cells, Biological & Pharmaceutical Bulletin, 2008",cited-by,10.1248/bpb.31.217,Clarithromycin Inhibits Progeny Virus Production from Human Influenza Virus-Infected Host Cells,"[['Daisei', '', 'Miyamoto'], ['Sayaka', '', 'Hasegawa'], ['Nongluk', '', 'Sriwilaijaroen'], ['Sangchai', '', 'Yingsakmongkon'], ['Hiroaki', '', 'Hiramatsu'], ['Tadanobu', '', 'Takahashi'], ['Kazuya', '', 'Hidari'], ['Chao-Tan', '', 'Guo'], ['Yuichi', '', 'Sakano'], ['Takashi', '', 'Suzuki'], ['Yasuo', '', 'Suzuki']]",Biological & Pharmaceutical Bulletin,2008,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/31.217?from=CrossRef'],./output/11215168.pdf/citedby/10.1248~bpb.31.217
10.1016/S0166-3542(97)00065-X,"Ono, H., Nagano, Y., Matsunami, N., et. al, Oseltamivir, an Anti-influenza Virus Drug, Produces Hypothermia in Mice, Biological & Pharmaceutical Bulletin, 2008",cited-by,10.1248/bpb.31.638,"Oseltamivir, an Anti-influenza Virus Drug, Produces Hypothermia in Mice","[['Hideki', '', 'Ono'], ['Yuko', '', 'Nagano'], ['Noriaki', '', 'Matsunami'], ['Shinichi', '', 'Sugiyama'], ['Shohei', '', 'Yamamoto'], ['Mitsuo', '', 'Tanabe']]",Biological & Pharmaceutical Bulletin,2008,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/31.638?from=CrossRef'],./output/11215168.pdf/citedby/10.1248~bpb.31.638
10.1016/S0166-3542(97)00065-X,"Pu, X., Liang, J., Wang, X., et. al, Anti-influenza A virus effect of Hypericum perforatum L. extract, Virologica Sinica, 2009",cited-by,10.1007/s12250-009-2983-x,Anti-influenza A virus effect of Hypericum perforatum L. extract,"[['Xiu-ying', '', 'Pu'], ['Jian-ping', '', 'Liang'], ['Xue-hong', '', 'Wang'], ['Tao', '', 'Xu'], ['Lan-ying', '', 'Hua'], ['Ruo-feng', '', 'Shang'], ['Yu', '', 'Liu'], ['Yan-mei', '', 'Xing']]",Virologica Sinica,2009,"[u'http://www.springerlink.com/index/f6652mq1k78x4023.pdf', u'http://www.springerlink.com/content/f6652mq1k78x4023', u'http://www.springerlink.com/index/10.1007/s12250-009-2983-x', u'http://www.springerlink.com/index/pdf/10.1007/s12250-009-2983-x']",./output/11215168.pdf/citedby/10.1007~s12250-009-2983-x
10.1016/S0166-3542(97)00065-X,"Leneva, I., Russell, R., Boriskin, Y., et. al, Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.10.009,Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol,"[['Irina', 'A.', 'Leneva'], ['Rupert', 'J.', 'Russell'], ['Yury', 'S.', 'Boriskin'], ['Alan', 'J.', 'Hay']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208004312', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208004312']",
10.1016/S0166-3542(97)00065-X,"Wyde, P., , Chemotherapy of respiratory viruses: prospects and challenges, Drug Resistance Updates, 1999",cited-by,10.1054/drup.1999.0091,Chemotherapy of respiratory viruses: prospects and challenges,"[['Philip', 'R.', 'Wyde']]",Drug Resistance Updates,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1368764699900912', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764699900912']",
10.1016/S0166-3542(97)00065-X,"Sauerbrei, A., Haertl, A., Brandstaedt, A., et. al, Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors, Medical Microbiology and Immunology, 2006",cited-by,10.1007/s00430-005-0002-x,Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors,"[['A.', '', 'Sauerbrei'], ['A.', '', 'Haertl'], ['A.', '', 'Brandstaedt'], ['M.', '', 'Schmidtke'], ['P.', '', 'Wutzler']]",Medical Microbiology and Immunology,2006,"[u'http://www.springerlink.com/content/m37932425096l606', u'http://www.springerlink.com/index/m37932425096l606.pdf', u'http://www.springerlink.com/index/10.1007/s00430-005-0002-x', u'http://www.springerlink.com/index/pdf/10.1007/s00430-005-0002-x']",./output/11215168.pdf/citedby/10.1007~s00430-005-0002-x
10.1016/S0166-3542(97)00065-X,"Yokozawa, T., Sekiya, M., Cho, E., et. al, Effect of Wen-Pi-Tang extract on lung damage by influenza virus infection, Phytomedicine, 2004",cited-by,10.1016/j.phymed.2003.05.006,Effect of Wen-Pi-Tang extract on lung damage by influenza virus infection,"[['T.', '', 'Yokozawa'], ['M.', '', 'Sekiya'], ['E.', 'J.', 'Cho'], ['M.', '', 'Kurokawa'], ['K.', '', 'Shiraki']]",Phytomedicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0944711304000315', u'http://linkinghub.elsevier.com/retrieve/pii/S0944711304000315']",
10.1016/S0166-3542(97)00065-X,"Huang, H., Li, H., Zhou, P., et. al, Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice, Cytokine, 2010",cited-by,10.1016/j.cyto.2010.04.001,Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice,"[['Hai', '', 'Huang'], ['Hong', '', 'Li'], ['Pei', '', 'Zhou'], ['Dianwen', '', 'Ju']]",Cytokine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1043466610000967', u'http://linkinghub.elsevier.com/retrieve/pii/S1043466610000967']",
10.1016/S0166-3542(97)00065-X,"Oxford, J., , Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza, Influenza and Other Respiratory Viruses, 2007",cited-by,10.1111/j.1750-2659.2006.00006.x,Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza,"[['John', 'S.', 'Oxford']]",Influenza and Other Respiratory Viruses,2007,[u'http://doi.wiley.com/10.1111/j.1750-2659.2006.00006.x'],./output/11215168.pdf/citedby/10.1111~j.1750-2659.2006.00006.x
10.1016/S0166-3542(97)00065-X,"Lu, F., Tseng, S., Li, M., et. al, In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid, Archives of Virology, 2002",cited-by,10.1007/s705-002-8319-5,In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid,"[['F.-J.', '', 'Lu'], ['S.-N.', '', 'Tseng'], ['M.-L.', '', 'Li'], ['S.-R.', '', 'Shih']]",Archives of Virology,2002,"[u'http://www.springerlink.com/content/ajvvqnn6jcjmg9bc', u'http://www.springerlink.com/index/ajvvqnn6jcjmg9bc.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s705-002-8319-5', u'http://www.springerlink.com/index/pdf/10.1007/s705-002-8319-5']",./output/11215168.pdf/citedby/10.1007~s705-002-8319-5
10.1016/S0166-3542(97)00065-X,"Sidwell, R., , A consideration of animal models used for study of influenza virus inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00388-0,A consideration of animal models used for study of influenza virus inhibitors,"[['Robert', 'W', 'Sidwell']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003880', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003880']",
10.1016/S0166-3542(97)00065-X,"Khare, M., Sharland, M., , Influenza, Expert Opinion on Pharmacotherapy, 2000",cited-by,10.1517/14656566.1.3.367,Influenza,"[['Milind', 'D', 'Khare'], ['Mike', '', 'Sharland']]",Expert Opinion on Pharmacotherapy,2000,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.1.3.367'],./output/11215168.pdf/citedby/10.1517~14656566.1.3.367
10.1016/S0166-3542(97)00065-X,"Welliver, R., Monto, A., Carewicz, O., , Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in, , 2010",cited-by,13851601Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,"[['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz']]",,2010,[u'http://jama.ama-assn.org/cgi/reprint/285/6/748.pdf'],./output/11215168.pdf/citedby/13851601Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in
10.1016/S0166-3542(97)00065-X,"Leibbrandt, A., Meier, C., König-Schuster, M., et. al, Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection, PLOS One, 2010",cited-by,10.1371/journal.pone.0014320,Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection,"[['Andreas', '', 'Leibbrandt'], ['Christiane', '', 'Meier'], ['Marielle', '', 'K\xc3\xb6nig-Schuster'], ['Regina', '', 'Weinm\xc3\xbcllner'], ['Donata', '', 'Kalthoff'], ['Bettina', '', 'Pflugfelder'], ['Philipp', '', 'Graf'], ['Britta', '', 'Frank-Gehrke'], ['Martin', '', 'Beer'], ['Tamas', '', 'Fazekas'], ['Hermann', '', 'Unger'], ['Eva', '', 'Prieschl-Grassauer'], ['Andreas', '', 'Grassauer'], ['Man-Seong', '', 'Park']]",PLOS One,2010,"[u'http://adsabs.harvard.edu/abs/2010PLoSO...514320L', u'http://dx.doi.org/10.1371/journal.pone.0014320']",./output/11215168.pdf/citedby/10.1371~journal.pone.0014320
10.1016/S0166-3542(97)00065-X,"Whitley, R., , The role of oseltamivir in the treatment and prevention of influenza in children, Expert Opinion on Drug Metabolism & Toxicology, 2007",cited-by,10.1517/17425255.3.5.755,The role of oseltamivir in the treatment and prevention of influenza in children,"[['Richard', 'J', 'Whitley']]",Expert Opinion on Drug Metabolism & Toxicology,2007,[u'http://informahealthcare.com/doi/abs/10.1517/17425255.3.5.755'],./output/11215168.pdf/citedby/10.1517~17425255.3.5.755
10.1016/S0166-3542(97)00065-X,"Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737'],
10.1016/S0166-3542(97)00065-X,"Lipatov, A., Govorkova, E., Webby, R., et. al, MINIREVIEW Influenza: Emergence and Control, , 2004",cited-by,12108822MINIREVIEW Influenza: Emergence and Control,MINIREVIEW Influenza: Emergence and Control,"[['Aleksandr', 'S.', 'Lipatov'], ['Elena', 'A.', 'Govorkova'], ['Richard', 'J.', 'Webby'], ['Hiroichi', '', 'Ozaki'], ['Malik', '', 'Peiris'], ['Yi', '', 'Guan'], ['Leo', '', 'Poon'], ['Robert', 'G.', 'Webster']]",,2004,"[u'http://jvi.highwire.org/cgi/reprint/78/17/8951.pdf', u'http://jvi.asm.org/cgi/reprint/78/17/8951.pdf']",./output/11215168.pdf/citedby/12108822MINIREVIEW Influenza: Emergence and Control
10.1016/S0166-3542(97)00065-X,"Munoz, F., , Antiviral agents in the critically ill child, Seminars in Pediatric Infectious Diseases, 2000",cited-by,10.1053/spid.0110035,Antiviral agents in the critically ill child,"[['Flor', 'M.', 'Munoz']]",Seminars in Pediatric Infectious Diseases,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1045187000700239', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187000700239']",./output/11215168.pdf/citedby/10.1053~spid.0110035
10.1016/S0166-3542(97)00065-X,"Massarella, J., He, G., Dorr, A., et. al, The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers, Journal of Clinical Pharmacology, 2000",cited-by,10.1177/009127000004000804,The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers,"[['Joseph', 'W.', 'Massarella'], ['George', 'Z.', 'He'], ['Albert', '', 'Dorr'], ['Keith', '', 'Nieforth'], ['Penelope', '', 'Ward'], ['Andy', '', 'Brown']]",Journal of Clinical Pharmacology,2000,[u'http://dx.doi.org/10.1177/009127000004000804'],
10.1016/S0166-3542(97)00065-X,"Dowle, M., Howes, P., , Recent advances in sialidase inhibitors, Expert Opinion on Therapeutic Patents, 1998",cited-by,10.1517/13543776.8.11.1461,Recent advances in sialidase inhibitors,"[['Michael', 'D', 'Dowle'], ['Peter', 'D', 'Howes']]",Expert Opinion on Therapeutic Patents,1998,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.8.11.1461'],./output/11215168.pdf/citedby/10.1517~13543776.8.11.1461
11215168.pdf,"Smith, F. I., and P. Palese. 1989. Variation in influenza virus genes—Epidemiological, pathogenic, and evolutionary consequences, p. 319–359. In R. M. Krug, (ed.), The influenza viruses. Plenum, New York, N.Y.",references,NOT found in MAS
11215168.pdf,"Stella, V. J., W. N. A. Charman, and V. H. Naringrekar. 1985. Prodrugs: do they have advantages in clinical practice? Drugs 29:455–473. 30a.Sweeny, D., et al. Unpublished results.",references,10.2165/00003495-198529050-00002,Prodrugs: Do They Have Advantages in Clinical Practice?,"[[u'V.', u'J.', u'Stella'], [u'W.', u'N. A.', u'Charman'], [u'V.', u'H.', u'Naringrekar']]",Drugs,1985,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-198529050-00002'],
10.2165/00003495-198529050-00002,"Greenwald, R., Choe, Y., McGuire, J., et. al, Effective drug delivery by PEGylated drug conjugates, Advanced Drug Delivery Reviews, 2003",cited-by,10.1016/S0169-409X(02)00180-1,Effective drug delivery by PEGylated drug conjugates,"[['Richard', 'B.', 'Greenwald'], ['Yun', 'H.', 'Choe'], ['Jeffrey', '', 'McGuire'], ['Charles', 'D.', 'Conover']]",Advanced Drug Delivery Reviews,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X02001801', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X02001801']",
10.2165/00003495-198529050-00002,"Greenwald, R., , PEG drugs: an overview, Journal of Controlled Release, 2001",cited-by,10.1016/S0168-3659(01)00331-5,PEG drugs: an overview,"[['R.', 'B', 'Greenwald']]",Journal of Controlled Release,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168365901003315', u'http://linkinghub.elsevier.com/retrieve/pii/S0168365901003315']",
10.2165/00003495-198529050-00002,"Han, H., Amidon, G., , Targeted prodrug design to optimize drug delivery, Aaps Journal, 2000",cited-by,10.1208/ps020106,Targeted prodrug design to optimize drug delivery,"[['Hyo-Kyung', '', 'Han'], ['Gordon', 'L.', 'Amidon']]",Aaps Journal,2000,"[u'http://www.springerlink.com/content/2261kx4t4m424uw2', u'http://www.springerlink.com/index/10.1208/ps020106']",./output/11215168.pdf/citedby/10.1208~ps020106
10.2165/00003495-198529050-00002,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.2165/00003495-198529050-00002,"Conover, C., Greenwald, R., Pendri, A., et. al, Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker, Cancer Chemotherapy and Pharmacology, 1998",cited-by,10.1007/s002800050837,Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker,"[['Charles', 'D.', 'Conover'], ['Richard', 'B.', 'Greenwald'], ['Annapurna', '', 'Pendri'], ['Carl', 'W.', 'Gilbert'], ['Kwok', 'L.', 'Shum']]",Cancer Chemotherapy and Pharmacology,1998,"[u'http://www.springerlink.com/content/pvry4chqatj1uvhh', u'http://www.springerlink.com/index/pvry4chqatj1uvhh.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s002800050837', u'http://www.springerlink.com/index/pdf/10.1007/s002800050837']",./output/11215168.pdf/citedby/10.1007~s002800050837
10.2165/00003495-198529050-00002,"Kumpulainen, H., Heimbach, T., Oliyai, R., et. al, Prodrugs: design and clinical applications, Nature Reviews Drug Discovery, 2008",cited-by,10.1038/nrd2468,Prodrugs: design and clinical applications,"[['Hanna', '', 'Kumpulainen'], ['Tycho', '', 'Heimbach'], ['Reza', '', 'Oliyai'], ['Dooman', '', 'Oh'], ['Tomi', '', 'J\xc3\xa4rvinen'], ['Jouko', '', 'Savolainen'], ['Jarkko', '', 'Rautio']]",Nature Reviews Drug Discovery,2008,"[u'http://www.nature.com/doifinder/10.1038/nrd2468', u'http://dx.doi.org/10.1038/nrd2468']",./output/11215168.pdf/citedby/10.1038~nrd2468
10.2165/00003495-198529050-00002,"Habgood, M., Begley, D., Abbott, N., , Determinants of Passive Drug Entry into the Central Nervous System, Cellular and Molecular Neurobiology, 2000",cited-by,10.1023/A:1007001923498,Determinants of Passive Drug Entry into the Central Nervous System,"[['M.', 'D.', 'Habgood'], ['D.', 'J.', 'Begley'], ['N.', 'J.', 'Abbott']]",Cellular and Molecular Neurobiology,2000,"[u'http://www.springerlink.com/content/x2hl33w45q142j42', u'http://www.springerlink.com/index/x2hl33w45q142j42.pdf']",./output/11215168.pdf/citedby/10.1023~A:1007001923498
10.2165/00003495-198529050-00002,"Pauletti, G., Gangwar, S., Siahaan, T., et. al, Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies, Advanced Drug Delivery Reviews, 1997",cited-by,10.1016/S0169-409X(97)00045-8,Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies,"[['Giovanni', 'M.', 'Pauletti'], ['Sanjeev', '', 'Gangwar'], ['Teruna', 'J.', 'Siahaan'], ['Jeffrey', '', 'Aub\xc3\xa9'], ['Ronald', 'T.', 'Borchardt']]",Advanced Drug Delivery Reviews,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X97000458', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X97000458']",
10.2165/00003495-198529050-00002,"Liederer, B., Borchardt, R., , Enzymes involved in the bioconversion of ester-based prodrugs, Journal of Pharmaceutical Sciences, 2006",cited-by,10.1002/jps.20542,Enzymes involved in the bioconversion of ester-based prodrugs,"[['Bianca', 'M.', 'Liederer'], ['Ronald', 'T.', 'Borchardt']]",Journal of Pharmaceutical Sciences,2006,[u'http://doi.wiley.com/10.1002/jps.20542'],./output/11215168.pdf/citedby/10.1002~jps.20542
10.2165/00003495-198529050-00002,"Testa, B., , Prodrug research: futile or fertile?, Biochemical Pharmacology, 2004",cited-by,10.1016/j.bcp.2004.07.005,Prodrug research: futile or fertile?,"[['Bernard', '', 'Testa']]",Biochemical Pharmacology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0006295204004745', u'http://linkinghub.elsevier.com/retrieve/pii/S0006295204004745']",
10.2165/00003495-198529050-00002,"Sinhababu, A., Thakker, D., , Prodrugs of anticancer agents, Advanced Drug Delivery Reviews, 1996",cited-by,10.1016/0169-409X(95)00109-K,Prodrugs of anticancer agents,"[['Achintya', 'K.', 'Sinhababu'], ['Dhiren', 'R.', 'Thakker']]",Advanced Drug Delivery Reviews,1996,"[u'http://www.sciencedirect.com/science/article/pii/0169409X9500109K', u'http://linkinghub.elsevier.com/retrieve/pii/0169409X9500109K']",
10.2165/00003495-198529050-00002,"Banaszczyk, M., Carlo, A., Millan, V., et. al, Propofol Phosphate, a Water-Soluble Propofol Prodrug:In Vivo Evaluation, Anesthesia and Analgesia, 2002",cited-by,10.1097/00000539-200211000-00034,"Propofol Phosphate, a Water-Soluble Propofol Prodrug:In Vivo Evaluation","[['Mariusz', 'G.', 'Banaszczyk'], ['Alison', 'T.', 'Carlo'], ['Violeta', '', 'Millan'], ['Adam', '', 'Lindsey'], ['Ronald', '', 'Moss'], ['Dennis', 'J.', 'Carlo'], ['Sheldon', 'S.', 'Hendler']]",Anesthesia and Analgesia,2002,"[u'http://www.anesthesia-analgesia.org/cgi/reprint/95/5/1285.pdf', u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00000539-200211000-00034']",./output/11215168.pdf/citedby/10.1097~00000539-200211000-00034
10.2165/00003495-198529050-00002,"Prokai, L., Prokai-Tatrai, K., Perjési, P., et. al, Mechanistic insights into the direct antioxidant effects of estrogens, Drug Development Research, 2005",cited-by,10.1002/ddr.20050,Mechanistic insights into the direct antioxidant effects of estrogens,"[['Laszlo', '', 'Prokai'], ['Katalin', '', 'Prokai-Tatrai'], ['P\xc3\xa1l', '', 'Perj\xc3\xa9si'], ['James', 'W.', 'Simpkins']]",Drug Development Research,2005,[u'http://doi.wiley.com/10.1002/ddr.20050'],./output/11215168.pdf/citedby/10.1002~ddr.20050
10.2165/00003495-198529050-00002,"Niemi, R., Turhanen, P., Vepsäläinen, J., et. al, Bisphosphonate prodrugs: synthesis and in vitro evaluation of alkyl and acyloxymethyl esters of etidronic acid as bioreversible prodrugs of etidronate, European Journal of Pharmaceutical Sciences, 2000",cited-by,10.1016/S0928-0987(00)00099-3,Bisphosphonate prodrugs: synthesis and in vitro evaluation of alkyl and acyloxymethyl esters of etidronic acid as bioreversible prodrugs of etidronate,"[['Riku', '', 'Niemi'], ['Petri', '', 'Turhanen'], ['Jouko', '', 'Veps\xc3\xa4l\xc3\xa4inen'], ['Hannu', '', 'Taipale'], ['Tomi', '', 'J\xc3\xa4rvinen']]",European Journal of Pharmaceutical Sciences,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0928098700000993', u'http://linkinghub.elsevier.com/retrieve/pii/S0928098700000993']",
10.2165/00003495-198529050-00002,"Hamel, A., Hubler, F., Carrupt, A., et. al, Cyclosporin A prodrugs: design, synthesis and biophysical properties: Cyclosporin A prodrugs, Journal of Peptide Research, 2008",cited-by,10.1111/j.1399-3011.2003.00111.x,"Cyclosporin A prodrugs: design, synthesis and biophysical properties: Cyclosporin A prodrugs","[['A.', 'R.', 'Hamel'], ['F.', '', 'Hubler'], ['A.', '', 'Carrupt'], ['R.', 'M.', 'Wenger'], ['M.', '', 'Mutter']]",Journal of Peptide Research,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1399-3011.2003.00111.x'],
10.2165/00003495-198529050-00002,"Navath, R., Wang, B., Kannan, S., et. al, Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation, Journal of Controlled Release, 2010",cited-by,10.1016/j.jconrel.2009.10.035,Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation,"[['Raghavendra', 'S.', 'Navath'], ['Bing', '', 'Wang'], ['Sujatha', '', 'Kannan'], ['Roberto', '', 'Romero'], ['Rangaramanujam', 'M.', 'Kannan']]",Journal of Controlled Release,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0168365909007494', u'http://linkinghub.elsevier.com/retrieve/pii/S0168365909007494']",
10.2165/00003495-198529050-00002,"Rautio, J., Laine, K., Gynther, M., et. al, Prodrug Approaches for CNS Delivery, Aaps Journal, 2008",cited-by,10.1208/s12248-008-9009-8,Prodrug Approaches for CNS Delivery,"[['Jarkko', '', 'Rautio'], ['Krista', '', 'Laine'], ['Mikko', '', 'Gynther'], ['Jouko', '', 'Savolainen']]",Aaps Journal,2008,"[u'http://www.springerlink.com/index/0914070017703569.pdf', u'http://www.springerlink.com/content/0914070017703569', u'http://www.springerlink.com/index/10.1208/s12248-008-9009-8']",./output/11215168.pdf/citedby/10.1208~s12248-008-9009-8
10.2165/00003495-198529050-00002,"Wang, N., Liu, B., Wu, Q., et. al, Regioselective Enzymatic Synthesis of Non-Steroidal Anti-Inflammatory Drugs Containing Glucose in Organic Media, Biotechnology Letters, 2005",cited-by,10.1007/s10529-005-5799-2,Regioselective Enzymatic Synthesis of Non-Steroidal Anti-Inflammatory Drugs Containing Glucose in Organic Media,"[['Na', '', 'Wang'], ['Bo', 'Kai', 'Liu'], ['Qi', '', 'Wu'], ['Jun', 'Liang', 'Wang'], ['Xian', 'Fu', 'Lin']]",Biotechnology Letters,2005,"[u'http://www.springerlink.com/content/q65113566204407p', u'http://www.springerlink.com/index/10.1007/s10529-005-5799-2', u'http://www.springerlink.com/index/pdf/10.1007/s10529-005-5799-2']",./output/11215168.pdf/citedby/10.1007~s10529-005-5799-2
10.2165/00003495-198529050-00002,"Balant, L., Doelker, E., Buri, P., , Prodrugs for the improvement of drug absorption via different routes of administration, European Journal of Drug Metabolism and Pharmacokinetics, 1990",cited-by,10.1007/BF03190197,Prodrugs for the improvement of drug absorption via different routes of administration,"[['L.', 'P.', 'Balant'], ['E.', '', 'Doelker'], ['P.', '', 'Buri']]",European Journal of Drug Metabolism and Pharmacokinetics,1990,"[u'http://www.springerlink.com/index/m1150qn01625pm31.pdf', u'http://www.springerlink.com/content/m1150qn01625pm31', u'http://www.springerlink.com/index/10.1007/BF03190197', u'http://www.springerlink.com/index/pdf/10.1007/BF03190197']",./output/11215168.pdf/citedby/10.1007~BF03190197
10.2165/00003495-198529050-00002,"Yang, C., Mitra, A., , Nasal absorption of tyrosine-linked model compounds, Journal of Pharmaceutical Sciences, 2001",cited-by,10.1002/1520-6017(200103)90:3<340::AID-JPS9>3.0.CO;2-F,Nasal absorption of tyrosine-linked model compounds,"[['Chun', '', 'Yang'], ['Ashim', 'K.', 'Mitra']]",Journal of Pharmaceutical Sciences,2001,[u'http://doi.wiley.com/10.1002/1520-6017%28200103%2990%3A3%3C340%3A%3AAID-JPS9%3E3.0.CO%3B2-F'],
10.2165/00003495-198529050-00002,"Hamel, A., Hubler, F., Mutter, M., , Water-soluble prodrugs of cyclosporine A with tailored conversion rates, Journal of Peptide Research, 2005",cited-by,10.1111/j.1399-3011.2005.00234.x,Water-soluble prodrugs of cyclosporine A with tailored conversion rates,"[['A.', 'R.', 'Hamel'], ['F.', '', 'Hubler'], ['M.', '', 'Mutter']]",Journal of Peptide Research,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1399-3011.2005.00234.x'],./output/11215168.pdf/citedby/10.1111~j.1399-3011.2005.00234.x
10.2165/00003495-198529050-00002,"Pezron, I., Mitra, A., Duvvuri, S., et. al, Prodrug strategies in nasal drug delivery, Expert Opinion on Therapeutic Patents, 2002",cited-by,10.1517/13543776.12.3.331,Prodrug strategies in nasal drug delivery,"[['Isabelle', '', 'Pezron'], ['Ashim', 'K', 'Mitra'], ['Sridhar', '', 'Duvvuri'], ['Giridhar', 'S', 'Tirucherai']]",Expert Opinion on Therapeutic Patents,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.12.3.331'],./output/11215168.pdf/citedby/10.1517~13543776.12.3.331
10.2165/00003495-198529050-00002,"Pires, A., Rothman, J., Santos, A., , L1 acquisition across Portuguese dialects: Modular and interdisciplinary interfaces as sources of explanation, Lingua, 2011",cited-by,10.1016/j.lingua.2010.06.002,L1 acquisition across Portuguese dialects: Modular and interdisciplinary interfaces as sources of explanation,"[['Acrisio', '', 'Pires'], ['Jason', '', 'Rothman'], ['Ana', 'L\xc3\xbacia', 'Santos']]",Lingua,2011,[u'http://www.sciencedirect.com/science/article/pii/S0024384110001622'],
10.2165/00003495-198529050-00002,"Downey, A., Castagnoli, N., Gandour, R., et. al, Synthesis and MAO Activity of a Series of Benzimidazolyl and Indazolyl Prodrugs, , 2006",cited-by,4898812Synthesis and MAO Activity of a Series of Benzimidazolyl and Indazolyl Prodrugs,Synthesis and MAO Activity of a Series of Benzimidazolyl and Indazolyl Prodrugs,"[['Aaron', 'L.', 'Downey'], ['Neal', '', 'Castagnoli'], ['Richard', 'D.', 'Gandour'], ['James', 'M.', 'Tanko']]",,2006,[u'http://scholar.lib.vt.edu/theses/available/etd-11062006-094848/unrestricted/AaronDowneythesis2.pdf'],./output/11215168.pdf/citedby/4898812Synthesis and MAO Activity of a Series of Benzimidazolyl and Indazolyl Prodrugs
10.2165/00003495-198529050-00002,"Zhu, J., Arnoldussen, T., , Side writing phenomena in narrow track recording, , 1992",cited-by,10.1109/INTMAG.1992.696437,Side writing phenomena in narrow track recording,"[['Jian-Gang', '', 'Zhu'], ['T.', 'C.', 'Arnoldussen']]",,1992,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=696437'],./output/11215168.pdf/citedby/10.1109~INTMAG.1992.696437
10.2165/00003495-198529050-00002,"Barbour, N., Lipper, R., , Introduction to Biopharmaceutics and its Role in Drug Development, , 0",cited-by,10.1007/978-0-387-72379-2_1,Introduction to Biopharmaceutics and its Role in Drug Development,"[['Nancy', 'P.', 'Barbour'], ['Robert', 'A.', 'Lipper']]",,0,"[u'http://www.springerlink.com/index/n70qt133k4844514.pdf', u'http://www.springerlink.com/content/n70qt133k4844514']",./output/11215168.pdf/citedby/10.1007~978-0-387-72379-2_1
11215168.pdf,"Taylor, G. 1990. The absorption and metabolism of xenobiotics in the lung. Adv. Drug Delivery Rev. 5:37–61.",references,10.1016/0169-409X(90)90006-E,The absorption and metabolism of xenobiotics in the lung,"[[u'G', u'', u'TAYLOR']]",Advanced Drug Delivery Reviews,1990,[u'http://linkinghub.elsevier.com/retrieve/pii/0169409X9090006E'],
10.1016/0169-409X(90)90006-E,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],
10.1016/0169-409X(90)90006-E,"Forbes, B., , Human airway epithelial cell lines for in vitro drug transport and metabolism studies, Pharmaceutical Science & Technology Today, 2000",cited-by,10.1016/S1461-5347(99)00231-X,Human airway epithelial cell lines for in vitro drug transport and metabolism studies,"[['Ben', '', 'Forbes']]",Pharmaceutical Science & Technology Today,2000,"[u'http://www.sciencedirect.com/science/article/pii/S146153479900231X', u'http://linkinghub.elsevier.com/retrieve/pii/S146153479900231X']",
10.1016/0169-409X(90)90006-E,"Steimer, A., Haltner, E., Lehr, C., , Cell Culture Models of the Respiratory Tract Relevant to Pulmonary Drug Delivery, Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung, 2005",cited-by,10.1089/jam.2005.18.137,Cell Culture Models of the Respiratory Tract Relevant to Pulmonary Drug Delivery,"[['A.', '', 'Steimer'], ['E.', '', 'Haltner'], ['C.-M', '', 'Lehr']]",Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung,2005,[u'http://www.liebertonline.com/doi/abs/10.1089/jam.2005.18.137'],./output/11215168.pdf/citedby/10.1089~jam.2005.18.137
10.1016/0169-409X(90)90006-E,"Gonda, I., , Systemic Delivery of Drugs to Humans via Inhalation, Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung, 2006",cited-by,10.1089/jam.2006.19.47,Systemic Delivery of Drugs to Humans via Inhalation,"[['Igor', '', 'Gonda']]",Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung,2006,[u'http://www.liebertonline.com/doi/abs/10.1089/jam.2006.19.47'],./output/11215168.pdf/citedby/10.1089~jam.2006.19.47
10.1016/0169-409X(90)90006-E,"Mathias, N., Yamashita, F., Lee, V., , Respiratory epithelial cell culture models for evaluation of ion and drug transport, Advanced Drug Delivery Reviews, 1996",cited-by,10.1016/S0169-409X(96)00420-6,Respiratory epithelial cell culture models for evaluation of ion and drug transport,"[['Neil', 'R.', 'Mathias'], ['Fumiyoshi', '', 'Yamashita'], ['Vincent', 'H. L.', 'Lee']]",Advanced Drug Delivery Reviews,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X96004206', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X96004206']",
10.1016/0169-409X(90)90006-E,"Mathias, N., Hussain, M., , Non-invasive systemic drug delivery: Developability considerations for alternate routes of administration, Journal of Pharmaceutical Sciences, 2010",cited-by,10.1002/jps.21793,Non-invasive systemic drug delivery: Developability considerations for alternate routes of administration,"[['Neil', 'R.', 'Mathias'], ['Munir', 'A.', 'Hussain']]",Journal of Pharmaceutical Sciences,2010,[u'http://doi.wiley.com/10.1002/jps.21793'],./output/11215168.pdf/citedby/10.1002~jps.21793
10.1016/0169-409X(90)90006-E,"Salem, L., Bosquillon, C., Dailey, L., et. al, Sparing methylation of β-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro, Journal of Controlled Release, 2009",cited-by,10.1016/j.jconrel.2009.01.019,Sparing methylation of β-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro,"[['L.', 'Belhadj', 'Salem'], ['C.', '', 'Bosquillon'], ['L.', 'A.', 'Dailey'], ['L.', '', 'Delattre'], ['G.', 'P.', 'Martin'], ['B.', '', 'Evrard'], ['B.', '', 'Forbes']]",Journal of Controlled Release,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0168365909000583', u'http://linkinghub.elsevier.com/retrieve/pii/S0168365909000583']",
10.1016/0169-409X(90)90006-E,"He, L., Gao, Y., Lin, Y., et. al, Improvement of pulmonary absorption of insulin and other water-soluble compounds by polyamines in rats, Journal of Controlled Release, 2007",cited-by,10.1016/j.jconrel.2007.06.017,Improvement of pulmonary absorption of insulin and other water-soluble compounds by polyamines in rats,"[['Lin', '', 'He'], ['Yang', '', 'Gao'], ['Yulian', '', 'Lin'], ['Hidemasa', '', 'Katsumi'], ['Takuya', '', 'Fujita'], ['Akira', '', 'Yamamoto']]",Journal of Controlled Release,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0168365907003045', u'http://linkinghub.elsevier.com/retrieve/pii/S0168365907003045']",
10.1016/0169-409X(90)90006-E,"Koizumi, F., Murakami, M., Kageyama, H., et. al, Smoking accelerates absorption of inhaled neutrophil elastase inhibitor FK706, Clinical Pharmacology & Therapeutics, 1999",cited-by,10.1016/S0009-9236(99)70013-5,Smoking accelerates absorption of inhaled neutrophil elastase inhibitor FK706,"[['Fumiaki', '', 'Koizumi'], ['Manabu', '', 'Murakami'], ['Hiromitsu', '', 'Kageyama'], ['Masataka', '', 'Katashima'], ['Masato', '', 'Terakawa'], ['Akihiro', '', 'Ohnishi']]",Clinical Pharmacology & Therapeutics,1999,"[u'http://dx.doi.org/10.1016/S0009-9236(99)70013-5', u'http://www.nature.com/clpt/index.html']",./output/11215168.pdf/citedby/10.1016~S0009-9236(99)70013-5
10.1016/0169-409X(90)90006-E,"Tronde, A., Bosquillon, C., Forbes, B., , The Isolated Perfused Lung for Drug Absorption Studies, , 0",cited-by,10.1007/978-0-387-74901-3_6,The Isolated Perfused Lung for Drug Absorption Studies,"[['Ann', '', 'Tronde'], ['Cynthia', '', 'Bosquillon'], ['Ben', '', 'Forbes']]",,0,"[u'http://www.springerlink.com/content/p803557u25886pr7', u'http://www.springerlink.com/index/p803557u25886pr7.pdf']",./output/11215168.pdf/citedby/10.1007~978-0-387-74901-3_6
10.1016/0169-409X(90)90006-E,"Alshawawreh, J., Houli, N., Smith, J., et. al, SHA 028. Harmonic scalpel harvesting of conduits in coronary artery bypass surgery (CABGS), Journal of The Saudi Heart Association, 2011",cited-by,10.1016/j.jsha.2011.02.029,SHA 028. Harmonic scalpel harvesting of conduits in coronary artery bypass surgery (CABGS),"[['Jaser', '', 'Alshawawreh'], ['N.', '', 'Houli'], ['J.', '', 'Smith'], ['G.', '', 'Shardy'], ['J.', '', 'Goldstein'], ['A.', '', 'Almeida']]",Journal of The Saudi Heart Association,2011,[u'http://www.sciencedirect.com/science/article/pii/S1016731511000418'],
10.1016/0169-409X(90)90006-E,"Hollinger, M., , Drug-Induced Lung Toxicity, International Journal of Toxicology, 1993",cited-by,10.3109/10915819309140620,Drug-Induced Lung Toxicity,"[['Mannfred', 'A.', 'Hollinger']]",International Journal of Toxicology,1993,"[u'http://dx.doi.org/10.3109/10915819309140620', u'http://ijt.sagepub.com/cgi/doi/10.3109/10915819309140620']",./output/11215168.pdf/citedby/10.3109~10915819309140620
11215168.pdf,"von Itzstein, M., W.-Y. Wu, G. B. Kok, M. S. Pegg, J. C. Cyason, B. Jin, T. V. Phan, M. L. Smythe, H. F. White, S. W. Oliver, P. M. Colman, J. N. Varghese, D. M. Ryan, J. M. Woods, R. C. Bethell, V. J. Hotham, J. M. Cameron, and C. R. Penn. 1993. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418–423.",references,NOT found in MAS
11215168.pdf,"von Itzstein, M., M. Wan Yang, and B. Jin. 1994. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. Carbohydrate Res. 259:301–305.",references,10.1016/0008-6215(94)84065-2,"The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor","[[u'Mark', u'von', u'Itzstein'], [u'Wen-Yang', u'', u'Wu'], [u'Betty', u'', u'Jin']]",Carbohydrate Research,1994,[u'http://linkinghub.elsevier.com/retrieve/pii/0008621594840652'],
10.1016/0008-6215(94)84065-2,"Asano, N., , Glycosidase inhibitors: update and perspectives on practical use, Glycobiology, 2003",cited-by,10.1093/glycob/cwg090,Glycosidase inhibitors: update and perspectives on practical use,"[['Naoki', '', 'Asano']]",Glycobiology,2003,"[u'http://glycob.oxfordjournals.org/cgi/reprint/cwg090v1.pdf', u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/cwg090']",./output/11215168.pdf/citedby/10.1093~glycob~cwg090
10.1016/0008-6215(94)84065-2,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/11215168.pdf/citedby/7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
10.1016/0008-6215(94)84065-2,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf'],./output/11215168.pdf/citedby/11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071
10.1016/0008-6215(94)84065-2,"Itzstein, M., , The war against influenza: discovery and development of sialidase inhibitors, Nature Reviews Drug Discovery, 2007",cited-by,10.1038/nrd2400,The war against influenza: discovery and development of sialidase inhibitors,"[['Mark', 'von', 'Itzstein']]",Nature Reviews Drug Discovery,2007,"[u'http://dx.doi.org/10.1038/nrd2400', u'http://www.nature.com/doifinder/10.1038/nrd2400']",./output/11215168.pdf/citedby/10.1038~nrd2400
10.1016/0008-6215(94)84065-2,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/11215168.pdf/citedby/11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
10.1016/0008-6215(94)84065-2,"Hinek, A., Bodnaruk, T., Bunda, S., et. al, Neuraminidase1, a Subunit of the Cell Surface Elastin Receptor, Desialylates and Functionally Inactivates Adjacent Receptors Interacting with the Mitogenic Growth Factors PDGF-BB and IGF-2, American Journal of Pathology, 2008",cited-by,10.2353/ajpath.2008.071081,"Neuraminidase1, a Subunit of the Cell Surface Elastin Receptor, Desialylates and Functionally Inactivates Adjacent Receptors Interacting with the Mitogenic Growth Factors PDGF-BB and IGF-2","[['Aleksander', '', 'Hinek'], ['Tetyana', 'D.', 'Bodnaruk'], ['Severa', '', 'Bunda'], ['Yanting', '', 'Wang'], ['Kela', '', 'Liu']]",American Journal of Pathology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0002944010614940', u'http://ajp.amjpathol.org/cgi/doi/10.2353/ajpath.2008.071081']",
10.1016/0008-6215(94)84065-2,"Kok, G., Phan, T., Itzstein, M., , BROMOHYDROXYLATION OF GLYCALS—AN INVESTIGATION INTO THE REACTION OF SOME 4-N-ACYLATED DERIVATIVES OF METHYL 5ACETAMIDO7,8,9-TRI-O-ACETYL-2,6-ANHYDRO-3,4,5-TRIDEOXY-D-GLYCERO-D-GALACTO-NON-2-ENONATE AND ITS 4EPIMER, Journal of Carbohydrate Chemistry, 2001",cited-by,10.1081/CAR-100105710,"BROMOHYDROXYLATION OF GLYCALS—AN INVESTIGATION INTO THE REACTION OF SOME 4-N-ACYLATED DERIVATIVES OF METHYL 5ACETAMIDO7,8,9-TRI-O-ACETYL-2,6-ANHYDRO-3,4,5-TRIDEOXY-D-GLYCERO-D-GALACTO-NON-2-ENONATE AND ITS 4EPIMER","[['Gaik', 'B.', 'Kok'], ['Tho', 'van', 'Phan'], ['Mark', 'von', 'Itzstein']]",Journal of Carbohydrate Chemistry,2001,"[u'http://www.informaworld.com/openurl?genre=article&doi=10.1081/CAR-100105710&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3', u'http://dx.doi.org/10.1081/CAR-100105710']",./output/11215168.pdf/citedby/10.1081~CAR-100105710
10.1016/0008-6215(94)84065-2,"Meloni, D., Monaci, R., Rombi, E., et. al, Synthesis and characterization of MCM-22 zeolites for the N 2O oxidation of benzene to phenol, Studies in Surface Science and Catalysis, 2002",cited-by,10.1016/S0167-2991(02)80025-8,Synthesis and characterization of MCM-22 zeolites for the N 2O oxidation of benzene to phenol,"[['D.', '', 'Meloni'], ['R.', '', 'Monaci'], ['E.', '', 'Rombi'], ['C.', '', 'Guimon'], ['H.', '', 'Martinez'], ['I.', '', 'Fechete'], ['E.', '', 'Dumitriu']]",Studies in Surface Science and Catalysis,2002,[u'http://www.sciencedirect.com/science/article/pii/S0167299102800258'],
10.1016/0008-6215(94)84065-2,"Sate, T., Ohtake, F., Ohira, Y., et. al, Inhibition of 2,7-Dideoxy-7-fluoro-2,3-didehydrosialic Acid for Binding of Influenza Virus H1 Hemagglutinin to GM3, Chemistry Letters, 1999",cited-by,10.1246/cl.1999.145,"Inhibition of 2,7-Dideoxy-7-fluoro-2,3-didehydrosialic Acid for Binding of Influenza Virus H1 Hemagglutinin to GM3","[['Toshinori', '', 'Sate'], ['Fuyuka', '', 'Ohtake'], ['Yutaka', '', 'Ohira'], ['Yoshio', '', 'Okahata']]",Chemistry Letters,1999,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/cl/1999.145?from=CrossRef'],./output/11215168.pdf/citedby/10.1246~cl.1999.145
10.1016/0008-6215(94)84065-2,"Vavricka, C., Li, Q., Wu, Y., et. al, Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition, PLOS Pathogens, 2011",cited-by,10.1371/journal.ppat.1002249,Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition,"[['Christopher', 'J.', 'Vavricka'], ['Qing', '', 'Li'], ['Yan', '', 'Wu'], ['Jianxun', '', 'Qi'], ['Mingyang', '', 'Wang'], ['Yue', '', 'Liu'], ['Feng', '', 'Gao'], ['Jun', '', 'Liu'], ['Enguang', '', 'Feng'], ['Jianhua', '', 'He'], ['Jinfang', '', 'Wang'], ['Hong', '', 'Liu'], ['Hualiang', '', 'Jiang'], ['George', 'F.', 'Gao']]",PLOS Pathogens,2011,[u'http://dx.doi.org/10.1371/journal.ppat.1002249'],./output/11215168.pdf/citedby/10.1371~journal.ppat.1002249
10.1016/0008-6215(94)84065-2,"García, E., Brimble, M., Vogel, P., , Synthesis of New Aza-C-disaccharides Linking 4-Deoxy-4-amino-β-L-erythro-furanose to C-2 ofD-Glucose andD-Allose, European Journal of Organic Chemistry, 2006",cited-by,10.1002/ejoc.200600199,Synthesis of New Aza-C-disaccharides Linking 4-Deoxy-4-amino-β-L-erythro-furanose to C-2 ofD-Glucose andD-Allose,"[['Eliazar', 'Rodr\xc3\xadguez', 'Garc\xc3\xada'], ['Margaret', 'A.', 'Brimble'], ['Pierre', '', 'Vogel']]",European Journal of Organic Chemistry,2006,[u'http://doi.wiley.com/10.1002/ejoc.200600199'],./output/11215168.pdf/citedby/10.1002~ejoc.200600199
10.1016/0008-6215(94)84065-2,"Dawson, R., Alderton, M., Itzstein, M., et. al, Combatant Protection and Nutrition Branch Aeronautical and Maritime Research Laboratory, , 0",cited-by,10979682Combatant Protection and Nutrition Branch Aeronautical and Maritime Research Laboratory,Combatant Protection and Nutrition Branch Aeronautical and Maritime Research Laboratory,"[['Raymond', 'M.', 'Dawson'], ['Malcolm', 'R.', 'Alderton'], ['Mark', 'von', 'Itzstein'], ['Jeffrey', 'C.', 'Dyason'], ['Milica', '', 'Radovanovic']]",,0,[u'http://dspace.dsto.defence.gov.au/dspace/bitstream/1947/4218/1/DSTO-TR-0837%20PR.pdf'],./output/11215168.pdf/citedby/10979682Combatant Protection and Nutrition Branch Aeronautical and Maritime Research Laboratory
11215168.pdf,"Wood, N. D., M. Aitken, S. Sharp, and H. Evison. 1997. Tolerability and pharmacokinetics of the influenza neuraminidase inhibitor Ro 64-0802 (GS4071) following oral administration of the prodrug Ro 64-0796 (GS4104) to healthy male volunteers, abstr. A-123, p. 25. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.",references,NOT found in MAS
11215168.pdf,"Woods, J. M., R. C. Bethell, J. A. V. Coates, N. Healy, S. A. Hiscox, B. A. Pearson, D. M. Ryan, J. Ticehurst, J. Tilling, S. M. Walcott, and C. R. Penn. 1993. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37:1473–1479. VOL. 42, 1998 PRODRUG OF INFLUENZA VIRUS NEURAMINIDASE INHIBITOR 653 on September 2, by UNIVERSITY OF NEW SOUTH WALES http://aac.asm.org/ Downloaded from",references,NOT found in MAS
